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ABSTRACT 
There is increasing scientific understanding and growing public awareness of the 
influence of genetics on the development of cancer. It is known that up to ten percent of 
cancers are associated with a genetic predisposition. This study asks ‘How does the 
family history of cancer affect the care needs of palliative care patients?’ in this 
context. This question is addressed using the principles of phenomenology to explore 
the meaning of a family history of cancer for palliative care patients and nurses. Data 
was collected through recorded, semi-structured interviews with purposively sampled 
participants. The information obtained was analyzed using Miles and Huberman’s 
(1994) framework, where data is displayed, reduced, and conclusions drawn. Emergent 
themes were organized around Van Manen’s (1990) schema for existential reflection, 
which considers the relationship between phenomena and four universal themes: lived-
body, lived-relationship, lived-time and lived-space. Findings describe how the 
physical, social, emotional and cultural dimensions of care are modified when viewed 
through the genetic lens. Patients’ poor understanding of cancer and novice nursing 
practice (Benner 1984) were barriers to appropriately meeting the needs of this patient 
group. A new approach to the care of palliative patients with a family history of cancer 
is proposed.  
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CHAPTER ONE: THROUGH THE GENETIC LENS 
  If you want to change the world – take up your pen 
(Martin Luther King 1929-1968) 
 
Introduction to the Reasons for the Study 
      Individuals with a family history of cancer are more likely to have experienced the 
deaths of other family members from the same disease, develop cancer at a younger age 
than normal and to develop multiple primary cancers (Claus et al 1990, Ford et al 1998, 
Butterworth et al 2006). Unfortunately there is a dearth of research literature to guide 
nurses and other health care professionals about how the family history of cancer 
affects the care needs of the dying (Kneubel and Hudgings 2002, Lillie 2006). 
However, a series of clinical encounters that occurred whilst working as a hospital 
clinical nurse specialist in palliative care drew attention to the fact that patients were 
being affected by this new knowledge.  
       Two scenarios were particularly challenging. The first was a seventy year old 
woman with advanced metastatic breast cancer who was worried about the implications 
of her cancer for her daughters. Although she had been told by an oncologist that her 
illness did not imply an inherited susceptibility, the fact that both she and her mother 
had died/were dying from breast cancer meant that she required on-going reassurance 
about the potential ramifications of her disease for her adult daughters and 
granddaughters until she lost consciousness. The second scenario was the identical twin 
sister of a young dying woman who asked how long it would be until she too developed 
cancer and died. She and her sister were part of an ongoing twin study and she was 
aware that her shared genetic heritage might indicate that she had an increased risk of 
future disease. These encounters were an indication that the knowledge that cancer 
could be associated with an inherited genetic predisposition was affecting the way some 
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people perceived the cancer within their family. Reflection on these encounters 
developed into an interest into the care needs of patients with a family history of 
cancer. 
 
Introduction to the Context of the Study 
       It is now known that up to ten percent of cancers are related to an inherited genetic 
predisposition to cancer (Claus et al 1991, Collaborative Group on Hormonal Factors in 
Breast Cancer 2001, Risch 2001). New technological breakthroughs that were 
developed alongside the Human Genome Project mean that it is increasingly practical 
to identify the inherited genetic alterations that are associated with adult onset diseases 
like cancer (Bell 2004). Unfortunately the ability to identify the genetic alterations, 
which predispose individuals to cancer, has developed more rapidly than the ability to 
develop effective cancer prevention and control strategies (Sadler et al 2004). Hence 
the present focus of cancer genetic services is on early and more accurate prediction 
and treatment of disease, which is frequently associated with improved treatment 
outcomes and lower morbidity rates (de la Chapelle 2004, Bell 2004). It is perhaps 
because the ultimate goal of human genome research is the development of new 
treatments and cures for disease that the effects of this knowledge on the dying have 
been overlooked (Lillie 2006). 
       A family history of cancer may be due to shared lifestyle, environmental or genetic 
factors (Collaborative Group on Hormonal Factors in Breast Cancer 2001). That is, a 
family history of cancer may be associated with an inherited genetic predisposition to 
cancer but may also be due to other factors. This study was concerned with any patient 
who had a family history of cancer, irrespective of cause. Hence it was acknowledged 
from the outset that the study would include (but not be restricted to) concerns about 
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genetic predisposition to disease: a major focus of interest for this study. As the 
scenarios described above demonstrate, clinical encounters had suggested that concerns 
about an inherited genetic predisposition to cancer could be present for people who 
were unlikely to be at increased risk of cancer as well as for patients who had an 
identified inherited predisposition to disease. Information about this aspect of the 
family history of cancer was timely as a key government objective is to ensue that all 
healthcare professionals are confident and effective when dealing with genetic 
susceptibility to disease (DH 2003: 7).  
 
Introduction to the Research 
       The overarching research question that guided the study was ‘How does a family 
history of cancer affect the care needs of palliative care patients?’ It was anticipated 
that an increased understanding of the meaning of a family history of cancer for 
palliative care patients would provide insight into their care needs. This was achieved 
using the principles of phenomenology: a research methodology that gathers, describes 
and reflects on the everyday experiences of a particular phenomenon to consider their 
essential meaning within a specific context (Todres and Holloway 2006).  Individual 
experiences are the starting point for this phenomenological enquiry. This was apt for 
research into palliative care, which was based on a methodology of listening to, and 
analysing, the needs of individual dying patients (Saunders 2001). 
       Information was collected through recorded, semi-structured interviews with 
twelve hospice patients and ten nurses. Although the patient experience was the prime 
focus of the study, it was anticipated that insight into the lived-experience of nurses 
caring for patients with a family history of cancer would deepen the analytical 
understanding and explanation as well as help clarify the tension between the particular 
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needs of individual patients and the universal requirement of palliative care to provide 
‘the best quality of life for patients and their families’ (NICE 2004, NCPC 2007).  
 
The Structure of the Thesis 
      The thesis is presented in eleven chapters. Chapter Two presents the context and 
rationale for the study. Chapter Three discusses the ethical and philosophical 
underpinnings of the study whilst Chapter Four describes the ‘natural history’ 
(Silverman 2005) of the research process. 
        Chapters Five to Nine present the phenomenological analysis. Chapter Five 
introduces the participants. It describes how their bodily experiences of cancer relate to 
the indicators of an inherited predisposition to disease, and reflects on the effect of 
cancer throughout the participants’ lifecycle. Chapter Six looks at how the patient-
participants’ family history of cancer affected their relationships within the family. It 
draws attention to the effect of previous deaths in the family on family communication 
and coherence. Chapter Seven uses the concept of lived-time to show how the meaning 
of the family history of cancer changed for participants when the concept of an 
inherited predisposition to cancer was introduced. Chapter Eight considers the patient-
participants’ understanding of the aetiology of cancer, whilst Chapter Nine focuses on 
the nurse-participants’ experiences of caring for patients with a family history of cancer 
and their concerns with regard to caring for patients and families with an inherited 
predisposition to disease.  
        The key implications of the research are discussed in Chapter Ten. The 
relationships that emerged from the study are discussed from two different interpretive 
perspectives: from ‘outwith’ and ‘within’ a genetics paradigm. The chapter shows that 
the family history of cancer is a missing discourse within the present model of care and 
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uses the findings from the study and the research literature to present a new approach to 
care. Chapter Eleven concentrates on the strengths and weaknesses of the research 
process. The thesis ends with a personal reflection on the research process. 
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 CHAPTER TWO: CONTEXT 
Men are disturbed not by things, but by the views which they take on those things 
(Epictetus 135-55 BC) 
 
Introduction 
      This chapter presents the rationale for this study. It documents four changes that 
made an examination of the care needs of palliative patients with a family history of 
cancer an important and timely question. These developments were: a) an increased 
understanding of the biological mechanisms that cause an inherited predisposition to 
cancer; b) the impact of inherited genetic predisposition to cancer on clinical care; c) 
the increasing public awareness of multifactorial disease, and d) concern about the way 
these developments were affecting palliative care.  
 
Inherited Predisposition to Cancer 
       The first stimulus for this study was new developments in the understanding of the 
biological mechanisms that lead to an inherited genetic predisposition to cancer within 
some families. Cancer is now thought to occur through a multi-step process during 
which the properties of cells gradually change over time as a series of genetic 
alterations occur to the deoxyribonucleic acid (DNA) within an individual cell. This 
gradually confers new traits to incipient cancer cells (Nowell 1976, Kleinsmith 2006). 
To understand the link between genetics and heritable cancer it is important to be aware 
that there are two fundamentally different ways that alterations to the cell that 
predispose an individual to cancer can occur (Rieger 2004). These are somatic (or 
primarily environmental), and germline (or primarily inherited) alterations. Somatic 
alterations are acquired after conception and occur within individual cells in a body. 
Germline alterations occur in either the egg or the sperm at/before conception. They are 
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present in all the cells of a person’s body and can be inherited by future generations 
(Rieger 2004). Hence all cancer can be considered genetic in the sense that all cancer is 
thought to occur when the genes are damaged and normal cell function is altered, but 
only a proportion of cancers are associated with an inherited genetic predisposition to 
disease (Kleinsmith 2006).  
       The fact that cancer is a multistep process explains why the greatest risk factor for 
cancer is increasing age: the longer we live the more alterations we accumulate in our 
genes (Nowell 1976). It has been suggested that families that have an inherited genetic 
predisposition develop cancer at a younger age than expected because they inherit 
certain germline alterations that must be acquired somatically in other families (Frank 
2004).  Somatic alterations can occur spontaneously during the normal processes 
associated with DNA reproduction and repair or be due to environmental and lifestyle 
factors: these include smoking, dietary factors, infectious agents and exposure to 
chemicals or radiation (Kleinsmith 2006). Consequently, a family history of cancer may 
be due to an inherited genetic predisposition, but shared environmental and lifestyle 
factors will also significantly impact upon the amount of cancers within families 
(WCRF/AICR 2007). Although the somatic alterations that occur within the genome 
are random there are evolutionary pressures that select which altered cells survive: 
those that divide fastest will eventually dominate over other cells (Ridley 1999). 
      The presence of an inherited genetic predisposition to cancer only increases the risk 
that an individual will develop a particular cancer. The frequency with which a known 
genetic alteration yields the expected trait within a population is known as penetrance. 
Incomplete penetrance arises when other components of a person’s genetic makeup 
and/or the environment influence whether a particular trait will be expressed 
(Kleinsmith 2006). The more penetrant a genetic alteration, the more closely a disease 
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will show familial clustering of cancers and segregation of the disease in a Mendelian 
manner (MacDonald et al 2004).  However, no identified genetic alteration for cancer is 
truly deterministic and detailed study has shown varying levels of penetrance signifying 
significant levels of complexity at a genetic level (Bell 2004). Whether an individual 
subsequently develops cancer will depend upon different gene-gene interactions and/or 
the interactions that the individual has with the environment (Peto 2002, Easton et al 
2007). Hence an individual with an unusually high liability may not be affected if 
environmental factors are favourable but the converse may also occur in an 
unfavourable environment (Harper 2004).   
       Some of the genetic alterations that predispose an individual to cancer have been 
identified. For instance, two breast cancer susceptibility genes have been identified: 
BRCA1 (Miki et al 1994) and BRCA2 (Wooster et al 1995). They were identified 
through investigation of families that showed a near autosomal dominant distribution of 
breast cancer that commonly occurred at a young age (Wooster et al 1995). Both these 
genes are also associated with an increased lifetime risk of ovarian cancer (Wooster et 
al 2005). 
      Large population based studies suggest that  around one in ten breast cancers are 
associated with a family history of breast cancer (Claus et al 1991, Collaborative Group 
on Hormonal Factors in Breast Cancer 2001). These studies also indicate that 
developing cancer at a young age is associated with an increased risk of familial 
disease, as is the occurrence of multiple primary cancers within individuals and the 
occurrence of breast cancer in men (Claus et al 1990, Collaborative Group on 
Hormonal Factors in Breast Cancer 2001). Nevertheless most women with a family 
history of breast cancer are not members of families with the characteristics of BRCA 1 
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& 2 (Claus et al 1998). It is thought that identified susceptibility genes account for less 
than a quarter of the familial risk of breast cancer (Easton et al 2007).    
      It has been suggested that there might be a third breast cancer gene, but this has 
not been found despite intensive searching (Peto 2002). Instead it is suggested that 
families with a family history of cancer, but no known disease causing variant might 
carry several inherited disease causing variants that each individually influence 
disease susceptibility in a more subtle or more complex way (Peto 2002, Hodgson et 
al 2004). That is, that many familial breast cancers are polygenetic in origin. Large 
scale genome wide association studies have identified at least four plausible causative 
genes that show strong and consistent evidence of association with breast cancer 
(Easton et al 2007). Hence the increased risk of disease in a relative of an affected 
individual may be the result of hereditary factors or the consequence of a shared 
environment or a combination of the two (Butterworth et al 2006).  There are, 
however, some comparison and twin studies that suggest that most of the shared risk 
is inherited (Risch 2001, Hemminki and Chen 2004). 
         The genetic alterations that predispose individuals to some colorectal cancers 
have also been identified. These include familial adenomatous polyposis (FAP), and 
hereditary non-polyposis colorectal cancer (HNPCC). However these two highly 
penetrant genetic variants probably only account for around five percent of colorectal 
cancers, whilst different reputable epidemiological studies suggest that many more 
colorectal cancers are associated with familial disease (De la Chapelle 2004). This 
suggests that there are other families with a familial linkage that is not fully understood. 
The explanation for this discrepancy may be associated with polygenetic susceptibility 
and/or other as yet undiscovered genetic alterations (Lynch et al 2004, Hemminki and 
Chen 2004). Epidemiological studies suggest that most cancers are familial to 
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approximately the same degree although there are some exceptions (Risch 2001). 
Thyroid, testicular and laryngeal cancers appear to have the most elevated recurrence 
risk (Risch 2001).  There are currently many ongoing studies looking for the particular 
genes that predispose to other cancers (Bell 2004).  
        There has also been an increased awareness that epigenetic factors may provide a 
new explanation for family patterns of cancer. Epigenetic factors are factors that affect 
the expression of gene activity without alteration to the genome (Feinberg and Tycko 
2004). Hitchens et al (2007) found evidence of epigenetic transgenerational inheritance 
of disease susceptibility in a family with colorectal cancer. This showed that familial 
cancers could be the consequence of epigenetic changes in one or more genes (Hitchens 
et al 2007). This finding has been replicated in other studies (Young 2008). The 
frequency of this phenomenon is unknown and may be uncommon; nevertheless 
epigenetic mechanisms provide new insight into the mechanisms of inherited 
susceptibility to cancer (Lynch et al 2007).  
      It is hoped that this new knowledge will lead to new clinical treatments (Nippert et 
al 1999). How it is beginning to affect the clinical care of patients is discussed below.  
 
 
Impact of Inherited Genetic Predisposition to Cancer on Clinical Care 
       
       The second stimulus for this study was the knowledge that information about 
inherited susceptibility to cancer has begun to impact the clinical care of people with a 
family history of cancer. The fact that specific cancers had a higher prevalence in 
certain families has been noted for centuries (Lynch et al 2004). There have long been 
efforts both to understand why this occurs and to care for such families appropriately. 
For instance, the St Mark’s Hospital registry of families with familial adenomatous 
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polyposis (FAP) was set up in 1925. However it is only recently that technological 
improvements have begun to enable molecular genetics to inform clinical practice 
about the mechanisms of disease (Bell 1998).  
       The government white paper ‘Our Inheritance, Our Future: Realising the Potential 
of Genetics in the NHS’ (DH 2003) makes a clear commitment to harness the potential 
of genetics and to ensure that the benefits of genetic medicine are realised throughout 
the NHS.  The anticipated benefits include the improved diagnosis of disease, earlier 
detection of disease, and the development of new individually tailored drugs and 
treatments (Feetham & Thomson 2006). Genetic medicine is already associated with 
more accurate prediction of people who are at increased risk of developing cancer in 
the future and the early identification of cancer in people who are at high risk of 
developing cancer (Bell 2004). This is important because it is associated with improved 
treatment outcomes and lower morbidity rates in cancer (Bell 2004). This is discussed 
with respect to breast and bowel cancer, two common cancers where predictive genetic 
testing is readily available for the identification of alterations that predispose 
individuals to disease. 
       If the family history of disease is indicative of an inherited susceptibility gene for 
cancer it is now thought appropriate to test individuals for the BRCA 1 & 2 genes 
within the NHS so that they can benefit from appropriate health education and 
prevention measures (DH 2003).  This includes access to a regular screening 
programme with the aim of identifying developing cancer at an early stage. This is 
associated with an increased survival rate at both five and twenty years (Cancer 
Research 2007). Prophylactic mastectomy is also offered to women at high risk and has 
been associated with a reduction of incidence of at least ninety percent (Hartmann et al 
1999). Hence the early and more accurate prediction and diagnosis of breast cancer can 
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both reduce the incidence and decrease mortality in people at high risk of developing 
breast cancer. 
      Predictive genetic testing is also available for familial adenomatous polyposis 
(FAP) and hereditary non-polyposis colorectal cancer (HNPCC). The prognosis for 
patients with colorectal cancers is heavily dependant on stage at diagnosis: the five year 
survival rate is over ninety percent for Dukes stage-A cancers but only five percent for 
Dukes Stage-D (de la Chapelle 2004). Hence regular surveillance of people at risk of 
the disease leading to early detection can affect disease outcome. As breast cancer is the 
most common cause of death in women in the United Kingdom and bowel cancer the 
third most common cancer after lung and breast cancer, these discoveries have the 
potential to enhance the outcome of disease for a significant number of families. 
       Regular screening is recommended for individuals at high risk of hereditary breast 
or bowel cancers as it is associated with reduced mortality and increased longevity 
(Bell 2004).  However regular screening means that individuals have to undergo regular 
procedures, which may be invasive as well as emotionally stressful (MacDonald et al 
2004). Procedures like colonoscopy and mammography have attendant risks as well as 
potential benefits for individuals so it is important that they are only used with 
individuals who are likely to benefit from them (Burn 2005). Hence one of the main 
functions of specialist clinical genetic services is to identify individuals who are at high 
risk of cancer before it develops, and to ensure that they have access to appropriate 
screening and preventative procedures (MacDonald et al 2004). 
 
Assessment of Risk for a Genetic Predisposition to Cancer 
      Traditionally, the risk that an individual would inherit a genetic condition was 
evaluated through calculation of the recurrent risk (based on the family history of 
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disease). This can be calculated when there is certainty about a diagnosis, the mode of 
inheritance of the condition is understood and the biological relationships between 
family members are known (Skirton et al 2005). However for a multifactorial disease 
like cancer the inheritance pattern is not clearly understood, so empirical data is used to 
estimate who is at risk of developing future disease. This has been used to produce 
evidence based guidelines to assist healthcare professionals identify who may be at risk 
of developing future disease in families with a family history of cancer. For instance, 
the Amsterdam criteria were developed to assess the risk of hereditary non-polyposis 
colorectal cancer. 
       Unfortunately there are no internationally agreed methods of calculating the risk of 
heritability of any one particular cancer (Chung and Rustgi 2003). Hence the clinical 
criteria for hereditary non-polyposis colorectal cancer include the Amsterdam criteria, 
Amsterdam II criteria, the Modified Amsterdam criteria and the Bethesda criteria. The 
original Amsterdam criteria were strict and excluded small families so looser, less 
specific criteria have since been developed (Chung and Rustgi 2003). 
       Several factors can make it difficult to assess hereditary risk from familial disease 
including small family size, reduced penetrance, a low number of individuals of the 
susceptible gender in sex-limited cancers and inaccurate information about the family 
history of cancer (Trepanier et al 2004). Ongoing research into the inherited 
predisposition to cancer can also lead to changing risk criteria (Chung and Rustgi 
2003). There is less empirical data about the distribution of cancers in families where 
cancer is polygenetic in origin and, although familial cancers may occur within families 
more commonly than statistically expected, it can be very hard to distinguish a specific 
pattern of inheritance from cancers that occur due to shared environmental factors and 
‘chance clustering’ (Berliner and Fay 2007: 247). Hence broader guidelines, (which are 
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derived from the above criteria), have been developed for referral to a specialist 
practitioners, who usually completes the assessment of a family history of cancer to 
assess the risk of an inherited genetic predisposition (DH 2003). To illustrate this point, 
both the Amsterdam Criteria and the West Midlands Family Cancer Service guidelines 
for referral are given in Appendix 1.      
      The family history of disease is only able to show whether there may be an 
inherited predisposition to cancer within a family. If an individual family member 
wishes to know whether they themselves have inherited a predisposition to cancer it is 
necessary that they have a predictive genetic test. There may, however, be a number of 
potential genes involved and the specific genetic alteration that predisposes to cancer 
may differ from family to family. Hence it is necessary to identify the specific gene in 
an affected family member first. This requires a blood sample from a relative who is 
known to have cancer to allow the unaffected family members to be tested for the 
specific genetic alteration that is in their familial bloodline (Skirton and Patch 2002, 
Sadler et al 2004).  
       Predictive genetic testing can ensure that family members who have a normal 
population risk of developing cancer do not undergo the risks of unnecessary screening 
programmes, whilst family members who have a genetic predisposition to cancer have 
access to regular surveillance programmes (MacDonald et al 2004). Predictive genetic 
testing is now possible for some familial cancers, however it is a new and rapidly 
evolving technology and many tests remain imperfect (Feetham and Thomas 2006). 
Although tests results can clearly indicate the presence or absence of a known cancer 
predisposing gene in a particular family, they may also give an inconclusive or 
indeterminate result. An inconclusive result indicates the presence of an altered gene 
whose significance is not known, whilst an indeterminate result indicates that no known 
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cancer predisposing gene has been found in a family (Miller et al 2006). However it is 
thought that there are many yet to be identified altered genes and gene combinations 
that may cause a history of cancer (Feetham and Thomas 2006). This, alongside the 
uncertainty about the penetrance of specific gene alterations, means that genetic testing 
for cancer can still leave families with ambiguous information about their own risk 
(Miller et al 2006). Hence, even in cancers where genetic testing is possible the family 
history of disease remains an important clinical tool for risk assessment of cancer 
(Skirton et al 2005).  
 
The Role of the Nurse in a General Setting 
       One key NHS objective is to ensure that all health care professionals are confident 
and effective when dealing with genetic diseases (DH 2003: 7). Subsequently, 
guidelines for all nurses, midwifes and health visitors have been produced with the aim 
of developing core educational competencies that are appropriate for all nurses (Kirk 
2005a). These are shown in Table One below (P16). This competence based nurse 
educational framework contains seven core competency standard statements that are 
appropriate for every nurse. There have been attempts to disseminate these widely, for 
instance through a series of articles in the Nursing Standard (Gaff 2005, Middleton et al 
2005, Haydon 2005, Kirk 2005b, Bradley 2005, Benjamin & Gamet 2005, Skirton & 
Barnes 2005).  
        It is, however, unclear how thoroughly these competencies have been integrated 
into nursing practice. In a literature review of genetics in education and nursing, Burke 
and Kirk (2006) show that although there is widespread agreement about the relevance 
of genetics to nursing education and practice there is evidence to suggest that there are 
widespread deficits in the skills and knowledge base. This is often linked with low 
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confidence levels in nurses’ ability to provide appropriate clinical care (Burke & Kirk 
2006). This causes concern because it is anticipated that genetic issues will have an 
increasingly significant impact on the practice of nurses. There have therefore been 
calls for more information about genetics issues to be inserted into the curriculum for 
nurse education and research into the most effective means of educational delivery 
(Metcalfe & Burton 2003, Frazier et al 2004, Burke & Kirk 2006).  
 
 
Table 1: Core Competency Standard Statements for Nurses 
 
Core Competency Standard Statements (Kirk et al 2003) 
I. Identify clients who might benefit from genetics services and information. 
II. Appreciate the importance of sensitivity in tailoring genetic information and services to 
clients’ culture, knowledge and language level. 
III. Uphold the rights of all clients to informed decision making and voluntary action. 
IV. Demonstrate a knowledge and understanding of the role of genetics and other factors in 
maintaining health and in the manifestation, modification and prevention of disease 
expression, to underpin effective practice. 
V. Demonstrate a knowledge and understanding of the utility and limitations of ones own 
genetics experience. 
VI. Recognise the limitations of one’s own genetic expertise. 
VII. Obtain and communicate credible, current information about genetics, for self, clients and 
colleagues. 
 
       The first core competency for nurses is to identify people who might benefit from 
genetic services. However, as discussed above, there are specific evidence based 
criteria for different cancers indicating who may be at risk of different genetic 
alterations. Due to the specific knowledge required base and the complexity of risk 
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assessment for cancer, this is usually completed by specialist practitioners. As up to one 
in three people develop cancer (Cancer Research 2007) many families show some 
characteristics of an inherited predisposition to cancer. Consequently non specialists are 
urged to be aware of four key indicators that an inherited germline alteration may be 
causing a predisposition to cancer within a family, especially in the absence of specific 
environmental or lifestyle factors, (Skirton and Patch 2002, Kirk 2004b). These factors, 
which help identify appropriate patients for specialist referral, are shown in Table Two 
below. 
 
Table 2: Indicators of an inherited genetic predisposition to cancer 
• Cancer occurs in the same or related parts of the body in different individuals 
within a family (especially in the absence of shared risk factors like diet or 
smoking).   
• The same or related cancer occurs in several generations of the same family.  
• Individuals within a family are affected by multiple primary cancers. 
• Individuals within the family develop cancer at a younger age than is usual 
 
       These broad indicators appear to hold across different cancers and may be relevant 
to identifying families with a genetic predisposition to specific cancers where the 
predisposing genes have not yet been identified, for cancers where no internationally 
recognised criteria have been developed, and for families where polygenetic origins of 
cancer lead to more poorly understood pattern of disease in families (Berliner and Fay 
2007). These indicators are also helpful when considering whether it may be 
appropriate to refer a family to a specialist genetic service for risk assessment. 
Nevertheless there is little evidence to show whether nurses have the confidence or 
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competence to know who to refer to specialist services (Burke & Kirk 2006). There is, 
however, evidence that knowledge of inherited susceptibility to cancer is widespread 
within the general public as will be seen below. 
  
The Public Understanding of Multifactorial Disease  
      The third impetus for this study was that it was thought that there was sufficient 
public awareness of inherited genetic predisposition to cancer such that it might be 
beginning to alter the way people with a family history of cancer understood and 
experienced their own disease and its potential repercussions for other family members. 
There is evidence to suggest that there is widespread awareness of inherited 
susceptibility to cancer amongst the general British population. For instance, a survey 
of nine hundred practice nurses found that over half of the respondents had been 
consulted by patients who were worried about a family history of cancer during a three 
month period (Bankhead et al 2001). Emslie et al (2003) found that nearly half of the 
participants in a study of families with heart disease spontaneously mentioned that 
cancer could be inherited. This may be because cancer genetics, especially stories of 
families with breast cancer, are frequently reported in the media. 
        Although there is frequent coverage of cancer genetics in the media the 
presentation of information is not always nuanced, detailed or accurate (Peterson and 
Bunton 2002). Media stories focus on new genetic discoveries and frequently portray 
genetics discoveries as a quest to unlock nature’s secrets and to find new cures for 
disease (Peterson 2001), or as personal interest stories that discuss how particular 
families are affected by familial disease (Henderson and Kitzinger 1999). However the 
media rarely highlights the multifactorial nature of diseases like cancer (Peterson and 
Bunton 2002). If environmental causes are discussed in conjunction with genetics it is 
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usually only in passing and towards the end of an article. Furthermore, the fact that the 
aetiology of disease is multifactorial and may be due to the interaction of different 
genes is rarely mentioned (Peterson and Bunton 2002).  
      Clarke (2004) shows how breast cancer in particular is portrayed as a threat to 
the family in the media. She describes how the family is described as both the source 
of love and the source of a fearsome disease that paradoxically both threatens and 
strengthens family ties (Clarke 2004). Cancer is described as a family curse, a legacy 
and even as a member of the family (Clarke 2004: 545). Media stories have provoked 
spontaneous conversation in the general public about what preventative and 
prophylactic treatments they would consider if they were in that situation (Henderson 
and Kitzinger 1999) and can suggest that the whole family has become diseased 
(Clarke 2004).       The language used to describe genetic predisposition to disease 
also has the ability to influence how individuals and communities perceive genetic 
conditions (Hodgson et al 2005). Within clinical genetic practice the language used to 
discuss the genetic diversity is clearly defined. For instance, the term ‘mutation’ is 
defined as a ‘change in the normal structure or sequence of a gene’ (Young 2005: 
295) or as a change in genetic material, either of a single gene, or in the number or 
structure of the chromosomes (Turnpenny and Ellard 2007). The word 
‘polymorphism’ is used to refer to the occurrence in the population of two or more 
genetically determined forms which occur in such frequencies that the rarest of them 
could not be maintained by recurrent mutation alone (Turnpenny and Ellard 2007). By 
convention the term polymorphism is used for gene sequence alterations that are 
found in more than one percent of the population, whilst the term variant is used for 
gene sequence alterations that occur in less than one percent of the population (Young 
2005).  
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      The word ‘mutation’ is commonly used in both medico-scientific literature 
(Hodgson et al 2005) and the media (Peterson and Bunton 2002). However this has 
been shown to have strong negative connotations for people who often associate it with 
science fiction mutants and ‘scary’ science (Condit et al 2004: 248). It has been shown 
that the words ‘variation’ or ‘alteration’ have more neutral associations. It is suggested 
that their use would help ensure that unintended negative meanings are not conveyed 
when discussing genetic risk and illness (Condit at al 2004).  However the word 
‘variation’ is easily confused with the clinical term variant (discussed above), so the 
word alteration has been used throughout this thesis. 
        It is known that the way people assess their own risk of developing multifactorial 
disease differ from the medico-scientific method of assessing risk. Walter et al (2004) 
systematically reviewed and synthesized the qualitative literature that explored the lay 
understanding of familial risk of common chronic diseases including cancer. They 
show that familial risk perceptions are affected by the salience of the disease to an 
individual, how the individual personalised the risk and also their individual sense of 
vulnerability. Walter & Emery (2005) later interviewed thirty individuals who had a 
family history of common chronic diseases including cancer. They state that the 
development of a personal sense of vulnerability depended on both how the biomedical 
model of counting affected relatives and also on a sophisticated interplay of emotional 
factors, including the emotional closeness to the affected family members, impact of 
witnessing illness in the family and the physical similarity to affected relatives.  
 
The Effect on Society 
      There are also concerns about the social consequences of the rapidly expanding 
understanding of human genetics (Cunningham-Burley & Kerr 1999, Conrad & Gabe 
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1999, ten Have 2001, Cunningham-Burley & Kerr 2002, Bunyon & Peterson 2005). 
Many of these focus on practical concerns about the use and misuse of genetic 
information. This is because genetic information contains a unique identifier of each 
individual alongside heritable information that has relevance to other family members 
(Feetham & Thomson 2006). These include concerns about the issues of 
confidentiality, choice and discrimination. 
        Concern about discrimination and the social impact of genetics is often associated 
with the eugenics movement. The eugenics movement is discussed in Appendix Two as 
the ramifications of eugenics are important and widespread; nevertheless they are 
peripheral to this study which focuses on care of the dying rather than reproductive 
decision making. Concerns about discrimination is, however, an important 
consideration for people living with a genetic predisposition to disease because the 
knowledge of an inherited trait not only provides information that individuals can use to 
inform their own lifestyle and health choices, it can also affect the way they are treated 
by society (Shiloh 1996). Individual life choices, including career and important 
relationships, can be affected (Finkler 2000). There may be fiduciary implications with, 
for instance, consequences for life insurance, health insurance and even mortgages 
(Morgan 1996, Doukas 2003). Knowledge of inherited susceptibility to disease can also 
have a fundamental affect on families and the way they view themselves (Finkler 
2000).  
 
The Family and Genetic Predisposition to Cancer 
      Traditionally, in the western world, including Britain, a family was defined as a 
group of persons linked by kinship, which can be established through lines of descent 
that connect blood relatives or through marriage (Kissane & Bloch 2002). However this 
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definition of a family has been challenged by many social changes including high rates 
of divorce, increasing incidences of lone parenthood, advances in the control of fertility 
and a liberalisation of attitudes towards homosexual partnerships (Payne et al 1999). 
This has generated a diversity of new family ties that are subject to negotiation and 
frequent change (Finkler 2000).  
       The concept of inherited predisposition to disease can challenge the way families 
perceive themselves (Finkler 2005). It challenges the fluid social definitions of family 
and re-inforces older definitions that are grounded in biologically produced ties (Finkler 
2005).  This is because the risk of inherited illness only exists for biologically related 
family members, and the information used to define who is and is not at risk of disease 
is based entirely on the concept of shared DNA. Consequently the knowledge of 
inherited predisposition to disease can re-establish traditional conceptualisations of a 
biogenetic family, established through lines of descent that connect blood relatives, and 
exclude individuals who are defined as family through social choice like adoptees or 
step children (Finkler 2005).  
       When confronted with any life-threatening illness each family member has to 
redefine their expectations of themselves and their relationships with one another. Any 
illness experiences can challenge families and their sense of cohesion leading to a 
profound redefinition of the family, who they are and how they relate to one another 
(Altschuler 2005). There are, however, added dimensions for families who are 
confronted with genetic illnesses (Richards 1996). 
       The increased impact of genetic disease on families is so significant that it is 
claimed that genetic diseases are family diseases and that the patient is the family in 
clinical genetics (Richards 1996, Peterson 2005). Specific concerns include issues 
about who may be responsible for introducing the disease into the family and the need 
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to adjust to the risk that each family member may develop the disease or carry the gene 
that predisposes to illness into future generations (Richards 1996). Hence the revelation 
of an inherited predisposition to disease within a family involves an initial period of 
adjustment for all the individual members as they communicate and learn about 
whether they or other relatives may be affected (Rollands and Williamson 2006). There 
is evidence that knowledge of a genetic predisposition to disease can cause a variety of 
emotions, tensions and recriminations within families (Richards 1996, McAllister et al 
2007).   
        It can be especially difficult for individuals who are aware that they are carriers of 
a heritable cancer (Wagner-Costalas et al 2003). They can feel guilty and responsible 
for introducing the gene into the family (Hallowell et al 2006). Parents may feel 
especially guilty that they may be responsible for transmitting an increased risk to their 
children (Agincourt-Canning 2006, Hallowell et al 2006). For the affected individual, 
knowledge of a genetic disorder can promote feelings of isolation, self- stigmatisation 
and loneliness (Wood-Harper & Harris 1996, Kenan et al 2006). Other family members 
may feel guilty that they have not inherited the predisposition to disease, separating 
families psychologically (Madigan 1996).  
      When an individual is told about inherited susceptibility to cancer they themselves 
become involved in dilemmas about how, or whether, they should inform relatives of 
this (Hallowell et al 2003).  Communicating within a family can be difficult as different 
family members may have different attitudes to genetic information (Madigan 1996), 
and knowing that there is an increased risk in the family can cause distress to relatives 
who would prefer not to know (Madigan 1996). It may be unclear who should be 
responsible for telling different individuals within a family (Forrest-Keenan et al 2005, 
Forrest et al 2003) and even who should be defined as family (Foster et al 2004, 
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Forrest-Keenan et al 2005). The experience of a genetic predisposition is also unusual 
because it frequently includes a period of awareness of potential illness before the 
disease shows clinical symptoms (Rollands and Williams 2006). People who are at risk 
of developing future disease can find themselves in a liminal position between health 
and sickness, leading to increased monitoring of health and an increased desire for 
health surveillance (Scott et al 2004, Finkler 2001).  There is, however, little 
information about how knowledge of inherited susceptibility to cancer affects patients 
with advancing incurable disease. 
 
Impact on Palliative Care 
     The fourth impetus for this study was the awareness that concerns about familial 
disease were impacting on patients receiving palliative care (as described in the 
introduction). Palliative care is: 
‘… the active holistic care of patients with advanced progressive illness. 
Management of pain and other symptoms and provision of psychological, social 
and spiritual support is paramount. The goal of palliative care is the achievement 
of the best quality of life for patients’ and their families. Many aspects of palliative 
care are also applicable earlier in the course of the illness in conjunction with 
other treatments. Palliative care aims to 
• Affirm life and regard dying as a normal process 
• Provide relief from pain and other distressing symptoms 
• Integrate the psychological and spiritual aspects of patient care 
• Offer a support system to help patients live as actively as possible 
• Offer a support system to help the family cope during the patient’s illness 
and in their own bereavement (NICE 2004, NCPC 2007). 
 
       Palliative care affirms life and regards dying as a normal process. It attempts to 
offer support systems to help the terminally ill live as actively and creatively as 
possible until death (Twycross 1995). The word ‘palliative’ is derived from the Latin 
word for ‘to cloak’ or ‘to cover’ and indicates that the focus of care is on covering the 
symptoms of progressive disease and death rather than cure (Twycross 1995).       
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       The NHS Cancer Plan (DH 2000) stated that palliative services should be available 
to all patients dying from cancer. It is estimated that ninety-four percent of patients 
admitted to inpatient units providing specialist palliative care have cancer and that 
approximately seventy percent of people who die from cancer within the United 
Kingdom are seen by a specialist community palliative care team (Hospice Information 
2007). As around one in ten cancers are associated with familial disease (Clause et al 
1991) it can be suggested that specialist community services may see around ten 
thousand new patients with a family history of cancer each year, and that there are 
approximately four thousand patients admitted to hospice annually where familial 
disease has the potential to be a relevant factor in care. 
 
The Family in Palliative Care  
     Care of the family is an integral part of palliative care (WHO 2002, NCPC 2007). 
The family provides the most important social context within which health is 
maintained and illness occurs (Bond & Bond 1986). Terminal illness profoundly 
influences families, not only because of its effect on family activities, roles and 
relationships, but also because it confronts them with overwhelming issues associated 
with death and transcendence beyond death (Panke & Ferrell 2005). A systematic 
review of ninety four papers suggests there is unequivocal research evidence to show 
that good patient care, good communication and good information giving to patients 
and families are of decisive importance when supporting families through the dying 
process (Andershed 2006). A systematic review of the effectiveness of interventions to 
help families found that they generally prioritised the need for information and 
psychosocial support (Harding and Higginson 2003). Although the palliative care 
movement has embraced the desirability of family centred care it has struggled to 
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devise means of doing this effectively (Kissane & Bloch 2002), and the National 
Institute for Health and Clinical Excellence (NICE) have highlighted the need for more 
research into the care needs of families at the end of life (NICE 2004: 358). 
           The term ‘family’ is often loosely defined in the palliative care literature to 
include caregivers and those who have strong societal, emotional and care-giving links 
to the patient (NICE 2004). That is, palliative care often uses a functional (Parsons 
1955) definition of family. This is illustrated by Andershed (2006) who drew attention 
to the different ways that family was conceptualised in the ninety four papers she 
reviewed. These included ‘caregiver, carers, informal carers, primary caregiver, home 
caregiver, cancer caregiver, caring relatives, relatives, spouses, next of kin, family 
caregiver, family carers, family member and family’ (Andershed 2006: 1160). Not one 
of the ninety-four papers defined family in terms of their bio-genetic linkage. This is a 
significant omission as only people with bio-genetic ties will potentially be at risk of 
developing the same or related cancer in the future. This may profoundly affect the way 
families relate to one another whilst someone is dying (Mallet and Chekroud 2001).  
      Andershed also comments that patients were considered separately from families 
and notes the need to integrate the care of patients and families. She states that 
irrespective of the word used to define family the outcome was the same: ‘one person 
as a voice for the family’ (Andershed 2006: 1160). However different family members 
frequently have very different perspectives (Kissane and Bloch 2002), and the 
perspective of a family member with a shared predisposition to disease might be 
different to family members without the genetic variant. 
      Families also typically follow a life cycle: couples commonly move from being 
childless, to parenting young children, then experiencing those children growing up and 
leaving home, then perhaps becoming grandparents (Riches & Dawson 2000). Each 
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change in stage involves families and individuals in emotional processes of transition 
and major changes in family structure and relationships to allow individual and family 
development (Rolland 2006). Hence through a family’s life cycle the roles of 
individuals change, as do the relationships between individuals with time (Payne et al 
1999). The impact of death within a family is altered by the stage of the family life 
cycle in which they occur (Riches & Dawson 2000, McDaniel et al 2006). Patients 
needs are influenced by/and interlinked with the needs of their families and hence by 
the stage in the family lifecycle in which their illness occurred.  
 
Genetics and Palliative Care 
        There has been little research into how the palliative care needs of adults are 
affected by inherited genetic predisposition to disease (Lillie 2006). Table Three 
highlights the key literature on this topic which was identified through a review of the 
literature.  
 
Table 3: Literature about palliative care and genetic medicine 
Author Level of 
Evidence 
Aims Experience/ 
Perspective 
 
Key Concerns and 
Arguments 
Clifford et 
 al (2007) 
Survey of 328 
adult hospice 
nurses  
To identify the training 
needs required by 
hospice nurses to 
support patients with 
genetic conditions 
University Researchers
(UK) 
Nurses had a low level of 
confidence in dealing with 
genetic diseases 
 
Need to develop educational 
provision  
Kirk 
 (2004a) 
Opinion 
Paper 
To alert/encourage 
palliative care services 
to the benefits of 
genetic testing 
Director of a  Familial 
Cancer Service: has 
been involved in the 
genetic testing of 
palliative care patients
(Australia)  
Raise awareness of indicators 
of inherited disease 
Alert readers to the ethical & 
practical implications of testing
at the end of life 
Lalloo et al 
(2000) 
Opinion  
Paper 
To highlight the 
importance of obtaining
accurate information 
about a family history 
of cancer 
Consultant Geneticist  
(UK) 
Palliative care can be the last 
opportunity to obtain a family 
history of disease from older 
relatives 
Important to assess family 
history for inherited 
predisposition to disease 
Lillie  
(2006) 
Literature 
Review 
To understand how the 
awareness of genetic 
predisposition to cancer
was affecting palliative 
Palliative Care Nurse 
and Ph.D. Student 
(UK) 
Need for further research to 
better understand how to 
support patients with concerns 
about genetic predisposition 
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care patients  
Mallet & 
Chekroud 
(2001) 
Opinion  
Paper 
To highlight the risks 
of emotional distress 
when discussing 
inherited disease with 
the dying 
Hospital Physicians 
(French) 
Death is inherently 
psychologically challenging 
for families. It is possible to do
harm by adding concern about 
genetic predisposition at this 
time 
      Three of these papers (Kirk 2004a, Lalloo et al 2000 and Mallet and Chekroud 
2001) are opinion papers that discuss the issue of risk assessment at the end-of-life. 
Expert opinion is frequently systematically biased in favour of performing procedures 
in which the expert has a vested interest (Mulrow 1995, Shekelle et al 1999).  
      Fiona Lalloo (2000) and Judith Kirk (2004a) are both specialist geneticist 
practitioners. They emphasise the potential benefits of identifying families at high risk 
of genetic predisposition to disease within a hospice environment. They point out that 
palliative care may be the last opportunity for an elderly relative to document the 
family history of cancer for future generations. This can inform future generations of 
their family history of disease and inform them about potential susceptibility to disease. 
It may also be the last chance for a family member who has cancer to undergo genetic 
testing to identify the specific genetic alteration to which the family may be susceptible. 
This allows other family members to have predictive genetic testing to learn whether 
they individually are at increased risk of developing cancer in the future. Blood 
banking, for testing in the future should relatives decide to consider genetic testing after 
the family member with cancer has died is also possible. Although Kirk (2004a) draws 
attention to the ethical issues like gaining consent and the potential for conflict within 
families involved with predictive testing with terminally ill patients, the assumption 
that underlies these articles is that the benefits of predictive genetic testing outweighs 
the potential risks.  
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       Mallet and Chekroud (2001) are physicians, not genetic specialists. They 
emphasize the potential for discussion about genetic disease to have a negative 
psychological impact if the topic is introduced when a patient is dying. They suggest it 
can provoke guilt and recrimination in patients and their families. Their key concern is 
to highlight the importance of maintaining a patient autonomy, and they suggest that 
this should take precedence over any potential benefit that testing might have for the 
family unit as a whole. None of these opinion pieces give details about particular 
incidents or specific cases to allow the reader to evaluate the evidence upon which their 
opinions have been formed; but all do highlight the potential for the dying process to be 
affected by fears about inherited genetic predisposition to disease. 
        Clifford et al (2007) surveyed three hundred and twenty eight adult hospice nurses 
to identify nurses training needs to support end-of-life patients with inherited 
predisposition to disease. They found that adult nurses had low levels of confidence 
when dealing with the physical, clinical and biological aspects of inherited disease. 
They draw attention to the need to develop educational provision that integrates the 
clinical and biological aspects of care. However, this was primarily determined through 
a Likert scale questionnaire and had limited space for qualitative free text data to 
ascertain why their level of confidence was low in this area of care.  
       The short free-text responses were analysed using content analysis (Clifford et al 
2007). A fifth of the comments received were made by individuals commenting on their 
lack of experience caring for families with an identified genetic predisposition. The 
illnesses that provoked most comment were breast cancer and Huntington’s disease, but 
bowel, bladder, ovary, thyroid and oesophageal cancers alongside familial CJD, cystic 
fibrosis and Von Hippel-Lindau syndrome were also mentioned, showing that concerns 
about the family history of disease can affect a wide spectrum of palliative care 
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patients. The respondents commented on the wide range of emotions provoked within 
families by genetic testing within a hospice environment including guilt, fear, anxiety 
and family discord. They also noted the emotional impact that these additional issues 
had made on them as staff and a fifth commented that they felt such issues should be 
dealt with prior to palliative care. This shows that palliative care nurses had cared for 
patients and families with identified genetic alterations which predispose to cancer as 
well as other inherited illnesses. 
       Clifford et al (2007) also surveyed children’s hospice nurses. They reported higher 
levels of confidence than their counterparts working in adult hospices. This may be 
because most children’s hospice nurses routinely care for patients and families with 
commonly recognised genetic conditions (Clifford et al 2007). If this is correct, it 
suggests that many adult hospice nurses do not think of cancer as a genetic disease. 
Several respondents commented that they had not realised the importance of genetics to 
their nursing practice prior to completing the survey (Clifford et al 2007).  
        Lillie (2006) reviewed the literature that examined the affect of genetic 
predisposition to cancer on palliative care patients. It showed that there had been very 
little consideration of how this issue might affect people with advancing terminal 
disease. Although a comprehensive search strategy was used it is not a systematic 
literature review. Hence it is possible that relevant research, (especially studies reported 
in languages other than English), were overlooked.  
        The review of the literature only found opinion pieces about the needs of palliative 
care patients and relatives, a survey that suggested that adult hospice nurses were not 
confident in dealing with biological, psychosocial or clinical aspects of care and a 
literature review that showed more research was required.  Nevertheless these papers 
did confirm the potential for inherited genetic predisposition to affect care. There was, 
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however a dearth of literature looking at the patient’s perspective, and how the 
knowledge of genetic predisposition was affecting their experience of palliative care.  
This was the final stimulus for this study. 
 
Conclusion 
      This chapter has presented the rationale for a study into the care needs of palliative 
patients with a family history of cancer. It describes how new knowledge about the 
biological mechanisms of familial disease are impacting on clinical care. It has shown 
that the knowledge of genetic predisposition to cancer can affect patients and families 
but that there has been little research into how this affects patients receiving palliative 
care.  
      The next two chapters describe the process of designing a study to consider this 
issue. Chapter Three discusses the ethical and philosophical issues that defined the 
scope of the study whilst Chapter Four describes the research process.  
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CHAPTER THREE: THE ETHICAL AND PHILOSPHICAL 
FOUNDATIONS 
Be careful then, and be gentle about death. For it is hard to die, 
It is difficult to go through the door even when it is open. 
(D. H. Lawrence:  All Souls Day) 
 
Introduction 
      A prime concern throughout the research process was to ensure that a meaningful 
and ethical approach to the research was maintained at all times. Consequently this 
chapter initially discusses the ethical issues that shaped the research process and then 
presents the rationale for using the Heideggerian hermeneutical phenomenology that 
was chosen as the research methodology. It documents the importance that was placed 
on designing a study that enabled the researcher to compassionately and sensitively 
elicit the experiences of participants, whilst ensuring a reasonable expectation of 
obtaining meaningful information. This is of the utmost importance when researching 
in palliative care (Seymour and Clark 1998).  
 
Research Ethics 
      The first step in designing this study was to think through the ethical issues 
involved. There are three types of ethical issues that are commonly identified in 
research with human subjects (de Castro 1998). The first relates to questions of 
autonomy and respect for research participants and the second pertains to justice in the 
distribution of benefits and burden of research related activity. The third involves the 
accurate assessment of potential benefits and risks of harm (de Castro 1998). 
      To avoid exploitation of participants the research process must allow participants 
the opportunity to make autonomous decisions based on their own value systems (de 
Castro 1998). This means ensuring that their participation is both informed and 
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voluntary. Informed consent occurs when participants are given sufficient information 
about the proposed research, are capable of understanding that information, and have 
the power of free choice which allows them to give or withhold consent to participate 
(Polit & Hungler 1997). Issues of justice include the fair and non-discriminatory 
recruitment of participants, the non-prejudicial treatment of people who refuse to 
participate in research and the honouring of agreements made between the researcher 
and the participant, including respect for confidentiality and anonymity. It also pertains 
to the appropriate use and dissemination of research results (Polit & Hungler 1997, de 
Castro 1998). The processes used to ensure appropriate recruitment and informed 
consent are discussed in Chapter Four.  
     The theoretical foundation for a risk/benefit evaluation can be found in the 
principles of beneficence and non-maleficence. Reference is often made to Kant’s 
Categorical Imperative; ‘Act in such a way that you treat humanity in both your own 
person, and in the person of all others, never as a means only but also equally as an 
end’ (de Castro 1998). In non-therapeutic research, like this study, where there were no 
anticipated direct benefits for participants, the potential risks to participants needed to 
be considered commensurate with the potential benefits to society. It was therefore 
incumbent on the researcher to minimise potential risks to participants (Polit & Hungler 
1997). There were two key specific issues that needed to be considered before 
commencing this study. These were the ethics of research with palliative care patients 
and consideration of the sensitivity inherent in the topic of a family history of cancer. 
 
The Ethics of Palliative Care Research. 
       This study was undertaken in the belief that research into the needs of palliative 
care patients was a necessary activity to guide practice and inform service development 
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(Bruera 2000, Jubb 2002, Karim 2005). However it was recognised that participants 
with advanced incurable cancer constituted a vulnerable participant group (Dean & 
McClement 2002, Karim 2005). People with terminal illness are considered vulnerable 
due to their physical decline, which is often associated with debilitating symptoms. 
Their situation is further complicated by the emotional intensity inherent in the 
knowledge of impending death and the reality of diminished time (Dean & McClement 
2002).  
      Vulnerability arises in several ways (Regehr et al 2000, Dean & McClement 2002, 
Karim 2005). Intrinsic vulnerability is associated with factors such as age or reduced 
cognitive ability. Extrinsic vulnerability is associated with factors like hospitalisation or 
financial hardship. Relational vulnerability stems from the unequal balance of power, 
which can occur in interactions between caregivers and patient. Palliative care patients 
are often vulnerable in all three dimensions (Regehr et al 2000, Dean & McClement 
2002, Karim 2005).  
       Research participants who will not benefit personally from the research are also 
highlighted as a vulnerable group in the Declaration of Helsinki (2000) and there are 
specific guidelines for research studies where this applies. This is because ‘in research 
on man the interests of science and society should never take precedence over 
considerations related to the well-being of the subject’ (Declaration of Helsinki III: 4). 
As this includes palliative care patients who are unlikely to live long enough to benefit 
from the information that this research will provide, the research was designed in 
accordance with these guidelines that 1) all participants should be volunteers, 2) that 
the research should be discontinued if it was perceived to be harmful to individual 
participants and 3) that the prime duty of the practitioner is to protect the life and health 
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of the participant. The duty of care to patient-participants under the NMC code of 
conduct was given full consideration during each stage of the research process. 
      The ethical understanding behind this research reflects a belief that well designed 
research which has a reasonable prospect of leading to relevant knowledge that may 
benefit people in the future is appropriate in palliative care, whilst acknowledging that 
the vulnerability of palliative patients means that particular and compassionate attention 
must be applied to ethical principles throughout the research process (Rees 2001, Jubb 
2002, Dean & McClement 2002, Lee & Kristjanson 2003, Karim 2005). 
 
The Ethics of Research into the Family History of Cancer 
      This research was predicated on the assumption that the knowledge that a family 
history of cancer could be associated with an inherited genetic predisposition could 
make a difference to the individuals experience and representations of their cancer. 
Hence it was important to consider the potential ramifications of raising the topic of a 
family history of cancer. This was to ensure the study was designed in such a way that 
it minimise any potential risks to participants.  
     The literature highlighted three different areas of concern: 
• The effect of knowing that familial disease is associated with a genetic 
predisposition to cancer 
• The ambiguity associated with genetic predisposition and  risk 
• Specific issues associated with palliative care 
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The effect of knowing that familial disease is associated with an inherited genetic 
predisposition to cancer 
      It has been suggested that the lack of research into the effect of being identified as 
being at risk of an inherited genetic predisposition to cancer on people who have cancer 
is an oversight on the part of researchers (Hallowell et al 2004). However, Bonadona et 
al (2002) found that over half of his participants (who all had cancer) reported at least 
one negative feeling and nearly a third felt distressed after being told that their cancer 
was due to an inherited genetic alteration. Most were concerned about the implications 
for their children’s health. They may also feel guilty that they have been responsible for 
transmitting an increased risk to their children (Hallowell et al 2006, Kenan et al 2006, 
Van Oostrom 2007). Although these results were not replicated in all studies (Hallowell 
et al 2004) they underscored the potential for discussion about familial cancer to 
distress research participants. 
       Although current evidence suggests that adverse psychological consequences of 
knowledge about inherited predisposition (through genetic testing) are uncommon in 
people who have not previously had a cancer diagnosis (Broadstock et al 2000), there is 
evidence that certain individuals may be at increased risk of negative psychological 
outcomes such as depression, distress and anxiety (Vadaparamphil et al 2004). The 
documented risk of psychological harm meant that the potential for the study to cause 
distress if it introduced fears about genetic predisposition had to be taken seriously and 
emphasised the need to ensure that the research design minimised the potential distress 
to participants. 
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The ambiguity associated with genetic predisposition and  risk 
       The ambiguity associated with genetically inherited risk factors is well documented 
in the literature (Callahan 1996, Berliner and Fay 2007). Even the results of predictive 
genetic testing are ambiguous. This is because the discovery of a genetic variant 
associated with cancer does not lead to the certain knowledge that an individual will 
develop cancer. Rather it indicates that they have an increased statistical risk of 
developing cancer at some indeterminate point in the future (Callahan 1996).  There is 
even greater ambiguity involved when using the family history to assess risk (Berliner 
and Fay 2007).  
       Unfortunately the limits on genetic information are not well understood. It can be 
difficult even for healthcare professionals to understand the implications of a statistical 
risk for an individual (Gigerenzer & Edwards 2003). It is also difficult for patients and 
relatives to apply these statistics to their own situation (Shelford 2003). This, linked 
with the tendency to reduce complex phenomena to simpler models, leads to an attitude 
that can link the knowledge or likelihood, of a genetic alteration that predisposes to 
cancer to a perception of genetic fatalism: that the family is doomed to cancer. The 
knowledge that genes operate within particular environments and in the presence of 
additional causal factors is often lost in the popular discourse (Callahan 1996, Sherwin 
2004).  
 
Specific issues associated with palliative care       
       It has been suggested that the topic of genetic predisposition to cancer is a 
particularly sensitive subject within a palliative care setting. This is because it risks 
disturbing the complexity of the conscious and unconscious ties that constitute the 
family structure (Mallet & Chekroud 2001).  Family ties and interactions are often 
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particularly intense when a family member is dying. Relatives may be increasingly 
aware of their own susceptibility to future disease (Sanders et al 2003). It may also lead 
to an increase in recollections of previous deaths within the family, which may or may 
not be healthy for the family as a whole (Mallet & Chekrout 2001).                    
     This meant that the research question ‘How does a family history of cancer affect 
the care needs of palliative care patients?’ had to be considered sensitively, not only 
because of the obvious risk of bringing to the fore distressing memories associated with 
previous bereavements, but also because the topic of a family history of disease, with 
its new, widely publicised, attendant overtones of inherited predisposition to cancer, 
had the potential to cause new tensions and stress to vulnerable participants. It was 
therefore decided that it would be inappropriate for the research to introduce the topic 
of cancer genetics directly into the research study.  
 
Reflections on the Impact of Ethical Consideration on this Study 
       On reflection, the sensitivity of the topic of genetics linked to the vulnerability of 
the research participants was the single most important factor in the design of this 
research study. The potential for the study to harm participants was taken seriously 
throughout the research process.  
      The design of any research study is a critical aspect of ensuring that a framework 
for addressing ethical issues is developed (Seymour & Ingleton 1999/2005). In this 
study many of the key decisions about research methodology were taken to reduce the 
potential for harm. The decision to proceed with an in-depth exploratory study of how a 
small number of participants were affected was made primarily because of the ethical 
issues associated with the research topic, as well as the anticipation that it would 
provide new insight into a complex and topical issue. Interviews were selected as the 
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data collection method as it was felt they reduced the potential for the research to 
provoke emotional distress. However, even using semi-structured qualitative interviews 
(the data collection method chosen for this study), it was felt that the topic of cancer 
genetics was too sensitive to openly and systematically raise it with palliative care 
patients. Even the term ‘family history’ was felt to be too indicative of genetic disease 
in this context.  How this was overcome is documented in Chapter Four. The scope and 
direction of this study was directly affected by the requirements of ethical research 
practice from an early stage in the research process.   
 
The Philosophical Understanding behind the Research Methodology 
       There is no consensus on the best way to study the social world or how to 
systematically approach the study of human action (Holloway and Wheeler 1996). 
Hence a variety of different methodologies are currently used as tools to understand 
human society. However, it is widely agreed that the selection of a research 
methodology should not be due to personal preference, fashion or whim but rather 
should reflect a harmony between the aims of the research and the underlying 
assumptions about the nature of reality as understood by the researcher (Van Manen 
1990, Crotty 1998). 
      This study uses the principles of phenomenology. It was thought that this 
methodology would help to illuminate the effect of a family history of cancer within a 
palliative care setting whilst enabling the entire research process to proceed in an 
ethically appropriate manner. Phenomenology, alongside other qualitative 
methodologies, has been increasingly used to understand how individuals make sense 
of their experiences of illness and healthcare (Froggatt et al 2003, Borreani et al 2004).  
The potential of phenomenology to make a significant contribution to research within 
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palliative care is widely documented (Seymour and Clark 1998, Wright and Flemons 
2002, Froggatt et al 2003, Borreani et al 2004, Kendall et al 2007). It was anticipated 
that phenomenology would present new ways of describing and understanding what it 
means to be a finite and situated human (Dreyfus 1994) when dying with a family 
history of cancer.  
         The principles of phenomenology appeared to be in harmony with the evolution 
of palliative care, which was based on listening to, and acting on, patients’ perceptions 
of their own experience and needs (Saunders 2001). It was anticipated that 
consideration of the meaning and lived experience of the family history of cancer from 
patients’ and nurses’ perspective would be a first step to understanding how their 
family history affected their care needs. 
 
Paradigm 
       The concept of paradigm change was fundamental to this study. A paradigm can be 
defined as ‘a conceptual or methodological model underlying the theories and practices 
of a science or discipline at a particular time’ (OED Online accessed 1/9/07).  The 
change in perception of cancer from a set of heterogeneous diseases linked by 
uncontrolled cell growth to a multifactorial disease of the human genome can be 
conceived of as a paradigm shift (Anderson et al 2000). A paradigm change is the 
transfer of allegiance from one paradigm to another leading to a conceptual and/or 
methodological change in the theory and practices of a particular discipline (OED 
Online accessed 1/9/07). This understanding derives from Kuhn (1962, 1996) who 
revolutionised the understanding of scientific development. He described how new 
discoveries are not integrated into the existing perception of the world but can totally 
change the worldview of an individual. Hence an individual who conceives of cancer as 
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a multifactorial genetic disease (i.e. within the genetic lens) may view a diagnosis of 
cancer, or the experience of a family history of cancer, very differently from someone 
who does not have this knowledge (i.e. outwith the genetic lens).  
      The concept of paradigm change has been influential throughout this study. It 
• Underpinned the research aims: The whole study was designed around a belief 
that the knowledge of the multifactorial aetiology of cancer (with the 
implication that cancer was heritable) was an important change in worldview 
that could influence care need. 
• Reinforced the ethical concerns that raising the issue of inherited susceptibility 
to cancer could cause distress, even to nurse-participants:  Kuhn (1996) 
documents how being presented with a new worldview can cause intellectual 
bewilderment and even distress to practitioners as they question the basic 
principles and relevance of their work. 
• Influenced the data analysis: Kuhn’s (1996) description of the way different 
worldviews frequently co-exist during a period of paradigm change emphasised 
the need to be aware that different worldviews could influence how participants 
experienced their family history of cancer. The term ‘within the genetics lens’ is 
used to refer to care that specifically concerns issues associated with inherited 
susceptibility to cancer in this study. The term ‘outwith the genetic lens’ refers 
to practice where the heritable component of disease is not taken into account. 
• Influenced the literature review: Kuhn (1996) emphasises that research must 
proceed from a research paradigm as without this it cannot cohere into an 
acknowledged body of knowledge (or be evaluated by other researchers). This 
thesis proceeded from within the genetics paradigm. 
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         The concept of a paradigm has also been influential when distinguishing between 
different research approaches (Robson 2002). In research the concept of a paradigm 
acts like a net that contains the researcher’s basic epistemological, ontological and 
methodological premises (Guba & Lincoln 1994). This research is firmly situated in the 
interpretivist paradigm: it is a qualitative study, concerned with how the family history 
of cancer is being interpreted, experienced and constituted in a palliative care context in 
the early twenty-first century.  
       However the scope of qualitative research undertaken within the interpretivist 
paradigm has grown out of a wide range of intellectual and disciplinary traditions and 
does not constitute or imply a unified code of philosophical understanding or set of 
techniques (Mason 2002). Hence the ontology, epistemology and philosophical 
understanding that underpins the hermeneutical phenomenological methodology 
adopted are discussed in more detail below. 
 
Ontology 
     Ontology is the branch of philosophy that is concerned with existence and the nature 
of those things that exist (Williams & May 1996). It is concerned with the structure of 
reality (Crotty 1998). The ontological understanding that underlies this study is realism; 
or what is frequently known as commonsense realism (Warburton 1995). 
     Commonsense realism assumes that there is an external world of physical objects 
that can be learnt about directly using the five senses (Warburton 1995). However the 
commonsense perception of phenomena has been challenged by empirical investigation 
and philosophical debate.  Philosophers have long questioned whether objects even 
exist when they are not being observed (Warburton 1995). The ontology behind this 
study, however, does not deny the possibility of material existence; rather it questions 
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an individual’s ability to know the world beyond our communal representations of it 
(Williams & May 1996). The ontology behind this study means that it is not concerned 
with the ‘truth’ behind any explanation for why certain families have multiple 
experiences of cancer but focuses on how the meaning of a family history of cancer was 
impacting the experiences of participants.  
 
Epistemology 
    Epistemology is the branch of philosophy concerned with how we know what we 
know and our justification for claims to knowledge (Williams & May 1996). It is 
important as it defines the principles and ways that knowledge can be demonstrated 
(Mason 2002), and the weight given to different types of evidence and how it is 
legitimised (Crotty 1998). The epistemology that underlies this research is social 
constructionism. 
      In a constructionist epistemology meaning is constructed by human beings as they 
engage with the world they are interpreting (Schwandt 1994). Knowledge is understood 
to be a constructive interplay between actual objects that exist and the meanings which 
occur when they are consciously attended to. For instance, a family history of breast 
cancer has been attributed to excess black bile, God’s(s’) judgement, contagion and 
shared lifestyle (Olson 2002).  Meanings in the constructionist epistemology are 
bounded by the natural qualities of an object yet they only take actual meanings when 
consciousness engages with them (Crotty 1998). In social constructionism the focus is 
on how the world is known inter-subjectively: on the shared understanding of 
phenomena rather than on individual internal processes (Schwandt 1994).   
      Van Manen laments what he describes as the epistemological nihilism associated 
with the constructivist epistemology, saying ‘it forces us always to see the relative, 
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historical, constructive and social character of truth at the expense of its deep 
hermeneutic facticity’ (Van Manen 1990: 49). He states that the richness of 
phenomenology is that it speaks through lived experience and brings the phenomena 
into consciousness. 
       The epistemological and ontological underpinning of this study was congruent with 
using interviews to collect data. Interviews reflect the ontological belief that the 
experiences, understandings and interpretations of individual participants are 
meaningful properties of social reality (Mason 2002). In the social constructionist 
epistemology interviews are understood to generate situated knowledge (Mason 2002): 
that is, the interview data collected is acknowledged to be a reconstruction of events 
and experiences that is built between the participants and the researcher.  
 
Inductive Reasoning 
       Qualitative research was initially characterised by its opposition to the strict design 
characteristics of quantitative research and encouraged a pure inductive methodology 
where meaning emerged solely from in-depth exposure to the data (Silverman 2005). 
However, this naïve inductive approach has been criticised because it ignores the need 
for research to build a cumulative body of knowledge and ignores the reality that many 
studies, like this one, are focused around an orienting concept and/or interest (Miles and 
Hubermans 1994, Silverman 2005). 
      The study used inductive reasoning to analyse the data collected. Inductive 
reasoning ‘is reasoning which goes from particular instances of a pattern to a 
generalised pattern’ (Morton 2004: 434). Unfortunately there are inherent limitations in 
using inductive reasoning to understand and predict the world. This was first clearly 
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demonstrated by Hume (1711-1776) who showed that it was always possible for 
inductive reasoning to produce false results (Morton 2004).  
      Inductive reasoning is contrasted with deductive reasoning which begins with 
assumptions and shows that certain conclusions follow logically from these 
assumptions (Morton 2004). Hence a deductively valid argument is one where the 
conclusions always have to be true if the premises are true. However with induction 
there is always the possibility that further evidence could show that the inductive 
reasoning is false. Therefore even a reasonable conclusion obtained through inductive 
reasoning can never be proven with certainty (Morton 2004). 
       Nevertheless induction does have two important features that make it a useful way 
of examining the world (Morton 2004). Firstly, the knowledge gained by inductive 
reasoning must fit with the given evidence. It therefore does not allow conclusions or 
inferences to be drawn that go beyond the given evidence. Secondly, it aims to remove 
inconsequential detail and delineate core patterns within the given evidence. These two 
features mean that inductive reasoning continues to be considered an attractive and 
trustworthy method of reasoning about the world in which we live (Morton 2004). 
 
Phenomenology 
       Phenomenology is the study of phenomena (Crotty 1996). However 
phenomenology has evolved as a philosophical context for research (Lopez and Willis 
2004) and two different approaches are commonly used within nursing. These are a) 
Husserlian Descriptive Phenomenology and b) Heideggerian Hermeneutic 
Phenomenology. 
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a) Husserlian Descriptive Phenomenology 
       Husserlian Descriptive Phenomenology was developed at a time when huge 
changes were going on in the scientific community and commonsense understandings 
of phenomena were being challenged by new discoveries and experimentation 
(Cahoone 2003). Husserl (1859-1938) aimed to consider the original phenomena that 
present themselves to our consciousness before we engage in systematic reasoning 
about them: to ‘go back to the things themselves’ (Velarde-Mayol 2000). His approach 
was descriptive (Van Manen 2002). 
       This approach did not deny or disclaim other scientific or philosophical 
understandings of objects, but claimed that they needed to be laid aside or bracketed if 
the meaning which attended to the experience of an object was to be understood. 
Husserl advocated bracketing to free the phenomenologist from preconceived ideas, 
irrespective of whether they originate from cultural tradition, empirical science or other 
authority (Velarde-Mayol 2000). Husserl did not deny that individuals had subjective 
reactions to, and/or received understandings of, phenomena, or that groups within 
societies commonly had intersubjective understandings of phenomena. Nevertheless he 
felt that the ultimate goal of phenomenology was to understand the essential essences of 
the objects themselves (Crotty 1996).  
        The research reported here has been influenced by Husserl’s interpretation that 
phenomenology enables the identification of the essence of an object as consciously 
conceived. Use of phenomenology enabled the study to focus on the essence of a family 
history of cancer for palliative care patients. Whilst acknowledging the influence of 
Husserlian phenomenology it was not fully adopted because, as discussed below, the 
philosophical concept of bracketing was not thought to be possible or even necessarily 
desirable in this research. 
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b) Heideggerian Hermeneutic Phenomenology 
      Heidegger (1889–1976) was Husserl’s student. He developed Husserl’s ideas 
(Moran 2000). He felt that the interpretation of the lived experience of objects could not 
be a neutral, theoretical or dispassionate contemplation, as advocated by Husserl, but 
must take into account the involvement of the enquirer themselves (Heidegger 1967, 
Moran 2000). Hence Heidegger rejected bracketing and sought to return to the things 
themselves, not as free-floating constructions or essences, but to consider them in the 
context in which they occurred (Crotty 1996). This has come to be known as 
hermeneutical or interpretive phenomenology.  
     Hermeneutics is the theory and practice of interpretation (Ree 1991). It originally 
applied to biblical criticism and the practice of reading religious texts with respect for 
the context in which they were written. It has migrated to other areas of scholarship as a 
practice of reading texts and human situations in the context that best brings 
understanding (Crotty 1998). It usually carries the implication that whilst some 
interpretations are better than others, none can ever be final (Ree 1991). Heidegger’s 
phenomenology therefore aimed to be interpretive as opposed to the primarily 
descriptive practice of Husserl (Van Manen 2002). 
      A Heideggerian hermeneutic phenomenology was selected as the research 
methodology because it enabled an interpretive framework to be used to search out the 
relationships and meanings that knowledge and context have with each other 
(Streubert-Speziale and Carpenter 2007). This was congruent with the motivation of 
understanding the relationship between a family history of cancer and needs of patients 
with advancing disease within a cultural context where the awareness of inherited 
susceptibility to cancer was becoming more prominent.  
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      Hermeneutical phenomenology was considered appropriate because it 
acknowledged that the research was deliberately undertaken from a particular stance 
that had a potential to enhance understanding (Crotty 1998). This was consistent with   
this study which arose from an intellectual and clinical stance that considered it 
important to be mindful of the effect inherited cancer was having within palliative care. 
It acknowledged that the study would engage reflexively with the concept of a family 
history throughout the research process, and that instead of preconceived ideas about 
their importance being bracketed out of the research process they were inherently 
included within it. The strengths and weaknesses of this approach for this study are 
discussed in Chapter Eleven. 
 
Phenomenology and Sample Size 
        In qualitative research the sample size is determined by the methodology selected 
and the topic under investigation, not by the need to produce generalisable findings. 
Phenomenological enquiry is essentially concerned with individual experience and 
uncovering the individual meaning of a phenomenon (Higginbottom 2004). Hence it 
may, in some cases, be appropriate to study a phenomenon from the perspective of a 
single participant (Miles & Huberman 1994).  A single case study was not thought to be 
appropriate for this study for several reasons. Firstly, an aspect of the phenomenon 
under investigation, ‘a family history of cancer’, does not have a simple clearly defined 
definition. Secondly, because of the ethical issues discussed above it was not 
appropriate to ask participants directly about their family history of cancer. Too small a 
sample can lead to the data collected having inadequate scope to answer the research 
question (Richards 2005). This may be especially problematic when cases are only 
selected from either the centre or periphery of a phenomenon and can reduce the 
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understanding gained (Miles & Huberman 1994). Multiple cases add confidence to the 
data and strengthen the validity and the stability of the findings (Miles & Huberman 
1994). However if the sample size in qualitative research is too large to allow for a 
deep, in-depth, investigation of a specific case it loses its raison-d’etre: its prime focus, 
which makes qualitative research valuable (Van Manen 1990, Sandelowski 1995). 
Also, in research studies with high levels of complexity, data analysis can quickly 
become unwieldy with large sample sizes (Miles & Huberman 1994). 
        It was anticipated that a sample of between six and twelve participants from each 
participant category would give insight into the phenomenon, whilst remaining 
informative, manageable and achievable within the given research constraints. Van 
Manen (2002) suggests that this sample size is appropriate in conjunction with 
purposive sampling. Published qualitative studies by established research teams into 
psychosocial aspects of inherited disease frequently have larger sample sizes, however 
Miles and Hubermans (1994) suggest that when the sample size is greater than thirty a 
survey design is more appropriate, even when the resources of a research team are 
available. 
 
Reflection on the Choice of Heideggerian Hermeneutical Phenomenology 
      Heideggerian hermeneutical phenomenology was seen as an appropriate and tested 
methodology to use to make intelligible the lived experience of the participants who 
were dying with a family history of cancer. There were, however, two drawbacks to this 
choice. Firstly, as discussed (p35) it was ethically inappropriate to use the term ‘family 
history’ with patient-participants. This presented the challenge of designing a 
phenomenological study where it was not possible to mention the phenomenon under 
investigation directly. For this reason it is perhaps better to describe this study as using 
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the principles of phenomenology. Secondly, phenomenological investigation would 
primarily give insight into the meaning of the lived experience of a family history of 
cancer for participants. It was selected because it was thought this understanding was 
an appropriate first step to providing appropriate care to patients with concerns about 
their family history of cancer. 
        A limitation of Heideggerian hermeneutical phenomenology is that it would not 
produce an objective understanding of the effects of a genetic predisposition, which 
was independent of culture. Rather the aim was to objectively consider how the 
phenomenon of a family history of cancer was engaged with and constructed by the 
participants within British culture at a time when there was an increasing public 
awareness and scientific endorsement of cancer genetics. This limits the ways that the 
information obtained can be extrapolated (Green 2000), as the results need to be 
evaluated in light of researcher and societal bias (See Chapter Eleven). It intended to 
offer a plausible insight (Van Manen 1984) about the effect of a family history on 
patients to palliative care nurses, which could be used to inform the care of patients and 
families.  
 
Conclusion 
       This chapter has presented the ethical and philosophical underpinnings of the 
study. It describes how the sensitivity of the research topic and the vulnerability of the 
research participants were of prime importance from the outset. This influenced the 
decision to undertake an exploratory study of the phenomena. Heideggerian 
hermeneutic phenomenology was chosen for this study as allows the researcher to take 
a deliberate stance. This was consistent with the study rationale, which deemed it 
important to understand how a family history of cancer was affecting palliative care 
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patients in the context of genetic predisposition to cancer. How the philosophical and 
ethical foundations of the study were integrated into the research process is described in 
the next chapter.  
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CHAPTER FOUR: THE RESEARCH PROCESS 
By wisdom a house is built and through understanding it is established. 
Through knowledge its rooms are filled with rare and beautiful treasures 
(Psalm 24:3) 
 
 
Introduction 
      This chapter describes the methods of enquiry that were used during the study. The 
aim of the chapter is to provide a clear description of the research process so that the 
findings can be evaluated with regard to the methodological processes that underpin 
them. The key practical ‘real world’ constraints that affected the research process are 
also discussed. 
 
Defining the Research Question 
        An iterative process (Miles and Huberman 1994) was used to define the 
overarching research question ‘How does a family history of cancer affect the care 
needs of palliative care patients?’ that has guided this study. This was important as 
clear research questions are needed to provide meaningful information with which to 
develop nursing practice (Streubert-Speziale and Carpenter 2003). In qualitative 
research a clear question can prevent unfocused, overly descriptive studies (Mason 
2002) and help ensure that appropriate data is collected to allow the researcher to 
consider the complexities and subtleties of the phenomena under investigation (Miles 
and Huberman 1994). 
      The research question was developed in conjunction with an initial review of the 
literature and of the ethical issues involved. The literature review was undertaken to 
learn what was already known about the topic (Silverman 2005). It helped ensure the 
study did not unnecessarily duplicate previous research (DH 2005) and was part of a 
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cumulative body of knowledge (Silverman 2005). It also determined that the study 
would be an original piece of work (Clifford 1997). 
      The process of defining the research question was started by brainstorming the 
different ways that cancer genetics might affect palliative care. These ideas were 
organised into groupings using a mind map (Buzan 1991). Initially the possibility of 
researching the needs of palliative patients with an identified genetic alteration which 
predisposed to cancer was considered. This was rejected because clinical experience 
suggested that concerns about familial disease were meaningful to patients and families 
who had not had previous contact with specialist genetic services. Practical concerns 
about recruitment were also considered. Consequently the decision was made to focus 
on people with a family history of cancer. 
     The research question first selected was ‘How does a family history of cancer affect 
the care needs of palliative care patients and their families?’  As indicated it was 
initially anticipated that the research would also directly investigate the experience of 
the relatives of palliative care patients. However, as the study progressed it became 
apparent that there were significant barriers to the recruitment of relatives into the 
study. These barriers are discussed in Appendix Three. To take this into account the 
final overarching research question became: ‘How does a family history of cancer 
affect the care needs of palliative care patients?’  
         Although it was recognised that palliative care is a multidisciplinary service it is 
acknowledged that each discipline has its own perspective on patient care (Doyle et al 
2005). In focusing on care needs this research deliberately took a nursing perspective of 
the effect of a family history of cancer on patient care. This was because the study was 
motivated by experiences in clinical practice and a desire to better understand this 
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aspect of care. Nevertheless it was hoped that the study would have resonance for other 
healthcare professionals who work within palliative care. 
       The literature review showed this question addressed a gap in the knowledge base 
(Lillie 2006). Most of the existing research about the psychosocial implications of 
inherited cancer has focused on people who had attended regional specialist clinical 
genetics units to consider predictive genetic testing (Hallowell 1999, Hallowell et al 
2003, Foster et al 2002a, b, Forrest et al 2003) and that there had been less investigation 
into the care needs of patients who had a family history of cancer but had not been 
referred to clinical genetics. The need for research to focus on the patient experience 
was emphasised by Hallowell et al (2004: 554). They state that ‘the fact that much of 
the research in this area (inherited susceptibility to cancer) has focused upon people at 
risk of cancer but who have no personal experience of cancer can be seen as an 
oversight on the part of researchers’.  
       As a result the aims and objectives developed were as follows.                                                              
Aims  
• To describe the experience of a family history of cancer on patients within a 
palliative care setting 
• To understand the meaning of a family history of cancer for patients within a 
palliative care setting 
• To understand how a family history of cancer affects the care needs of patients 
receiving palliative care 
• To describe how qualified nurses perceive and understand the effect of a family 
history of cancer on the care of the family within palliative care 
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Objectives 
• To review, analyse and critique the literature on the psychosocial affects of an 
inherited predisposition to cancer on patients with advanced progressive disease 
• To explore the perceptions of a family history of cancer in palliative care 
patients 
• To explore how nurses working in palliative care perceive and understand the 
care needs of patients and families with a family history of cancer 
• To analyse the data obtained to understand the lived experience and meaning of 
a family history of cancer within the palliative care setting 
• To discuss the implications of the study for the provision of appropriate 
palliative care 
 
Designing the Research Study 
       Prestructured, well-delineated designs provide clarity to qualitative research studies 
and help ensure that relevant data is collected (Miles and Huberman 1994). 
Pragmatically a considered and appropriate research design was necessary to allow the 
researcher to request and obtain access to terminally ill research participants. The study 
design developed was single, semi-structured recorded interviews with a purposive 
sample of six - twelve hospice patients who had a family history of cancer, and six - 
twelve hospice nurses. All the participants were recruited through a hospice that agreed 
to participate in this study.  
 
Design of the Interview Proforma 
       As discussed (p49) the choice of phenomenology had one specific drawback in the 
context of this study: the sensitivity of the research topic. There was a genuine 
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possibility of causing emotional distress to participants with advancing incurable 
disease, through the introduction of the concept of predisposition to cancer within their 
family. Consequently it was not ethically appropriate to ask patient-participants directly 
about how they were affected by the potential that their cancer could be inherited. A 
major design challenge was designing a study that would reveal pertinent and 
meaningful information about the effect of a family history of cancer without directly 
enquiring about inherited genetic predisposition to disease, a focus of interest for the 
study. 
       The construction of the interview proforma was an important part of this process as 
it determined what data would be collected (Holstein & Gubrium 2004). The interview 
process needs to be disciplined and focused around the fundamental question that 
prompted the research (Van Manen 1990). In this study the main challenge was to 
design an interview proforma which would yield relevant and meaningful data about 
the effect of a family history of cancer, whilst minimising the potential that the 
interview would raise new fears about genetic disease and the potential consequences 
of this for the participant’s family. Separate interview proforma were constructed for 
patients and nurses (Appendices Four and Five). They were constructed during a three 
stage process.  
1. Initially direct open questions about how the family history of disease and the 
potential for an inherited genetic predisposition to cancer were affecting 
palliative care patients were considered. This process clearly delineated the type 
of information that the researcher hoped to uncover through the exploration of 
patients’ views. However the questions were unsuitable for use with patients in 
this format due to the potential for causing emotional distress. The proforma for 
the nursing interviews was however completed at this stage. 
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2. The second phase consisted of an attempt to reconstruct the interview questions 
for patient-participants into a suitable format. It was, however, decided that 
even commonly used medical or colloquial language like ‘family history’ or ‘in 
the family’ had the potential to provoke distress in the context of terminal 
disease. Furthermore, it became increasingly apparent that the sensitivity of the 
research topics and the diverse ways that families could be affected by their 
family history of cancer meant that pre-constructed formal questions would be a 
blunt tool with which to obtain relevant information.  
3. As a result a semi-structured format (Robson 2002) was developed. It was 
decided to focus the interviews around three key themes that related to familial 
cancer. These were developed from the questions considered in stages one and 
two. They were: 
• Theme One: Previous experiences of cancer within the family 
• Theme Two: Understanding of cancer 
• Theme Three: How the participants felt that their care needs were altered by 
their previous experiences of cancer within their family and their 
understanding of cancer. 
          Although there were a series of pre-determined prompts to guide the research 
interviews within each theme, it was anticipated that these would be modified or 
omitted depending on what seemed most appropriate during the interview (Robson 
2002). That is, they were topic drivers rather than formal questions. Nevertheless an 
opening introductory question was used to open all the patient interviews. It was 
intended that the introductory question would allow the researcher to be guided by the 
participants’ language and response when formulating questions around the themes 
(Robson 2002). For instance, the question ‘What do you understand about the aetiology 
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of cancer?’ (I10) was used with one participant, Jenny, who described herself as having 
a grade four adenocarcinoma (Jenny), whilst the phrase ‘Where do you think your 
cancer came from?’ (I5) was used with another, Ezra, who had stated that he did not 
like medical language and had chosen not to discuss his cancer with doctors.  
       The use of key themes and prompts utilized the flexibility and adaptability of 
individualised face-to-face interviews (Robson 2002). It had the advantage of enabling 
the researcher to ensure that the interviews covered the same topics and obtained 
comparable responses, whilst allowing for the development of conversation between 
the participant and the researcher to give rich and thick data (Wisker 2001). The 
interview proforma did not contain a highly structured sequence of questions to obtain 
standard biographical data. This was intended to help the interviews feel like a 
conversation with a purpose (Burgess 1984), and to encourage the participants to speak 
freely about their experiences from their perspective (Robson 2002).  
       The researcher had to minimise the potential that the interview would provoke new 
or unnecessary distress about the participants’ own anticipated death (Kendall et al 
2007). Hence the prompts within the proforma focused on the participants’ past and 
present circumstances. The participants were not asked about the future actions they or 
their family members might make, in the hope that this would prevent the interviews 
from leading the participants to think about their own future dying process when 
previous deaths within the family were discussed. 
       Consequently, the design of the interview proforma, with the deliberate omission 
of direct questions or prompts about cancer genetics or family history of cancer, was a 
compromise between the underlying impetus for the research and the ethical 
requirements of the research process. This compromise had two major consequences. 
Firstly, it meant that it was known from the outset that the data collected might focus on 
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the effects of previous experiences of cancer within the family rather than on the effect 
of a genetic predisposition to disease. It was recognised that what was not said could be 
as meaningful as what was said: for example, it was thought that it would be 
noteworthy if the topic of inherited genetic predisposition did not emerge from the 
interviews. The second consequence was the need to be constantly alert during the 
interviews to ensure that questions focused on the three central themes and that the 
prompts used did not promote new fears about a genetic predisposition.       
      The validity of a single qualitative interview has been questioned as the researcher 
may make unwarranted assumptions that they share a common perspective with their 
participants (Angen 2000). Returning the transcripts to the participants to read to allow 
them to confirm whether they have said what they meant to say is recommended to 
prevent this. It also gives participants the option of withdrawing statements with which 
they are not comfortable (Angen 2000).  However, the review of a verbatim transcript 
where oral language can appear incoherent or confused can provoke shock (Kvale 
1996) and leave participants feeling that they have been portrayed as having a lower 
level of intellectual functioning (Dearnley 2005). It was thought this could be especially 
distressing due to the sensitivity of the interview content. However, in this study, the 
decision to use a single interview design was primarily pragmatic. It was taken because 
there was the potential for significant deterioration or death in hospice patients over 
short periods of time and it was thought that returning transcripts to patients might not 
be practical or helpful.  
 
Selecting the Study Setting 
      The decision to complete the research through the auspices of a hospice that 
provided specialist palliative care services (NCPC 2007) was taken early in the research 
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process. It was considered the best location to obtain the sample group required for the 
study (Borssteede et al 2006). The participating hospice provided in-patient services, a 
day centre and specialist community services. Sampling of a single organisation is 
clearly not representative of the broader world due to the potential introduction of 
unspecifiable biases and influences into the research (Robson 2002). The decision to 
access all the participants through one participating hospice was taken in the knowledge 
that it would limit the trustworthiness of the data to provide general recommendations 
for patient care. It represented a compromise between the ideal and the practical 
resource limitations of this project.  
 
Selecting an Appropriate Sampling Strategy  
       A purposive sampling strategy was selected. This is a deliberate, non-random 
method of sampling which aims to access participants with a particular characteristic 
(Bowling 2002). Although purposive sampling does not provide an empirical 
representation of the wider world, it enables the researcher to obtain a relevant and 
strategically chosen sample that covers an appropriate range of contexts to build a well-
founded argument (Mason 2002). Hence data obtained from a purposive sample can be 
used to increase the insight into specific social phenomena, but cannot be used to make 
generalisations about the general population (Green 2000). It is easy to use and has a 
good response rate (Bowling 2000). 
     Purposive sampling requires that the research design clearly and critically delineates 
the parameters of the sample (Silverman 2004). Two sample categories were selected 
with the expectation that they would provide different perspectives on the effect of a 
family history of cancer and allow cross-contextual comparisons of the data to be made.  
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The categories were: 
• Hospice Patients: Hospice patients who had a diagnosis of cancer, and who had 
at least one first or second degree blood relative who had died from cancer 
could participate in this study 
• Nurse Participants: Qualified nurses who were employed by the participating 
hospice and had at least one years experience working in palliative care and/or 
oncology could participate in this study 
 
      A deliberate decision was made to include patients who had a cancer with a clearly 
identified genetic component (like breast cancer), as well as cancers where there were 
no identified predisposing genes. Similarly the decision to use the broadest definition of 
family history of disease (at least one first or second degree blood relative) was taken 
because it was hoped that this would indicate whether people who were at low risk of a 
genetic predisposition  were also concerned about this issue. The principle inclusion 
and exclusion criteria for patient-participants are given in Table Four (see below p62). 
     It was recognised that palliative care is a multidisciplinary service. However each 
discipline has its own needs (Doyle et al 2005). There is an identified need for nurses to 
re-examine the knowledge base that is required for nursing practice as the scope of 
genetics extends to include multifactorial diseases like cancer (Anderson 1999, Frazier 
et al 2004). This is to ensure that there are no gaps in knowledge that would limit the 
evidence base of clinical nursing when dealing with patients and families concerned 
about genetic illnesses (Donaldson 1999). Hence it was decided to focus on a nursing 
perspective, although it was hoped that the study would be meaningful for other health 
care professionals who work within palliative care.  
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Table 4: Inclusion and Exclusion Criteria for Patient-participants 
Inclusion Criteria 
• Participants were patients of the participating hospice 
• Participants had to be physically, mentally and emotionally fit for interview 
and able to give informed consent. This was assessed by designated hospice 
staff 
• Participants needed to be able to speak fluent English. This was primarily 
because there was no budget for an interpreter and because the presence of an 
interpreter might alter the dynamics of an interview. Equally it was not known 
what information about the causes of cancer were available to non-English 
speakers. It was highlighted to hospice staff that participants from all ethnic 
minorities were invited to participate in the interview as long as they spoke 
English 
Exclusion Criteria 
• No participants under Eighteen 
• No participants who were actively participating in other research studies 
  
Designing the Participant Recruitment Protocol         
      Recruitment into research studies in a palliative care setting is known to be difficult 
and many local and national studies have been abandoned due to poor recruitment 
(Ross and Cornbleet 2003, Addington-Hall 2002). This is variously attributed to the 
perceived ethical challenges of research with the dying (Jubb 2002) and the physical 
frailty and rapid deterioration associated with advanced terminal disease (Ross and 
Cornbleet 2003). Hence considerable attention was given to appropriate ways of 
recruiting patients to this study (See Appendix Six).  
       The sensitivity of the research alongside the vulnerability of palliative care patients 
meant that it would have been inappropriate to approach all the patients within the 
hospice about the study. To minimise the potential for harm there was a clearly defined 
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protocol for the: a) identification, b) initial approach and c) recruitment for all 
participants.  
 
Patient-Participants 
a) Identification: Designated hospice staff were asked to identify potential patient 
participants for this study. These nurses were referred to as ‘link nurses’. This 
helped ensure that only people who were physically, emotionally and mentally 
fit for interview and who were able to give informed consent were approached 
to participate.  
b) Initial Approach: The hospice staff were asked to give potential patient-
participants an information sheet and an introductory letter (Appendix Seven & 
Eight). Community patients were asked to complete a reply form (Appendix 
Nine) indicating how they wished to be contacted. This was returned by post. A 
stamped addressed envelope was included. 
        It was recognised that asking hospice staff to distribute the participant 
information leaflet meant that there was the potential for confusion between the 
function of the research and the care-giving role of hospice staff. Seymour & 
Ingleton (2005) suggest that some patients may feel obligated to participate in 
research in gratitude for the care given or through wanting to please their 
caregivers. This may be especially true in the supportive environment of a 
hospice where the social, emotional and spiritual aspects of cancer and dying 
may have been addressed for the first time (Calman & Hanks 1998). Hence care 
was taken to ensure that there was a distance created and kept between the 
research process and the hospice care-giving activities. All written information 
about the research was headed by the University logo and all hospice link staff 
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were asked, verbally and in writing (see Appendix Ten), to ensure that all 
potential participants were aware that the researcher worked for the University 
and was not part of the care team at the hospice. Hospice staff were asked to 
emphasise at all times that participation was voluntary and that the care of 
potential participants would not be affected in any way by their decision to 
participate.  
c) Recruitment: The researcher contacted potential participants at least twenty four 
hours after she was informed by hospice staff that they were interested in 
participating in the study. This was to ensure that all potential participants had 
time to read the information leaflet, which included an outline of the themes that 
would be covered during the research interviews. This allowed potential 
participants to reflect on whether they wished to participate and formulate any 
questions they had about the research process. As people with terminal illness 
frequently experience rapid change in their cognitive function (Rees 2001) staff 
were asked on the day of interview whether they still felt that potential 
participants were able to give informed consent. 
 
Nursing Participants 
      The internal post was used to deliver a covering letter and information leaflet to all 
the qualified nurses working at the hospice. Nurses who considered participating in the 
study were asked to initiate contact using a reply letter (see Appendix Nine), or by 
telephoning the researcher. This meant that the researcher did not directly approach any 
nurse personally to request their participation in the study. This was intended to reduce 
any potential pressure on nurses to participate. Interviews occurred at least twenty-four 
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hours after the potential nurse-participant contacted the researcher so they could 
consider any extra information received. 
 
Obtaining Approval for the Study 
Ethical Approval 
     Ethical approval for the study was obtained from the appropriate NHS local research 
ethics committee (LREC). It was accepted with minor modifications (LREC Number: 
05/Q2707/146). However two of the modifications that were required by the LREC 
directly impacted on the research data obtained. Firstly, LREC felt that due to the 
sensitivity of the research topic and the vulnerability of the research participants, it was 
inappropriate for the researcher to directly ask participants whether they were able to 
discuss their understanding and experience of cancer with the younger generation of the 
family. Hence the prompts in the final interview proforma (see Appendix Four) ask 
more generally about discussions within the family. No specific questions were asked 
about the younger generation of the family unless the topic was first raised by the 
research participants. The second modification that affected the study concerned the 
potential recruitment of relatives as indicated above (See Appendix Three). 
 
Negotiating Access 
    The research proposal was submitted to the hospice research steering group. The 
main concern raised by this committee involved the systems in place to support any 
participant if the research interviews provoked distress. A meeting with the hospice 
social work manager was organised specifically to address this issue. It was agreed that 
all participants would be given the contact details of the hospice’s own counselling 
team, as well as the details of an external organisation, in case they wished to further 
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explore any of the issues raised in the interviews. If appropriate participants would be 
linked with the regional clinical genetics unit so they could rapidly access specialist 
support. 
      Permission to proceed with the study was contingent upon maintaining the 
anonymity of the research participants, a right which is enshrined in law under the Data 
Protection Act (1998). Reassurance was given that the name of the participating 
organisation would not be mentioned in any published data and that identifying details 
about participants would be anonymised. Throughout the research process care has 
been taken to balance consumers need for contextual information with the ethical/legal 
requirement to maintain anonymity. 
      Prior to commencing the research study the project was introduced to the hospice 
staff. Five separate presentations were made to general ward staff, community staff, day 
centre staff, medical staff and the social work team. This was useful as it enabled the 
researcher to discuss the inclusion criteria, the interview proforma and ethical issues 
with staff prior to the commencement of the project, complementing the written 
information provided (Appendix Seven). 
      
Data Collection 
       Interviews have been described as ‘conversations with a purpose’ (Burgess 1984: 
102) and can be considered to be a social situation much like any other human 
interaction (Mason 2002). The interviews for this study were structured interactions. 
Each one began with a review of the main themes of the interview followed by the 
completion of a written consent form (Appendix Eleven), before the tape recorder was 
switched on.  
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       Within the constraints of the research process, every effort was made to promote a 
relaxed atmosphere during the interviews. They occurred in a side room situated within 
the participating hospice or within the participant’s home. The room in the hospice was 
well-decorated with comfortable seating and natural light. It was a familiar 
environment to the participants as they had previously used it for other activities. 
Participants often had a cup of tea perched next to the tape recorder. The researcher 
wore smart casual outfits.   
      The way an interviewer is perceived by a participant can affect the information 
obtained (Robson 2002). It was therefore important to consider both how the researcher 
would be introduced to the patient and nurse participants and to think about how this 
might affect the interview process. The participants were first introduced to the 
researcher through the introductory letter (Appendix Eight). This informed them that 
the interviewer was a nurse by background but the emphasis was always on her role as 
a researcher from the University. Patient-participants were not informed that the 
researcher had considerable experience of working in palliative care. This was to try to 
ensure that participants did not see the interviews as an alternative source of care and to 
enable the researcher to separate her role as a palliative care nurse from her role as a 
researcher. Prior to the interview the researcher was introduced to patient-participants 
as a researcher from the University by a nurse from the hospice. This both reaffirmed 
that the participating hospice supported the project but emphasised that the researcher 
was separate to the hospice. The nurse-participants were aware that the researcher was 
a palliative care nurse. The effect of this on the research findings is discussed in 
Chapter Eleven. 
       The need for research interviews within palliative care to leave participants in a 
safe emotional state has been emphasised (Kendall et al 2007). After the tape recorder 
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was switched off it was acknowledged that the research discussion had covered areas 
that some participants might have found difficult. The process for obtaining ongoing 
support was explained verbally and in writing. It is good practice to thank people for 
their participation in research (Chapple 2006). All participants were thanked at the end 
of the interview. This was followed by a handwritten thank-you card, as this had been 
especially appreciated by participants in a similar study (Grinyer 2004).  
 
The Research Participants 
        Twelve patient-participants and ten nurse-participants were recruited into the 
study. The patient-participants consisted of six men and six women. Of these one was 
single, two widowed, and nine married. Their age ranged from the mid-forties to mid-
seventies. Two of the male participants described themselves as Black-British, both 
born overseas in the Caribbean. Although participants were not asked about their socio-
economic background most participants spontaneously mentioned their occupation. 
These included housewife, refuse collector, cook, heavy vehicle driver, musician, 
council worker, administrator and self-employed business women. Three of the 
participants commented on their lack of formal education and no participant mentioned 
going to university. They all lived within the diverse urban catchment area of the 
participating hospice. 
        The purposive sampling method ensured that all participants had been diagnosed 
with incurable cancer and had been predeceased by a first or second degree relative 
from cancer. No attempt was made to select participants according to any other 
biographical factors. It is known that several participants died whilst data collection 
was ongoing, confirming the advancing nature of their disease. The patient-participants 
have been assigned pseudonyms with a brief anonymised biography. These contain 
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contextual biographical detail about the participants’ family history of cancer. They are 
very basic to ensure the anonymity of patient-participants and their families.     
      The nurse-participants were all female, white, qualified nurses with between one 
and twenty years working within a specialist palliative care and/or oncology setting. 
They included four ward nurses, two day centre nurses and four community palliative 
care nurses. To preserve the anonymity of the nurse-participants personal details have 
not been reported.    
 
The Knowledge Generated through the Research Interviews  
      Interviews that are undertaken for clinical reasons have a very different purpose 
than those undertaken for qualitative research (Britten 2000). The clinical task is to use 
the interview to fit a situation or problem into an appropriate category in order to 
choose an appropriate management strategy. In phenomenological research the aim is 
to discover the participants’ own understanding of a situation (Britten 2000). Research 
interviews can also be viewed as social encounters during which knowledge is actively 
constructed (Holstein & Gubrium 2004), or at the very least, reconstructed within a 
specific context and situation (Mason 2002). Consequently the researcher was aware 
that the participants might not just be describing their family history and the meanings 
that these events had for them but actively selecting a particular narrative or way of 
reconstructing events for the purpose of the interview.  
     This view was reinforced by the first response to the first question during the first 
interview. 
Researcher: So my opening question is, can you tell me about yourself and your 
experience of cancer? 
 
Participant: What do you want to know about me?  Just my illness? (Anne) 
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That is, the first participant interviewed clearly asked that the terms of the research 
interview be made more explicit, specifically whether the locus of the information 
given should revolve around her experiences as a person with cancer or whether she 
could present a broader more holistic picture of herself and her life experiences. Other 
participants also showed their awareness that the interviews were orchestrated 
encounters for the production of situated knowledge by regularly checking that they 
were giving information that was relevant to the research study. 
Is that the sort of thing you want? (Grace) 
 
Are you sure you want to hear all this? (Jenny) 
 
Similarly several participants (especially nurse-participants) explicitly indicated that the 
interview was causing them to re-evaluate their experiences and not just recall them.  
I hadn’t thought about it till now … On reflection now, perhaps not at the time 
… on reflection I think that … (NP3) 
 
That is, some participants acknowledged that the interviews were causing them to 
reconstruct their understanding of events rather than just recall them. Other participants 
appeared to enjoy the research interview as it gave them the chance to simply recall 
past events and talk about the meaning these events had for them in their present 
circumstances. Hence the data on which the analysis is based was both recalled and 
generated (Mason 2002) during the research interviews. 
 
The Research Interviews: The Researcher’s Perspective 
      It was apparent from the first interview that the interviews had the potential to be 
revealing, sensitive and distressing for the researcher. The research interviews with 
patients were challenging due to a) the emotional content of the interviews, b) the 
physical frailty of the participants and c) technological mishaps. 
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     a) The emotional content of the interviews: It had been anticipated that the 
interviews, which focused on previous experiences of cancer within families would be 
sensitive but the full extent of the emotional impact of the interviews had not been 
anticipated. This was partly due to an ongoing discomfort, which was associated with 
the information gathering aim of the research interview as opposed to the care 
management aim of a clinical interview (Britten 2000); but also due to the content of 
the interviews. Inherited genetic predisposition to cancer is associated both with 
multiple experiences of cancer in individuals and families and with experiences of 
cancer at a young age. Hence many participants had experienced multiple deaths, 
including deaths of parents when they were children, deaths of siblings in young 
adulthood, and deaths of children, nieces and nephews. This had been anticipated but 
the full range of consequences for the participants had not. The interviews ranged over 
sensitive issues including childhood abuse, adoption (both being cared for by other 
family members and the demands of adopting family members), suicide and euthanasia. 
Lastly, during one interview the researcher felt that the interview had raised/exposed 
fears about the possibility of inherited disease and the potential implications for the 
interviewee’s children. Due to the emotional demands of the interview, a small 
advisory group was set up to allow the researcher to discuss, in a confidential forum, 
the research experience. This comprised an experienced nurse-researcher and 
psychologist-researcher. 
     b) The physical frailty of the participants: One interview was stopped by the 
researcher because the participant was frail, in pain and fell asleep during the interview. 
It was decided to include the data from this interview in the research as the participant, 
despite being ill, wanted to participate and to use her story to ‘give something back’ 
(Grace). Nevertheless physical frailty did limit the participant’s ability to fully 
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contribute her experience to the study (Chapple 2006). Three interviewees had speech 
impediments due to concurrent disease, cancer or as a side effect of treatment. This 
significantly increased the time required for transcription. 
      c) Technological difficulties: Good recording equipment is essential when 
interviewing people with terminal illness as people who are seriously ill cannot always 
talk loudly or clearly (Chapple 2006). Unfortunately on one occasion the digital 
recorder failed (interview with Claire). However, full notes were written up following 
the interview (within four hours) and it is thought that all the major themes of the 
interview were accurately recorded. These were included in the data analysis although 
verbatim quotes were not available for illustration in the analysis. 
      It is tempting to make assumptions about the meaning of being a participant in 
research (Grinyer 2004). However no systematic attempt to evaluate the research 
experience from the participants’ perspective was made in this study. Several 
participants spontaneously mentioned that they had enjoyed being listened to 
courteously, whilst others clearly wanted their experiences to be used to help other 
families who had had multiple experiences of cancer. Nevertheless it is known that the 
interview actively provoked distress in one participant. The hospice staff supported this 
participant using the systems designed when they agreed to take part in the study (see 
p65). They sought feedback from this participant about whether the research should 
continue. He is reported to have said that he felt it was appropriate and that he would 
choose to be interviewed again. Frank (1997) suggests that telling their story can help 
people construct narrative accounts of their illness and find healing in the process. 
Hence it is hoped, but not known, that the interviews did not cause any ongoing 
distress. 
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Completing Data Collection 
      One important task within qualitative data analysis is the decision about when the 
data collected provides access to enough data, with the right focus to enable the study 
to answer the research question (Mason 2002). This point is usually termed ‘data 
saturation’ (Morse 1995, Robson 2002). However, due to the inductive nature of 
qualitative research, it always remains possible that new evidence could alter the 
conclusions drawn (Morton 2004). Consequently the concept of saturation is contested. 
It has been suggested that it may be a myth (Streubert-Speziale and Carpenter 2003) 
and that the best outcome that can be hoped for is saturation of a specific phenomenon 
at a particular time and location. Van Manen (1990) suggests that phenomenological 
description is never complete but ‘only an example, an icon that points at the thing 
which we attempt to describe’ (Van Manen 1990: 121). He emphasises that the nature 
of human experiences are as infinite and varied as humanity itself. 
      This research was undertaken in the belief that saturation was a philosophically 
flawed concept. As discussed (p44) quantitative data analysis is based on inductive 
reasoning, which means that there is always the potential for new evidence to show that 
the inductive reasoning is false, irrespective of sample size (Morton 2004). However 
the concept of saturation was a useful heuristic tool in deciding that there was adequate 
data to answer the overarching research question ‘How does a family history of cancer 
affect the care needs of palliative care patients?’ albeit within the participating hospice 
in 2005/2006 whilst data collection occurred.  Morse’s (2000) exposition of the 
assumptions underlying the concept of saturation was helpful.  She suggests that the 
size of a study is determined by five factors: the use of shadowed data, the scope of the 
study, the quality of the data, the nature of the topic, and the study design.  Three of 
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these factors were especially important in deciding that an appropriate amount of data 
had been obtained.  
• The Use of Shadowed Data:   Shadowed data refers to data where the 
participants are talking about the experiences of others, and how their own 
experience resembled or differed from the experience of others (Morse 2000).                                
In this study the patient-participants were discussing their relatives’ experiences 
of cancer alongside their own. The nurse-participant data also provided copious 
shadowed data that both enhanced the analysis and helped verify the emergent 
themes. This ‘shadowed experience’ (Morse 2000: 4) is particularly important 
in obtaining an understanding of the range and domain of a phenomenon.  
• The scope of the study: In general the narrower the focus of the study the more 
rapidly the data becomes saturated (Morse 2000). This study was designed 
around a clearly defined, overarching research question. No new information 
was collected about the way the family history of cancer was affecting the care 
needs of patients within the participating hospice at the time the study was 
undertaken – before data collection was discontinued. (For instance, no new 
information was learned from the final three nurse interviews). Nevertheless 
continuing data collection beyond this point gave a deeper appreciation about 
the way people could be affected by the phenomenon of a family history of 
cancer and allowed recurrent discussion of emergent themes which broadened 
the understanding of the phenomenon and increased the validity of the study. 
• Quality of data: Morse (2000) discusses how some participants are able to 
reflect on a topic and express themselves more clearly than others. She notes 
that fewer participants are required when an appropriate sampling strategy 
targets participants with the appropriate experiences and are willing to share 
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them with the researcher (Morse 2000). The purposive sampling used in this 
study was effective in locating participants who were both dying with a family 
history of cancer and who were willing to discuss this experience. Consequently 
the data obtained was rich, experiential and informative. 
 
Data Analysis 
        Gaining insight into the essence of a phenomenon involves a process of clarifying 
and of making explicit the structure of meaning of lived experience (Van Manen 1990). 
This was accomplished using qualitative data analysis, which is characterised by its 
attempt to analyse language with the aim of understanding the way that experiences are 
re/constructed, described and made meaningful (Gibbs 2002).    
      Confidence in this process is enhanced by a systematic and structured approach to 
obtaining meaning from qualitative data (Miles and Huberman 1994). Therefore the 
process of data analysis was structured in accordance with established, well-
documented methods of analysis. Miles and Huberman’s (1994) framework was used to 
complete a content analysis using an iterative approach where codes emerged from the 
participants’ experiences. Miles and Huberman’s (1994) framework describes three 
concurrent flows of activity: data display, data reduction and conclusion drawing and 
verification. However in phenomenology it is necessary to go beyond content analysis 
to develop a nuanced understanding and description of the lived experienced (Hsieh 
and Shannon 2005). This was accomplished using Van Manen’s (1990) schema of 
‘lifeworld existentials’.   
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Thematic Analysis: Data Display  
       The first step in data display was transcribing the interviews then repeatedly 
reading the transcripts to obtain an overall sense of the phenomenon (Hsieh and 
Shannon 2005). The data was then coded using a content analysis approach as this 
allows the categories to emerge from the data. Simple data analysis is a particularly 
useful analytical method when there is limited existing research or theory about a 
phenomenon (Hsieh and Shannon 2005).  
        The initial codes were descriptive but these became more conceptual and 
interpretative as the analysis progressed (Miles and Hubermans1994). For instance, ten 
descriptive codes emerged from the initial coding of the patient data about the causes of 
cancer. These were 
 
• CC-(cancer cause)-bereavement 
• CC-diet 
• CC-environment 
• CC-genetic 
• CC-iatrogenic 
• CC-lifestyle 
• CC-other 
• CC-smoking 
• CC-stress 
• CC-unknown 
 
These initial codes were revised as the analysis progressed (Miles and Huberman 
1994).  
• The cc-smoking, cc-diet and cc-lifestyle codes were merged into one code 
named cc-lifestyle 
•  The cc-bereavement and cc-stress codes were discontinued. They both had very 
little data (each from a single participant). The data within these codes was 
recoded into a code that was emerging as conceptually more meaningful (Miles 
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and Huberman 1994). Hence the bereavement data was recoded into a node 
about the effect of previous familial deaths. 
• The cc-other code was large. On close examination it became clear that the data 
could be sub-coded. It was apparent that some explanations had their origins in 
historical scientific theories. These were re-classified as cc-historical. Others 
appeared to be idiosyncratic environmental explanations for cancer and were 
recoded as cc-environmental-idiosyncratic and became a sub-code of cc-
environment.  
      Coding is not just segmenting data but the act of dissecting transcribed data into 
meaningful segments whilst maintaining the relationships between the different parts 
(Miles and Huberman 1994). The use of a computer software package NVIVO helped 
maintain the link between coded material and their context within the interview 
transcript throughout the project. The process of recoding continued until it was felt 
that all the information had been placed in a conceptually appropriate code.  
      Family trees were also constructed from the data obtained from the interviews as 
they are a succinct means of displaying information (Skirton and Patch 2002). 
However, as the study did not aim to assess whether participants had a genetic 
predisposition to cancer, no attempt was made to systematically collect information for 
this purpose. For instance, there were no probes about the cause of death of aunts, 
uncles or grandparents, nor was information obtained about unaffected siblings or other 
relatives. Hence the family trees (see Appendix 13) are incomplete and probably 
contain inaccuracies.  
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Data Reduction 
       The first step in data reduction occurred after all the interview material had been 
coded. The data was reduced to information that was relevant to answering the research 
question. In practice this meant deliberately extracting codes of data from the analysis. 
There were three subsets of repeatedly occurring data that were systematically removed 
from the data. 
• Information about the participant’s experience of treatment (surgery, 
radiotherapy and chemotherapy)  
• Information about living with the symptoms of advanced incurable cancer (e.g. 
pain, nausea, tiredness, poor mobility)  
• The relationship with healthcare professionals during the participant’s cancer 
journey 
There were also two interrelated areas where it was particularly difficult to decide 
whether or not to include the data. This was information about the non-cancer deaths of 
family members and the deaths from cancer of non-relatives. These deaths had often 
had a significant impact on how the participants viewed the cancer within their family 
and therefore impacted on the phenomena of interest. Nevertheless this was not the 
focus of this study. In practice an individual decision was taken in every case 
depending on how the participants associated the deaths with their own and/or their 
family history of cancer. Hence the fact that a mother thought that the aetiology of her 
cancer was associated with the (non-cancerous) death of her son was included.  Two 
participants discussed suicide within their family at length; one was included as the 
suicide had direct relevance to her present ‘lived-experience’, whilst another 
participant’s concern that his brother had committed suicide due to a particular incident 
was not. Although this incident had significantly influenced the participant’s attitude 
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towards his family and affected his experience of family whilst dying, it did not directly 
relate to the phenomena under investigation. 
       A final key step in data reduction was the selection of appropriate text for display. 
The aim was to find examples that pithily summarised the key issues that arose from 
the interview data whilst ensuring that all the participants’ voices were heard. However 
some participants were more articulate than others and the lucidity of the text was the 
final arbitrator of which quotes were included in the thesis. On occasions, extracts from 
the interview transcriptions are included. This occurs when the meaning of the 
participants’ comments is more clearly understood in the context of the interview. In 
these extracts the researcher’s ‘voice’ is indicated by (I), to signify interviewer.    
 
Conclusion Drawing And Verification 
       The third concurrent activity in Miles and Huberman’s (1994) framework is 
conclusion drawing and verification. This was started by considering the data contained 
within each code. The aim was to understand the underlying patterns and explanation 
for the relationship between these patterns to express new ideas about the phenomenon 
(Richards 2005) whilst maintaining openness and scepticism about any conclusions 
drawn (Miles and Huberman 1994).  
      Codes were clustered into groupings that had similar patterns and characteristics 
(Miles and Huberman 1994). The data within these clustered codes was re-examined to 
look for common emergent themes and conceptual relationships. For instance, within 
the cc-cancer cause nodes discussed above it became clear that the core emerging 
themes contained within the coded data was scepticism about the given causes of 
cancer and the limited understanding of the causes of cancer displayed. (See Chapter 
Seven). 
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        As the analysis progressed the relationships between the different clustered codes 
became more conceptual and interpretative (Miles and Huberman 1994). For instance, 
there were five code-clusters that brought together data about the different ways that the 
participants had been affected by people dying at a younger age than normal. These 
were 
• Parental death in childhood 
• Death of a young sibling 
• Death of nieces and nephews 
• Death of own children 
• Dying young 
The five code-clusters were reflexively analysed.  That is, the information within the 
cluster-codes was read repeatedly whilst asking questions like ‘What is this about?, and 
‘What does this mean?’ (Morse 2008). It became clear that there were several common 
themes that emerged throughout the data. For instance, the cluster codes above all 
contained information about 
• The effect of young adult death on children/childhood 
• Communication issues when a young adult is dying 
• Changes to family structure due to young adult death 
The relationship between these ‘common themes’ and the rest of the data was then 
considered. For instance, was there a difference between the data about communication 
in young adult death and older individuals in the family? Were the themes verified by 
the nurse-participants identifying it as an issue that affected care? The common themes 
that emerged from the clustered codes were linked using Van Manen’s (1990) schema 
of ‘lifeworld existentials’ to systematically describe the phenomenon of the family 
history of cancer for palliative care patients. 
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      Visual displays and mind-maps were a useful heuristic devise for exploring the 
relationship between the different codes throughout the analysis (Buzan 1991). At their 
simplest matrix tables of the different participants’ experiences helped ensure that all 
relevant material remained contextualised during the analysis (Miles and Huberman 
1994). More complex thematic diagrams were also used to assist in the understanding 
of the relationships between the different codes facilitating the development of themes 
(Appendix Twelve). 
       The process of conclusion drawing and verification is also an iterative process 
within Miles and Huberman’s (1994) framework. Verification started during data 
collection. For instance, as the patient interviews progressed it emerged that for many 
participants the experience of earlier multiple primary cancers and the younger age that 
relatives had died had greatly impacted on them. To help verify these findings specific 
prompts about these factors were added to the nurse-participant interview proforma. 
This process continued throughout the research process (see Chapter Eleven).  
 
Lifeworld Existentials as a Guide to Reflection (Van Manen 1982, 1990) 
       The challenge of phenomenology is to go beyond a content analysis to develop a 
nuanced understanding of the lived experience and meaning of a phenomenon (Hsieh 
and Shannon 2005). This was achieved using Van Manen’s (1982, 1990) concept of 
phenomenological existential analysis, which provided a systematic way of reflecting 
on the structures inherent in the experience of a family history of cancer for palliative 
care patients. It allowed the emergent themes to be discussed in a systematic, structured 
and meaningful way. It identified the way the family history of cancer related to four 
existential themes that pervade the lifeworld of all human experiences irrespective of 
their cultural, social or historical significance (Van Manen 1990, 2002). These 
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existential themes are lived body (corporeality), lived time (temporality), lived human 
relationship (communality) and lived space (spatiality).  
• Lived Body: The bodily experience of cancer and death within the family was 
central to the patient-participants’ data. Focusing on the participants’ corporeal 
experience of cancer ensured that the analysis considered the nature of the 
cancer and deaths from which their lived experience arose. As discussed in 
Chapter Three one inherent difficulty in phenomenology is the difficulty of 
isolating the lived experience of a phenomenon from the essence of a 
phenomenon under investigation. The corporeal analysis facilitated 
consideration of the essence of the participants’ experience (See Chapter Five).  
• Lived Relationship: This relates to the way that relationships are maintained 
with others (Van Manen 1984). The patient-participants focused on how family 
relationships were affected by previous deaths within the family and how this 
affected their present experience of living and dying (See Chapter Six).  
• Lived Time: This refers to the subjective experience of time as opposed to 
chronologically measured time. It is the temporal experience of being in the 
world (Van Manen 2002).  For the participants this involved reflection on how 
the past influenced the present, as well as the projection of hopes and fears for 
their family in the future (See Chapter Seven). 
• Lived Space: The study occurred within a hospice, an institution where patients 
receive support for living and dying with advanced incurable illness. This 
chapter focuses on the nurse-participant data as only the nurses were asked 
directly about the phenomenon of caring for patients with a family history of 
cancer in the context of terminal disease (See Chapter Nine). 
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      Heidegger (1967) emphasized that people cannot abstract themselves from their 
understanding of the world (Lopez and Willis 2004). Hence information about the 
patient-participants’ understanding of cancer has been included in this study. This 
information, which links to the way the lived experience was affected by broader social 
and cultural constructs of cancer, is described in Chapter Eight. 
       The focus of hermeneutic phenomenology is on human experience (Van Manen 
1990), hence Chapters Five to Eight focus on the patient-participants’ lived experience. 
The nurse-participants’ perspective on the emergent themes are integrated into the 
findings to enhance the depth of the phenomenological analysis.     
       Although the five existential themes are discussed separately (in different 
chapters), it is important to be aware that they form an ‘intricate unity’ (Van Manen 
1990: 105) in the participants’ lived experience and that the detachment of one 
dimension is somewhat artificial as during the lived experience of any phenomenon the 
corporeal, temporal, communal and spatial aspects are integrated.  
 
Writing 
        Writing up the analysis continued the process of data display, reduction and 
conclusion drawing and verification. Writing has been described as ‘a form of 
cultivated thoughtfulness’ (Van Manen 1990: 127). The process of writing has, in and 
of itself, contributed to the data analysis as it has prompted reflection and rethinking 
about the data. It has been especially useful as an aid to reflecting on what was silent or 
missing within the data (Van Manen 2006). The concept of missing data, which 
originated from the initial literature review, gradually became more evident during the 
process of analysis and re/writing until it became the overarching theme, as ‘The 
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Missing Discourse’ seemed to epitomise the silence about the effect of a family history 
of cancer within palliative care. 
 
Data Analysis: Researcher Perspective 
      As discussed in Chapter Three the study used a Heideggerian phenomenological 
methodology. This assumes that the research will take into account the involvement of 
the enquirer (Moran 2000). It allows the data to be analysed in the light of previous 
knowledge about the phenomena (Lopez and Willis 2004).  Although the study was not 
attempting to ascertain whether participants had an inherited predisposition to cancer 
(rather to consider how a family history affected their care needs), it was motivated by 
the knowledge of inherited genetic predisposition to cancer. Hence it was appropriate to 
take this stance into account at all stages of the data analysis. This influenced how the 
data was reduced, displayed and the conclusions drawn (See Chapter Eleven).  
 
Using the Research Literature 
     As stated above (p52) an initial literature review was undertaken to help define the 
research question. In addition, reviewing the literature has been an ongoing feature of 
the research process. A key function of a literature review in qualitative research is 
concerned with the generalizability of findings (Silverman 2005). With this in mind the 
literature reviewed is considered alongside the findings presented. This shows how the 
findings relate to the cumulative body of knowledge about people with a family history 
of cancer (See Chapter Ten). 
      Different electronic databases were used to search for relevant literature as no one 
database provides comprehensive coverage of the literature (Cochrane Collaboration 
2006). These included Medline, CINAHL, Web of Knowledge, Embase, and the British 
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Nursing Index. They were searched using Sackett et al (2000) schema for dissecting the 
research question in evidenced based medicine, which: 
• Defines who the research is about: palliative care patients  
• Defines the topic under investigation:  inherited predisposition to cancer / 
familial cancer 
• Defines the desired outcome: affect on care needs 
This could also be described as a modified PICO (Patient, Intervention, Comparison 
and Outcome) search strategy (Gerrish and Lacey 2006). The search was limited to 
papers written after 1994, because 1994 was when the breast cancer gene BRCA 1 was 
discovered (Miki et al 1994). Although the idea of a family history of cancer long 
predates this, this discovery led to widespread debate about the ultimate impact of 
genetics on clinical medicine, and discussion about the implications for individuals at 
high risk of developing future disease (Holtzman and Marteau 2000, Conrade and Gabe 
1999).  
       The comprehensive search strategy was helpful in ensuring that as many relevant 
studies as possible were identified and minimised the selection bias within the 
identified literature (Cochrane Collaboration 2006).  It is noted throughout that there is 
a dearth of literature about the affect of a genetic predisposition to cancer on the care 
needs of the terminally ill. However, proving a lack of literature is difficult.  
Consequently other search strategies were employed to ensure a comprehensive subject 
search. This included citation searching, hand-searching, use of the grey literature and 
using ‘human contact sources’. 
      Citation searching is an efficient way of locating relevant literature (Greenhalgh 
2006). It was a helpful strategy with regard to many of the emergent themes (for 
instance, communication about inherited susceptibility to cancer), but less useful with 
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regard to the main research question due to the lack of articles with appropriate 
citations.  
      Hand-searching of journals is a necessary adjunct to searching electronic databases 
because papers may be indexed in a way that makes it difficult to identify their 
relevance for a study (Cochrane Collaboration 2006). The available palliative care 
journals, sociological journals (Mortality; Omega; Death Studies) and nursing journals 
that focused on cancer care were hand-searched. This proved useful in identifying 
information that was relevant to this study.  
     The ‘grey literature’ was also searched for relevant information. This includes work 
of potentially high quality that is not published in peer reviewed sources (Beecroft et al 
2006). DH and NICE documentation have informed this study. Lastly, contacting 
colleagues who have an interest in the research topic can be a fruitful way of locating 
relevant literature (Greenhalgh 2006). This was done, for instance, through professional 
networking at conferences. Despite these different search strategies only a limited 
literature was identified.  
 
Evaluating the Research Literature    
       Critical appraisal of research is necessary to ensure that it is trustworthy, valid, and 
applicable to the context where is going to be used (Robson 2002, Booth 2006). 
Research is commonly appraised using a hierarchy of evidence. These hierarchies 
frequently evaluate quantitative research as having more consequence than qualitative 
research (Greenhalgh 2006, Cochrane Collaboration 2006). Nevertheless it has been 
argued that qualitative evidence is pertinent (when looking for evidence) to evaluate 
healthcare interventions, because of the need to address the impact of change from the 
perspective of the recipient and to take account of the broader environment in which the 
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change is situated (Evans 2003). It is argued that good and valid evidence about the 
appropriateness and feasibility of healthcare interventions can be obtained from 
interpretative studies because they present the patients’ perspective and capture the 
subjective human experience which is often excluded from experimental work (Evans 
2003).  
       In this study the paucity of appropriate and relevant evidence meant that no study 
was excluded because it used a methodology that is not generally considered to provide 
a strong evidence base for clinical practice. Expert opinion papers have been used. 
Expert opinion is frequently systematically biased towards the authors’ opinion 
(Shekelle et al 1999), and can perpetuate bad practice (Greenhalgh 2006). Consequently 
it is regarded as having the lowest ranking within a hierarchy of evidence (Greenhalgh 
2006, Evans 2003). Nevertheless it is used to implement change: notably with the use 
of expert patients in services development (Crawford et al 2002), and deciding when 
clinical guidelines need to be updated (Shekelle 2001).  
      The highest levels of evidence available to inform this study were information from 
a survey, and qualitative evidence (Evans 2003, Cochrane Collaboration 2006). This is 
perhaps unsurprising as qualitative methods are most appropriate for exploratory work 
about new phenomenon, like the emerging understanding of inherited genetic 
susceptibility to multifactorial disease, where many of the parameters are poorly 
understood, ill defined and difficult to control (Greenhalgh 2006). However, assessing 
quality in qualitative research is complex (Pope and Mays 2000), because qualitative 
research is dependant on the subjective experience of both researcher and researched 
(Greenhalgh 2006). Nevertheless much qualitative research (as this study) is based on 
the belief that there is an underlying reality which can be studied subjectively. From 
87 
this perspective, qualitative research is an attempt to represent reality rather than attain 
truth and it is possible to assess qualitative studies against agreed criteria (May and 
Pope 2000).  
       The Critical Appraisal Skills Programme (CASP) qualitative guidelines 
(www.phru.nhs accessed 2006) were used to evaluate qualitative research studies. 
Although both the appropriateness of using criteria, and the nature of appropriate 
criteria are fiercely debated (Mays and Pope 2000, Booth 2006), these have been 
widely used in the evaluation of qualitative research in healthcare.  
 
Conclusion 
     This chapter has described the methodological processes adopted throughout study. 
It shows that the research has been systematically conducted within a specific context 
in a manner that was consistent with the underlying research philosophy. Further 
information about the strengths and weaknesses of these processes with regard to the 
study findings are described in Chapter Eleven.  
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CHAPTER FIVE: THE MISSING BODIES 
(The Lived Body)  
No man is an island entire unto itself …every man is a piece of the continent a part of 
the main ... And therefore never send to know for whom the bell tolls: it tolls for thee 
(John Donne 1572-1631) 
 
Introduction 
     The lived body (or corporeality) refers to the fact that we are present bodily in the 
world and that we meet and know others primarily through their physically embodied 
presence (Van Manen 1990). The experience of death, the annihilation of the physical 
body, was an inherent part of the experience of cancer for all the participants. All the 
patients were aware that they had advancing incurable disease with death being the 
anticipated outcome. Purposive sampling ensured that they had all been predeceased by 
at least one family member from cancer. This chapter is called ‘The Missing Bodies’ as 
it draws attention to the multiple ways that the participants’ families had been affected 
by previous deaths from cancer.  
      With inherited genetic predisposition to disease the family is the patient (Richards 
1996). Hence this chapter considers the patients’ experience of cancer as an integral 
part of their family history of disease. Although this chapter equates to the physical 
dimension of care, it does so in an unconventional manner. Traditionally, palliative care 
has focused on the way cancer affects an individual physically (for instance, their 
symptoms and body image) but this chapter focuses on the physical experiences of 
cancer within the participants’ families. 
This Chapter: 
1) Introduces the Patient-Participants: This spotlights the individual patient’s 
experiences of cancer.  
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2) Reflects on their corporeal experiences: This draws attention to how the 
patients’ experiences of cancer related to the corporeal experiences that are 
common in families with an inherited predisposition to cancer. 
3) Presents a life stage perspective of their experiences: This highlights how the 
participants had been affected by their family history of cancer throughout their 
lives. 
       As stated in Chapter Three, hermeneutic phenomenology aims to go beyond the 
description of experiences to look for the meanings embedded within them (Lopez and 
Willis 2004). However, this chapter presents the situated bodily experiences (Crotty 
1996) of the phenomena within which these meanings are embedded. It primarily 
addresses the first study aim: to describe the experience of a family history of cancer on 
patients within a palliative care setting. It underpins the subsequent chapters which 
focus on the meanings of these corporeal experiences for the participants.                       
 
Introduction to the Patient-Participants   
      Each participant discussed previous occurrences of cancer within their family. A 
family tree was constructed for each participant (See Appendix Thirteen). A brief 
summary of the participants’ experiences of cancer are given below.  
• Anne had breast cancer. She was a sixty year old widow. Her sister, brother and 
niece had recently died from different cancers. A sixteen year old nephew had 
died from cancer approximately twenty years before. Her sole surviving sibling 
had been successfully treated for lung cancer as a young man. 
• Beth had ovarian cancer eighteen years before her present diagnosis of bowel 
cancer. Her elderly father had also died from bowel cancer. She had three 
children. 
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• Claire had breast cancer. Her mother had died when she was five. Her sister had 
died from breast cancer aged twenty-eight and she had become legal guardian of 
her sister’s children. Her elderly father also died from bowel cancer. She had 
four daughters. 
• Diane was a married woman in her fifties. She had five children. Her maternal 
grandmother had died from cancer aged forty-three and her mother aged thirty-
three. She had developed her first primary cancer whilst in her thirties and now 
had metastatic breast disease. Her niece, who was in her twenties, had recently 
been treated for breast cancer.  
• Ezra’s forty year old niece had died in the hospice; his nephew was also dying 
from terminal cancer in his forties. Although he had cancer he did not think that 
it was ‘in his family’ but in his ‘sister-in-law’s family’ as she, like both her 
children had developed cancer and died whilst young. He had seen his 
grandparents die in childhood but was unsure of their diagnosis. 
• Finlay was in his fifties. He had developed the same rare tumour, at a similar 
age, as his mother.  
• Grace was forty-five. Her mother and sister had both died from cancer at a 
young age, whilst her father had died of cancer as an elderly man. Her brother 
was also living with cancer. 
• Harry was the only participant who had been told that his disease was associated 
with a genetic predisposition to cancer by an oncologist. His father had died 
first in his family but two of his siblings had predeceased their mother: one 
leaving five dependant children. A third sibling had recently died whilst two 
were concurrently living with early stage disease. Harry was dying from his 
second primary cancer. 
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• Iain was fifty-five. He had lost his father and an older sister to cancer as a 
teenager. His mother and four other siblings had also died from cancer at a 
young age. A sixth sibling was concurrently receiving palliative care. Both Iain 
and his father had had multiple primary cancers. 
• Jenny was in her fifties. She was the third of six sisters to develop ovarian 
and/or breast cancer. She also had a primary bowel tumour. 
• Keith was sixty-four. His sister, niece and several in-laws had died in the 
hospice from cancer. He had lost both parents by the age of ten but was unaware 
of any details about their deaths. 
• Leon was a seventy year old gentleman with prostate cancer. His only natural 
child had died predeceased him from ovarian cancer aged forty-two. He had 
adopted his granddaughter and two other children, one of whom had died aged 
forty-four (not from cancer). A brother had recently died from cancer. 
 
    These short summaries accentuate how diverse the lived experience of a family 
history of cancer can be for different individuals. For instance, Finlay only drew 
attention to his own experience in the context of his mother’s experience of the same 
rare tumour at the same age, whilst Harry had been predeceased by seven first-degree 
relations. Each participant’s experience gave a deeper appreciation of the way people 
could be affected by the phenomenon of a family history of cancer. Hence Anne, Diane, 
Jenny, and Leon all described the effect of the death of a young, female, family 
member in detail but from different perspectives: that of an aunt, child, sister and parent 
respectively. 
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The Corporeal Experiences 
    All the participants were asked directly about previous occurrences of cancer within 
their family. Three corporeal experiences appeared to be important to the participants 
when they discussed this. These were: 
a) Multiple occurrences of cancer within the family  
b) Dying at a younger age than normal  
c) Living with multiple primary cancers  
 
Multiple Occurrences of Cancer within the Family 
        The impact of previous occurrences of cancer within the family was a major focus 
of the interviews. Table Five gives the details of the deaths and family cancers that 
were discussed in the interviews. 
 
Table 5: Multiple Occurrences of Cancer within the family 
Name Significant Family 
Deaths from Cancer –
1st & 2nd degree 
relatives 
Uncertain 
Diagnosis: 
Possibly 
Cancer? 
Concurrent 
Cancers 
Other deaths 
from Cancer
Other 
Significant 
Deaths 
Discussed (not 
cancer) 
No. of 
1st/2nd  
relatives 
with 
Cancer 
Anne Siblings (2) niece, 
nephew, uncle 
  Brother Husband, 
niece-in law
Parents 
/grandparents 
6 
Beth Father    Son 1  
Claire Father, sister Mother  Son-in-law Husband (RTA)
Brother in law 
2 (?3) 
Diane Mother, Grandmother  Father, Niece   4 
Ezra Grandparents 
Niece 
 nephew niece’s 
mother 
 Parents 2 
Finlay Mother     1 
Grace Mother, Father, Sister   Step mother  3 
Harry Mother, Father, 
Sister, Brothers (2) 
 Brothers (2)   7 
Iain Mother, Father, 
Siblings (5) 
 Sister   8 
Jenny Sister  Sister Cousins  
Cousin’s 
children 
 2 
Keith Sister, Niece Mother, 
Father 
  Sister,  
Nieces (2) 
2 (?4) 
Leon Daughter, Brother Brother   Daughter, 
Brother 
2 (?3) 
*Unsure of the diagnosis of grandparents 
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      All the participants except Ezra had at least one first-degree blood relative with 
cancer, whilst Iain had the most with eight first-degree relatives with cancer. The 
number of relatives (bloodkin) with cancer in the participants’ families (including the 
participants) ranged from between two to nine. The following two quotes show how 
varied participants lived experiences of cancer had been. 
My father:  He had bowel cancer (Beth) 
 
Out of nine brothers and sisters, which there was: there are four left, all the 
other ones have died of cancer. I had a sister die a few weeks ago of cancer ... 
I’ve got another sister, she is completely riddled with cancer (Iain) 
 
Many participants emphasised their awareness that multiple members of the family had 
cancer. 
It seems very unfair that you get so many people, especially as you have got me 
Dad, (three siblings named) and me who all have cancer of the stomach or 
bowel or something like that, and mother had this sort of skin cancer thing 
(Harry) 
 
My niece ... my sister... my brother ...  such a lot of it (Anne) 
 
A lot of members of my family ... are ill ... from cancer (Jenny) 
 
      Most of the people mentioned were first degree relatives. Five participants 
discussed the experiences of second-degree relatives. Jenny and Ezra were the only 
participants who discussed the experiences of more distant relations in detail.  
 
Dying at a Younger Age than is Usual  
      There was a huge variation in the amount of information given by patients about the 
deaths of different relatives. This variation perhaps reflected the different cancer 
experiences within different families, the different periods in the patient-participants’ 
life histories in which the deaths occurred, and their relationship with the relative.  
However there was a consistent trend towards talking about deaths that occurred within 
the younger generation of the family. For example, five patient-participants discussed 
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the deaths of nieces and/or nephews whilst only one participant mentioned the deaths of 
aunts and uncles (see Table Five p93). The main reason for this trend appeared to be the 
increased emotional impact that these deaths had caused due to the young age at death. 
Because my sister didn’t really have a life. … She was so young ... So young, so 
young, but well, it is just unbelievable (Keith) 
 
My mother, she was an old person, and she'd had her whole life. But with my 
sister, and my niece, and my husband, I just thought that it was very cruel 
(Anne) 
 
And because of the consequences of the deaths for the young-children within the 
family. 
She (Sister) had her family; a family of five…  Five girls and she died (Harry) 
She (Niece) was thirty six, she had two children (Keith) 
 
Eleven of the participants had been affected, some in multiple ways, by the affects of 
death occurring at a younger age than usual. Their relationship to these relatives who 
died young is shown in Table Six below.  
Table 6: Young Adult Death  
Patient 
Participant 
Parental death in 
childhood 
(Age at death) 
Sibling death or cancer 
when young adult 
Death of child Death or concurrent cancer
of young relative 
Anne  Brother (Lived)  Niece, Nephew 
Beth   Son  (Not Ca)  
Claire Mother (5) Sister   
Diane Mother (11)   Niece (living) 
Ezra    Niece,  
Nephew (living) 
Finlay     
Grace Mother (15) & 
Step-Mother  
Sister   
Harry  Sister   
Iain Father (14) Sister   
Jenny    Cousins, Nieces & 
Nephews 
Keith Mother (4) & 
Father (10) 
Sister (not ca)  Niece  
Leon  Brother 2 Daughters (one
cancer) 
 
 
95 
For many of the participants the experience of young death interacted with the 
experience of multiple occurrences within the family: 
I lost my Mum to cancer when I was fifteen. My brother has got cancer. A lot of 
the family and relatives, like, have got cancer. My sister died when she was just 
forty-nine ... I’m forty-five. My mum died when she was fifty-five (Grace) 
 
Information about the meaning and impact of the young deaths of relatives from cancer 
for the participants is the primary focus of Chapter Six. 
 
Multiple Primary Cancers 
     Five participants stressed that they themselves had had two different experiences of 
cancer, some at different life stages. This is shown in Table Seven.  
 
 Table 7: Lived Experiences of Multiple Primary Cancers 
Patient Participant First Primary Time between Primaries Second Primary 
Beth Bowel 18 years Ovarian 
Diane Rare Tumour  23 years Breast 
Harry Bowel 5 years Oesophageal 
Iain Stomach 22 years Brain 
Jenny Bowel 3 years Ovarian 
 
I’ve had cancer twice (Diane) 
I’m going back, that was 18 years ago: I had got bowel cancer then (Beth)     
They frequently compared these two different experiences (see Chapter Seven).  
Only one participant discussed a relative who had lived with multiple primary cancers.  
He (father) had cancer of the prostate for quite some time and then he got the 
other cancer and they couldn’t do anything for him (Iain) 
 
It is not known whether the lack of information about this experience in the 
participants’ relatives is a reflection of the relative rarity of multiple primary cancers or 
because participants emphasized how they had been affected by the deaths of relatives 
rather than their relatives’ experiences of cancer. 
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 Reflection on Corporeal Experiences 
       One noteworthy aspect of the corporeal experiences that emerged from this study is 
that they are similar, but not identical to, the indicators of familial cancer that nurses are 
urged to consider when evaluating whether it is appropriate to refer a patient/family to 
specialist genetic services (See Table Two p17). Reflection on the differences between 
the way participants spoke about their family history of disease and the criteria in Table 
Two was revealing as it highlighted differences between the way the participants spoke 
about their cancer and the way healthcare professionals evaluate the risk of inherited 
predisposition to cancer.  
       The experience of ‘multiple experiences of cancer within the family’ included 
information that pertains to two of the criteria commonly used as indicators of an 
inherited predisposition to cancer within the family (Skirton and Patch 2002; Kirk 
2004b): that there is cancer in several generations of the family, and that cancer occurs 
in the same or related parts of the body in different individuals within a family (Table 
Two p17). However it was not possible to ascertain whether the same or related cancers 
occurred within many of the participants’ families because: 
I. Several participants seemed to think that all cancer was the same disease rather 
than a word used to describe a family of diseases where abnormal cells proliferate 
(Kleinsmith 2006). 
 A lot of the family and relatives, like, have got cancer (Grace) 
 
That's when I found that I had cancer (Keith) 
 
II. Confusion between metastatic and primary disease was commonly apparent in the 
interviews: 
In the meantime it had jumped from me prostate into me bones and I had 
the bone cancer as well (Leon) 
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Then my brother died of liver cancer, but it started off as bowel cancer 
(Anne) 
 
III. Lack of knowledge about the type of cancers that other family members had 
experienced: 
A different sort to me, I think. They didn’t put names to those things in 
those days (Diane) 
 
It was a completely different cancer ... but I can't remember. Why do all 
the medical names have to be all the letters of the alphabet (Jenny) 
 
Many participants were unsure about the type of cancer from which their relatives 
had died.  
IV. Lack of clarity about their own disease: 
I forgot the name:  it’s on me records somewhere. It is some funny one 
(Iain) 
 
Ezra had deliberately chosen not be informed about his own disease. He knew that 
he had terminal cancer but not where it was in his body. He said his wife and 
daughter often spoke with the doctors about his illness but that he chose not to ask 
questions. He trusted his wife to make the right decisions.   
V. Communication difficulties within families meant that several participants had not 
been informed of their relative’s diagnosis.  
I didn’t even know she (sister) had died (Iain) 
I said to my sister ‘why didn’t he (brother) tell people?’ and she said ‘I 
don’t know’ (Leon) 
 
This is discussed in detail in Chapter Six 
VI. Although all the participants discussed cancer in at least two generations of their 
families, only two participants gave details about three or more generations of 
their family history as required when completing a family pedigree. 
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      The difficulty of relating the patients’ descriptions of their lived-experience of a 
family history of cancer to the indicators of genetic predisposition emphasised that the 
participants were discussing their experiences as they saw them, with minimal or no 
reference to the discourse on cancer genetics. This suggests that participants were not 
primarily viewing their experiences from within a genetics paradigm. However the 
corporeal analysis emphasises that all the patient-participants had lived experience of 
an aspect of a family history of cancer that could be associated with inherited 
predisposition to disease. 
       The way that many participants emphasised the fact that relatives had died at a 
young age is related to, but not synonymous with the indicator that individuals with an 
inherited predisposition develop cancer at a younger age than is usual (Claus et al 
1990). However, while participants rarely mentioned the age at which relatives had 
been diagnosed with cancer they commonly and spontaneously commented on their 
young age at death.  
        The precise meaning of the word ‘younger’ is ambiguous. For instance, when 
assessing for genetic predisposition different ages are used for different cancers. Hence 
the local regional genetic clinic suggests that for families with breast cancer referral 
may be appropriate when one relative develops the disease before aged forty or two 
before sixty. For colorectal cancer the given ages are forty-five for one relative and 
seventy for two relatives. The term ‘earlier age that expected’ is used for all other 
cancers (www. bwhct.nhs accessed 12/2/2008). For the purposes of this study the word 
‘young’ has been used to refer to any death where the participant emphasised the young 
age of the relative or when the participants’ relatives were known to be fifty-five or 
under. 
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       The corporeal analysis showed how diverse the physical consequences of a family 
history could be within different families. Despite this diversity, the fact that 
participants, when asked about previous occurrences of cancer within their family, 
focused on the deaths of first-degree relatives, alongside the experiences of young 
second degree relatives (for instance, nieces not aunts) suggest that they were salient 
features of the family history of cancer for participants. 
 
 
The Life-Cycle Perspective 
       The life-cycle analysis considers how the participants described being affected by 
cancer during the different stages of their lives.  It was possible to synthesize the 
participants’ experiences (as shown in Figure One) because of the consistent way the 
participants highlighted particular deaths as meaningful.  
 
Figure 1: The Lifecycle Perspective 
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Childhood 
         The deaths described as having the most impact on the participants during 
childhood were parental deaths. This was a significant event for each of the five 
participants who had this experience. Although parental death had different 
ramifications for individual participants, they all felt that it had impacted on their life 
history and their present experience of dying. Three participants had experienced the 
deaths of siblings during their childhood. Only one participant, Ezra, described the 
deaths of his grandparents during childhood as having any meaning or impact on his 
experience of living and dying with cancer.  
 
Deaths in Early Adulthood 
      The deaths that generated most comment from the participants about their early 
adult experiences of cancer were the deaths of siblings. Five participants had 
experienced this (See Table Six p95). These deaths had not only affected the 
participants emotionally because of their siblings’ young age at death, they had also 
affected the participants’ family structures, for instance, it altered the relationship with 
nieces and nephews (see p126). The death of parents continued to generate comment 
(but less information than parental deaths in childhood).  Notably three participants had 
been multiple bereaved by early adulthood (see p127).  No participant discussed the 
death of a grandparent in early adulthood. Three participants had been diagnosed with 
their first primary in early adulthood, causing them to consider their own mortality.    
 
Mature Adulthood  
     The deaths that appeared to have had the most impact on participants during their 
mature adult years were the deaths of the generation below them in the family. This 
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included adult children, nieces and nephews. The details of the deaths of more distant 
young relatives (for instance, Jenny’s cousin’s children) were also meaningful to the 
participants who emphasised their emotional impact. Several participants had also lost 
siblings and parents to cancer as mature adults.  Many of the participants were 
themselves in this age group and were dealing with their own imminent deaths. 
 
Early Old Age 
      The type of deaths that impacted upon participants in early old age appeared to be 
similar to that which affected them in their mature adulthood. The main distinction 
appeared to be in the increasing number of siblings and other relatives that had pre-
deceased them. Participants in this age group were also dealing with their own 
imminent deaths alongside concurrent illness within the family.  
 
Old Elderly 
     There were no participants in this age group. The only patient-participant (Harry) 
who had reached the average life expectancy in England of eighty-one for women or 
seventy-six years for men (http://www.gad.gov.uk/life-tables accessed 6/10/06) was, 
somewhat ironically, the sole participant who had been informed that he had an 
inherited genetic susceptibility to cancer.  
 
Reflection on the Life Cycle Perspective 
       Reflecting on the patient data from a life cycle perspective accentuated the fact, 
noted above, that participants’ data emphasised deaths that occurred at a relatively 
young age, and that young deaths within the family have the potential to affect 
relatives, albeit in different ways, throughout their lifespan.  
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          The pattern of deaths that affected the participants with a family history of cancer 
can be contrasted with the pattern of deaths that might be anticipated in a family with 
sporadic cancer. With sporadic cancer, children and young adults would be expected to 
experience the deaths of grandparents; mature adults, the death of parents, and early old 
age to be primarily affected by the deaths of parents and siblings with relatives who had 
died at a younger age than normal being a less common event. See Figure Two (below 
p104). 
       Investigation into how age at death affects the dying process can be found in the 
literature. This includes information about young adult dying (Grinyer 2002, Kyngas et 
al 2001, Grinyer 2007), death in young families (Willis et al 2001, Sheldon and Tribble 
2004, MacPherson 2005, MacPherson and Emeleus 2007), mature adults deaths (Van 
der Molen 2000a,b) and the elderly (Esbensen et al 2004, Greco 2006). However this 
literature has a tendency to focus on the affect of individual deaths within families, not 
how they relate to other deaths within the family. With familial disease health care 
services are urged to consider the whole family as the patient (Richards 1996).   
      The comparison of the participants’ experiences with the anticipated pattern from 
sporadic cancers (Figure Two p104) underlined the fact that patients with a family 
history of cancer may not only have experienced the deaths of more relatives but that 
these deaths can affect them throughout their lifespan.  
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Figure 2: Comparison of participants’ life cycle with the anticipated pattern from sporadic cancer 
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      The life-stage analysis may also help explain why half of the participants had 
another relative who was concurrently living with and/or dying from cancer. This is 
described as a rare event in the literature (Kissane and Bloch 2002). The participants 
were all mature adults or entering early old age. At this life-stage they are exposed to 
the sporadic cancers (that occur due to lifestyle, environmental and other factors) on 
both sides of the family. If the participants did have a genetic predisposition, it would 
be expected that other relatives who shared that predisposition might also develop 
cancer at a younger age than normal. Other family members, who were not predisposed 
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to cancer, would still be affected by sporadic cancers, (especially older relatives). 
Theoretically this would start to have its greatest impact around early old age: the age 
range of most of the study participants. 
 
Discussion 
       This chapter is called ‘The Missing Bodies’ to draw attention to the different ways 
that participants had been affected by previous deaths within their families. The 
introduction to the participants emphasised the diversity of events encompassed by the 
term ‘family history of cancer’. Although this study was not attempting to ascertain 
whether the participants had a genetic predisposition to cancer (rather to consider how 
their family history affected their care needs), consideration of the participants’ 
descriptions of the previous occurrences of cancer within their families called attention 
to several obstacles to the accurate assessment of risk within palliative care, as 
advocated by Kirk (2004a) and Lalloo et al (2000). Many participants were unsure 
about the details of their own disease and/or their relatives’ experiences of cancer. 
Moreover, the difficulty of obtaining an accurate family tree may be compounded by 
the fact that many specialist palliative services are independent and do not have 
automatic access to NHS patient notes. 
        The wide variety of experiences that constituted the family history of cancer for 
the participants drew attention to the need for sensitivity when this is being assessed. It 
may involve discussing meaningful and significant life experiences, as well as an 
intellectual assessment of the risk of genetic predisposition to cancer within a family. 
The fact that many participants had experienced multiple deaths, often of young 
relatives, stressed the importance of setting aside time for unhurried conversation, to 
allow patients to fully discuss how they had been affected by their family history. 
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Effective palliative care interventions require time, good communication skills and the 
development of a sense of connectedness with the patient (Twycross 2003, Fallowfield 
2005). As the experiences associated with a family history of cancer alongside the 
potential for inherited disease may upset and distress patients and relatives (Mallet and 
Chekroud 2001), assessing the family history of cancer within palliative care would 
require similar skills. 
        Consideration of the findings from a life cycle perspective suggest that, the fact 
that individuals who have a family history of cancer commonly develop cancer and die 
at a younger age than usual, has the greatest and most consistent potential to affect 
participants throughout their lifespan. Deaths that occur at a younger age than normal 
can be inherently stressful to families due to the impact on children and the increased 
emotional response of families: even when they are considered outwith the genetic lens 
(MacPherson 2005, Willis et al 2001, Sheldon and Tribble 2004, MacPherson and 
Emeleus 2007). This suggests that an inherited predisposition to cancer may frequently 
be a pertinent issue in deaths which are already stressful for families due to the young 
age of the family member with incurable cancer.  
       The analysis of the corporeal experiences within the participants’ families called 
attention to three physical experiences within the family that emerged as being a 
common concern to many participants. These were the multiple experiences of cancer 
within the family, the significance of the deaths of relatives at a young age and the 
experience of multiple primary cancers. These experiences are related to, but not 
synonymous with, indicators of an inherited predisposition to disease. The fact that 
these physical events normally have little significance within palliative care, underlines 
the way that the selection of variables considered to be significant changes depending 
upon the paradigm through which the world is viewed (Kuhn 1996). It underlines the 
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need to question basic principles during paradigmatic change (Kuhn 1996). It shows 
how fundamentally different the assessment of cancer within the family needs to be 
when consideration is given to the family history of disease as an integral part of care 
‘within a genetic paradigm’. 
 
Conclusion 
      Applying Van Manen’s concept of the lived-body to Richards’ (1996) insight that 
‘the patient is the family’ with genetic disease clearly emphasises how different the 
physical assessment of care is ‘outwith’ and ‘within’ the genetics lens. Within the 
genetics paradigm the physical characteristics of the family history of cancer are vitally 
important, as a detailed and systematic investigation of the family pedigree can lead to 
the identification of individuals at risk of future disease. Outwith the genetics lens the 
physical attributes of relatives’ cancer have a limited impact on the physical care of 
patients and their families. Nevertheless, previous occurrences of cancer do have the 
potential to affect the psychosocial aspects of care. This chapter contextualises the 
following chapters that focus more deeply but narrowly on how these corporeal 
experiences had affected the meaning of the participants’ experience of cancer within a 
palliative care setting. The next chapter focuses on the effect on the lived-relationships 
within families and discusses how this affected the social dimensions of care. 
 
 
107 
CHAPTER SIX: THE MISSING GENERATION 
(The Lived Relationship) 
 
In every conceivable manner the family is link to our past, bridge to our future 
(Alex Haley 1921-1992) 
 
 
     Relationality is the lived relationship we maintain with others in the interpersonal 
space that we share with them (Van Manen 1990). As we interact with others it allows 
us to develop and to transcend ourselves through shared communication and 
experience. Living in a particular family can inform how we see ourselves and are seen 
by others (Van Manen 1990). Genetic predisposition to disease is not only relational in 
the biological sense that altered genes are passed on in families. It is also relational in 
the psychosocial sense that it impacts on the way that families communicate and 
support one another (Koehly et al 2003). This relational analysis puts the patients at the 
centre of their families and considers how their family history of cancer has affected 
their relationship with their family. It draws attention to aspects of the patient 
experience that are important to the social dimensions of care. 
      The chapter opens with discussion of three themes that emerged from the patient 
data about their lived relationships.  
1)  Family Communication: This theme draws attention to the barriers to 
communication about the family history of cancer despite the participants’ 
preference for open communication 
2)  Family Cohesion: This theme discusses the effect of death on the structure of 
the participants families 
3)  Multiple deaths at a young age: This theme considers how multiple 
bereavements in children and young adults can impact on family relationships 
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    This is followed by the nurse-participant perspective on caring for young adult 
patients as the lived experience of young deaths emerged as a major component of each 
of the three themes discussed above.   
4)  Caring for Adults who Die at a Younger Age than Anticipated: This presents 
the aspect of caring for young adults and families that the nurse-participants 
found challenging 
      The chapter concludes with a discussion about how the altered lived relationships 
due to the family history of cancer may affect the social dimension of patients care. 
 
Emerging Themes 
Family Communication  
     Knowledge of the way families communicate about familial disease is becoming 
increasingly important to healthcare professionals (Peterson and Bunton 2002). This is 
because an individual’s knowledge of their family history can inform them about what 
hereditary diseases may be in their family (Walter and Emery 2005, Walter and Emery 
2006) and because the fastest and most efficient way to trace people at high risk is 
when individuals pass on information about known risk to their relatives (Mester et al 
2005, Wilson et al 2004).  
      All families have their own style of communication and vary in their 
communication patterns (Kenen et al 2004). The importance of family communication 
about cancer and death was stressed by all the participants. They frequently drew 
attention to the different ways that various family members had communicated about 
their disease. Perhaps unsurprisingly in a group of participants who volunteered to take 
part in a research interview, all bar one of the participants were explicit about their 
belief that it was appropriate and helpful to speak openly about cancer. 
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Talking is the thing that helps.  It helps me the most (Anne) 
And somebody will say; don't ask too many questions you might find out too 
much. And I’ve said,’ I'm not worried. Tell it to me now.  Let me be ready’ 
(Diane) 
 
I don’t believe in having secrets from anybody. If people come in here and they 
ask me about how I am they have been told I’ve got cancer (Harry) 
 
     Several participants pointed out they how had benefited from the present culture of 
open communication about cancer. In the past cancer carried metaphorical overtones of 
punishment or curse and people were frequently secretive about cancer in their families 
(Sontag 1978). This attitude has changed with the media placing cancer high on the 
public agenda (Bunyon and Peterson 2005) and research that has encouraged open 
communication with patients (Maguire 1999). The participants felt they had benefitted 
from this in comparison to relatives who had died a generation ago when their family 
and social culture was that cancer was not openly discussed.  
My father never talked about it … I don't think people talked about things so 
much in those days … Because I've got people I can talk to and I do talk to …so 
I don't think I worry about those things … I think mainly the strength that I get 
is from the nurses I talked to, plus from my daughter particularly, and my 
husband (Beth)  
You see in our days, in our younger days, you never talked about cancer. The 
big C was a (whispers) big secret (Leon) 
 
      Several of the patients described particular incidents within their family where they 
felt that poor communication about cancer and death had adversely affected their 
family relationships. The difficulties that occurred within the family when secretive or 
obstructive communication patterns (Peterson 2005) were used by other family 
members had made some participants deliberately choose to communicate openly about 
their disease.  
My sister … she knew at the end but she never told anybody … It was a 
horrendous time. A horrible, horrible time…. When my other sister got hers 
(Diagnosis of cancer) I said ‘look we had such a terrible time. Let’s tell 
everybody you have got it: let’s tell everybody … So when I was diagnosed two 
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months later she said to me, ‘we will tell everybody shall we’ ...  I tell everybody 
about it (Jenny) 
He (Brother) had never let anybody really know that he had, that he was 
suffering and he just died. It was a shock to us him dying. Put it this way, me 
father and me sister, they were suffering over twelve months or eighteen months 
before they died and we knew eventually it would catch up with them (Harry) 
 
      One participant also stated that poor family communication had affected their 
ability to assess their family history of cancer. Leon felt that this had contributed to 
delays in the diagnosis of his disease. 
When I came down with the prostate, he (Doctor) asked me if any other member 
of the family had it … I said no. When me brother died, I found out that he had 
had prostate cancer and he had got over it: they had treated him ... but if 
anybody else in the family had it, I don’t know (Leon) 
 
As he thought that his prostate cancer might have been treatable at an earlier stage he 
felt that the lack of family communication might have contributed to the fact that his 
illness was terminal. He also regretted that he had not had the opportunity to discuss his 
illness with his brother as he thought that this might have been beneficial and helpful 
for him. 
I couldn’t discuss it with me brother, cause I didn’t know nothing about it. He 
died before I was finally diagnosed (Leon) 
  
      Only one participant did not advocate open communication. Although Grace 
participated in the study (hoping it would benefit others), she found the topic of cancer 
difficult and distasteful.  
I didn’t want to talk about it …We’ve all had cancer but we didn’t talk about it. 
I mean it isn’t nice (Grace) 
 
However, even she described how angry and frustrated she felt at her family’s inability 
to discuss her illness and impending death with her. 
I told my family. At least I tried to talk to them about it but they don’t seem to 
want to know. … they try to change the subject. It makes me very, very, very 
angry (Grace) 
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      The perceived benefit of open communication was that it increased family cohesion 
and support: 
Since I’ve had this cancer, me two sisters ... They have made contact with me 
more (Iain) 
 
And I think if you do tell people you’ve got the cancer ... I think people treat 
you, you know, a little bit better. They know you have got a serious illness and 
they make allowances (Leon) 
 
     Family patterns of communication are challenged when the content of the 
communication is stressful (Panke and Ferrell 2005). Timely, sensitive, open and direct 
communication within families is essential to living well with familial disease (Rolland 
2006). This study highlights the fact that the participants felt that open communication 
within families was equally important in the context of terminal disease. Although they 
consistently promoted open communication the research interviews highlighted two 
specific contexts that could make communication about a family history of cancer 
difficult. These were 
a) Communication in Families with Young Children 
b) Communication about Inherited Genetic Predisposition 
 
Communication in Families with Young Children. 
      Ten of the patients described the deaths of relatives who had young children. The 
participants’ family history of cancer meant that they had either experienced parental 
death as children, watched as siblings had tried and/or failed to communicate with their 
nieces or nephews or had to discuss their own cancer and impending death with young-
children (see Table Six p95). Discussion of parental illness and death with young-
children is complex (Forrest et al 2006, Holt 2006) and the difficulty of communicating 
with children was a recurring concern within this data.       
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       Children want to know the truth and to be informed and involved in family events 
(Landry-Dattee & Delaigue-Cossett 2001).  They may suspect that something is wrong 
before they are formally told about their parent’s illness (Forrest et al 2006). 
Participants who had experienced the death of family members during their childhood 
often clearly recalled their inability to instigate conversation or questions about familial 
illness as children.  
He (brother) died … something to do with his blood when he was a child. That 
may have been a cancer, I just don’t know. They never talked about it and in 
them days you didn’t talk about cancer (Leon) 
And we didn't ask questions where people do now: but you didn't ask questions 
when you were a child (Diane) 
Three of the five participants who had lost a parent in childhood were uncertain about 
the cause of their parents’ death.  
My mum probably died of cancer, you know. I wouldn’t know … I don’t know. I 
don’t know, I don’t know whether they would call it cancer then? Because, I 
was four, and it was sixty odd years ago. My father died, he was fifty-one, Eh, I 
don’t remember, I was ten (Keith) 
 
One participant thought that he had been deliberately misinformed by his father who 
had not been able to discuss how serious his illness was with his children. 
He said to me it was a cyst on his stomach. But it was like this (indicates extent 
with his hands), it was out here. And it was cancer (Iain) 
 
      Barnes et al (2000) found that the most common reason that parents gave for 
choosing to withhold information about their initial diagnosis of cancer was to avoid 
talking about cancer and death. Parents, even those who normally communicate well 
with their children, find it difficult to discuss their own, or their partners’ approaching 
death (Landry-Dattee & Delaigue-Cossett 2001). This can be because the parent has 
real difficulty in accepting that they are in the terminal stage of illness and find it easier 
to talk about treatments. It can also be because they do not know what words to use to 
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explain their illness to their offspring or because of fears about their children’s response 
and a desire to protect their children (Landry-Dattee & Delaigue-Cossett 2001).   
     Communication and the quality of family relationships are important for preventing 
adverse long term consequences (Hurd 1999). Difficulties in communicating about a 
parent’s death appeared to persist, even for participants who thought that their family 
cohesion (see below) had been strengthened because of their childhood bereavement. 
We've only just started talking about it. … My sister said to me,’ can you ask 
aunt (named) a few questions about mum? And I said ‘Oh, well, I'll see’, I don't 
like going down that road.  But I'm going to see her next week, and I might 
bring it up, and sort of see what she says (Diane) 
 
     The participants’ parents’ deaths happened at least a generation ago. However poor 
communication with children may still be widespread, for instance, one retrospective 
study of death in single parent families found that half of the children were not aware of 
the custody plans that had been arranged for them (Willis et al 2001). A study of 
bereaved children in Scotland (MacPherson 2005) also found that many children had 
not been told of their parent’s impending death.  
 
      Telling a child that they have a terminal illness is one of the most difficult tasks that 
parents have to face (Brennan 2004, MacPherson 2005). The difficulties involved were 
stressed by those participants who were dying with young children, (and Diane who 
had been told she would die from her first primary cancer when her children were aged 
two to fifteen).  
 About how long I’ve got to live. And how painfully, painfully it affects my 
children and my husband ... I’m worrying at the moment. I don’t want to leave 
them here … It scares me ... My only worry at the moment is my two kids 
(Grace) 
 
As noted above (p111) Grace did not feel she had been able to discuss her illness 
satisfactorily with any of her family. Nevertheless she had a plan to initiate 
conversation with the whole family (including her youngest child).  
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I’m going to like, make a meeting ... Go for a meal, and I’ll ask them what they 
want to do with me, when I die ... And thing like that. And I’m going to let them 
know what I want (Grace) 
 
Parents know their children better than any healthcare professional and it is good 
practice to support parents in their efforts to communicate with their children in the 
manner that they think will be most supportive for the children (Brennan 2004, 
MacPherson 2005). The participants accentuated the difficulty of doing this.  
They don’t want to talk about it because I think they are frightened to talk about 
it. So, sometime I do mention a certain thing, which, especially my younger 
daughter, she just cannot accept. She just don’t want to talk about it. Sometime, 
my older daughter she will ask me questions about it but the younger one … 
(unable to continue) (Iain) 
 
Diane underscored her shock when she realised that her husband had told their children 
about her anticipated future death and how she had wanted to protect them from this 
knowledge until they were older. 
They were too young … my husband talked to them and told them, ‘I just heard 
from the doctor.  I don't know how long mum will live’.  I said, ‘What! You can't 
say that to the kids’ (Diane) 
 
        Strong negative emotions in children are common in acute parental illness 
(Leedham and Meyorowitz 1999). These participants were very aware that their 
children were being affected by their impending death. They drew attention to the way 
that this had altered their relationships with their children. However the changes they 
described were very different in each case.  
And my third child ... He said ‘I'm coming with you, mum’ … he meant he 
wanted to come with me when I die … I mean, he was crying … And then he 
turned out to be a horrible little trial.  He was quite beyond me and he gave me 
a lot of problems at school and all that (Diane) 
 
Hence Diane emphasised how her son had wanted to be close to her as she was dying 
and had dealt with the knowledge of her illness in a way that meant that she had to 
focus on his needs as well as her own. This can be contrasted with Iain’s experience 
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where he perceived that communication about his cancer had caused a distancing 
between himself and his teenage son. 
My lad at first was distanced to me: ‘You’re never going to die’ like, or ‘you are 
never sick’. And he is realising how bad I am because I am using the wheelchair 
and things. He is shocked I know that. He is like me; he is holding it back (Iain) 
 
This account of continuing to hold back suggests that Iain still felt distanced from his 
son, and was still holding back from discussing his advancing illness and impending 
death. This description highlighted that communication with children is an ongoing 
process (Brennan 2004) and that their understanding of the imminence of death can 
change with time, especially as the symptoms of the illness become more overt. 
       All three of the participants who were dying (or had faced death) with dependant 
children had lost a parent in childhood. Although they were conscious of this, 
  I thought, ‘Oh no, this is history repeating itself’ (Diane) 
none of them made an overt comparison between their childhood experiences and their 
lived experience as a dying parent, but they all consistently emphasized the importance 
they placed on communicating with their children. 
       Participants who had seen other young-adult relatives die also regularly 
emphasised the importance of, and difficulties in, communicating with children. They 
emphasised the tragedy and sadness inherent in discussing parental cancer with children 
even when it done well by a family relative. 
She had a little boy a couple of years ago…  It happened at Christmas time, just 
about Christmas time. She was telling her son then (Diane) 
 
They also described how difficult it had been to watch what had happened when 
relatives had not been able to talk about their cancer with their children before they 
died.  
She did not prepare her children. It was horrendous. She died on her son’s 
birthday and we felt completely ... (participant can’t find right word) (Jenny) 
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       Good family communication is important for children’s psychological adjustment 
to illness (Leedham and Meyorowitz 1999, Hurd 1999). Non-verbal communication is 
also important (Brennan 2004). It is important to note that many participants, even 
those who said they found talking about cancer and death difficult, highlighted that they 
had good memories of other ways that they had been involved in caring for their dying 
relatives. This included good memories of being able to participate in the practical care 
of their relatives. 
And about me mum … I used to make her drinks when she said she wanted them 
... I liked doing that. She was asking me … I would wait for her to wake … I was 
there to help her (Grace) 
 
They also commented that that being present at their parent’s death had been 
meaningful to them. Harry was nineteen when his father died: 
I was there when he died … there was a friend of me mother’s that was there 
and she went in to see him, and she said ‘you had better come quick’ and I went 
in … and he was dying. He died of cancer; he died of that cancer (Harry) 
 
Conversely, Diane repeatedly commented how difficult she had found it that she had 
not been permitted to care for or visit her mother in hospital whilst she was dying: 
My mother... She was in hospital, she had an operation, she had treatment, and, 
it was too late when they got her sadly ... it was a traumatic time, she was taken 
away and I never saw her again.  Well, I seen her, and my other sister seen her, 
but she was in the mortuary at the time.  And, it wasn't a very nice picture to see 
of your mother, was it? (Diane) 
 
      In this study, the communication issue that was most frequently highlighted as 
being complex and stressful was communication between a dying parent and their 
young children. This suggests that the fact that individuals from a family with an 
inherited predisposition to cancer are likely to die at a younger age than is usual (Risch 
2001) can be a barrier to individuals who wish to know about their family history of 
cancer, due to the difficulties that parents have discussing their illness and impending 
death with children. The fact that three of the participants who had themselves lost a 
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parent as a young child had developed cancer whilst they had dependant children shows 
the potential for the repeated intergenerational experience of young adult death to make 
communication of an accurate family history of cancer very difficult and complex. 
        Only a small number of studies have specifically considered how the knowledge 
of inherited susceptibility to disease is passed on (Wilson et al 2004, Kenan et al 2004, 
Metcalfe et al 2008). However it is known that ‘barriers that may hinder disclosure to 
close or distant relatives include family rifts and tensions, divorce, separation and a 
desire not to cause alarm’ (Forrest-Kenan 2005: 210, Green et al 1997, Forrest et al 
2003). This list is notable because it does not mention previous deaths within the 
family. This study suggests that death, especially the death of young adults with 
dependant children can be a barrier to communication about the family history of 
cancer. 
 
Communication about Inherited Genetic Predisposition 
      The interview with Iain drew attention to the difficulties of introducing the topic of 
genetic predisposition with palliative patients. It revealed that he was concerned about 
his family history of cancer because he was very aware that a genetic predisposition to 
cancer could have real and significant implications for his children’s future. He was 
openly worried and emotionally distressed when he called attention to this: 
My only worry at the moment is my two kids. I was wondering if there was any 
way that they could be screened? To see if they have got cancer cells …I just 
wondered if they had then whether they could get it treated at an early stage 
(Iain) 
 
As Iain became emotionally distressed whilst discussing these fears the tape recorder 
was switched off during part of the interview. 
        There is a consensus that children should not be tested for adult onset genetic 
illnesses because there are no known medical benefits for them in having this 
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information, and the psychosocial consequences of this information for children are not 
well understood (World Federation of Neurology 1990, Clarke and Flinter 1996). 
However, most children obtain their information about genetic disease within their 
family, from their interactions with adult family members (Tercyak et al 2001a,b). 
There has been little research into the best way to inform and counsel children about the 
possibility of inherited predisposition to disease (Miesfeldt et al 2003), although a 
meta-synthesis of this (limited) literature suggests many parents struggle with 
communicating about this topic with their children (Metcalfe et al 2008). Nevertheless, 
there is evidence to suggest that children have concerns about ‘inheriting’ cancer. For 
instance, one study of young adult breast cancer survivors found that just over half of 
the participants said that their children had expressed concern about developing cancer. 
Participants were more likely to have discussed this risk with their older children. They 
felt that any concerns should be dealt with by parents rather than professionals 
(Miesfeldt et al 2003).  
      Iain later recommenced the interview to explain why he did not want to discuss the 
possibility of genetic predisposition with his young-children: 
They will find out that it is hereditary or whatever the word is and it will start 
them worrying. It might knock them out of all their studying, I’d rather they did 
their studying than thinking about cancer ...  And to tell the kids, oh, you have 
got cancer, blah, blah, blah. You might get it in five years time or whatever; I’d 
rather them not know about it (Iain)  
 
         Tercyak noted that ‘it is important that children know that a positive test result is 
not equivalent to a cancer diagnosis and should not be treated as such. Rather it is an 
indictor of risk’ (Tercyak 2002: 152). Iain’s statement ‘And to tell the kids, oh, you 
have got cancer’, suggests that he, himself, had not fully understood this distinction. It 
is a very subtle distinction that might be very difficult for children to make if the 
subject was first raised by a parent with advancing incurable disease. Iain’s 
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ambivalence about his children becoming aware of the potential for inherited disease 
was emphasised by his suggestion that he would raise the topic (by proxy), after death 
(sic): 
When I do die I’ll have a word with my missus about getting them screened. In a 
couple of year’s time: That way they are older and should understand more 
(Iain)  
 
The interview with Iain emphasises how difficult it could be to discuss an inherited 
predisposition to disease with dependant children in a palliative setting. It suggests that 
the attendant practical and ethical dilemmas that attend genetic counselling for parents 
and children (Hallowell et al 2003, Sherwin 2004) could be intensified in the context of 
advancing incurable disease. With Iain’s permission and in his presence his concerns 
were disclosed to the hospice team after the interview. This was both to ensure that he 
was supported emotionally following his disclosure of his fears about his children’s 
future, and to allow him more time to consider whether he wished to be referred to a 
specialist genetic service. 
      Although communication about inherited genetic predisposition within families is 
known to be complex (Green et al 1997, Forrest et al 2003, Foster et al 2004, Kenan et 
al 2003, Kenan et al 2004, Patenaude et al 2006), Iain’s distress about the ramifications 
of family communication about the topic of inherited predisposition to cancer appeared 
to be exceptional in this study. Relatively little other information about the difficulty of 
communicating about the family history of cancer emerged.  
       Other participants had discussed their fears that cancer could be inherited with their 
adult-children: 
I do tell my kids now, be careful …because it could be inherited, so be careful 
(Finlay) 
 
I think it’s hereditary ... and sometimes I say to my son, particularly, that you 
should have checkups (Beth) 
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It is noteworthy that none of the participants who mentioned these discussions with 
their adult-children suggested that it had been a particularly difficult conversation, 
rather it appeared that they were a part of their ongoing efforts to ensure open 
communication about their disease within the family. 
      All the participants who mentioned discussing the potential for familial disease 
within the family had done so with the same intent, which was to encourage other 
family members to access preventative measures to reduce their relatives’ chances of 
dying from the disease. Open communication about cancer risk was particularly 
important to the only participant who had been predeceased by an adult-child. He 
repeatedly linked the need for open communication about cancer to the potential for an 
inherited genetic predisposition to cancer.   
We talk about it ... I mean we have already had two; me daughter and myself. 
So we are not afraid to talk about cancer. I keep telling (grand/daughter) that 
she must do, because we don’t know how her mother got her cancer so ...  I keep 
telling her to have a check up, any lumps, you know what I mean. I tell her to 
have the smear and anything else. I say you are (Daughter named) daughter and 
if it is hereditary, you’re liable to have it you know. So keep yourself checked 
(Leon) 
 
He wanted to ensure that his grand/daughter took advantage of cancer screening in case 
she developed cancer like her mother. He also talked about how the reality of losing 
two adult-children had meant that his surviving grand /children had to face the 
possibility that their deaths might also occur prematurely.  
So now the other two are reaching their forties. In fact they joke about it. They 
say ‘well, what about us? One of us is going to die at forty six and the other at 
forty eight because there was two years between them (Leon)  
 
       These pragmatic statements contrast with the earnest deliberation about 
communication within the family that has been documented in families who have made 
contact with genetic counselling services (Forrest et al 2003, Foster et al 2004, Kenan 
et al 2004, Gaff et al 2005). These studies document the importance that clients place 
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on informing other family members and the careful consideration that the participants 
had put into deciding whom to tell, when to tell and how to tell, including clients 
making concerted efforts to contact distant family members - even choosing 
intermediaries to discuss concerns about family members who might be at risk of future 
disease.  
      It has been shown that the knowledge of an inherited predisposition to cancer can 
invoke guilt (Lerman et al 1998, Mallet and Chekroud 2001), especially with regard to 
children (Van Oostrom 2007). However, none of the participants in this study 
expressed any guilt about the possibility of passing on their family history of disease. 
This might indicate that there is a genuine difference between having a family history 
of cancer and having a medically-endorsed inherited predisposition to cancer. This may 
be because genetic testing can reposition clients (Scott et al 2005) and alter the way 
they perceive illness within the family. These findings suggest that the psychosocial 
sequellae of a known genetic predisposition which frequently includes guilt (Mallet and 
Chekroud, Van Oostrom 2007) are not necessarily present in patients with a family 
history of cancer.  
 
Family Cohesion  
      The family is a complex, relational social system that allows for the exchange of 
resources like information and support (Koehly et al 2003). There has been research 
into how the knowledge of an inherited genetic predisposition to cancer affects family 
cohesion (Koehly et al 2003, Edwards and Clarke 2004, McDaniel et al 2006, Van 
Oostrom et al 2007). Cohesion is defined as the sense of togetherness or emotional 
bonding within a family (Van Oostrom 2007) and reflects the level of commitment, 
help and support that families provide for one another (Edwards and Clarke 2004). 
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However these studies have not primarily focused on the effect of death within families 
with a family history of cancer. 
        The death of a parent in childhood had the most significant effect on family 
cohesion in this study. All five patients commented on the way these deaths had 
affected their experience of childhood. In particular they noted the emotional impact 
that it had had on them: 
That was the whole terrible experience: that was it really. I have got over it, but 
it took me a while.  It took me a while to recover (Diane) 
 
That seems tragic. You know, to think that it actually happened (Keith) 
 
But they also described profound changes in their experience of family life. Claire 
described how her mother’s death when she was five had left her and her siblings open 
to physical and emotional abuse by her father. Her descriptions were graphic and were 
a major theme within the interview. The long lasting impact of this abuse was clearly 
illustrated when she described the scars on her back from the abuse as being much 
worse than the scars from her surgery. Diane also suggested that her childhood would 
be ‘in the News of the World now’. As she was the eldest daughter she took increased 
responsibility for caring for her seven siblings at aged eleven, and described, with 
humour, the lengths the family had gone to, to keep the authorities out and maintain 
family life.  
I’d go to school one week, my sister would go the other week, and she was 
nearly two years younger than me ... And we had no help, there was no help 
coming in. And we had this guy come in, I think he was a child officer or 
something, and I was in the house on my own. … And he said ‘who has done 
that?’ (Cooked & Baked). And I said that I had; … I was told not to say nothing 
(Diane) 
 
Nevertheless Diane felt that the experience of parental death had strengthened the 
relationship with her respective siblings and extended family: 
I was eleven and a half, the second eldest.  The youngest one was one and a 
half, so we had to look after each other.  You can imagine (Diane) 
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This was also strongly emphasised by Keith who was the only participant who had lost 
both parents in childhood: 
I could have been an orphan, but you don’t think about that because I wasn’t. 
Because your brothers and sisters they just look after you ... We all lived 
together (Keith) 
 
       These participants commented that this still affected their relationships with their 
family at the time of interview. They felt that their relationship with their siblings was 
closer because of the experience of parental death in childhood.  
So, I think I am quite close to all the family, like that being a mother, cause I 
used to, I brought them all up (Diane) 
 
I think it makes me closer to the family I’ve got ...  I’ve got a lovely family ...The 
family is there and so you have got to be there for them (Keith) 
 
This close relationship was demonstrated through practical support. For instance, 
Diane’s family were arranging a last family holiday where she and all her siblings and 
children would visit her ailing father together (See p154). Keith’s family had organised 
a rota where at least one sibling visited daily. These visits happened whether he was at 
home, hospital or an in-patient in the hospice.  
I’ve got such a wonderful family it is just a matter of who I speak to. I think I 
see one of my brothers or sisters once a day. Because they come and see me, I 
think they are worried about me (Keith) 
 
Hence two of the participants reported a strong family cohesiveness, which they 
directly associated with the way their family had pulled together when their parent died 
in childhood. These participants reported specific benefits from their families’ ability to 
function together to support them. When cohesiveness in families is high it can buffer 
them through the dying process (Kissane and Bloch 2002).  
      In contrast, other participants’ experiences illustrated how early parental death had 
caused or contributed to a breakdown in their family cohesion. Claire had left home as 
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soon as possible. She had had no contact with her mother’s family since her mother 
died when she was five. She very much wanted to know what her mother looked like.  
She did not have any photographs and wondered if any of her grandchildren took after 
her mother. She was considering contacting the Salvation Army to see if they could 
trace any relatives on her mother’s side so she could meet them before she died. Iain 
also felt that parental death had adversely affected his childhood. 
I never had much of an education. I’ll be truthful, I’ve taught myself discipline 
and all, as I’ve got older (Iain) 
 
 He also left home at an early age and simply said:   
And I’m not in touch with me family much (Iain).   
Poor family cohesion was also having an ongoing impact on these participants’ present 
circumstances. Like Claire, Iain had tried to reconnect with his surviving siblings when 
he had been told that his cancer was incurable. Although his two surviving sisters had 
responded to his overtures he had been distressed by his sole surviving brother’s 
response: 
Me one brother, I don’t think I’ve seen him in about twenty years. And he said 
he thought I’d be dead by now already (Iain) 
 
Poor family cohesion is a factor that can predispose to higher levels of psychological 
distress and depression (Edwards and Clarke 2004).  
       The death of a parent is a non-normative life transition and the loss of both mothers 
(Shultz 2007) and fathers (East et al 2006) has been shown to have ongoing 
ramifications in adults. This study shows that the participants felt it was still affecting 
the support they received from their families. However, it was having very different 
impacts on different families. It is beyond the scope of this study to disentangle why 
parental deaths had such different effects on the cohesion of the different families. 
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       The change in family cohesion was not restricted to participants who had lost a 
parent. It was also noted by other participants who had lost other young first degree 
adult relatives, especially the way that their contact with their relative’s children had 
altered. Two participants had adopted their deceased relative’s children. Claire, whose 
sister had died from breast cancer aged twenty-eight, had become the legal guardian for 
her nephews. She had maintained contact with them, spoke of them with affection and 
was proud of their on-going achievements. Leon had also adopted his grand/daughter. 
However two other participants commented on how much harder it had been to 
maintain contact with their deceased relative’s children following their deaths.  This 
was because of the difficulty in maintaining contact with relatives-in-law.  
We felt our hands were tied … He (Brother-in-law) didn’t even want us to know: 
her sisters and brothers and my mother particularly (Jenny) 
 
She was 36, and she had a little boy ... so the little boy was with her husband; 
That was that (Anne) 
 
It is known that genetic information can be interrupted if a parent dies as aunts and 
uncles feel that they do not have the authority to talk to nieces and nephews about 
inherited disease (Forrest et al 2003, Wilson et al 2004), and lack of regular contact 
with relatives is a barrier both to communication about genetic risk and to knowledge 
about cancer in the family (Koehly et al 2003, Mesters et al 2005). Findings from this 
study suggest that the death of a parent may lead to relatives of the deceased parent 
feeling that even general continued contact with their in-laws is discouraged after death, 
never mind discussion about inherited susceptibility to disease. 
        In this study, the deaths of parents, siblings and children which occurred at a 
younger age than normal had the most consistent and significant impact on the 
participants’ family structures. This is more likely to occur in families with a family 
history of cancer (Risch 2001). Foster et al (2002) suggest that the deaths of younger 
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relatives can be seen as suspicious and unnatural causing other family members to 
worry about the possibility of inherited cancer. Few of the participants in this study 
appeared to have made this link. Their concern was more focused on the emotional and 
practical impact that these early deaths had made on their experience of living and 
dying as part of a family with a family history of cancer. These deaths had both 
increased and decreased family cohesion. This in turn, has the potential to make 
contacting people about their potential risk of disease both easier and more difficult. It 
shows that in some families with a family history of cancer deaths of young adults will 
reduce family cohesion. This can limit their ability to know whether their family history 
of cancer indicates that they are at high risk of developing future disease (Koehly et al 
2003, Mesters et al 2005).  
 
Multiple Deaths at a Young Age  
         It was notable that for three of the participants who had experienced parental 
death the impact was compounded by other significant deaths whilst they were children 
or in their very early twenties.  
Unfortunately my eldest sister has died. … I was probably twenty then. …, 
twenty one … She was in her thirties. She looked after us when my parents died 
(Keith) 
I was fourteen when me dad died ... Then me sister died on me fifteenth birthday 
of cancer. … She was in her late twenties (Iain) 
 
These sibling deaths generated much less data than the parental deaths and appeared to 
have had less effect on the participants’ family structures or communication patterns. 
Nevertheless they emphasised the potential for repeated bereavements to affect 
individuals whilst they are still young where there is a family history of cancer.  
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Multiple bereavements within a short time space can have both immediate and long 
lasting consequences for children (Kaufman and Kaufman 2005, 2007).  
      Grace’s story also demonstrated how the deaths of significant others who were not 
blood kin could also cause repeated bereavement. Her mother died from cancer when 
she was fifteen, her father had remarried but her step-mother then died of cancer when 
she was in her twenties. During the interview there was a ‘slip of the tongue’ when she 
said ‘I was ten years with my mum: My step mum.’ (Grace). It led her to comment that 
she still missed and grieved for both her mothers. Very little has been written about 
grief and loss in children from reconstituted families although this is increasingly 
common in Britain due to remarriage after widowhood and divorce (Sheldon and 
Tribble 2004). There is a need to develop a better understanding of the complex 
emotional and familial issues involved (Sheldon and Tribble 2004).  
      The nurse interviews also raised the way multiple bereavements could affect the 
dying process and impede family coping. One nurse described how the death of a 
young adult was affected by the fact that her mother had died of the same cancer before 
her.  
We had a young girl who had cancer of the bowel, which was sort of in the 
family. Her mother had died of it, and she was only nineteen and she was dying 
of it. She … couldn’t cope and her father he just couldn’t take it in. …  Because 
it had killed her mother, he couldn’t cope with her having it. Her sister hadn’t 
got it, but she had responsibilities to her in-laws and her own children... So it 
was just horrible and messy (NP8)  
 
In this scenario the complexities inherent in young-adult deaths (Grinyer 2002, 2007) 
were compounded by the stress of multiple occurrences of cancer within the family. 
The stress on the family system was such that it was faltering due to the complex 
emotional and social stressors that familial cancer had placed upon it. This meant that 
the family was not able to cohere into a unit to care for the dying. When the nurse 
reflected on the challenges that the scenario had made on the hospice team she said: 
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What I learned was that there isn’t an easy answer … And the thought that she 
hadn’t got her mother to look after her, to be tender with her. Her father 
couldn’t look after her. Her sister was doing her best but was struggling … It 
was lonely, it was horrible, it was ever so lonely (NP8) 
 
This scenario is similar to the life histories of the participants who had lost both a 
parent and sibling as young adults/children as given above. Interestingly, the nurse’s 
strong emotional response to this scenario contrasts with the patient-participants’ much 
briefer descriptions of their sibling deaths in childhood /early adulthood. The nurse’s 
description of the scenario, (which had occurred several years before the interview) 
demonstrated how a family history of cancer can significantly affect the psychosocial 
and emotional care needs of patients and families receiving palliative care.  
      Although the nurse-participant stated that the cancer ‘was sort of in the family’ and 
highlighted that her ‘sister hadn’t got it’ the nurse did not describe any specific actions 
that were taken due to the risk of heritable disease. However the complexity of the 
emotional and psychosocial distress emphasises the difficulties of leaving discussions 
about a family history of cancer until the dying phase. It also highlights the difficulties 
of finding a ‘right’ time, as the daughter was dying just as she left childhood, leaving a 
sister with young children possibly unaware of their future risk of disease. In addition, 
multiple losses can put great strain on families (Kissane and Bloch 2002). The nurse 
emphasised the emotional needs of the patient’s father and sister. The comment ‘that 
there isn’t an easy answer’ underlined her understanding that caring for a family where 
a family history of cancer has made it difficult for them to cohere together provides 
complex challenges for the palliative care team.  
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Caring for Adults who Die at a Younger Age than Anticipated 
      The patient data presented above suggests the fact that individuals with a family 
history of cancer die at a younger age than normal had the greatest effect on the patient-
participants’ family relationships, and that this could be compounded by the potential 
for families to experience multiple losses of young family members. None of the nurses 
spontaneously associated the occurrence of cancer at a younger age than normal with 
familial cancer, however, when prompted, they all emphasised that the deaths of young 
adults frequently presented them with complex challenges; even without the issue of 
inherited disease.     
      The prime reason for this was because dying at a young age was perceived as 
untimely: 
I think, although it is almost ridiculous to say it, you associate death with old 
age don’t you (NP6) 
 
Several of the nurses contrasted the acceptance of death in elderly patients with a 
feeling that life had not been fully lived when a younger patient was dying. 
Because there is an acceptance of death, when you are older, more so than 
there is when you are young (NP3) 
 
Whereas mainly with the elderly… mainly they have said to me …’I have had a 
good life and I am ready to go’ … You don’t really get that with the younger 
people or only with difficulty (NP8) 
 
      Cancer and impending death can challenge any patient’s self-identity, especially 
their body image, family, social and work relationships (Van Der Molen 2000a,b). All 
the nurses stated that dying young commonly increased these challenges, especially 
with regard to emotional and spiritual aspects of care.   
Physically I don’t think it makes much difference at all but mentally, 
emotionally, spiritually it does make a big difference (NP5)  
The younger deaths that I have seen here have all seemed more intense. … I 
suppose there is more anger and more questions (NP2)  
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It is the shock element of somebody younger dying. And the questions, why me? 
Why has it happened to me when I have still got my life ahead of me.  I think 
that is much more difficult to deal with, sometimes (NP4) 
 
       Illness is known to interface differently at different stages in the family lifecycle 
(Brouwer-Dudokdewit et al 2002, Rolland 2006). The nurses highlighted the stress 
involved for all the family when a young adult was dying, including spouses: 
The younger husbands and wives … I can see one husband looking at me, 
hoping that I will say that it will be OK. And I can’t: and that is hard (NP3) 
 
And parents: 
 
The wrong order for the parents. It is the wrong way round. The parents say 
that it should be me not the child going first (NP1) 
 
But most participants described the main difference as being the care needs of children 
whose parents were dying: 
Also somebody younger is leaving behind dependants, people who depend on 
them, and that makes it all much more complicated (NP5)  
There are obviously different support needs if you are trying to support children 
through that experience (NP3) 
Particularly if there are children at home: they don’t want to die at home ... 
they don’t want the children to get distressed (NP8) 
 
        When confronted with life threatening illness each family member has to redefine 
their expectations of themselves and their relationship with one another (Altschulter 
2005). The way the patients’ family interacted with one another was also said to 
influence the need for nursing care, with families of young patients who worked 
together as a unit being more able to support one another. When family members were 
unable to cohere together to care for the patient, nursing was more complex:  
They may have got previous partners and current partners, mothers and fathers 
who don’t get on. And it is never just the patient; it is a whole melee of other 
things going on (NP8) 
The way that each of the member of the family reacted was so different:  It was 
a very, very exhausting assessment (NP1) 
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Several nurses commented that they frequently accessed the resources of the 
multidisciplinary team when caring for young adults because of the inherent emotional 
stressors for patients and relatives. 
You can never really plan for how people are going to feel but basically I think 
you are in for a tumultuous time with young people who have got palliative 
cancer. … You just know that you are in for a rough ride … you have to have a 
team meeting and get the whole team on board because there is such a 
multiplicity of problems (NP8) 
 
This highlights the importance of adult palliative care nurses being able to refer to a 
multidisciplinary team. This is a necessary and appropriate resource within palliative 
care (Munroe 2005, Doyle 2005).  
      Lastly, young adult deaths were the one topic where it emerged that the nurse-
participants themselves found their work stressful. All except one of the participants 
commented on how they personally found it more stressful to care for younger patients. 
The extra complexities of care included the difficulties of ‘being with’ (Andershed 
2006, Johnson and Smith 2006) a young patient who did not want to die: 
And I think that it is much more difficult to be with someone who says ‘I want to 
live, I haven’t lived’; than to be with someone who says ‘when my children were 
little they did this and we did this’ who …  tells you their story than to be with 
someone who says I want to live my story (NP6) 
I know we struggle as a team of nurses when we have had a young person in 
who is dying. Especially when he has a reason, every need to stay alive (NP3) 
 
They also drew attention to the way watching children loose a parent affected them. 
Very, different emotionally ... Especially if there are young children involved for 
them. Then we become really sad (NP6) 
 
I think a lot more strain on us, I feel. It is always very difficult with the 
youngsters, all the way through. They deserve a lot more time that you haven’t 
always got to give (NP1) 
 
Children of dying parents may manifest significant distress (Beale et al 2004). They 
need age appropriate information to understand about cancer: its nature and meaning, 
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treatment and prospect of death (Laundry-Dattee and Delaigue-Cosset 2001, Kaufman 
and Kaufman 2005). Findings from this study suggest it was stressful for the nurses to 
provide this care. However it is known that palliative services that support children and 
surviving adults who commit to caring for children after a death can help those 
children’s ongoing response to bereavement (Rolls and Payne 2003, Beale et al 2004). 
       The deaths of young-adults were the only scenario raised where the nurse-
participants consistently stated that they felt stressed when providing care. This perhaps 
underlines how much young-adult death impacts upon the care needs of palliative care 
patients. As none of the nurses were aware that dying at a younger age than normal 
could be related to familial cancer, they were unable to comment on how these stresses 
might be compounded by inherited susceptibility to disease. However it does highlight 
that concerns about inherited disease are likely to occur in conjunction with care needs 
associated with deaths in young adults that are already challenging and stressful for 
nurses. 
 
Discussion  
      This chapter is called ‘The Missing Generation’ to draw attention to the way that 
previous deaths within the family (especially the deaths of young adults) had resulted in 
changes to family structures and difficulties in family communication about death, 
cancer and inherited disease. This chapter has described how the family history of 
cancer can affect family relationships, subtly altering the social dimensions of patients’ 
care.  
      Traditionally, ‘outwith the genetics paradigm’ palliative services have concentrate 
on supporting people with strong societal, emotional and care-giving links to a patient 
(NICE 2004), rather than considering why patients have close supportive family 
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structures or less cohesive family structures.  Poor family communication and cohesion 
can make it harder for family members to support one another during the dying process, 
whilst strong cohesion can enhances families’ ability to support members through the 
dying process (Kissane and Bloch 2002). The nurse-participants found caring for 
families with poor cohesion more difficult as they tried to support the different needs of 
different family members 
     ‘Within the genetic paradigm’ the issues of family cohesion and communication 
have an altered significance. They are important because family communication is the 
primary way that people learn about their risk of an inherited genetic predisposition to 
disease (Forrest et al 2003). Poor family cohesion and communication can prevent 
relatives learning about the cancer in their family, thus preventing them from accessing 
appropriate health prevention measures. The analysis of the participants lived 
relationships suggests that it is the fact that individuals with a family history of cancer 
are more likely to develop cancer at a younger age than normal (Claus et al 1990) that 
has the greatest potential to impact on family cohesion and communication. Findings 
further suggest that the deaths of young adults with dependant children could be a 
significant barrier to communication about cancer within the family. Although all the 
patient-participants drew attention to the benefits of open communication, they 
consistently emphasised the difficulties of communication about dying with young 
children. Difficulties in family communication meant that several participants were 
unaware of the cause of deaths of first degree relatives.  
       Findings also suggested that the young age of children at death could be a major 
barrier to communication about inherited predisposition to cancer. Iain drew attention 
to how emotionally distressing it could be for parents to consider introducing the 
subject of inherited susceptibility to cancer when a family member had advancing 
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incurable disease. In this study all the participants who had discussed the potential for 
an inherited genetic predisposition to cancer with adult children had done so in the 
context of an overall decision to discuss cancer openly within their family. This 
suggests that discussion about inherited disease presupposes a willingness to discuss the 
illnesses and deaths of other family members in the context of death. This, in itself can 
be difficult for relatives of dying patients (Kissane 2008), and communication about 
death with children is difficult even for parents who prioritise open communication 
(Kaufman and Kaufman 2005).   
       The nurse-participants found caring for young adults stressful, especially if the 
patient involved, had young children. Although none of the nurse-participants were 
aware that developing cancer at a younger age than normal was associated with 
inherited cancers, they all felt that there were inherent stressors associated with caring 
for people who were dying at a younger age than normal. This suggests that the issue of 
inherited susceptibility to disease has the potential to complicate care scenarios that 
were inherently challenging for palliative care nurses.   
      Caring within the genetics paradigm would demand looking beyond the present 
practice. New challenges would include helping families communicate about the 
potential for an inherited genetic predisposition. This may be a particularly stressful 
issue for families with dependant children, although no similar distress was expressed 
when participants described discussing the issue with adult children. The genetic 
paradigm would similarly demand a change in perspective when assessing family 
support. It highlights the need not only to care for family members who are presently 
supporting patients, but also to question whether previous occurrences of cancer had 
affected the family cohesion and the support available. Similarly, caring within the 
genetics lens would accentuate the need to consider why individuals have undergone 
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multiple bereavements, alongside providing appropriate support. This could present 
new stressors to patients and nurses in a scenario which was already stressful for both 
participant groups.  
 
Conclusion 
      This chapter shows how the fact that individuals with a family history of cancer are 
more likely to develop cancer at a younger age than normal (Clause et al 1990) can 
have a significant affect on the lived-relationships within families. It shows how family 
communication and cohesion can be affected. It underscores the potential for 
individuals within the family to have been multiply bereaved at a young age. It drew 
attention to the way the nurse-participants described caring for young adults and 
families as being inherently stressful, especially if there were young-children involved. 
Finally, it calls attention to the way family communication and coherence are important 
issues within the genetics paradigm because they impact on individuals’ knowledge 
about familial disease. (This is discussed further in Chapter Ten). 
     Although these issues affect the social dimensions of care, and primarily affect the 
lived relationship with other family members, they are obviously closely interwoven 
with the emotional care needs of patients. Hence it is important to consider how a 
family history of cancer can affect the emotional needs of patients. This is the focus of 
the next chapter. 
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CHAPTER SEVEN: THE MISSING FUTURES 
(Lived Time) 
 
I  think the best physician is the one who has the providence to tell the patients 
according to his knowledge the present situation, what has happened before, and what 
is going to happen in the future (Hippocrates) 
 
Introduction 
      The temporal experiences of past, present and future are the horizon of a person’s 
lived experience of time (Van Manen 1990). The past influences the way that the 
present is experienced, both through vivid memories and near-forgotten experiences. 
The way that the past is conceptualised and interpreted may also change due to the 
pressures and influences of the present (Van Manen 1990). Similarly, expectations 
about what the future may hold influences the decisions and choices that are made in 
the present (Van Manen 1990). This chapter reflects on the temporal dimensions of the 
participants’ experience of previous occurrences of cancer within their family and 
previous primary cancers. Reflection on the data from a temporal perspective revealed 
how the patient-participants’ temporal focus changed when they discussed their 
experiences of cancer with regard to inherited susceptibility to disease.  
       This chapter addresses two issues. The first section draws attention to four 
temporal dimensions identified in relation to the experience of multiple occurrences of 
cancer in the family. These are 
• Past to Present: ‘Shadows in the Mind?’  This theme describes how patients 
were affected by previous occurrences of cancer within their family. 
•  The Lived Present: ‘In it Together’: This theme looks at the effect of 
concurrent cancer within the Family 
• Present to Future ‘No Man is an Island’: This discusses the participants’ 
perspectives on the future 
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• Present to Past: ‘Re-evaluating the past’ This theme looks at how changed 
understanding of the aetiology of cancer made participants re-examine their past 
This is followed by a discussion of how the potential for inherited disease altered the 
patients’ concerns about the previous experiences of cancer within their family.  
       The second section of the chapter presents the temporal analysis of the information 
obtained about multiple primary cancers. Two temporal themes emerged from this data. 
They are 
• Past separate from present ‘The Past is Another Country’ 
 
• Past continuous with present ‘BOGOF: Buy One Get One Free’  
 
The analysis concludes with a discussion about how knowledge of an inherited 
predisposition to cancer has the potential to affect the way patients perceive the 
experience of multiple primary cancers. 
       Reflection on the data from a temporal perspective drew attention to the emotional 
dimensions of the care needs of the terminally ill with a family history of cancer. It 
underlined the way that participants’ emotional needs changed depending on whether 
they were describing their family history of cancer in the light of the potential for 
inherited disease or were focusing on their own cancer journey.  
 
Temporal Analysis of Multiple Occurrences of Cancer within the Family 
Past to Present:  Shadows in the Mind? 
    This theme documents how past occurrences of cancer within the family affected the 
patients’ present care needs. All the participants (patients and nurses) were directly 
asked about this. The patient responses fell into three categories: a) participants who 
felt it had no impact, b) participants who felt it had had a minor impact due to their 
increased awareness of death, and c) one atypical patient who described how the 
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previous occurrences had a major impact on their present needs. The nurses’ responses 
also suggested a range of effects, which have been triangulated with, and presented 
alongside the patient data. This shows how the nurse and patient data corroborated each 
other and enhanced the understanding of the phenomena 
 
a) No Impact  
      Almost half the patients did not think that previous occurrences of cancer within the 
family had affected their present care needs. 
No, I don't actually think so (Beth) 
No ... it's not something I think about every day, you know (Diane) 
       Claire elaborated on the reasons that she did not think that previous deaths had 
affected her needs; stating that she was five when her mother died so she could not 
remember any details, and that her sister had died in a different country so she had not 
been very involved whilst her sister was ill or dying. Other participants emphasised the 
lack of impact by indicating that they had not even discussed their relatives’ 
experiences of cancer with hospice staff. 
I have never mentioned to anybody here that my mother had the same (Finlay) 
Have you wanted to discuss what has happened in your family with the 
hospice?(I) 
No (Grace) 
       Many of the nurse-participants also thought that the family history of cancer had 
little impact on the care needs of palliative care patients. In fact, several nurses initially 
had difficulty answering the opening interview question: ‘Can you tell me about a 
memorable scenario where a previous experience of cancer had a significant effect on 
the care needs of a patient?’ The immediate responses included: 
I can’t think of a significant one at the moment … It is not something that I can 
recall with patients at all (NP8) 
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Gosh, you mean have I actually nursed a patient here who has had another 
death in the family? (NP3) 
 
Oh, I’ll have to think: You mean when it had an effect on the actual patient? 
(NP9) 
 
Some of the nurses were themselves surprised and interested by this: 
One of the things that I have noticed … is that often there is a family history. 
For that reason I am surprised that I can’t think of more examples of people 
who are afraid and I think that is interesting (NP5) 
 
b) Minor Impact: Increased Awareness of  the Dying Process 
    The most commonly perceived effect, which was emphasised by half of the patients 
and all the nurse participants, was that previous experiences of cancer in the family 
could increase the awareness of death and make the present threat of death more 
concrete. 
Really I think I could die because, well really, nobody has survived cancer. My 
sister, my niece, they didn’t survive (Keith) 
 
Yes it has changed things really. We realise, my wife and I, that cancer is a 
dangerous thing (Leon) 
 
I watched them, you see, I watched them ...  And I just sort of gradually, over 
the time, watched them deteriorate (Anne) 
 
Even Finlay, who had not discussed his family history of disease with hospice staff, 
reflected on how it had made the reality of death more imminent from the start of his 
own cancer journey. 
It has affected my own experience because, thinking about it, back to the 
hospital where my mother was. She died at the same hospital where I had the 
operation. She died there at the hospital (Finlay) 
 
       A few patients also described how their increased awareness of the dying process 
had affected them. Three participants specifically stated that it had made it more 
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difficult for them to deny the fact that referral to palliative care services indicated that 
their disease was incurable.  
I’ve got a sister who died of cancer. She died in here, and her husband died of 
cancer. He died in here. My niece, she died in here … I was apprehensive 
because my sister and two brother-in-laws died. And the illusion was that you 
go to (Hospice Named) and you don’t come out (Keith) 
 The practice nurse ... and she offered to put me in touch with the Macmillan 
nurse or a hospice nurse.  Well, I was horrified, because I thought hospice - 
death. So I said ‘No, I don't want that. I don't want to go anywhere near’ 
(Jenny) 
 
         However, Jenny also drew attention to the way she felt her increased awareness of 
death due to her family history of cancer meant that she was more able to discuss her 
illness and death openly than other patients in the hospice. She had initially been 
surprised that other hospice patients had not accepted that they were dying from their 
cancer and had deliberately modified the way she talked with other patients.  
I tell everybody about it (Terminal Cancer) ... I mean, some of the ladies here 
have not accepted cancer.  They died in the course (of aromatherapy) that we 
were having ..., I mean, one lady died in the three or four weeks. She hadn't 
accepted that she had cancer then.  And so I thought you've got to be very 
careful about how you talk to people. I thought they are not all like you (Jenny) 
 
      Iain also felt that his increased awareness of death had affected his response to 
cancer.  He had been predeceased by six first degree relatives with cancer and felt this 
had helped prepared him for his own diagnosis, as his increased awareness had reduced 
the shock of his experience: 
I feel in no way shocked over what is happening to me (Iain) 
He said that his oncologist had been surprised by his acceptance that his treatment 
regime might not prove curative. 
He (Oncologist) said ‘and if the treatment don’t work, what then?’ I said ‘well if 
I’ve got any spare parts that are any good: flog them’: I said ‘because they are 
no good to me are they’. And he just looked at me. He said ‘you’ve accepted it’ 
and I said ’well we have all got to die sometime haven’t we?’ 
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And although he was ambivalent about the way his awareness of death affected him, he 
did appear to think it made him accept the reality of his terminal prognosis. 
I’ll be truthful love, if I die, I die  …  Out of nine brothers and sisters, which 
there was, there are four left, all the other ones have died of cancer… And it 
upset me but I have got to accept it. We are all going to go and that is how I 
have accepted everything. I’ll be upset for a couple of hours, or a day, but after 
that I’m OK. I’ve accepted it.  (Iain) 
 
Iain’s awareness that he was dying meant that he had actively tried to put his affairs in 
order to support his family. 
And I’ve accepted everything. I’ve even done me will. I’ve sorted out for me 
kid’s education; the two youngest ones.  ... if I die while still employed my two 
youngest are paid to go to university and everything (Iain) 
 
He also felt it had helped him to make an informed decision about his place of care. 
We (Iain and Nurse) got talking and we sorted things out: That when I am ready 
to die that I come in here. And she says I can. And I’ve arranged for (family 
named) to be here as well (Iain) 
 
          Adapting to dying is one of the most monumental challenges that people have to 
cope with (Natanga 2003). Houghton states that his awareness that he was dying grew 
as his illness progressed and ‘from remembering the experiences of others’ (Houghton 
2001: 74). Findings from the patient data suggest that one way the family history of 
cancer can affect patients is by increasing their awareness that they were dying. They 
appeared ambivalent about how this affected them: both highlighting the increased 
distress associated with referral to hospice, which they associated with death, whilst 
also drawing attention to the ways that they felt they were better able to discuss and 
plan for their dying process than people who had not had their experiences. 
 
       The nurses also drew attention to the way previous experiences of cancer in the 
family could increase the awareness of the dying process. They described both 
beneficial and detrimental effects from this: that it could be a double edged thing 
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(NP5). They noted that the increased knowledge base that previous experience of 
cancer could give patients could be advantageous. They thought it empowered patients 
to participate more fully and autonomously in treatment decisions.  
But I thought she was very much in control of what was happening to her … 
What the future held. So in a way I felt that my role was less important in her 
case than others in a practical sense. Because so often when people are very ill, 
they need your input, your support, your knowledge whereas she … with her 
history, was more in control and would kind of suggest to us, to me, what she 
wanted or what she thought would be appropriate (NP3) 
 
They are probably coming in with a lot more knowledge as well, about the 
system and the situation, drugs and medication (NP7) 
 
They kind of knew what to expect more ... They do because they know what kind 
of care they are likely to get. … And they do take that care on board (NP6) 
 
 I have heard ...  comments like’ oh well I know what to expect because my mum 
died of this’ or ‘my mum died of this too’. That kind of thing, so maybe that does 
help prepare them (NP9) 
 
It was also suggested that it allowed them to better anticipate, and therefore control, 
ongoing events in their dying trajectory.  
The good side is that if they have an anticipated idea of what to expect … And it 
gives them some control over something which is uncontrollable (NP3) 
 
Two nurses specifically highlighted that they felt it enabled people to make a more 
informed choice about where they wanted to die.  
They have an awareness about what help is available … And therefore they 
know it can be done at home, rather than have no experience and thinking that 
this person will have to go to hospice or hospital (NP1) 
 
Reviewing past experiences is one way that patients learn about cancer (Friesen et al 
2002). The nurses suggested that patients’ prior experience of disease could be a tool 
that enabled patients to maintain their independence and autonomy whilst utilising 
hospice care services. Maintaining independence and control has been shown to be 
important in preserving the quality of life of palliative care patients (Johnston and 
Smith 2006).  
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      Despite this, the nurses regularly highlighted that previous experiences of cancer 
within a family were not invariably or automatically beneficial to patients, but rather 
depended on the specific characteristics of the deaths that they had witnessed. For 
instance, one nurse gave an example where an increased awareness of the dying 
trajectory had been helpful, then qualified her comment by saying that the experience 
was not generalisable.  
It can not be helpful as well, because it can make them more worried. Because 
then they can see the steps coming … They can anticipate the nearness of death. 
Sometimes that is good and sometimes that is not good at all (NP6) 
 
Increased anxiety about the dying process was the most frequently discussed 
detrimental affect of previous experience of cancer within a family. This was thought to 
be especially prevalent when patients had previously witnessed a poorly managed death 
and anticipated that their own demise would follow a similar trajectory. 
It is maybe really unpleasant, how they have seen someone die. Then that is all 
they know. That is maybe the only person they have seen die. So they bring it up 
here (NP2) 
 
And obviously they compare their experiences to what they experienced with 
their relatives. And they can’t help but compare really, and often historical 
ones, that things once, ‘oh me mum was in loads of pain’, and often a long time 
ago and it can be hard to get them to realise that things have changed quite a 
lot (NP7) 
 
This lady (Previous deceased relative) who had had breast cancer died with 
brain secondaries. And this patient remembered that and was very afraid and so 
was the family. And I remember that an awful lot of time had to be given up to 
be with that patient. To just let her talk (NP5) 
 
However, it was the manner of previous deaths that the nurses felt usually affected 
patients detrimentally rather than the experience of death per se.   
And they sort of expect, their expectations are really there:  where that 
experience was. If they have had a bad experience in the past, they will come in 
here and expect the same or less (NP2) 
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Fear and anxiety are known to be common occurrences in the dying (Parkes et al 1996, 
Vachon 2005a). The nurse-participant findings showed how previous experiences of 
cancer within the family may promote specific fears. This emphasised the fact that 
deaths do not occur in a vacuum and that the patients’ own life history may not always 
be helpful to them as they die (Vachon 2005a). In addition the images that are held 
about death help shape individual responses to it (Brennan 2004) and previous 
experiences of badly managed deaths were thought by the nurses to present patients 
with images of their own death that caused them anxiety.  
        The nurses emphasised the need to spend time with patients and listen to these 
fears associated with previous deaths.   
You just need to be more sensitive to their needs. You obviously are more aware 
of their previous experience and you take more time explaining things. You try 
to be more approachable and more available. Get to know what their worries 
are and try to address it as best you can. You then go back to it to make sure 
everything is OK. That they understand and that they are getting what they want 
to get (NP2) 
 
... obviously just listen and let them just get it off their chest. And you try and 
confirm that we will do our best to make sure that those symptoms don’t occur if 
at all possible (NP8) 
 
Whatever experiences they have had in the past, so you listen to them, you learn 
to listen. And listen to their culture:  their way of seeing things, their way of 
doing things in the family, and how it affects them as well (NP7) 
 
      Fear and anxiety are normal responses to danger and their causes need to be 
understood when caring for the dying (Parkes et al 1996). Assisting people to revise 
and reform their assumptions about the dying process can help them build new coping 
structures (Parkes et al 1996).  
      Good patient care is also known to be important to the relatives of dying patients 
(Andershed 2006). The nurses highlighted how information about the manner of 
previous deaths within the family could be important when assessing patients’ anxieties 
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about particular aspects of the dying process. Findings from the nurse-participants 
suggested that the effect of previous poor care can continue and colour their relatives’ 
own dying trajectories.   
 
c) Major Impact: Overwhelming Distress 
      There was one patient (Anne) whose entire dying process and present care needs 
appeared to be linked to the deaths of other family members from cancer. Although her 
life story did not appear inherently more calamitous than several others (see family 
trees: appendix 15), her description of her experiences differed from those of the other 
participants in several ways. These included: 
a) The recent suicide of a niece with cancer: ‘She had a brain tumour, and she 
committed suicide’ (Anne). She spoke at length about this and how it had made 
her consider whether she should end her own life.  
b) Multiple recent family deaths that occurred within a short time span: her sister 
had died from leukaemia just five months before her niece’s suicide. Her 
brother had since died from cancer. 
c) Emotional closeness to the deceased: Many of the people that she felt close to 
had predeceased her although she was just fifty-nine. Her husband had died 
(from a brain tumour). They had no children. Her sister, to whom she had felt 
particularly close, had died.  ‘In fact, all the people that I was close to are the 
ones who have died’ (Anne). Although she did have other living family she had 
never been close to them, did not know them well and felt little connection with 
them. 
They (remaining family) are fellow human beings ….  But I don't feel any link 
… I just feel totally detached from them (Anne) 
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d) Concurrent deaths of friends and in-laws: She had also had several friends and a 
nephew’s wife with cancer. As she said: 
I just seem to have come across such a lot of it, all at the same time … and I've 
never been to so many funerals: I was simply going from one funeral to another 
(Anne) 
             
These deaths had left her feeling extremely lonely, isolated and, in her own words, 
depressed, as she faced her own experience of cancer and death. 
I just felt as if I was the only person in the whole world, I just felt completely, 
totally isolated. I had nobody to turn to, I felt nobody would understand.  Just 
totally alone (Anne) 
And also angry, 
It’s left me angry really, more than anything (Anne) 
                  
Anne frequently stated that she felt that the previous deaths of her family had made her 
present life meaningless. 
Because there have been times when I think this is just completely pointless … if 
there was something for me to be around for (Anne) 
 
She regularly compared her own experience with her family’s saying: 
 I feel as if I'm in the same boat.       A different cancer, but the same boat really 
(Anne) 
This had left her feeling guilty, wishing that she had treated her relatives differently 
whilst they were ill: 
And I think God I did it all wrong. The wrong things I did (Anne) 
Lastly, she struggled with how she was going to face her own death without the support 
of people she cared about: 
I just dread the future. I can’t even bear the thought of the future at all: not in 
any way (Anne) 
 
     Hence for Anne the whole dying process was deeply and detrimentally affected by 
her family history of cancer. She felt overwhelmed by the previous losses within the 
family and unable to surmount these concerns. Anne was the only participant who 
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mentioned that she was receiving support from several members of the 
multidisciplinary team with regard to her family history of cancer. This included 
support from various people including: a trained counsellor: 
I see a counsellor at the hospice (Anne) 
 
Alternative Therapists: 
I found the hospice, having alternative or complimentary therapies helpful ...  
just somebody touching me actually very helpful (Anne) 
 
Chaplaincy: 
 
... with religion.  I've delved into Buddhism, and I've made lots of inquiries 
about lots of things (Anne) 
 
Anne did feel that the multidisciplinary hospice care was helpful to her: 
If I hadn't have had the hospice and their genuine care and concern, I think it 
would have just been unbearable, I don't know whether I would have committed 
suicide by now (Anne) 
 
Despite this, she still felt overwhelmed and isolated by the previous experiences of 
cancer within her family and continued: 
...  in spite of all that, deep down, I still feel exactly the same, in fact, probably 
even more hopeless.  Yes, more hopeless a way ... they (Hospice Staff) can’t put 
themselves in your shoes.  So, you can still feel completely isolated.  I do, 
anyway (Anne) 
 
     Several nurses also described scenarios where they felt that overwhelming distress 
associated with previous experience of cancer was a major component in a patients’ 
care needs. None of the nurses felt that this was common, but they acknowledged that 
when it occurred it presented them with complex and memorable challenges. Hence the 
least experienced nurse to participate in this study, who had only worked in palliative 
care for a year, could only remember two scenarios where distress due to the family 
history of cancer had presented a major challenge to care. 
I think she was just so overwhelmed by grief; she was just so overwhelmed that 
she didn’t know what. It was like she just couldn’t take anymore. She was just 
absolutely broken ... So the main issue with her, it was almost, we had to help 
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her with this horrific amount of grief, it was grief you were dealing with before 
you could even look at the symptoms (NP9) 
 
In the second scenario, the overwhelming distress associated with the hospice because 
relatives had previously died there was strong enough to prevent a patient from 
returning to the hospice. 
There was an incident with a lady who didn’t actually come to the hospice ...  I 
actually met once as an outpatient… I just went down to bring her up from 
reception: and she was in a terrible state … she was telling me about this awful 
history. I think the mum had recently died of breast cancer. I think she had 
another sister who was also affected ...  it had a real impact on her (NP9) 
 
The assessment of emotional and psychological distress associated with the dying 
process involve distinguishing between the normal symptoms of adjustment to a 
terminal illness and the symptoms of a major depression requiring psychological 
referral (Vachon 2005a, Parkes et al 1996). In these scenarios the effect of a family 
history of cancer had meant that patients needed specialist care from the 
multidisciplinary team. Hence the nurse who described the scenarios above stated that 
her role providing appropriate care included: 
Making sure that all the team members are fully aware of what is happening 
(NP9) 
 
Anne’s experience alongside the nurses’ descriptions of overwhelming distress for 
some patients reiterated the appropriateness, and perhaps necessity, of having a 
multidisciplinary care team to support nursing care for some patients with a family 
history of cancer. 
 
Reflection on Past to Present 
       These findings showed that the previous occurrences of cancer in the family could 
have a wide range of effects on patients, from no perceived effect to overwhelming 
distress. There did not appear to be any straightforward relationship between the 
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strength of the effect and the number of relatives affected by cancer. Nor did there 
appear to be a correlation with the degree of relationship with the relatives who had 
died. For instance, Beth and Harry who been predeceased by one and seven first degree 
relatives respectively both reported no impact on care needs, whilst Iain and Jenny who 
had been predeceased by seven and one relatives respectively both drew attention to the 
way their increased awareness of death had affected their experience. Anne, who 
described her feelings of overwhelming distress, had been predeceased by five relatives 
(see Appendix Thirteen).  
       The level of impact on care needs did not appear to be related to diagnosis either. 
For instance, Anne, Diane and Jenny had breast or ovarian cancer. Nor did it appear to 
be associated with concern about heritable disease. Irrespective of the reasons for the 
different responses, juxtaposing Anne’s lived experience with that of the other patient-
participants’ antithetical perceptions that previous occurrences of cancer within the 
family had no, or only a minor impact upon their care needs, emphasised how adeptly 
they were carrying their family history of cancer through their terminal phase. 
      It was notable, however, that Anne had lived through several experiences that are 
known to increase the risk of a complicated grief reaction following bereavement. 
These included multiple recent deaths, out of order death, and suicide (Parkes 1996, 
Parkes 1998). Similarly, individuals who have an absent or unhelpful family are more 
vulnerable to complex grief reactions (Parkes 1998, Stroebe et al 2006), and being 
recently predeceased by supportive family members had left this participant feeling 
alone and unsupported with terminal disease. Her description of her own lived-
experience of dying suggest that it had become entangled in, and dominated by, a 
complex grief reaction due to her family history of cancer. It is beyond the remit of this 
study to consider the impact of grief upon the dying process, but Anne’s experience, 
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alongside the scenarios described by the nurse-participants, does suggest that a family 
history of cancer can leave some patients particularly prone to the experience of living 
with advancing, incurable disease whilst dealing with a complex grief reaction due to 
the deaths of other family members. Anne’s example showed that a family history of 
cancer could have a significant impact on care, even in patients who had no concerns 
about inherited disease. 
        The most commonly noted effect was an increased awareness of the dying process. 
Findings suggest this increased awareness had the potential to affect quality-of-life for 
patients, both equipping them with knowledge about the dying process and heightening 
the emotional significance of particular emotional milestones (like referral to hospice) 
associated with dying. Quality of life, like well-being, is a subjective experience 
(Brennan 2004). It includes attributes of self-awareness, coping and adjusting 
effectively with stress (Lin and Bauer-Wu 2003). Increased awareness of dying was 
perceived as being a ‘two edged sword’ with regard to patients’ quality of life, both 
assisting patients to maintain their autonomy and/or increasing their anxieties about 
particular problematic aspects of dying.  
         Glaser and Straus’s (1965) seminal work drew attention to the way open 
awareness of death improved communication with dying patients. They also stressed 
the importance of understanding dying trajectories (Glaser and Strauss 1968). They 
showed how recognition of familiar trajectories enabled staff to support patients and to 
plan care. Some of the patient-participants in this study had learnt about the dying 
process from their relative’s experience. The nurse-participants suggested this 
knowledge can also help patients make autonomous decisions about their dying 
process. A recent literature review of psycho-spiritual well-being in patients with 
advanced cancer also supports the value that these participants placed on being aware 
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of their prognosis: ‘Although an awareness of having a limited time to live can evoke 
mixed emotions, this knowledge can facilitate coping and help patients live well in the 
present moment’ (Lin and Bauer-Wu 2003: 75). One study even found that awareness 
of dying was a better predictor of which patients would cope with dying at home than 
symptom load (Hinton 1994). Coping can be defined as ‘cognitive and behavioural 
efforts to manage specific external and/or internal demands that are appraised as 
taxing‘(Lazarus and Folkman 1984: 141). These findings suggest that awareness of the 
dying trajectory due to the family history of cancer could similarly assist patients’ to 
cope with their dying process.                 
        It is of interest that none of the patient outcomes, whether improved patient 
coping, specific fears or overwhelming distress, caused the nurses to focus on the 
family pedigree (see also Chapter Nine). This appeared to be because the previous 
history of cancer was not the loci of concern in any of the three potential outcomes. 
Firstly, increased coping was not a focus of care. As one nurse stated: 
I’m sure there are lots of positive effects but we tend to home in on the negative 
effects because that is where the patients tend to need the help (PP9)  
 
Secondly, when there were specific fears and anxieties related to a specific death the 
nursing objective was to reassure patients about those specific fears. Lastly, when there 
was overwhelming distress due to previous occurrences of cancer within the family the 
aim was to support the patients emotionally, using the diverse skills of the 
multidisciplinary team to deal with their distress rather than focus on the family history 
of cancer.  
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The Lived Present: In it Together  
      There was only one issue associated with the multiple occurrences of cancer within 
the participants’ families that appeared to consistently impact on the patients’ present 
lived experience.  This was the support of other family members who had concurrent 
cancer. Six of the participants expressed concern about this, suggesting that it may be a 
common source of anxiety for patients with a family history of cancer. Although all of 
the participants were concerned about their relatives’ health it was notable that they 
made a clear distinction between relatives who were dying from cancer, 
I’ve got another sister: she is completely riddled with cancer. There is nothing 
more they can do for her (Iain) 
My dad ... he's been suffering from bladder cancer in the last year, so he's been 
in three times.  But I don't think there's anything much more as they can do for 
him (Diane) 
 
and relatives who were living with cancer. 
 I’ve got another brother, he is still alive, and he is still going reasonably well. 
He had a cancer in his bladder. So they managed to get part of it out and they 
cauterised the rest. He has to go for check-ups now and again but he has got a 
cancer of the bladder but he is still alive. (Harry) 
 
Some of the participants had found it supportive to have relatives with which to discuss 
their illness and treatment.  
My other sister had cancer ... So we had our radiotherapy together... So we 
were great support. We have always been great friends ... She is very supportive 
(Jenny) 
 
Whilst others reported being able to listen to, and support their relatives’ concerns 
about hospital procedures:  
Then, me youngest brother, I was talking to him, a couple of days ago, well on 
Tuesday. And he told me, and he had told me before actually, that he had got to 
go to hospital as they had found some polyps in his bowel. He has been there 
and they have cauterised them ... and he said what a lot of courage I’d given 
him really (Harry) 
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Social support has been shown to play an important role in the way patients cope and 
adjust to illness (Carmack-Taylor et al 2007) and these participants found consolation 
in both supporting and being supported by other relatives. Making contact with other 
dying relatives appeared to be especially important to patients. Iain had re-established 
contact with his sister who was also receiving palliative care (See p112). Diane had put 
considerable effort into overcoming obstacles to visiting her terminally ill father. She 
spoke about her plans with real hope and enthusiasm.  
We are all going on a trip together, two cottages.  We are going to see dad.  We 
are flying …All of my kids are coming (Diane)  
 
       Hope can be restored and maintained through the setting of realistic and achievable 
goals (Twycross 2003) and Diane hoped to be able to achieve her goal with the support 
of adult children. However she also expressed regret that she was not able to do more to 
support her elderly father.  Ezra expected that his nephew would die before him. He 
was saddened because his lack of strength and mobility alongside transport problems 
prevented him from visiting and saying goodbye to his nephew who was an in-patient 
at a hospice in another city.  
        Being a relative of someone who has cancer and is dying is complex and people 
often need support to cope with the balance between the burden of caring and their 
capacity to care (Andershed 2006). This balance may be particularly difficult for 
relatives who have concurrent diagnosis of cancer, as they each depended on the 
support of other family members to enable them to, in turn, support each other. This 
suggests that assistance in enabling patients to support and communicate with other 
family members who have cancer, may be one effective way to care for patients with a 
family history of cancer. 
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       It has been suggested that the burden of concurrent terminal illness within the 
family can exacerbate distress and anxiety to levels that warrant providing professional 
support to sustain the family’s ability to cope (Kissane and Bloch 2002). However, 
none of the patient-participants appeared to display the intense grief that threatened the 
functioning of the family described by Kissane and Bloch (2002: 153). In contrast, in 
this study concurrent cancer was seen as an opportunity by the participants to offer as 
well as receive support. Nevertheless, being with and supporting other family members 
with cancer was an issue associated with their family history of cancer that these 
participants prioritised. It was a concern within their present lived experience.  
 
Present to Future: No man is an Island 
        When the patients discussed their own future the data was dominated by the way 
they felt it was proscribed by their forthcoming death.  
Well, I'm going to die from it.  I do realise that, yes, that that's the thing that 
will more than likely kill me (Beth) 
 
I know what is going to happen to me medically ... I know I am going to die 
(Finlay) 
 
They can help me, but they can't cure me.  So I know that they can't cure me, so 
I suppose, what else is there to say? (Anne) 
 
The dominance of death as a future concern meant that future plans were proscribed 
and limited due to the possibility of death: 
You ask yourself what’s going to happen, you want to know what's going to 
happen in the future, will I be alive? (Diane) 
 
I made plans to go back to the West Indies but all that, I put that on hold 
(Finlay) 
 
Hence the participants drew attention to the way that their advancing disease process 
limited their future horizons. 
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       It was notable, however, that when the topic of inherited genetic predisposition to 
cancer arose the participants drew attention to their fears that other family members, 
especially younger relatives, might develop cancer and die in the future. The depth of 
these fears was demonstrated by Jenny who stated that it was what had motivated her to 
participate in the study. 
If it is on the cards that one of my nephews and nieces, or one of my great 
nephews and nieces are going to have cancer, then I want to do everything 
possible to help the future. I will do anything; I will talk to anybody (Jenny) 
 
It was notable that all the concerns about the possibility of other family members 
developing cancer in the future were raised in the context of cancer being associated 
with an inherited genetic predisposition to cancer. Concerns about familial cancer were 
widespread in this study and existed in participants who:  
a) Did not think that their own cancer was associated with an inherited genetic 
predisposition to cancer. 
b) Had been informed by the regional clinical genetics unit that their family history 
of cancer did not indicate a high risk of genetic predisposition.. 
c) Had not discussed these concerns before. 
 
Each of these aspects is discussed in more detail below. 
a)  It was notable that several patients expressed fears that their children and 
grandchildren might be at increased risk of developing cancer due to their family 
history of disease, even when they excluded or had reservations about their own (or 
their deceased relatives’) illness being associated with a genetic cause.  For instance, 
when asked about the causes of her own cancer, Beth clearly linked the aetiology of her 
own disease with the stress that followed the (non cancer) death of one of her children. 
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I lost one son nearly 9 years ago, I was wondering if it was the shock of that. I 
don't know.  I'm just presuming … They do say shock can bring it on … I haven't 
really thought about the causes, except for the shock (Beth) 
 
However, (about half an hour later), when she was talking about whether she discussed 
her illness with other family members she said: 
I think it's hereditary, because I had it, and my father had it. And I sometimes 
say to my son, particularly, that you should have checkups. … That he ought to 
have checkups (Beth) 
 
Similarly Finlay attributed his own cancer to a Western diet full of additives. 
There is less of this cancer thing in the West Indies, cause people eat natural 
stuff, natural food … and they cannot afford to have junk food because they 
don’t know where their next meal is coming from … living in a fast country, a 
country like England you don’t have the time to cook sometimes, so you just eat 
anything (Finlay) 
 
But he too, later mentioned that he was aware that cancer could be associated with an 
inherited predisposition and had warned his adult-children about this. 
I do tell my kids now, be careful …because it could be inherited:  so be careful 
(Finlay) 
 
Leon was aware that genetics could have a powerful and significant impact on health.  
Because your genes rule your life don’t they? ... They build you to what you are: 
whether you are going to be ill, seriously ill, or whether you are going to live 
till you are one hundred. It’s your genes … that progress your life (Leon) 
 
Nevertheless he was also aware of the potential lifestyle factors that might have 
contributed to cancer within his family.  
Dad was an avid smoker ...  then as we grew older me brothers started smoking. 
So you was living in an atmosphere of smoke ... I’d walk into the house and you 
could cut the air with a knife with smoke ... And then when I had the family they 
all smoked (Leon)  
 
He attributed his daughter’s cancer to iatrogenic causes. 
We swear to this day that if she hadn’t have had that treatment (IVF) she would 
have been here today. Everybody says (Leon) 
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Hence he was ambivalent about the role of inherited genetic susceptibility as a cause of 
cancer within his family: 
We can’t say whether cancer runs in the family or not (Leon) 
 
Despite his ambivalence, his awareness that cancer could be inherited had caused to 
him to raise the issue with his grand/daughter because he was anxious that his 
grand/daughter accessed all and any screening checks and received treatment as soon as 
possible. 
Because we don’t know how her mother got her cancer so… So I keep telling 
her to have a check up … I tell her to have the smear and anything else. I say 
you are her daughter and if it is hereditary, you’re liable to have it you know 
(Leon)  
 
Hence, even the awareness that cancer could be genetic appeared to lead to increased 
fears for relatives, even when participants were unclear or hesitant about the 
involvement of inheritance in the aetiology of their own disease. 
       It is known that the death, or anticipated death, of a relative can enhance fears of 
susceptibility to cancer in the relatives of cancer patients (Saunders et al 2003). This did 
not appear to be the case in this study (although the study design means it is impossible 
to say whether the patients’ concerns were enhanced by the participants’ advanced 
disease) but it does show that concerns for the future health of other family members 
due to fears about genetic predisposition are not only present in palliative care patients 
who believe their own disease is due to an inherited susceptibility to cancer. 
       Participants in this study had discussed these fears with their relatives. Hallowell 
(1999) found that at-risk relatives had been prompted to attend for genetic counselling 
following discussion of risk of future disease with dying relatives. Consequently, these 
conversations have the potential to impact on the actions of the participants’ relatives. 
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Despite these reported conversations with relatives, none of the participants above had 
discussed their concerns for their children with healthcare professionals. 
 
b) There was one participant who had previously been referred to the regional clinical 
genetics unit for assessment of her family history of cancer by her GP. 
That was Dr P. that suggested it.  Because I asked him and he said it would be a 
good idea (Diane) 
 
       Diane was unsure about where she had first heard of the possibility that cancer 
could be familial but thought that it might have been a magazine or a radio programme. 
She had seen a link with her own family history of cancer: 
My grandmother had it, my mother's mother and my mother (Diane) 
The young age that individuals within her family had developed cancer had also alerted 
her to the potential of an inherited susceptibility: her grandmother died of cancer aged 
forty-two and her mother aged thirty-three. She had developed her first primary cancer 
aged thirty-six and twenty-three years later had developed breast cancer. She had 
approached her GP about genetic counselling following her diagnosis with breast 
cancer because of concerns for her daughters’ future:  
I've got five kids and my sister … and I'll be very upset if anything happens to 
them … I would be very distraught, if anything happened to them (Diane) 
 
This is a common reason for individuals who already have cancer to request genetic 
counselling (Bonadona 2002, Hallowell et al 2004). In Diane’s case the GP had referred 
the family to the regional specialist genetic clinic. Although she had initiated the 
process of referral she had not attended the clinic due to poor health. Her daughters had, 
however, attended the consultation with the geneticist. 
They spoke to the doctor and got all the information, and they said it was just 
unfortunate, and that it mightn't happen to the girls at all: which is a relief 
(Diane) 
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This had allowed her to focus on her own illness but it had not fully reassured her about 
her daughters’ future health: 
They are all fine at the moment.  I just hope the girls watch themselves. Just in 
case it makes a repeat.  But, according to the gene clinic I was just unfortunate 
(Diane) 
 
And she continued to encourage them to be alert for the early stages of disease: 
 
I say look after yourself, keep on feeling around (demonstrated breast 
examination), if you feel anything, there, tell someone.  I would be very 
distraught, if anything happened to them, you know (Diane) 
 
Hence the referral to the regional clinical genetics unit had been initiated by the patient 
after she had re-evaluated her family history of cancer in the light of new information 
about the aetiology of cancer. The reassurance the family had been given had helped 
her focus on her own needs and had reduced her fears about her daughters’ future. 
Nevertheless she had not stopped worrying about her daughters’ future health, perhaps 
because her lived experience of her mother dying in her childhood and the awareness 
that her grandmother had also died as a young woman from cancer overrode the 
reassurance from the geneticist. She continued to think that her cancer was due to a 
‘rogue gene’ (Diane) but did not think that this in anyway affected the care that she 
needed from the hospice.  
       It had been suggested that relatives experience an increased perception of risk 
around the time of bereavement (Rees et al 2001, Sanders et al 2003). For this patient, 
concerns about the implications of her disease seemed to be held in balance despite 
disease progression: she had obtained some reassurance from knowing that her adult-
daughters were not thought to be at increased risk of disease but this was held in 
tension because of her family history of cancer and her deteriorating condition. That is, 
the historical and present reality of the disease had mitigated against the reassurance 
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received (Agincourt-Canning 2001). Hence she was still dying with fears for her adult-
children’s future.       
 
c) The research interviews also revealed one participant (Iain) who had not previously 
expressed his fears about inherited disease with healthcare professionals. He had not 
previously disclosed his full family history of cancer to a healthcare professional as he 
had not maintained close contact with his siblings following the deaths of his parents. 
He had, however, been predeceased by seven first degree relatives from cancer and had 
a sister who was concurrently dying from cancer. The interview, especially the 
questions about previous occurrences of cancer within the family, made Iain re/consider 
whether his family history of cancer might be related to an inherited genetic 
predisposition to cancer.  
No, and I’m just thinking out of the eleven of us there are four left. So I’m 
wondering if it is inherited (Iain) 
 
He had perhaps considered whether his cancer might have been associated with an 
inherited predisposition to cancer before this because he then said: 
Because I’ve got to find out; to see whether it is inherited. But others say it is 
not (Iain) 
 
However he had not discussed whether his family history might be associated with an 
inherited predisposition with the his medical team or hospice staff: 
Have you asked your doctors about it? (I) 
No, I’ve just been thinking about it now ... I don’t think I’m scared to ask (Iain) 
 
As discussed above (see p118), Iain became distressed when considering the 
implications of his disease for his children and chose to initiate a discussion with the 
medical team about the potential for genetic disease. Iain died three weeks following 
the interview. This indicated that without the research study he might not have had the 
opportunity to explore his concerns about his family history of cancer and its 
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implications for his family. Although this conversation provoked distress the value of 
open awareness about difficult and emotive aspects of terminal disease is one of the 
foundations of palliative care (Searle et al 1997, Glaser and Straus 1965).  
 
Reflection on Present to Future 
     There was a consistent and notable change in the participants’ fears about the future 
when the topic of inherited disease was raised. Outwith the genetic lens they focused on 
their own forthcoming experience of death and their limited future. However in the 
context of genetic disease the focus of their concern was on the implications of their 
illness for other family members. These concerns were pervasive and meaningful, even 
to participants who did not perceive their own disease to be due to an inherited 
susceptibility to cancer 
       Consequently, caring for patients with a family history of cancer needs to 
encompass an appropriate response to patients who are worried about whether the 
cancer in their family might have implications for their relatives’ future health. Nursing 
care relies on both a sound knowledge base and practical expertise (Benner 1984). 
Nurses need not only to be able to identify patients who might benefit from genetics 
services but also the ability to communicate this information appropriately with 
concerned patients. These are both core genetic competencies for nurses. (See Table 
One p16). 
 
Present to Past: Re-Evaluation of the past  
        There was some evidence that patients were re-evaluating their past family history 
in the light of new information about cancer genetics. For instance, Harry had 
reconsidered the family history of disease after a discussion with the oncologist. 
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It was one of the registrars ...  he says ‘has there been cancer in your family? 
And it set me thinking then … He was talking about the genes. It’s in the genes 
he said … I’ve got an idea, I think that somehow it is genetic (Harry) 
    
Hence for Harry the awareness that cancer could be associated with inherited genetic 
factors had caused him to reconsider the origin of his own and his family’s disease.  
Well I’m wondering myself sometimes whether it is a gene that goes through the 
family that causes this ... I don’t know. It seems very unfair that you get people, 
especially as you have got me Dad, (Three siblings named) and me who all have 
cancer of the stomach or bowel or something like that (Harry) 
 
He did not know about the experience of more distant relatives but had pondered 
whether investigating his family’s history of disease would be helpful: 
I keep thinking is it there in the family? I don’t know whether you can go back 
and see if it is in the (surname) clan ... But it is in my immediate family (Harry) 
 
For Harry the re-evaluation of the cause of his family history of cancer did not appear 
to cause any new fears, perhaps because he did not have children and many of his 
siblings had predeceased him. 
      Diane (see p159) had similarly re-evaluated her family history after reading about a 
family with ‘the breast cancer gene’. Although she could not now remember where she 
had first heard about this: 
I don't know, I'd read about it somewhere (Diane) 
 
The media are a crucial source of information about health and illness and ‘soft’, 
human interest, first person accounts about families with the BRCA genes have been 
shown to have engaged peoples imagination and understanding of genetic 
predisposition to cancer (Henderson and Kitzinger 1999). This and a direct 
conversation with an oncologist were the two sources of information that had made 
participants seriously re-evaluate their family history of disease in this study.  
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Reflection on the Temporal Analysis of Multiple Occurrences of Cancer in the 
Family                                                                                                          
        The temporal analysis of the experience of multiple occurrences of cancer within 
the family shows how the change to a genetic paradigm, where the potential for cancer 
to be inherited is endorsed, can affect the emotional needs of palliative care patients, as 
it affects the meaning and significance of past experiences of cancer within the family.   
      Outwith the genetic lens past multiple occurrences of cancer within the family 
encompassed a range of effects on participants’ present lived experience.  
• Previous occurrences of cancer had a range of effects on the participants: many 
stated that they had very little or no impact on their present care needs. Others 
described how it had subtly increased their awareness that they were dying and 
informed them about the dying process. Only one participant, Anne, stated that 
they had a major impact on her present experience. (See P146).  
• All the participants who had relatives who were concurrently living with cancer 
wanted to support them and/or appreciated being supported by them.  
• Outwith the genetics lens the participants’ future concerns focused on their own 
forthcoming deaths and how their present lived experience was proscribed by 
their approaching deaths.  
All of these effects appeared to continue within the genetic lens. However the 
introduction of the concept of genetic inheritance also added two new temporal 
dimensions to the participants’ experience. 
• The participants’ concerns about the future changed from a concern about their 
own death to concern about whether other family members would develop 
cancer in the future. 
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• Some participants had re-evaluated their family history in light of their 
knowledge about genetics. 
This change is illustrated diagrammatically in Figure Three below. 
Figure 3: Diagrammatic Model of Temporal Analysis 
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Outwith the Genetic Paradigm 
Within the Genetic Paradigm 
      The number of participants who expressed concern about the implications of their 
family history of disease for future generations showed how pertinent concerns about 
genetic susceptibility to cancer can be within the palliative care setting. Concerns about 
the implications of genetic predisposition to cancer for their (adult) children’s future 
were widespread and relevant, even in patients who did not think that their own cancer 
was associated with inherited disease, as well as a patients who had been reassured by 
the regional clinical genetics unit that her family history of disease did not indicate that 
her children were at high risk of developing disease.  
      When evaluating the temporal analysis of the data it is important to remember that 
the research interview primarily focused on the impact of the past on the present. To 
prevent the research interviews provoking undue distress about the participants’ 
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forthcoming death the interview proforma was deliberately constructed around the past 
and the present (as opposed to their future and anticipated death). The research ethics 
committee specifically refused permission for the researcher to ask about the impact of 
cancer on the younger generation/children in the family. Hence all the information 
about participants’ concerns for the future was spontaneously given by the participants 
without prompting. This emphasises its importance to them. 
 
 
Temporal Analysis of Multiple Primary Cancers  
      Another indicator that there may be an inherited genetic predisposition to cancer 
within a family is that individuals within that family are affected by multiple primary 
cancers (Ford et al 1998, Aarnio et al 1995). Although five participants spontaneously 
talked about the experience of having had a previous primary cancer, only one, Harry, 
associated his experiences of cancer with an inherited susceptibility to cancer.  
 
Past Separate from Present: The Past is Another Country  
    The four patients who did not associate their experience of multiple primary cancers 
with genetic disease emphasised the distinction between their two experiences of 
cancer. The word ‘different’ was commonly used to highlight this.  
It was certainly a different experience, yes (Beth) 
It was different ... I knew it couldn't be secondaries, because they say after five 
years, it's left your body (Diane) 
 
For three of the participants their two experiences of cancer were clearly separated in 
time. However, even Jenny, whose multiple primaries occurred within the shortest time 
span (three years), clearly differentiated between the two occurrences: 
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It was a completely different one. … because I wanted to know if it was a 
secondary.  But it's not, it's a completely different one (Jenny) 
 
      Information about the earlier experience of cancer was often condensed into a short, 
snappy summary that contrasted with the longer, more detailed descriptions given about 
their present symptoms: 
It happens so quickly, I don't think anybody realised I had cancer till after the 
operation. Even myself really, I didn't know I'd got it, because it did happen so 
quickly … So then I had checkups, and then I was fine (Beth) 
Once I had the operation and suchlike: that was it. We never even spoke about 
it. I went on the chemo and that was it as far as I was concerned. I had a growth 
in me stomach, it was took out and I’m still here (Iain) 
 
These summaries were typical in that they minimised the impact that first experience of 
cancer was perceived as having on the participant’s life. This making light of their 
previous experience, and the distinct nature of the different experiences, was also 
emphasized through descriptions of a period of normality between the different 
episodes. 
I thought I been there and seen that and got the t-shirt, that sort of thing.  And I 
got on with my life.  I never thought about cancer again (Jenny) 
 
I was fine, I went back to my normal things, it didn't really affect anybody, 
really (Beth) 
 
I started to recover, slowly, I suppose, and got back into a routine.  I got back 
on my feet again (Diane) 
 
This emphasis on the normalcy of the period between cancers was unexpected as 
research shows that fears about the recurrence of cancer are common (Dixon et al 1996, 
Johnson-Vickberg 2001, Webb 2005). Although concerns about re-occurrence were 
mentioned: 
Although it was different: it is always at the back of your mind (Beth) 
I was always aware of it (Diane) 
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The overall impression was of two distinct experiences of cancers that occurred in 
different locations in the body at different times. 
     No participant overtly commented on the obvious stark distinction between their 
previous experience of cancer, which had been treated and cured, and their present 
experience where their disease was deemed incurable with only palliative treatment 
options available. Nevertheless there were statements that hinted that this might be a 
latent underlying factor that made the two experiences distinct. 
And as I say they done the eight-hour op, took the kidney out, mentioned about 
the football and all, and I thought that was it …and as luck is it hasn’t come 
back for twenty-two years. This batch I’ve got now, I don’t know (Iain) 
 
But, as it happens ... it's come back with a vengeance really (Diane) 
 
      The need for psychological support at the time of cancer recurrence is well 
documented (Dudgeon at al 1995, Dixon et al 1996, Herth 2000). However Dudgeon at 
al (1995) found a significantly increased (P<0.05) need for support with symptom 
control and maintaining function in cancer patients with disease progression compared 
to patients at the time of first recurrence of disease. This emphases the need for 
increased support as a patient’s disease progresses, and this increasing need might be 
one reason why patients did not see an obvious connection between their first 
experience of a different primary cancer with their present experience of palliative care. 
When prompted with a question like ‘How do you think that the previous experience of 
cancer has affected what is going on for you now?’ replied: 
It hasn’t really, to be truthful (Iain) 
But that was bowel cancer.  It was nothing to do with this cancer (Beth) 
 
That is, the clear focus on the different primary cancers as distinct experiences meant 
that the patients did not perceive their current palliative care needs as being affected by 
their earlier experience of a previous primary cancer. 
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      Although the patients did not think that their first primary cancer affected their 
palliative care needs, they did indicate that there had been some effect on the initial 
period when the second primary had been diagnosed. One patient noted that it had 
affected the way she perceived and interpreted what was going on in hospital whilst 
undergoing the investigations and treatments for her second primary cancer: 
Anyway, the senior doctor came in, and he took loads of pictures, and the young 
doctor came in, and he took some too.  And I thought, well, there's my answer 
isn't it.  I thought I've got cancer again before I actually saw anyone (Jenny) 
 
 This challenges the simplistic notion that information is held by health care 
professionals and given to patients (Payne 2002). Similarly Beth felt that she had 
deliberately ignored the symptoms of reoccurrence as she did not wish to face cancer 
again: 
And I realised I got those symptoms ... It's probably why I didn't go to the 
doctors sooner actually (Beth) 
 
It has been suggested that some people find the experience of cancer recurrence more 
upsetting than their initial diagnosis as they are less hopeful of cure and more fearful of 
dying (Mahon et al 1990), and Beth’s reluctance to inform health care professionals 
about her recurrent disease did appear to be associated with these concerns. In contrast, 
Diane felt that it had led her to approach the second experience of cancer with a more 
positive outlook. 
Less worried.  I wasn't at all worried, I was very positive … I’d got the 
impression, that when you beat it once you might beat it again (Diane) 
 
Although she acknowledged that this early hope had not been fulfilled, she also stated 
her previous experience was still helping her to deal with the present circumstances, 
stating that she felt less frightened because of the increased insight her previous 
experience had given her.  
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 I'm not frightened of it, because I think I've got more understanding than what 
a lot of people do because it's happened so many times (Diane) 
 
         These participants appear to have had a greater self-awareness about their 
condition during their second primary cancer. This appeared to have contributed to their 
open awareness about their condition. This can facilitate coping and help patients to 
live well in the present moment (Lin and Bauer-Wu 2003). This increased knowledge 
appeared to correspond to, and work in conjunction with, the increased awareness of 
the dying process due the multiple occurrences of cancer within the family reported 
above. 
 
Nurse-Participant Perspective 
      There is a dearth of literature about the palliative needs of patients who have had 
multiple primary cancers and no nurse-participant spontaneously linked the experience 
of multiple primary cancers with an inherited predisposition to cancer. When asked 
directly they suggested that it made little difference to patient care. Several participants 
commented that patients often did not distinguish between multiple primaries and 
metastatic spread from the original tumour 
I think a lot of them to be honest just think they have got cancer and that it has 
spread. I really do think that (NP7)  
 
Whilst another commented that she herself perceived the care needs as being similar 
I haven’t found that it has made much difference to the care. They sort of have 
similar needs emotionally. I don’t think it makes much difference than looking 
after someone who has had primaries and secondaries (NP2) 
 
However the main reason that the nurses perceived little difference in patients’ care 
needs was because they felt that it was the fact that the patients’ cancer has become 
incurable that makes the care needs of palliative patients distinctive. 
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I don’t think it is addressed actually. … But I suppose by the time they have got 
to us, it is not such a big issue (NP7) 
 
To the care that we give?  I don’t know really because by the time they get to us 
it is usually pretty terminal isn’t it ... The real shock is when, suddenly, they get 
to the end of the treatment and things really are progressing (NP9) 
 
     The range of psycho-emotional effects described in individuals with a second 
multiple primary cancer included increased anxiety, resignation, strength, coping and 
acceptance. Despite this range of responses much of the data collected emphasised the 
potential increased strength and coping that the nurse-participants had seen in patients 
with multiple primaries. Many of the nurses thought that the resilience they had seen in 
patients who had had a previous primary was somewhat counterintuitive and not the 
reaction they themselves would have expected to observe. 
They are stronger, they are grateful that they have had, that they survived the first 
one and for that extra time. They will say, ‘well I had breast cancer twenty years 
ago, so that is twenty years I might not have had’. That is a phrase that you hear 
quite often from someone who has got another cancer (NP1) 
 
And it is sometimes quite funny the way people talk about it. It is ‘oh, I’ve had this 
and then I had twenty odd years and now I have got it again’. ‘And I thought I’d 
beaten it once but it has come back to haunt me’… it is really quite mind-blowing, 
that people, well casual is not the right word but how people … cope (NP3) 
 
But this particular patient … had had a different cancer in the past and then been 
re-diagnosed with a different type of cancer and I thought that he would be more … 
panicky, but he took it all in his stride and that surprised me... But that is maybe me 
being illogical, but he was coping better because he had been through this before 
and he thought he knew better what to expect (NP9) 
 
      Nevertheless the nurse-participants felt that a previous primary could only partially 
prepare patients for palliative care. This was because the first experience of cancer had 
(by definition) been treatable and patients had not previously needed to fully face the 
issues associated with impending death. This suggests that the previous curable cancer 
had not fully prepared them for the dying role (Emanuel et al 2007) or informed them 
about their dying trajectory (Glaser and Strauss 1968). Hence the nurse-participants like 
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the patient-participants emphasised the difference between the experiences of different 
primary cancers and felt that it had a minimal impact on patients’ care needs. 
 
Past Continuous with Present: ‘BOGOF: Buy One Get One Free’ 
     As mentioned above, Harry was the only patient who had been told that his cancer 
was associated with an inherited susceptibility. He had been informed of this 
connection after he had been diagnosed with his second primary cancer.  
About this being inherited, a gene, it wasn’t till I had this second cancer when 
the doctor talked about it (Harry) 
 
Although he described his second primary as ‘a horrid shock’ (Harry); he used black 
humour to explain the link. 
The joke is because I’ve had one cancer and now I’ve got a second one it was a 
BOGOF cancer. Buy One and Get One Free (Harry)   
 
He used the term ‘BOGOF’ throughout the interview. He was the only participant who 
described the experience of two different primaries as one continuous episode rather 
than separate events (although Jenny had experienced her two primary cancers in a 
shorter time span). 
He (The hospital consultant) said, I think we can discharge you now, because 
it's been five years in the June and it is very rare that cancer comes again after 
five years. The next month we were down in the hospital again (Harry) 
 
And I said I don’t know how I will cope. All the time I’ve been dealing with it 
(Harry) 
 
Although Harry understood that his two separated primaries were probably linked by a 
common aetiology, like the other participants, he did not think that his experience of 
multiple primary cancers affected his interaction with the palliative care team.  
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      As the nurse-participants were unaware of the potential link between multiple 
primary cancers and an inherited genetic predisposition to cancer they were unable to 
comment on how this effected patients care needs. 
 
Reflection on Temporal Analysis of Multiple Primary Cancers 
     Although the information about the affect of multiple primary cancers from this 
study is limited there is a dearth of literature about the affect of multiple primary 
cancers on palliative care patients. The limited evidence from this study suggests that 
knowledge that multiple primary cancers are associated with a genetic predisposition to 
cancer had the ability to alter the way that the participants perceived their experiences. 
The four participants who made no connection with inherited disease underscored the 
differences between their two experiences whilst Harry accentuated the links, 
repeatedly calling his second cancer a ‘BOGOF’  and stressing the continuous nature of 
his lived-experiences of different cancers. 
      Knowledge of an inherited predisposition has been shown to give rise to increased 
feelings of not being cured for people with cancer prior to the development of a second 
primary (Bonadona et al 2002). For the participants in this study the experience of 
multiple primary cancers was a lived reality and not a future risk. Although three 
participants drew attention to the way their earlier experience of cancer had affected 
their initial approach to their second primary cancer, none of the patient-participants 
felt that it impacted on their present lived experience. 
 
Discussion 
      The chapter is called ‘The Missing Futures’ to spotlight the way that patients 
concerns about the future changed when they consider their disease through the genetic 
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lens. This temporal analysis has stressed the emotional dimensions of the care needs of 
palliative care patients. It shows how the knowledge of genetic predisposition to disease 
could change the meaning and significance of past occurrences of cancer for 
participants, and highlights how their concerns about the future expanded from an 
awareness that they themselves had a limited or ‘missing’ future, to fears that their 
relatives’ lives might also be curtailed by cancer.  
       One outcome from the temporal analysis was a better understanding of why the 
discourse of a family history of disease has not previously been a major focus of 
concern within palliative care. Outwith the genetic lens the participants described a 
range of effects: most participants described minimal effects from either previous 
occurrences of cancer within the family or multiple primary cancers on their present 
cancer journey. They described beneficial and detrimental aspects associated with an 
increased awareness of death on their present lived-experience. They wanted to support 
other family members who were concurrently living and dying from cancer. Only one 
participant (Anne) felt that the family history of cancer was a major factor in her 
present situation. She discussed how she continued to feel overwhelmed and distressed 
due to her family history of disease, despite ongoing support from the hospice 
multidisciplinary team.  
       The temporal analysis showed how the discourse changed when the topic of 
inherited genetic predisposition was raised. The temporal focus changed from how the 
past affected the present to concerns about the implications of the present for the future 
of other family members. It altered how patients viewed their family history of cancer 
and provoked concerns that other family members might develop cancer within the 
future.  
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      Concerns that other family members, especially (adult) children, might develop 
cancer in the future were widespread in this study.  It has been suggested that relatives’ 
fears about inherited genetic predisposition increase as a patient deteriorates (Sanders et 
al 2003). Similarly, it has been suggested that the increased perception of risk at 
bereavement explains why a significant minority of people who attend genetic 
counselling do not obtain reassurance from being told that they are not at an increased 
risk of inherited disease (Rees et al 2001). Hence it is possible that the participants’ 
awareness of their own imminent deaths had increased the salience of their fears for 
other family members. However, there was no direct evidence within the study to 
suggest that the participant’s concerns were provoked by their knowledge that their 
own disease was incurable; rather the fears appeared to originate directly from their 
knowledge that cancer could be inherited in families with multiple occurrences of 
cancer. 
       The fact that many participants were dying with concerns about whether their 
illness had implications for their children’s future health, irrespective of whether they 
associate their own, or their relatives’ disease with a genetic predisposition to cancer or 
other causes, has real implications for patient care. This is because it suggests that the 
mere potential for cancer to be inherited, (not only the fear that one’s family is at high 
risk of genetic predisposition), can increase anxiety about other family members 
developing cancer in the future. The fact that these fears were widespread suggests that 
it is important that palliative care services start actively managing these concerns.  
      Diane’s experience presents one model of care that might be helpful to patients. Her 
concerns had been taken seriously. She and her family had been referred to a specialist 
genetic service. Although her concerns for her children persisted despite reassurance 
from the genetics clinic, Diane had found the reassurance given meaningful and 
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repeatedly mentioned that it had given her a reason to hope that the cancer would not 
reoccur in her daughters. For her, the concrete reality of previous deaths within the 
family was, to some extent counterbalanced by the reassurance given by expert advice. 
This suggests that open communication about the risk of genetic predisposition could 
be useful and reassuring to palliative care patients who had concerns about familial 
disease. 
        It is also necessary to consider what actions would be appropriate if a patients’ 
family was thought to be at risk of heritable cancer. As discussed in the previous 
chapter (p159) many of the patients had discussed their concerns with other family 
members: urging them to be aware of the risk and to access any health promoting 
measures. Hence information about the services provided for family members at 
increased risk of future disease might be reassuring for patients. Patients might wish to 
consider genetic testing as this can allow other family members to more accurately 
assess their risk of future disease, or blood banking, which would allow family 
members to consider this option in the future. 
      The interview with Iain showed that there are patients with meaningful and emotive 
concerns for their children’s future who have not previously had the opportunity to 
discuss these fears with healthcare professionals. Palliative care is often the last chance 
for these discussions to occur (Lalloo et al 2000). This indicates the need to start an 
open dialogue about inherited disease where patients can more fully express their 
concerns. Open communication about other aspects of the dying process has helped 
patients plan their affairs more successfully (Searle et al 1997) and could prove a 
helpful tool for care within the genetic lens.  
       With the exception of their concern about other family members, the patients did 
not think that their family history of cancer had affected their own care needs. This 
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finding is similar to the limited research literature that has studied the effect that 
predictive genetic testing has on people with cancer. Hallowell et al (2004) found that 
people in remission from cancer were not generally distressed when told they had a 
known genetic alteration as they had already acquired an image of themselves as being 
at increased risk of cancer reoccurrence. Bonadana et al (2002) and Hallowell et al 
(2004) both found that increased concern for relatives was the most frequently 
expressed concern in people who had tested positive for an inherited susceptibility to 
cancer. Findings suggest that these concerns may also be widespread in patients with a 
family history of cancer who have not undergone genetic testing. 
       Knowledge gained from the media and medical information had caused two 
participants to re-evaluate their family history of disease and consider the implications 
of an inherited genetic predisposition to illness more seriously. This shows that there is 
the potential for people’s attitudes to their family history of cancer to change as and 
when clinical practice is able to harness the potential benefits of the increased 
knowledge about multifactorial disease (Bell 2004, DH 2003).  
      Findings also tentatively suggest that the meaning and significance of the 
experience of multiple primary cancers may change for patients. Although only one 
participant associated this experience with a genetic predisposition to cancer his 
account did indicate that being told he had a genetic susceptibility had made him re-
evaluate experiences of cancer. Although the data available is limited it does indicate 
that knowledge of genetic predisposition has the ability to make patients re-evaluate 
different experiences of cancer, (that were separated in time and space), into one 
interwoven narrative.  
       Hence findings from this study both help to explain why the family history of 
cancer has been a missing discourse ‘outwith the genetic paradigm’ and suggest that 
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patients’ concerns for the future health of other family members may mean that it will 
emerge as a more significant discourse when the slow but inevitable change (Bell 2004) 
to caring for people with cancer ‘within a genetic paradigm’ occurs.  
 
Conclusion 
      This chapter has presented the temporal analysis of the participants’ lived 
experiences of cancer. The analysis demonstrates that knowledge of genetic 
predisposition to disease had changed both the meaning and the significance of their 
family history of cancer for participants. Knowledge of inherited genetic predisposition 
to cancer meant that the patient- participants were not only concerned about their own 
forthcoming death, but also to concern that other family members might develop cancer 
in the future. They had also re-evaluated their family history of disease. Concern for 
other family members who were living and dying from cancer was also important to 
participants.  
      Caring appropriately for patients who are concerned about the potential that other 
family members will develop cancer in the future presents a new challenge for 
palliative care services. (See Chapter Nine). However it is important to consider what 
patients understand about the aetiology of cancer and the potential for an inherited 
predisposition to disease when considering how to support them with concerns for the 
family’s future health. This is the focus of the next chapter.  
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CHAPTER EIGHT: THE MISSING FACTOR 
(The Understanding of Cancer) 
 
Beware the Monocausal Fallacy (Anon) 
 
 
Introduction 
       The aetiology of cancer is important because the understanding of an illness can 
affect the way that it, and the people who live with it, are treated and viewed by society, 
the healthcare system and themselves (Shiloh 1996). Aetiology means ‘the assignment 
of a cause: the rendering of a reason’ (OED Online accessed 19/3/07). The aetiology of 
cancer was an important and meaningful concern to all the patient-participants. This 
was because the patients expressed a real need to understand why they were dying. This 
was often linked with a sense of frustration that they could not find a clear, elegant 
answer as to why they had developed their particular disease.  
So I’ve read up on the prostate but even that does not give you a real answer as 
to why, you know like, why, why, why has my prostate suddenly got cancer? 
How have I got cancer? … But nobody seems to be able to give me a direct 
answer for it (Leon) 
 
(I)Do you know what causes cancer?  
(Diane) No  
(I)Do you think about it?  
(Diane) All the time  
 
The patient interviews generated a lot of information about the patients’ understanding 
of cancer. This appeared to be because the question had an emotional as well as an 
intellectual aspect. Even the one patient (Grace) who did not wish to discuss the 
aetiology of their disease acknowledged that it was an issue that concerned and ‘scared’ 
her. Most patients had multiple and occasionally contradictory ideas about what had 
caused their own and their relatives’ cancer. They mentioned all the common causes 
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found in scientific textbooks (Kleinsmith 2006), except for aging and viruses, and 
included several idiosyncratic personal views.  
      This chapter looks at the patient-participants’ understanding of cancer. It discusses 
two themes that emerged from the data. These were ‘scepticism about given causes’ 
and a ‘limited understanding of genetics’. It concludes with a discussion about how the 
limited understanding of cancer as a multifactorial disease can be a factor that 
contributes to the family history of cancer being a missing discourse within palliative 
care.  
 
Emerging Themes 
Scepticism about given causes  
       A consistent and dominant theme that was interwoven throughout the patient data 
was scepticism about given causes. This included a general scepticism that the cause of 
cancer was known. 
I’ve got no answer. I’ve got no answer to it, and I don’t, can’t see how other 
people have got answers to it. Cancer just occurs (Leon) 
 
No, nobody knows what causes cancer. All these boffins: Oh, this has caused it, 
that has caused it. I look at it like the chickens and the eggs and God knows 
what (Harry) 
 
Because, they don't really know what causes cancer (Anne) 
 
I don’t know the answer. I puzzle it but I don’t know. I don’t know if anybody 
really does know? (Jenny) 
 
      Beliefs about illness are rooted in the cognitive world of an individual and are 
shaped by both personal experiences and by culture (Richer & Ezer 2000). They are 
primarily conscious, rational representations that influence the appraisal of current 
events (Richer & Ezer 2000). Health education aims to promote public health by 
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reducing adherence to practices deemed harmful to health and encouraging health 
enhancing activities (Frankel et al 1991). However, health promoting messages in the 
media are often very general, obtained from varied sources and change frequently 
(Arman et al 2006). The seemingly endless media focus on different and sometimes 
conflicting causes of cancer has increased the sense of scepticism about public health 
messages (Crossley 2003).  This may help explain the widespread scepticism about the 
different causes of cancer discussed in this study. The given causes included a) 
historical concepts b) lifestyle factors c) environmental causes d) iatrogenic causes and 
e) genetic causes. 
 
a) Historical Concepts 
     Historical explanations for the aetiology of cancer can still be influential decades or 
even centuries after they had been scientifically disproven. In the Sixteenth century 
scientific theories suggested that cancer might be contagious as when it was recognised 
that some cancers, including breast cancers, occurred in families or particular 
communities (Olson 2002). This was shown to be false in 1771 when James Nooth 
removed cancerous tissue from a patient and implanted it in his arm to decide whether 
familial breast cancer was due to contagion or to inherited factors (Olson 2002). 
However, it would appear that concerns about cancer being contagious remain, and two 
participants in this study felt a need to refute this. 
I couldn't touch somebody today with cancer and then find out the next day that 
I've got cancer tomorrow.  It's not like that (Harry) 
 
       A later eighteenth century theory proposed that cancer was due to localised trauma 
or injury. This theory persisted in the medical literature until the 1920’s despite 
evidence from the testing on animals that it was implausible (Greaves 2000, Lee 2000). 
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Injury, however, was also mentioned as a possible cause of cancer by one patient in this 
study. 
I was told that everybody has got cancer in the body and all it takes is a slight 
bump. … I was always frightened of falling over and hurting myself because I 
thought I was going to have cancer. I have known people who have been hit by 
a cricket ball, a golf ball and they finished off with a cancer. I think, you 
thought that was true but … (Leon) 
 
Wold et al (2005) found over twenty percent of six hundred and seventy cancer 
survivors (in North America) thought that physical injury could predispose to cancer. 
Although these historical theories were treated sceptically and refuted by the patient-
participants, the fact that they were commented on as potential causes of cancer 
alongside the recent understanding of cancer as an inherited genetic disease, illustrates 
that patients were grappling with disregarded old scientific theories alongside complex 
new ideas. 
 
b) Lifestyle Factors 
       All the patients were aware of health promotion messages that associated cancer 
with lifestyle factors such as smoking, diet and exercise (WCRF/AICR 2007). However 
the underlying theme to emerge from the patient data was a widespread scepticism 
about these given explanations for the aetiology of cancer.  This appeared to be because 
the given explanations did not tally with their own life experience.  For instance, both 
smokers and non-smokers expressed scepticism about the link between cancer and 
smoking. 
They are always running smoking down. They say it causes cancer blah, blah, 
blah. But everything causes it. It is just an excuse as far as I’m concerned. They 
are just using cigarettes as an excuse because everything causes cancer (Iain)  
You know passive smoking: it causes cancer but I say no … I’ve been a passive 
smoker all me life, even when I was young. … So you was living in an 
atmosphere of smoke … But I haven’t got lung cancer through it. … I think 
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unless they can define, really, really define, that smoking causes cancer I’m 
very sceptical about it (Leon)  
 
This scepticism extended to patients who had altered their lifestyle in the hope that it 
might prevent or postpone the spread of their disease. For instance, Finlay, quoted 
below, had been to an alternative therapist and made major alterations to his diet since 
his initial diagnosis. Nevertheless he remained sceptical about the link between his 
lifestyle and the origins of his own cancer. 
I do ask the question ‘Why me?’ because a lot of people abuse their body so 
much, drinks, smokes and eat all sorts of junk food and it seems to me a 
problem because I NEVER did; I would eat home cooking and try and keep 
myself fit (Finlay) 
 
Harry commented that his experiences since developing cancer, especially his 
experiences as a patient, had challenged his previous views that a healthy lifestyle 
could prevent or reduce the risk of cancer.  
The thing that amazed me, the young man who had a reasonably clean and 
moderate sort of life; they couldn’t do his operation, but the bloke … who ate 
fatty foods, smoking and drinking, they could operate on him (Harry)  
 
Claire was the only participant who clearly and unequivocally linked her own and other 
family members’ cancer to a shared lifestyle factor: smoking. However, despite the 
widespread scepticism about the association between their lifestyle and the 
development of their disease, there was some evidence that patients and their families 
had altered their behaviour due to health promotion messages about cancer aetiology 
being associated with lifestyle factors. 
The daughter packed in smoking in the end. The son-in-law … he finally packed 
it in … you weren’t allowed in the house because of smoking (Leon) 
 
And that some participants were trying to promote healthy habits within their families. 
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I encourage my grandkids to eat natural stuff. Chocolate, stop eating chocolate 
and sweets and things like that and try eating fruits and vegetables more than 
ever before (Finlay) 
 
Other participants drew attention to their resistance to health promotion messages, 
especially those about stopping smoking. 
I said I’m not going to pack in smoking just because I’ve got bloody cancer; 
what is the bloody point? (Iain) 
 
Although Iain also said that his resistance to changing his lifestyle had caused friction 
within his family, because other family members did perceive a link between cancer 
and smoking. 
Me daughter wants me to pack in smoking. I say to her it is a waste of time that 
is. It is too late anyway I’ve got cancer (Iain) 
 
     Resistance to health promoting advice about lifestyle is widely documented amongst 
the general public (Williams 1998, Crossley 2003). It has been described as ‘a symbolic 
form of transgression’ (Crossley 2003: 512) that enables people to assert the moral 
value of independence and individual rights as being more important than an 
unthinking commitment to the normative value of health. However this was not 
apparent in this study, where participants expressed scepticism about the scientific 
evidence that linked cancer and smoking, and emphasised a pragmatic 
acknowledgement that it was too late for a change in lifestyle to affect the outcome of 
their disease process.  
 
c) Environmental Causes 
There was a widespread awareness that environmental factors could be associated with 
the aetiology of cancer. Radiation and chemicals were frequently highlighted as 
potential causes of cancer. The environmental causes given were often very general, 
sometimes vague and again often considered sceptically.  
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And the environment as well (Finlay) 
 
I don’t really know. Whether it is the environment, whether it is the H-bomb, 
experiments, DDT on crops: I just don’t know. It is a puzzle (Jenny) 
 
Nevertheless some patients had clearly wondered about how the environment in which 
they lived and worked might have contributed to the development of their cancer. Some 
of these ideas fitted with the scientific literature about the causes of cancer (Kleinsmith 
2006).  
I suppose I have thought about what I have done at work. …Working in cyanide 
… Yes, chemicals. Could they have caused this? (Keith) 
 
Other theories were more idiosyncratic: 
There is so much, you know, microwaves and computers, and all these sorts of 
things, and I used to think to myself, was it the combination of the connection 
between the metal in my bra and all these vibrations and things that triggered 
something off (Anne) 
 
Epidemiological evidence suggests that environmental factors have a significant role in 
the development of cancer (Kleinsmith 2006, WCRF/AICR 2007). However the large 
number of potential environmental contributors to the aetiology appeared to increase 
the participants’ scepticism about any one given cause. 
 
 
d) Iatrogenic Causes 
Four of the twelve participants had also wondered whether some of the cancer in their 
family had an iatrogenic cause. 
Personally, I think, I was on the HRT for 12 years, and then I came off it.  And I 
think that it's that, that caused it (Anne) 
Because the chemotherapy I was on twenty-two years ago was experimental. 
And I feel as though that has caused this batch (Iain) 
 
There was less scepticism about iatrogenic causes of cancer than any other category, 
and three of the four patient-participants who discussed it as a potential cause of cancer 
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appeared to believe it was one of the more likely and credible explanations for their 
illness.  
 
e) Genetic Causes 
      It was notable that the only participant (Harry) who had been told that his cancer 
was due to an inherited genetic predisposition to cancer (by the registrar in his 
oncology team) remained sceptical about this information. He had been predeceased by 
five first-degree relatives from cancer (mostly stomach cancer), and had two other 
siblings who were concurrently living with cancer. 
I only talked to that doctor there and he made a note of it. But and he did come 
back after a couple of days. And he said; ‘I’m beginning to wonder whether the 
cancer is genetic’. I said ‘Well, our family has had it’ (Harry) 
 
      However Harry appeared to think that the idea of an inherited genetic predisposition 
to cancer was an unproven theory, and that cancer was primarily caused by smoking 
and drinking despite having led a ‘moderate lifestyle’ himself. He repeatedly described 
the doctor as ‘young’ and emphasised that he was a ‘junior registrar’.  He stated that 
the doctor ‘was trying to make a study of whether cancer is genetic’. Nevertheless he 
did not disregard the doctor’s words as the concept of a genetic predisposition to cancer 
appeared to resonate with his own family’s history of cancer and he was willing to 
contemplate it as a possible reason for his own illness saying: 
I think they have to ask patients like me, and put the record down.  If your 
family have had, if any members of your family have had cancer in the past 
(Harry) 
 
Harry felt optimistic that knowledge of the genetic origins of cancer could lead to new 
treatments and noted: 
 I would think if they do discover it is a gene, which goes through various 
families, then I think geneticists will find something to prevent it’ (Harry)  
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Therefore, despite his understanding that smoking, alcohol and diet were the main 
causes of cancer, Harry now wondered whether a genetic predisposition to cancer was 
significant for his family as he, and his family, had always ‘lived moderately’.  
... Well I’m wondering myself sometimes whether it is a gene that goes through 
the family that causes this. I mean, I don’t know (Harry) 
 
He balanced his scepticism with his belief that his cancer might be genetic by saying 
‘Well, it’s very odd. I don’t worry about it’, although he did acknowledge that it might 
worry ‘a lot of people’.  
       It was notable, and somewhat paradoxical, that Harry who had been informed that 
that his cancer was associated with an inherited genetic predisposition to cancer 
appeared more sceptical about this than other participants who discussed the fact that 
cancer could be associated with an inherited genetic predisposition to cancer. The 
understanding of cancer genetics is discussed below (p189). 
 
Reflection on Scepticism about Given Causes of Cancer 
       Beliefs can be considered as the ‘truth’ of a subjective reality (Wright et al 1996). 
Scepticism is closely related to trust and the ability to believe the scientific evidence or 
‘truth’ of official health promotion messages (Crossley 2003). It has been shown that 
conflicting media advice has reduced the ability of the general public to trust official 
sources, and that this distrust extends to health care professionals who were seen as 
complicit in this process; for instance, by being influenced by drug companies 
(Crossley 2003). This may have influenced the participants who attributed their own 
illness to iatrogenic causes. The widespread scepticism about the scientific 
understanding of cancer evident in this research may also be related to the study being 
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located within a hospice, where by definition the patients had advanced disease that 
could not be cured by modern science or medicine. 
        The pervasive scepticism about the scientific understanding of cancer is an 
important finding, as it highlights that doubt, scepticism and misunderstandings about 
an inherited predisposition to cancer need not be associated with factors that are 
specific to genetics like the complexity of the science or the distrust engendered by the 
eugenics movement. Rather they may be associated with a more widespread scepticism 
about the aetiology of cancer, which is perhaps associated with distrust of official 
health promotion messages. This may be due to the wide variety of health prevention 
messages (Williams 1998, Crossley 2003).     
      There was absolutely no indication that any patient was aware that recent scientific 
research considers the development of cancer to be a multi-step process: that cancer 
cells develop a collection of distinctive traits that develop over time due to a series of 
alterations to the DNA and that there are many factors that can alter the probability that 
each of these steps will occur in an individual (Kleinsmith 2006). Reports about 
multifactorial influences on cancer are rarely given media coverage (Peterson and 
Bunton 2002). Hence the participants in this study who were sceptical about any of the 
given causes of cancer as a monocausal explanation for their own disease process 
appeared completely unaware that this was in accord with emerging scientific thinking.  
      This chapter is called the ‘The Missing Factor’ to highlight the lack of awareness 
about multifactorial aetiology of cancer shown by the participants. This 
misunderstanding is crucial, not only because it may contribute to the scepticism that 
pervaded the patients’ perception about the causes of cancer, but also because it is a 
fundamental concept when considering the potential for an inherited genetic 
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predisposition to cancer. It contributed to the participants’ limited understanding of 
genetics, as demonstrated below. 
 
Limited Understanding of Genetics  
       Ten of the twelve patients spontaneously mentioned genetics, genes or having 
cancer ‘in the family’ as a potential cause of cancer, although only two (Diane and 
Harry) had discussed the possibility with healthcare professionals. This widespread 
awareness of genetics as a cause of cancer is commensurate with other studies that 
show that the widespread media coverage of cancer genetics is both raising awareness 
and causing concern about inherited disease (Emslie et al 2003, Bankhead et al 2001). 
However the understanding of cancer genetics was very limited and only a few 
participants choose to elaborate on the topic. They struggled to clarify their ideas, both 
when talking about genes and when discussing inherited genetic predisposition to 
disease.  
 
The Concept of Genes 
       The few patients who discussed genes clearly struggled to conceptualise a gene. 
Leon described genes as though he thought they were a discrete organ that moved 
around damaging the body. 
There should be a gene … where the cancer will occur. If it is in your breast 
you will get it in your breast, if it is in your lungs you will get it in your lungs ... 
Or if there are different genes for the different cancers I wouldn’t like to say 
(Leon) 
 
Diane described her cancer genes as an alien on three occasions. In this image the gene 
does not only appear to be a discrete entity but also an entity that is foreign to the body. 
Well, it is like you have rogues genes that you carry. It's like an alien, I suppose. 
It keeps coming back to me; I don't like it (Diane) 
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This idea of the gene as an alien invader that attacks the self is very different to the 
dictionary definition of ‘the basic unit of heredity in living organisms’ (OED Online 
accessed 17/6/08) and shows that genes are not always conceptualised as being integral 
to self.  A contrasting notion that genes predestined people to cancer was also raised. 
The concurrent ongoing media coverage of The Human Fertilisation and Embryonic 
Authority’s decision to permit embryo screening for cancer (www.bbcnews accessed 
10/05/06) may have enhanced this concept of genetic predestination, as opposed to 
predisposition to disease. 
Because your genes rule your life, don’t they? ... They build you to what you 
are: whether you are going to be ill, seriously ill, or whether you are going to 
live till you are one hundred. It’s your genes … that progress your life ... And 
they can find out, or they are supposed to find out that when you are born then 
they can look for the cancer gene: The genes which causes cancer (Leon) 
 
     The way individuals visualise and conceptualise genes and genetic disease may have 
the potential to affect the way they cope with familial cancer. The power of cancer 
imagery has long been recognised (Sontag 1978) and guided imagery, a technique that 
harnesses the power of the mind to form helpful mental representations of objects or 
situations, has been shown to reduce stress, anxiety and depression in cancer patients 
(Roffe et al 2005). Images of treatment acting as a defence against alien cancers can be 
effective in allowing patients to fight disease (Goldberg 1990). Other studies have 
reported a comparable confused conceptualisation of genes in people with familial heart 
disease (Emslie et al 2003), and in studies of lay knowledge about cancer risks (Adlard 
and Hume 2003). This suggests that consideration of patient’s understanding of genes 
might be important when discussing genetic predisposition to disease. 
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Assessment of Familial Risk 
      There was also confusion about patterns of inheritance and how this might affect 
other family members. In the following extract Harry is talking about the disease in his 
wife’s family (his sister–in–law and niece-in-law). 
It comes out every other, it’s skipped a generation. Her grandmother had it 
but her daughter hasn't had it and she has got it now. All I’m saying is that, if 
she marries and has a daughter, her daughter might marry and pass it on to 
her daughter ...  that must be a gene that passes on through the family (Harry) 
 
Although recessive inheritance of cancer is known to occur in certain rare cancers like 
xeroderma pigmentosum (Kleinsmith 2006), the distribution of cancer within his wife’s 
family would be suggestive of sporadic cancers rather than inherited predisposition. As 
discussed, Harry had been told that his cancer was possibly genetic but did not have the 
knowledge to differentiate between the risk to his blood relatives and his wife’s blood 
kin. The fact that he made no distinction about the aetiology of disease in his family 
where eight first degree relatives had cancer and his wife’s family who only appeared 
to have two cancers in three generations, again highlighted the fact that he had no 
concept of multifactorial disease causation and was struggling with monocausal 
explanations for cancer. 
       Although there was a widespread awareness that cancer could run in families, there 
were surprisingly few attempts by participants to explicitly link the pattern of cancer 
within the participant’s family with knowledge about how genes were linked to disease 
causation within families. However parental cancer appeared to be particularly 
important when patients considered why they had developed cancer: 
I think it's hereditary, because I had it, and my father had it (Beth) 
 
So I ask the question ‘Why me?’ but my mother did die of cancer (Finlay) 
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For these participants one parent with cancer was enough to raise questions about 
inherited disease. Conversely, the absence of parental cancer was seen as negating the 
likelihood of inherited genetic disease despite multiple cancers in the family. 
It's all on my mother side, yes ... But I can’t find that any of my mother’s 
previous family ...  had cancer. But there is a lot in my generation (Jenny) 
But my mother and father didn't have cancer.  It seems funny that it should be 
me, my sister, and my two brothers that have developed some sort of cancer 
(Anne) 
 
      It is important to note that awareness that cancer could be an inherited genetic 
disease did not automatically mean that the participants linked their own family history 
of cancer with a genetic cause, even when there were multiple experiences of cancer 
within the family. For example Anne was clearly aware of, and informed about, the risk 
of inherited disease with breast cancer.  
And today they say it's probably about your genes, genes…  You've got bad 
genes they say (Anne) 
 
However she had disregarded it as an explanation for her cancer because neither of her 
parents had cancer, despite the fact that her nephew, niece and all her siblings had 
developed cancer (several at a young age). In fact Anne, like most of the participants, 
was sceptical that the cause of cancer was known or understood.  
They don't really know what causes cancer … I think it could be one in a 
million things ...  I think it's so complicated, complex.  It might be a hundred 
years time, then they might have solved it (Anne) 
 
      However it was when multiple occurrences of cancer occurred in conjunction with 
parental cancer participants were most likely to associate the family history of cancer 
with a genetic origin. For instance, Iain was discussing his siblings’ and parents’ 
cancers when he drew attention to his fears that his children might have a cancer gene, 
and although Harry was sceptical about an inherited susceptibility to cancer he 
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appeared more open to the possibility when discussing the multiple occurrences of 
cancer within the family. 
That’s right, four sons and two daughters. Mum and Dad and (brother’s) and 
(sister) are deceased  ... Cancer is especially to you, so it must be your genes I 
reckon within the family (Harry) 
 
Reflection on the Limited Understanding of Genetics 
       These findings illustrate the very limited understanding of cancer genetics in the 
patient-participants. Participants were unable to clearly conceptualise a gene and had a 
poor understanding of how to assess the risk of inherited cancer. This is important 
because the accurate assessment of risk depends upon the understanding of genetic 
inheritance.  
        The participants’ limited understanding of cancer genetics is consistent with other 
studies that show that relatives of people with adult onset multifactorial diseases like 
cancer do not calculate their risk using bio-scientific models (Walter et al 2004). A 
synthesis of the literature suggests that people develop a sense of vulnerability to 
disease through the salience of their family history, which is interpreted within their 
personal understanding of causation and inheritance (Walter et al 2004). In this study 
the salience of disease was high for all participants (who all had incurable cancer and a 
family history of cancer) nevertheless they were sceptical about genetic, (and other bio-
scientific factors), that may have contributed to of the cause of their disease. This 
suggests that a high salience of disease is not, in itself, enough for participants to 
believe that the cancer in their family was due to genetic causes.  
      Parental illness appeared to be the most important factor that participants associated 
with genetic predisposition. Multiple occurrences of cancer within the family did 
appear to increase the likelihood that participants would attribute their disease to a 
possible genetic link – but only if they occurred in conjunction with parental disease 
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and many only discussed the possibility in passing. They were sceptical about the 
possibility of genetic causes of cancer alongside other explanations for the disease.  
       Adlard and Hume (2003) found that relatives of people with cancer had a better 
basic knowledge of cancer than the general public. They suggest that people learn from 
their relatives’ experiences. Findings from this study, where participants were both 
relatives of/and people who were living with cancer, suggest that it is possible to 
interact with cancer services over decades and still have a very limited understanding of 
why cancer occurs within a family. Nevertheless Adlard and Hume’s (2003) finding 
that relatives know more than the general public suggests that if patients were better 
informed about the multifactorial nature of cancer and the role inherited susceptibility 
to disease played in familial cancers, they might be able to pass this knowledge onto 
relatives. This is especially important with respect to inherited genetic predisposition as 
it can affect the way people manage their disease and risk within the family (Walter and 
Emery 2005) and as healthcare professionals are not able to contact relatives directly 
about disease risk (Hope 2004). However the poor understanding of the aetiology of 
cancer limited their ability to assess this risk accurately.  
 
Discussion  
        It has been claimed that ‘inquiry into patient health beliefs is perhaps the most 
powerful foundation for collaboration between patients, families and health care 
professionals’ (McDaniels et al 2006: 175). It encourages mutual trust and collaborative 
relationships that help professionals clarify patient concerns about their disease 
(McDaniels et al 2006). Health beliefs are culturally embedded (Conner and Norman 
2005). Hence consideration of the understanding of familial cancer is important when 
assessing the cultural component of care for palliative care patients, where culture is 
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defined as ‘the distinctive ideas of a particular society, people and period’ (OED Online 
2008). 
 
Behaviour and the Understanding of Cancer 
      There is a common sense appreciation that human behaviour is associated with 
attitudes and beliefs (Ajken and Fishbein 2005), however studies have shown that 
general beliefs and attitudes correlate poorly with specific actions, and that people who 
hold the same beliefs can act in different ways. Despite this, strong correlations are 
found between attitudes, beliefs and behaviour when behaviour measures are 
representative of a broad behavioural domain (Ajken and Fishbein 2005). Hence 
attitudes and beliefs can broadly predict behaviour.  However it is known that attitudes 
about disease threat alone are often insufficient to motivate individuals towards 
different patterns of behaviour (Egger et al 2002, Conner and Norman 2005). Other 
factors that are known to influence health behaviour include demographic, personality 
and social factors: despite this, it remains important to pay attention to cognitive factors 
like the understanding of/and attitude to disease because they differentiate between 
individuals from the same background, are open to change and represent one route to 
influence health behaviour and concerns about disease (Conner and Norman 2005).  
        It is not known exactly how understanding, beliefs and attitudes interact with other 
factors to influence behaviour, and several models have been constructed to try to 
explain the links between health beliefs and behaviour. These include, The Health 
Beliefs Model (Rosenstock 1974) and The Theory of Planned Behaviour (Ajzen and 
Fishbein 2005). The Health Beliefs Model suggests that the perceived severity of a 
health concern and the perceived susceptibility to the health problem, alongside the 
perceived benefits and barriers to acting on that concern, influences behaviour (Egger et 
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al 2002). That is, for behaviour to change an individual must have the incentive to 
change, must feel threatened by their current situation and must feel that change will be 
beneficial and at an acceptable cost (Egger et al 2002). 
      There has been limited use of health belief models in the context of genetic 
predisposition to disease (Janz and Becker 1994) and this study did not aim to examine 
the links between the participants’ beliefs and their behaviour. Nevertheless it was 
noteworthy that ten of the participants were aware that their family history of cancer 
might/could be associated with an inherited genetic predisposition to disease but only 
one had raised these concerns with healthcare professionals.  In the light of the 
widespread scepticism about the known causes of cancer shown by the participants, and 
their limited knowledge about an inherited genetic predisposition to cancer, discussion 
about why so few participants had acted (even by initiating discussions with nursing 
staff) on their concerns about having cancer in the family are perhaps superfluous. 
         However, phenomenological enquiry draws on many sources of meaning (Van 
Manen 1990), and consideration of how the participants understanding of cancer 
affected their care needs was integral to this study. Components from The Health 
Beliefs Model have been used as framework to structure this discussion. It must, 
however, be noted that they have been used with the intent of systematically discussing 
the information obtained, (not with the intent of predicting behaviour).  
• Perceived Severity: For the patient-participants in this study the perceived 
severity of the threat of cancer was high. They were aware that their illness 
would cause their death and were actively dealing with the physical and 
psychosocial sequellae of advancing incurable disease. They were also 
concerned that other family members were at risk of cancer in the future.  
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• Perceived Susceptibility: The perceived susceptibility to inherited genetic 
disease was very variable in this study. Few participants were concerned 
about inherited susceptibility with regard to their own illness but there was 
widespread concern about other family members developing cancer in the 
future: especially children. This had prompted several participants to 
discuss the potential for inherited disease with their adult-children and 
provoked significant distress for Iain when he contemplated his young-
children’s risk of susceptibility to future disease.  
• Perceived Benefits: All the participants who had discussed hereditary 
cancer with other family members had done this to encourage relatives to 
access screening and regular checks. They appeared to perceive early 
intervention and diagnosis as a benefit for relatives. Diane was the only 
participant to perceive that her family might benefit from contact with 
genetic councillors.  
• Perceived Barriers: Scepticism about the medico-scientific understanding 
of cancer was widespread. Scepticism was present regarding all of the 
known predisposing factors for cancer including lifestyle, environmental 
and genetic factors. This could constitute a barrier to accessing further 
information about the aetiology of cancer from healthcare professionals 
and reduced the perceived utility of health-promoting health behaviours for 
the patients and their children. The poor knowledge about the aetiology of 
cancer could also constitute a barrier. No participant showed an 
understanding of cancer as a multifactorial disease and the understanding 
of genetics and inheritance was poor. Concern about the impact of 
knowledge of inherited disease on children was also a barrier for Iain. He 
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felt the distress that it would cause to his children outweigh any potential 
benefits of informing them of inherited risk      
 
      These barriers appear to have been significant for many of the participants. Despite 
the severity of the threat and the concerns about the susceptibility of other family 
members expressed by many participants, only Diane had raised her concern with 
healthcare professionals. Similarly, despite the suggestion that advancing incurable 
disease might provoke anxiety about familial disease in patients and families (Sanders 
et al 2003, Rees 2001), and awareness that palliative care might be the last opportunity 
to identify people who are at risk of an inherited predisposition to cancer for a 
generation (Lalloo et al 2000, Kirk 2004a), healthcare professionals had only raised the 
issue of inherited genetic predisposition with one participant: Harry.  
     It has been claimed that as society becomes increasingly ‘geneticized’ knowledge 
about genetic predisposition to multifactorial disease has the potential to become 
increasingly influential to the way patients perceive their disease and the risk to other 
family members (McDaniels et al 2006). This study suggests that the scepticism of 
palliative patients about bio-scientific causes of cancer, alongside a poor understanding 
of cancer genetics, may be a barrier to patients acting on these concerns.  This is an 
important finding as communication with terminally ill family members about the risk 
of familial disease was identified by Hallowell (1999) as a reason why people contacted 
genetic services. Hence patient scepticism about the causes of cancer have the potential 
to block relatives access to genetic counselling and therefore, their access to risk 
reduction measures. 
       One potential reason for scepticism is the multiple and often conflicting health 
promoting advice that people are given (Crossley 2003). This emphasises the need for 
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good patient education about cancer being caused by a series of steps, each of which 
might have a separate trigger. This would allow the various proximal causes of cancer 
that were known to all the participants to be held within an explanatory framework, 
potentially reducing scepticism (Rees et al 2007).   
        This study suggests that patients with a family history of cancer may be aware of 
the potential risk of inherited disease but sceptical about this risk and the efficacy of 
acting on their concerns. That the lack of knowledge about multifactorial causes of 
disease can act as a missing factor, preventing patients from evaluating their family 
history, or considering how an inherited susceptibility might interact with other lifestyle 
and environmental factors to promote disease within the family.  
       Finally, the findings from this small study suggested that individual perceptions of 
genetics can be diverse: ranging from alien invaders to concepts of predestination to 
cancer from conception. This emphasises that individualised assessment with regards to 
the cultural aspects of patients’ understanding of cancer genetics is as important as with 
any other aspect of care. Listening to patients and reflecting on their perspective should 
be the starting point of all health-promoting education within palliative care (Kellehear 
1999). 
 
Conclusion 
       This chapter highlighted the patient-participants’ scepticism about the causes of 
cancer and documented their limited understanding of cancer genetics. It suggests that 
the lack of awareness of the multifactorial aetiology of cancer is a ‘Missing Factor’ that 
act as barriers that prevent patients raising their concerns about familial disease. It 
highlights the need for individualised culturally appropriate care to take account of 
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patients’ differing understandings of familial cancer when evaluating the care needs of 
patients with a family history of cancer. 
        This reinforces the need to ensure that patients have the opportunity to disclose 
and explore fears about risk and ensure that they are properly evaluated. A core 
competency for nurses is to be able to identify clients who might benefit from genetics 
services and information (Gaff 2005). The nurses’ perceptions of the care needs of 
patients with a family history of cancer are the focus of the next chapter. 
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CHAPTER NINE: THE MISSING AGENDA 
He who knows not and knows not he knows not: He is a fool – shun him 
 He who knows not and knows he knows not:  He is a student - teach him 
He who knows and knows not he knows:  He is asleep – wake him 
He who knows and knows he knows:  He is a wise man – seek him  
(Variously attributed to Confucius, Socrates or an Unknown Persian Source) 
 
Introduction 
     Lived space is the existential theme that refers to the lived experience of the world 
that the research participants inhabit (Van Manen 1990). There are cultural and social 
conventions associated with physical spaces that give places qualitative dimensions. 
Enquiry into the lived space of a phenomenon enhances the quality of meaning when 
researching lived experience (Van Manen 1990). The lived space within which this 
research took place was a hospice. In this study only the nursing staff were asked about 
whether they felt that palliative care was an appropriate service to address the issues 
relating to genetic predisposition to cancer, hence the spatial analysis considers the 
question primarily from their perspective. This chapter firstly highlights that the 
patients felt they were receiving expert care then, discusses five themes that emerged 
when the nurses reflected on the care required by patients with a potential inherited 
genetic susceptibility to cancer.  
         This chapter presents the nursing data about the care of families with an inherited 
predisposition to cancer. It uses Benner’s (1984) model of clinical development ‘From 
Novice to Expert’ to develop to argument that, although the care given outwith the 
genetics lens was expert, the nursing staff were novice with regard to the care of 
patients and families with a potentially inherited predisposition to cancer. 
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Emergent Themes 
Family Care Integral 
      Care of the family is integral to the definition of palliative care (NCPC 2007, WHO 
2002). All of the nurse participants acknowledged that care of the family was a central 
aspect of the care given: 
Everything we do in palliative care, the education that we get on it, it’s the 
family and the patient are a unit (NP5) 
 
And that caring for the family was integral to patient care: 
And then the patient is much better because the family, I think, supply the 
security for the patient and I think that is very strong. I do really (NP5) 
 
However, they stated that in practice the nursing care of the family was often 
constrained by the location where the care occurred. All the nurses who worked in the 
community palliative care team stated that care of the family was fully integrated with 
the care of the patient. They were aware that it was essential to ensure that the family 
were fully supported, to enable them to care for the patient at home where they are the 
primary caregivers (Doyle 2005)  
I think that our role is very much caring for the family ... As much as caring for 
the patient: because, especially if somebody wants to stay at home … I think it is 
important that the family are cared for… I think they need the maximum support 
that is available to the family. You have got more chance of a patient being able 
to stay at home (NP4) 
 
The nurses who worked in the inpatient unit also emphasised how integrated the care of 
the patient and family could be: 
The first priority is, of course, the patient, but there is a huge percentage of you 
goes to looking after the family … So for me I am constantly looking after the 
patient but constantly seeing how the family and relatives are affected by the 
situation (NP6) 
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In contrast, the nurses who worked in the day centre acknowledged that their work was 
often more focused on patients, as the purpose of day care can be to give patients 
respite from their families (Payne 2006). 
The emphasis in the day centre is more on the patient ...  often the patient is 
trying to get away from the family, because they are over-loved and over-
smothered and people talk about it all the time or it is ignored and the disease is 
not acknowledged, so they can come here and talk about it. But… it is very nice 
if you do see some of the family (NP7) 
 
However, even the day centre actively attempted to integrate families into care services 
(Payne 2006), including offering complementary therapies and counselling with trained 
counsellors: 
We do complementary therapies, they come to outpatients, obviously advice, all 
sorts of advice, including on the phone. There is some patients that I do a 
weekly phone call to the family ... Some of them come in with them ... we will 
talk about drugs and just what is going on (NP7) 
 
Hence all of the nurses were aware that relatives needed support, both for their own 
sake as well as to enable them to be close to and support the patient (Andershed 1999 
quoted Andershed 2006, Panke and Ferrell 2005).  
 
 
Palliative Care:  An Inappropriate Setting for Risk Assessment 
      All of the nurses were aware that the knowledge of inherited susceptibility to cancer 
had the theoretical potential to provoke new fears (Peterson and Bunton 2002, 
Henderson and Kitzinger 1999).  
I guess it might bring more anxiety. There is more information on genetics and 
… I suppose it makes people think more. When they have had it and this relative 
has had it, saying well what do you think? What is going on? They may need 
more support (NP2) 
 
I think there are many, many people who are afraid because it is a known factor 
that breast cancer can be hereditary. And I think people on the whole do ask 
that question (NP5) 
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        Despite the awareness that the care of the family was integral to palliative care 
(NCPC 2007, WHO 2002) the nurses did not think palliative care was an appropriate 
setting for risk assessment of inherited genetic susceptibility. All the nurses expressed 
reservations about discussing genetic predisposition within a palliative care setting and 
several participants felt a palliative care setting was definitely inappropriate. There 
were two reasons given for this: firstly, that genetic risk assessment was a separate 
speciality with its own expertise which they did not possess. 
That (the) genetics team have got that in-depth knowledge and that experience 
and I think it is a case of referring it on to the specialists (NP4) 
 
I think it would be better with geneticists ... Because it is so complex (NP7) 
 
I mean all we can do as nurses is make ourselves as aware as much as possible 
so we can act within our scope ... You know they (genetic specialists) do a lot of 
work, in terms of looking at who ...  whether people need to be screened and 
whether their risk is any greater. Or whether it is just random: there is no 
familial link at all (NP4) 
 
       Low confidence levels about their ability to deal with genetic issues has been 
shown to be widespread in nursing (Burke and Kirk 2006) and in palliative care nurses 
in particular (Clifford et al 2007).  
     The second reason given was that it was inappropriate to introduce the topic of 
inherited disease whilst the patient was dying. The fact that it was obviously too late for 
patients to benefit was regularly highlighted. 
It is much, much better earlier because you want to prevent it don’t you (NP7) 
I think it should be done long before palliative care personally ... Because it is 
really too late, isn’t it (NP1) 
If you have cancer in the family and perhaps you are worried that you might 
have it then a palliative care hospice is not the right situation. No: Because we 
are at the other end of the journey (NP3) 
 
204 
The main barrier to raising the topic of inherited disease with relatives was the 
emotional involvement of families with the dying patient, and the nurses felt that 
dealing with the death itself could be an overwhelming issue for many families 
It would be better to be somewhere where it was a little less emotive: … 
Because I think you can get a bit, well, overwhelmed here at times. And you 
can lose perspective here at times (NP9) 
 
Not really, is my answer. … They (Family) are more thinking about the patient 
dying and how they can help the patient (NP6) 
 
One nurse elaborated on this by suggesting that raising the topic of inherited 
susceptibility to disease near death might lead to an association with a predetermined 
death, rather than the potential for early disease identification and increased expectation 
of cure that is the rationale for identifying people at risk (Bell 2004). 
Being in palliative care … it might be a bit too late. They wouldn’t have hope: 
they would come to see death as the end, as opposed to getting wrapped in 
screening and treatment … It could really depress their whole life (NP8) 
 
Three nurses commented that the potential distress associated with the topic had 
prevented them from mentioning the possibility of inherited susceptibility (see also 
exemplar-case two below). 
We have actually had a study day here about it (genetic predisposition) so I 
have thought about it but never felt it necessary to raise it, or appropriate to 
raise it, would perhaps be better (NP7) 
 
One participant was also concerned that introducing genetic issues could open up 
divergent care needs between patients and their family that might be detrimental to 
patient care. 
I think it would distract from what we are trying to do to some extent. …, you 
can imagine someone on a ward bringing all this up … and trying to sort all 
that out and not concentrating on the patient who is actually dying (NP7) 
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        These concerns are similar to concerns expressed in Arden-Jones et al (2005) 
study that investigated the impact of genetic testing at the time of initial cancer 
diagnosis. They suggest that this was ‘too much too soon,’ and that the emotional 
overload in coping with the cancer diagnosis meant that offering genetic testing would 
add too much additional stress. Dying is also stressful for patients and families (Vachon 
2005a,b, Duhamel and Dupuis 2003) and these participants appeared to feel that raising 
the topic of inherited disease in palliative care was ‘too much too late’. 
        Identifying clients who might benefit from genetics services and information is a 
suggested core competency for all nurses (Kirk et al 2003, Gaff 2005). However the 
participants did not feel that this was necessarily appropriate when patients were dying. 
They appeared unaware of the two main arguments in the literature for the involvement 
of palliative care nurses in the assessment of risk for predisposition to disease: that 
palliative care could be the last opportunity to obtain a full family history of disease 
prior to the death of an older member of the family (Lalloo et al 2000), and that it can 
be the last opportunity for a generation for a blood sample to be taken to be used for 
predictive genetic testing (Kirk 2004a). Rather they felt it was more appropriate that the 
issues were raised at an earlier stage in the illness trajectory. 
 
Supporting Concerned Families  
        Although the nurse-participants did not think it was appropriate that they identified 
patients who might benefit from genetic services and information,  they did feel that 
intervention would be appropriate within palliative care if the patient or family 
themselves raised concerns about the potential risk of inherited genetic predisposition 
to disease.  
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But yes I would see a place … within palliative care, advising the rest of the 
family: if they ask for it and if they do ask about genetics, yes I feel we could 
support that and encourage it (NP1) 
 
And if it is happening within that family at that given time and it is within this 
place: then it can, or could be dealt with in some way (NP6) 
 
It would be difficult … because there would be all those issues about 
approaching death but … if it hadn’t been raised with them before, it might be 
wrong not to, if you thought they might be at risk. It could affect peoples’ lives 
(NP2) 
 
That is, they thought that it would be wrong to ignore the issue of inherited genetic 
predisposition if it was actively causing distress to the family. However, none of the 
nurses felt that they had an adequate knowledge base to properly support a patient and 
family who were worried about this issue. They consistently expressed a need for more 
education and training to feel confident about providing care to families who were 
worried about their susceptibility to cancer.    
We wouldn’t have that in-depth knowledge…. We would need increased 
training obviously (NP4) 
 
At the moment I don’t really know how things are worked out, Genetics, who 
knows what it brings up (NP8) 
 
It is quite a specialised area and I wouldn’t feel informed. I wouldn’t be able 
to do anymore than refer (NP3) 
 
Recognising the limitations of your genetics expertise is a key competency for nurses 
(Kirk et al 2003, Benjamin and Gamet 2005). The need to develop the educational 
provision for hospice nurses has been identified as a priority to enable nurses to support 
dying patients with a genetic prediction to disease (Clifford et al 2007). The nurses in 
this study all thought that their main (and perhaps only) role would be to enable patients 
to access appropriate expert advice: 
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I mean I don’t know a lot about it, but I could find out more. As with all 
questions that I am asked by families I will find it for them, or I will tell them 
where to find it (NP1) 
 
If a family member raised a question and you were able to point them in the 
right direction. But I don’t feel I could do anymore than point them in the right 
direction (NP3) 
 
I’d let them talk but I’d say there would be a number of things which I 
wouldn’t know how to answer. I’d get a man who knows (NP8) 
 
Seeking assistance from and referring to appropriate genetics specialists is the 
recommended practice for nurses when there is concern about a family history of 
cancer (Kirk 2004, Gaff 2005). However only three participants stated that they had 
been asked about this: two stated that they had referred the family to their general 
practitioner. (See also exemplar case three below). 
But I have had people ask me about the genetic link … So I just give them 
advice that they should go to their GP (NP1) 
 
This advice fits with the advice in the government white paper ‘Our Inheritance, Our 
Health’ (DH 2003) that general practitioners should be the key primary health care 
professionals involved in predictive genetic medicine. Nevertheless it also emphasises 
that the nurses did not perceive the issue of genetic predisposition to disease as being  
part of their role. Nurses are encouraged to use their listening and advocacy skills to 
support families both before and after the referral process (Gaff 2005). It would be, for 
instance, virtually inconceivable that the same nurses would merely have suggested that 
the patients contact the GP about concerns related to symptom control, or psychosocial 
concerns about the dying process, although the GP remains the healthcare professional 
in charge of a community patient’s care during their terminal phase.  
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 Clinical Practice: The Family Tree   
      The genogram, or family tree, has been widely promoted within palliative care to 
encourage family-orientated care (Loissi et al 1997). It is a tool that helps piece 
together the family dynamics to consider what support is available to the patient and 
family (Hockley 2000), including spiritual resources (Cobb 2007).  The hospice 
assessment procedure included a family tree which was used to assess the patient’s and 
family’s ability to cope with the impending death within the family. 
I do a family tree. … I don’t necessarily ask whether anybody else in the 
family has died of cancer, although it does generally come up then. But I will 
ask whether there have been any major losses really. What we are looking at 
is how they have coped with it … We are really looking for the impact of the 
illness on the family and how they have coped with it (NP1) 
 
To see if there are any dependants, to see what their support network is really. 
The ones I worry about are the ones where there is nobody around. I really 
worry about those. And then the big ones, with lots of people: they are 
probably fairly lively (NP7) 
 
I always personally look at the family tree just to look at where we are. To see 
if parents are alive, to see how many children there are, and what the 
dynamics are really (NP3) 
 
     Hence the purpose of the family tree was very different to its use in clinical genetics 
where the aim is to document the family history of cancer as accurately as possible 
(Skirton et al 2005). All the nurses were aware of this distinction. They were also all 
aware that an inherited susceptibility to cancer was associated with a pattern of multiple 
occurrences of the same or related cancers within families. However, none of the 
participants felt confident about completing a pedigree analysis or assessing risk of 
inherited disease from the distribution of cancer within a family.  
Sometimes it can seem that there is a lot of it, but it is just a kind of co-
incidence. … there had to be several people in the same family and that it had to 
be the same tumour and things like that from the research. And sometimes it just 
isn’t hereditary but sometimes it is (NP2) 
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They were also aware that inherited susceptibility was more common in some cancers 
than others. The most commonly mentioned breast and colon cancers, the two most 
common cancers for which genetic testing is possible. 
There is definitely a genetic link with breast and ovarian cancer, and bowel 
cancer (NP1) 
 
I mean there are certain types of cancer that you tend to think are more 
particularly linked, for instance breast cancer ... Some of the more gynae 
related cancers as well (NP9) 
 
Hence they were aware that pedigree analysis was a complex task and had a different 
purpose from compiling a family tree, and that the high incidence of cancer in Britain 
meant that it was not easy to distinguish between an inherited predisposition to cancer 
and other causes for familial clusters (Skirton et al 2005). Although the nurses felt 
competent to use the family tree as a tool to assess the psychosocial needs of families, 
they did not feel equipped as regards its use for recording the family pedigree. 
 
Clinical Practice: Patient Care  
       Only half the nurses had knowingly nursed a patient with a family history of cancer 
that they knew or presumed was associated with an inherited genetic predisposition to 
cancer. Some of these examples concerned patients whose concerns had been dealt with 
prior to their referral to palliative care services.  
I seem to remember one family. I seem to remember that they were already 
under the care of the hospital for that (NP8) 
 
These experiences do not seem to have presented any special concerns for nursing care. 
They were, however, more aware of the issues for families with other diseases that 
were more closely associated with a genetic predisposition to disease 
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Huntingdon’s disease: Her brother had it: he died of it. And she has 
Huntingdon’s and she is alive currently ... because there is a lot of worry 
going on in the patients’ mind and the families’ mind as well ... more than 
with cancer … certainly with Huntingdon’s there has been this sort of feeling 
that, will I get it next? (NP8). 
 
These two quotes, both given by the same nurse, highlight a paradox of the nursing data 
which is that the nursing staff were aware that inherited genetic disease could provoke 
specific concerns in relatives with the potential to develop the disease. They were also 
aware that these relatives might need extra support because they were worried that they 
might develop the disease in the future, but they did not perceive this as a concern for 
patients and families with cancer, even (as above) for patients and families who were 
already identified as having an increased risk of an inherited genetic predisposition. 
      None of the nurses in this study mentioned that they had participated in the care of 
any patient where any member of the hospice multidisciplinary care team had initiated 
action that led to any changes in care due to the potential of an inherited predisposition 
to cancer. That is, what was most notable about the nurses’ data is that any issues 
associated with potential future disease were not prioritised in any of the given 
examples. The need to identify clients who may benefit from genetics services (Kirk et 
al 2003, Gaff 2005) was missing from their agenda.  
     This is illustrated using exemplar cases from the nursing data. They are used to 
illustrate different scenarios where a potential genetic predisposition to cancer had 
impacted upon the care needs of palliative care patients and their families. They were 
selected (from a small pool of data) as they were especially representative cases (Miles 
and Huberman 1994) that illustrate the reasons for, and potential consequences of 
inaction, around issues of a genetic predisposition to cancer within a palliative care 
setting.  
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Exemplar-Case One 
      The first exemplar-case illustrates a scenario where concerns about the future risk to 
(adult?) children were recalled as one of the main psychosocial concerns of the dying 
patient.  
I mean his mum died of it, and her mum had died of it and her brother had 
died of it. So it was known to be in the family. So she was worried about her 
son and daughter (NP3) 
Did that bring up any different issues for you? (I) 
No, and I think because the family weren’t in this country. … The son and the 
daughter were abroad. So, perhaps I didn’t think about it any further because 
I didn’t have to (NP3) 
 
      Genetic counselling is not a necessity for every patient whose disease might have a 
heritable component (Frazier et al 2004). Any nurse educated in genetics can use their 
knowledge to identify and differentiate risks, and refer to specialists when appropriate 
(Frazier et al 2004). Systematically collecting information about three generations or 
more can help clarify risk, and contacting a specialist service with this information can 
help clarify when referral to a specialist service is appropriate (Gaff 2005).  
       In this exemplar case no proactive actions were taken and the patient died with 
worries for her children. However, as disease that occurs in the paternal family has no 
genetic association with disease that occurs in the maternal family (Gaff 2005), a 
simple knowledge of genetics would have enabled the nurse to explain why the 
incidence of cancer in the patient’s bloodline needed to be considered separately from 
the cancer in her husband’s family, when considering the risk to their children.  
      Ensuring that questions are systematically asked about other first and second degree 
blood relatives, who have not developed cancer, can also help clarify risk. With this 
knowledge the nurse could have asked pertinent questions about the patient’s siblings 
and maternal aunts and uncles, including questions about age at first diagnosis to see 
whether the patient’s family history of cancer warranted referral to the regional clinical 
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genetic unit (WMFACS 2007 Referral guidelines: see appendix One). This would have 
clarified whether the patients concern required actioning and perhaps reassured her that 
her concerns were being taken seriously. 
      Similarly, there did not seem to be any awareness about the possible actions that 
could have been taken to enable the patient’s children to access health promotion 
measures if they were at increased risk of developing disease. It may have been the last 
opportunity for them to learn about their family’s history of cancer from their mother 
(Lalloo et al 2000). It is also possible to consider genetic testing or blood banking 
within a palliative setting (Kirk 2004a). This allows other family members to be tested 
for the particular genetic alteration that occurs within the family. This may have 
reassured the patient that she could do something active to support her children if they 
were at risk, as people with cancer can be pleased to act altruistically and help other 
family members assess their own risk of disease (Hallowell et al 2004). This would, 
however, have been complex in this case as the children were overseas, as clear 
arrangements need to be in place as to who will be given the test results after a patient 
has died (Kirk 2004a). 
 
Exemplar-Case Two  
     This case highlights a scenario where the risk of an inherited predisposition to 
cancer had been identified but it was decided that palliative care was an inappropriate 
setting for risk assessment: 
The mother died here in the summer. The two daughters have breast cancer. 
One was very poorly from the minute the mum died … And she has just been 
diagnosed with ovarian cancer … And the other sister has got bone 
secondary’s (NP7) 
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The nurse was fully aware that the family history of disease could be associated with an 
inherited predisposition to cancer and the increased risk that the children/grandchildren 
had of developing future disease, as she continued:  
… because what we have to do is look at the eighteen year old 
(grand)daughters that these two women have as well and think about 
counselling for them but they just aren’t ready for that so we are holding back 
on that. Because they just couldn’t cope with the set back at the moment. And 
we are just trying to gently try to support and counsel them and then hopefully 
move onto that at a later date (NP7) 
 
Concurrent occurrence of cancer in more than one member of the family can cause 
intense grief (Kissane and Bloch 2002). It is a situation where even well-functioning 
families may require professional support to sustain their wherewithal to cope (Kissane 
and Bloch 2002). Genetic information has the ability to disturb further the ties that 
constitute the family structure (Mallet and Chekrout 2001). The judgement that ‘they 
just couldn’t cope’ did not appear to have been made lightly in this scenario.  
      Communication in palliative care can be very complex as feelings of grief and loss 
can be hard for patients with incurable disease to express (De Haes and Teunissen 
2005). This scenario highlights the disadvantage of leaving conversations about the risk 
of inherited disease until patients are dying. The experience of advanced progressive 
disease and the realisation of impending death can, in and of themselves, present 
patients and families with multiple psychosocial challenges (Vachon 2005a,b, Panke 
and Ferrell 2005). The juxtaposition of these fears with the additional stresses caused 
by the risk of potential future disease was perceived as too much in this instance.  
       Unfortunately the phrase 'and then hopefully move on to that at a later date’ (NP7) 
does not suggest that careful consideration had been given to where or when it might be 
appropriate to raise the issue of inherited disease. This is important because open 
awareness, a condition marked by knowledge of impending death and a value 
commitment to openness has led to increased satisfaction in the care of the dying 
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(Searle et al 1997). Glaser and Strauss’s (1965) seminal work on the awareness of 
dying documented how different states of awareness in patients could alter the way that 
an individual coped with the dying process. They described the way that ‘closed 
awareness’, where health care professionals were aware that a patient was dying could 
lead to ‘suspicion awareness’ in the patient. In this state the patient suspects he is dying 
and is trying to verify this with professionals. This may develop into ‘mutual pretence’ 
where both staff and patient  know about death but pretend otherwise. They 
documented how open awareness increased the ability to achieve the management of an 
acceptable dying process (Glaser and Strauss 1965).  
      Exemplar-case two appeared to document closed awareness about inherited 
susceptibility to disease. However it is possible that awareness suspicion of genetic 
predisposition to cancer was contributing to the patient’s and family’s stress. Media 
coverage of the breast cancer genes has been widespread and has been shown to cause 
spontaneous discussion and debate (Henderson and Kitzinger 1999). Chalmers et al 
(2003) found that the need for information about the personal risk of breast cancer was 
the topic most frequently identified as being very important in sisters and daughters of 
women with breast cancer. This study also revealed that several of the patient-
participants had concerns about inherited disease that they had that not discussed with 
healthcare professionals (See p155).  These concerns were emotionally charged for one 
patient. 
      In the communication between patients and healthcare professionals both parties 
have an active role in shaping and constructing encounters (Payne 2002). Prior 
expectation of role can affect how patients communicate with healthcare professionals 
(Jarrett and Payne 1995, Jarrett et al 1999), and the patients in this study did not appear 
to think that it was important to discuss their family history with palliative care nurses. 
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Nurses can also block communication about difficult patient concerns and worries 
(Wilkinson 1991), and no nurse in this study felt confident at dealing with this issue. 
      Daly et al (2001) suggest that Buckman’s (1992) six step strategy for breaking bad 
news can be adapted for discussion about an inherited genetic predisposition to cancer.  
These steps are 1) Getting started, 2) Finding out how much is known, 3) Finding out 
how much they want to know, 4) Sharing the information, 5) Responding to feelings 
and 6) Planning and follow-through. Even completing the first two steps, setting aside 
time for a discussion in an appropriate place with the appropriate people and then 
asking open questions to find out whether there are any concerns that relate to the 
family history, may potentially open up concerns about inherited disease (Daly et al 
2001, Buckman 1992). This would ensure that awareness suspicion or mutual pretence 
(Glaser and Strauss 1965) were not an issue and not contributing to patient and family 
distress. 
      Exemplar-case two was not the only scenario described where nurse-participants 
commented that they had deliberately decided not to raise the issue of inherited 
susceptibility to disease. 
I can remember a lady who had bowel cancer and she had other members of 
the family who had died of bowel cancer… because she had a son and a 
daughter… but we didn’t discuss, it wasn’t appropriate ... She struggled with 
emotional issues, which were more important at the time than that (NP3) 
 
Hence other emotional issues associated with advancing incurable disease were again 
seen as being more important than raising new concerns about inherited predisposition. 
These emotional concerns acted as a barrier to communication about familial disease. 
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Exemplar-Case Three 
      The third exemplar-case documents a scenario where relatives returned to the 
hospice to enquire about their risk of inheriting cancer following the death of their 
mother. 
But I do remember there were two … sisters who were grown up. … They 
came back here to ask about themselves … and I just came to talk to them and 
their fear:  Was it hereditary? … It was either their mother or their sister who 
had died here and then their grandmother had had it as well. So I thought 
well, there is something here … we sent them onto special clinics: breast 
(NP5)  
 
The nurse had appropriately referred the relatives to the regional clinical genetics 
service (DH 2003). However, she did not appear to have any awareness that the 
relatives’ ability to ascertain their individual risk of developing breast and/or ovarian 
cancer could be affected by whether the issue was raised before or after the deaths 
within the family (Lalloo et al 2000, Kirk 2004a). A death within a family, especially 
the death of a parent, can alter family communication patterns (Foster et al 2004, Kenan 
et al 2004) and ability to learn about cancer within the family. The participant also 
appeared unaware of the need for a blood sample from an affected relative to enable 
other relatives to be tested for the specific familial genetic alteration (Kirk 2004a). 
Hence the relatives in this exemplar-case may have missed the last opportunity for this 
to occur until one of them (potentially) develops the disease in the future. 
      The nurse remembered exemplar-case three because of the emotional content of the 
discussion that she had had with the patient’s (adult) children. 
… I remember the thing that came across was fear. They were fearful and one 
of them said that they wanted to have a mastectomy. Yes, I remember that 
because it did strike me: I thought ‘God, I would never have a mastectomy’… 
so they were very afraid (NP5) 
 
      Although these fears were strong enough to provoke these relatives into action 
following their mother’s death, they do not appear to have been recognised by hospice 
217 
staff or raised by relatives before the patient’s death. The fear and anxiety mentioned 
perhaps hint at how distressing it can be for a relative to watch the death of a family 
member wondering, if they might be going to develop and die from the same disease 
yet feeling unable to discuss it. It hints at the stress for relatives that can occur when 
they have an awareness suspicion (Glaser and Strauss 1965) of genetic disease but were 
unable to discuss it as their mother was dying.  
       This does not mean that it would always be helpful to introduce the topic of 
inherited disease in a complex scenario due to the potential to cause undue emotional 
distress (see exemplar case two above).  However, this exemplar-case demonstrates the 
potential emotional and practical cost to families when patients and families do not 
have opportunity to express any concerns they have about their family history of 
disease before death.  
Comparison of Exemplar-Cases Four and Five  
      The following cases were described by one nurse to highlight the rewards, strengths 
and benefits of continuity of caring for families when multiple deaths occurred over 
time. 
My initial contact was with a lady in her eighties ... I think it was bowel 
cancer. She died very nicely at home. All the family were very involved … The 
following year her son got a brain tumour and died. Not many years after, her 
husband ... got cancer. I can’t remember where, but he died. And again I was 
very much involved with each member of the family. I still get Christmas cards 
and such things (NP1) 
 
 I met ... a woman in her forties, who died of bowel cancer at home. She was 
looked after by a very supportive family consisting of mother and father, 
husband and two children. And not very long afterwards her mother got bowel 
cancer and died at home supported by her husband. The son-in-law died (Not 
cancer) ... quite suddenly. And I have been in contact with the father of the 
whole family, the granddad to the girls ... since really (NP1) 
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The nurse used these examples to highlight how knowing a family previously could 
benefit care: 
And then it is actually nice because I know the family set up. I know what 
actual support is going to be there. I know that it will be great because I have 
already experienced it with the other members of the family. We’re friends; we 
do become friends with many of the families that we visit. It is a real privilege 
to visit somebody at home (NP1) 
 
 However, comparing the two cases demonstrates how the psychosocial care of the 
patient and family was given without regard to the potential for an inherited genetic 
predisposition to cancer.  
       In the first scenario the nurse participated in the care of three family members with 
different cancers. As discussed above the disease that occurs in the paternal bloodline 
has no genetic association with the disease in the maternal bloodline (Gaff 2005). In 
this instance, the deaths of three family members from different cancers, two of which 
occurred when patients were in their eighties, suggest a sporadic rather than an 
inherited susceptibility to disease (WMFACS 2007: See Appendix 1). Although only 
two family members died from cancer in the second scenario, the fact that they both 
had the same cancer, which is known to be associated with an inherited predisposition 
to disease, and that one of the deceased was in their forties meant that they met the 
referral criteria to the regional clinical genetic specialist clinic (WMFACS 2007). The 
expert psychosocial care the family had received is evidenced by the fact that the nurse 
was contacted by the grandfather as he tried to support his grandchildren following the 
sudden death of their second parent. The lack of awareness about the potential risk of 
an inherited genetic predisposition to effect care is underlined by the fact that the nurse 
did not appear to recognise the different genetic implications apparent within the two 
exemplar cases. In exemplar-case five the lack of attention given to familial disease did 
not seem to be explained by the need to focus on other priorities around the time of 
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death: rather it suggested that the nursing care was being given within a paradigm 
(Kuhn 1996) that did not consider the implications of genetic predisposition to cancer.  
Patients’ Perception of Nursing Care 
      The information presented above documents how the nurse-participants felt that 
they did not have the appropriate knowledge or skills to support families who were 
concerned about their family history of cancer and the potential for an inherited 
predisposition to disease. The exemplar-cases demonstrate how this affected patient 
care. However, it was noteworthy that the nurse-participants’ anxieties about caring for 
families with a family history of cancer in the context of genetic predisposition were 
not reflected in the patient-participants’ comments about the care that they and their 
families had received.  The patient-participants all praised the standards of care at the 
participating hospice.    
They do more or less go double-jointed here to help. Anybody who wants to 
fault these nurses here, they need a good sledge-hammering across their head 
(Iain) 
 
I must admit coming to the hospice is really good thing, coming to the hospice 
has really helped me a lot (Finlay) 
 
Cause the care that they give me from the hospice is wonderful (Grace) 
 
 I must say the staff are very, very good (Harry) 
 
Because everybody has been good to me: It’s absolutely wonderful, absolutely 
wonderful place. Opened my eyes you know (Keith) 
 
     All the patients spontaneously commented on the nursing care that they had received 
from the hospice. It was universally praised and most commonly described as 
wonderful. The high standard of care received was frequently favourably compared to 
the care received by other services during their cancer journey. 
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Discussion                      
           This chapter is called ‘The Missing Agenda’ to draw attention to the way that the 
nurse-participants did not appear to recognise the potential for an inherited 
predisposition to cancer to affect the care needs of palliative care patients. This is 
important as all health care professionals are expected to be confident and effective 
when dealing with patients with an inherited susceptibility to disease (DH 2003, Kirk 
2004b). To understand these findings it is important to consider the nature of nursing 
and how nurses develop their expertise. A seminal model that examines this is Benner’s 
(1984) ‘Model of Skills Acquisition’. 
 
Benner (1984) Model of Skill Acquisition 
      Benner (1984) suggested that expert clinical nursing relies both on theoretical and 
practical expertise that is gained through experience. That clinical acumen consists of 
practical knowledge and skills (knowing how) as well as consideration of the 
underlying theoretical knowledge base (knowing that). In her phenomenological work 
‘From Novice to Expert’ Benner (1984) used the Dreyfus model of skills acquisition 
(1980) to model how nurses develop their practice. 
       Benner (1984) described a five stage process of increasing competency whereby 
nurses developed from novice, through advanced beginner, competent, proficient to 
expert. Each step is built on previous clinical learning. Novices have no experience of 
situations in which they are expected to perform. As they have no experience they 
require rules to guide their performance; however, following inflexible rules legislates 
against successful performance because the inflexibility and narrowness of rule-based 
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behaviour negates the individualised response required to respond to a particular 
patient’s needs (Benner 1984). 
      Competent nurses are characterised by their conscious, deliberate planning of care 
in the context of long term goals. This enables them to prioritise and manage the many 
contingencies of clinical nursing. Developing through advanced beginner to 
competency takes time, typically years, but all nurses are expected to develop 
competency (Benner 1984). With experience some nurses will progress through 
proficiency to expert, when the nurse no longer relies on analytical principles to 
connect their understanding of a situation to an appropriate action but is able to respond 
intuitively and appropriately to patient need (Benner 1984).  
       Benner’s (1984) model of skills acquisition has been enormously influential 
especially in the field of nurse education (English 1993, Field 2004). However, the way 
that the findings of single phenomenological study with critical care nurses has been 
transferred into other settings have been criticised (Altmann 2001). It has also been 
suggested that it promoted an uncritical development of a reflexive approach to nurse 
education (Field 2004), and that describing expert clinical judgement solely in terms of 
intuition is inappropriate (English 1993). Nevertheless it has provided insight into 
nursing and provides a valuable model for nurse education and practice. 
 
Evaluation of Findings with regard to Benner’s (1984) Model of Skills Acquisition 
       The findings from this study suggest that nurses who were expert (Benner 1984) at 
giving care outwith the genetic paradigm were novice (Benner 1984) at giving care 
within the genetic paradigm. This has profound implications for palliative care, because 
it suggests that if palliative care nurses wish to improve their care for families with a 
family history of cancer, they may not only have to develop their knowledge base but 
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change the paradigm within which they work: that is, to give care through the genetic 
lens (Kirk 2004b). Different paradigms cause different facts to have different 
significance (Kuhn 1996), and concerns about future occurrences of cancer perhaps 
seem much less significant when the focus of care is on ‘the active care of patients with 
advanced progressive disease’ (NCPC www. ncpc.org.uk accessed 16/8/07) than when 
seen through the lens of cancer genetics and realising the potential of genetic 
information for health (DH 2003).  
      Changing the paradigm within which people work can frequently cause confusion 
and even distress to individuals until the implications of the new paradigm are 
assimilated (Kuhn 1996). Novice care is defined as care by nurses who have no 
experience of the situations in which they are expected to perform (Benner 1984). Even 
expert nurses become novices when faced with new practice scenarios (Benner et al 
1994). Findings suggest that giving expert care to patients and families is different 
when ‘family’ is defined as blood relatives who may have a inherited predisposition to 
cancer, as opposed to the broader definition of family that includes caregivers and those 
who have strong emotional and societal ties to the patient, which is common in 
palliative care (NICE 2004).   
      The exemplar cases show that there was a discernable affect on patient care when 
experienced palliative care nurses were practising in scenarios where they had no prior 
experience, without a clear understanding of the knowledge or skills required to support 
patients. In exemplar-case one the risk of inherited disease was not prioritised even 
when it was acknowledged to be of major concern to the patient. Benner (1984) 
suggests that ‘the heart of the difficulty lies in the fact that since novices have no 
experience of a situation they face; they must be given rules to guide their performance. 
But following rules legislates against successful performance because the rules cannot 
223 
tell them the most relevant tasks to perform in an actual situation’ (Benner 1984). That 
is, a set of guidelines or instructions alone is not adequate, and a novice needs 
experience before guidelines can be applied to individual patients (Benner 1984).  
       It is easy to understand that nurses who were novice in providing care through the 
genetics lens might hesitate to starting looking at patients’ family’s histories  and 
related communication issues within a framework of genetic disease. Nevertheless, 
knowledge about genetic predisposition to disease offers new hope to families as it 
aims to identify individuals who are at increased risk of developing cancer and ensure 
that they are able to access health promotion measures and early treatment that is 
associated with improved treatment outcomes and lower morbidity rates in cancer 
(Sadler et al 2004, Rieger 2004, Bell 2004). That is, the aim is to try to prevent 
multiple, young deaths occurring in families and the attendant stressors on families that 
were highlighted in previous chapters. 
       To progress from being novice, nurses need both experience and role modelling 
from expert practitioners who have a vision of what it is possible to achieve within a 
given situation. Benner’s (1984) model of nurses progressing from novice to expert 
suggests that an improved knowledge base alone will not automatically improve 
practice, rather nurses also need to develop a practical knowledge that is embedded in 
clinical expertise. In this study the nurses readily acknowledged their lack of 
knowledge about genetics but they did not appear to be able to visualise expert practice. 
This is often learnt through role modelling (Benner 1984), and there were no 
experienced role models available in this setting. This left the nurses unaware that the 
present model of care for families with a family history of cancer was not considering 
all aspects of the patient experience: the link between their family history of cancer and 
the risk of a genetic predisposition was missing from their agenda.  As they did not 
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appear to fully perceive the specific care needs of this patient group, they were unable 
to act on them. This suggests that the nurses not only needed an increased knowledge 
base about the multifactorial aetiology of cancer but also an increased vision of the 
possibilities of care (Benner 1984) in families with a family history of cancer.  
      Findings further suggest that it is inadvisable to leave discussions about inherited 
susceptibility to cancer until the disease becomes advanced and incurable. The nurse-
participants gave cogent and reasoned arguments to support this view. There were two 
key concerns that were repeatedly raised about discussing genetic predisposition to 
cancer within a palliative care context. These were:  
• The imminence of death 
• Clinical genetics was a separate speciality 
      The imminence of death was the major factor when the nurses considered the 
appropriateness of dealing with issues related to genetic predisposition to cancer. 
Communication at the end of life is frequently complicated by the practical, emotional, 
spiritual and emotional issues that can attend the dying process (De Haes et al 2005). 
Several participants felt it was too late in the patient’s journey as they were aware that 
the dying person themselves would not benefit. They were also concerned that it might 
deflect the focus of care away from the dying patient onto the family, and felt that the 
imminence of death could mean that families associated an inherited susceptibility to 
disease with death rather than seeing it as an opportunity to take health promoting 
action. Exemplar-case two highlighted the complexity of psychosocial concerns that 
could attend deaths in families with a family history of cancer. Some nurses reported 
deliberately choosing not to have open discussions about the family history of cancer as 
they worried about increasing stress in an already distressed family. They felt it was 
‘too much too late’ in the patient journey. 
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       Despite this strong feeling that the issues about inherited susceptibility to cancer 
would be better dealt with before the palliative stage, the findings from this study show 
that in practice patients were dying without these needs being appropriately identified 
or met. The nurses freely and consistently acknowledged that their understanding of 
cancer genetics was limited. This indicates that improved knowledge and training for 
palliative care nurses is a priority if they are to give appropriate care to patients who are 
worried about their family history of cancer. Education in genetics has previously been 
documented as a priority for palliative care education (Clifford et al 2007). 
       However Benner’s (1984) model of nursing development suggests that an 
increased knowledge base alone may not be enough to improve practice and that a new 
bridge between practice and education may need to be developed (Dolan 1984). 
Clinical knowledge and skills are learnt through time, experience and from role models. 
Consequently novice palliative care nurses may need role modelling from practitioners 
who are experienced in giving care to people who are concerned about inherited 
disease. Achieving this would require more time, imagination and money than merely 
providing didactic information. It might be achieved in innovative ways: by forging 
links with a specialist genetics unit,  with joint visits to community patients, genetic 
nurses attending the hospice for ward rounds with specific patients, or even palliative 
care nurses shadowing genetic nurses for a period of  time.  
      These findings reinforce the idea that nursing care is reliant on knowledge being 
embedded in practice (Benner 1984). ‘Any nurse entering a clinical setting where she 
or he has no experience with the patient population will be limited to the novice level of 
performance if the goals and tools of patient care are unfamiliar’ (Benner 1984: 21).  
This does not impugn their ability to give competent or expert care within their areas of 
expertise, as documented by the patient-participants consistent and unsolicited praise 
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for the nursing received in the participating hospice.  It is, perhaps, unsurprising that 
these nurses were novice at caring through the genetics lens as the knowledge about 
inherited predisposition to cancer is a new and rapidly changing area of knowledge 
(Bell 2004). Thus, there had been little time and/or recognised relevant scenarios 
through which nursing staff could develop their clinical competence.  
      One very important finding, which should be emphasised in all the data presented, 
is that all the nurses that participated in this study freely and openly acknowledged their 
lack of knowledge about caring for families with concerns about inherited disease. In 
the conscious competence learning model variously attributed to Confucius, Socrates or 
an Unknown Persian Philosopher (see opening epigram) and several more recent 
authors, being consciously incompetent is the second key stage in learning.  It leads to 
the commitment necessary to learn new the skills and abilities needed to achieve a task. 
Consequently, in being aware of their need to learn more, and in their ability to 
articulate their concerns, these nurses may have started the process of becoming 
competent practitioners when caring for patients with a family history of cancer.  
Conclusion 
       This chapter has presented the nurse-participants’ insights into caring for patients 
who are concerned about inherited disease within a palliative care setting. It highlights 
their reservations about the appropriateness of raising the issue of genetic 
predisposition to cancer in the context of advanced progressive disease. It suggests that 
the nurses were novice at caring for patients and families within the genetics lens and 
documents how this affected patient care. 
       Limited understandings of the contextual meaning of facts in areas where the goals 
and tools of patient care are unfamiliar define novice care (Benner 1984). As indicated 
on p1, this study was provoked by a similar novice response to the complex care 
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requirements of relatives who were concerned about their family history of cancer. Kirk 
(2004a), Lalloo et al (2000), Mallet and Chekroud (2001) document how concerns 
about inherited susceptibility are impacting the care needs of palliative care patients. 
Ten percent of Clifford et al’s (2007) extensive survey of palliative care nurses had 
encountered issues associated with inherited diseases, including cancer. This suggests 
that concerns about inherited disease are a real, present issue within palliative care. The 
nurse-participants’ novice practice suggest that it is a missing agenda within palliative 
care.  
       However, the need for clinical genetics to become a mainstream component of the 
medical treatment of cancer is becoming increasingly apparent (Bell 2004). The 
demand for earlier and more accurate prediction and diagnosis of disease, alongside 
new pharmacogenetic treatments, will promote its integration into care. This move to 
clinical practice may be slow but it appears to be inevitable (Bell 2004). As between 
five and ten percent of all cancers are thought to be associated with inherited disease 
(Claus et al 1991) it is possible many more patients will become alert to the 
psychosocial issues linked with inherited susceptibility to disease. This challenges 
nurses to develop their competence ‘to be fit for practice in the genetics era’ (Kirk et al 
2003). This is discussed further in the next chapter. 
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CHAPTER TEN: THE MISSING DISCOURSE  
(Discussion and Implications for Practice) 
To genetic evolution, the human lineage has added the practical track of cultural 
evolution (Edward O. Wilson 1929) 
  
Introduction 
       This study provides insight into a complex phenomenon; the meaning of a family 
history of cancer, at a time when the understanding of the phenomenon is changing. 
This chapter describes how the family history of cancer is presently a missing discourse 
within palliative care. A discourse is ‘the spoken or written treatment of a subject in 
which it is handled or discussed at length’ (OED online accessed 7/9/08), and it is 
argued that more attention needs to be paid to the concerns of patients with a family 
history of cancer because of the potential for this to be linked with an inherited genetic 
predisposition to cancer.   
        This chapter discusses the information that emerged from the study from two 
different interpretive perspectives: from ‘outwith’ and ‘within’ a genetics paradigm. It 
draws attention to the way that different factors, like multiple occurrences of cancer in 
the family, multiple primary cancers, and individuals within the family developing 
cancer at a younger age than normal, have different significance depending on the 
worldview taken. It is proposed that a new model of care is required to provide 
appropriate support for families with a family history of cancer in the context of genetic 
predisposition to disease. Finally it highlights two barriers to the implementation of 
change. These are a) the poor understanding of cancer as a multifactorial disease and b) 
the novice practice of nurses with regard to caring for families where there is the 
potential for genetic susceptibility disease.  
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      Although it has been suggested that researchers using a phenomenological approach 
should refrain from engaging with previous research literature to avoid being 
influenced by preconceptions, research needs to be informed by what is already known 
about a phenomenon (Todres and Holloway 2006). As discussed (p28) there has been 
very little research into the effect of a family history of cancer on palliative care 
patients. Hence the findings are considered in the light of the existing knowledge about 
the psychosocial effect of a family history of cancer and/or an inherited predisposition 
to cancer at any stage of the cancer journey. This literature is also limited (Hallowell et 
al 2004), so research that examines the experiences of individuals with a family history 
of cancer and have attended genetic counselling (and undergone predictive genetic 
testing), has also been used, especially papers where the earlier deaths of other family 
members are discussed. Papers which informed this discussion are shown in Table 
Eight.  
 
Table 8: Research papers that contribute to discussion 
Author Aims Methods/ 
Analysis 
Participants
Sampling 
Strategy 
Death 
Dying 
theme 
Findings And 
Implications 
Arman et al 
(2006) 
To understand 
women’s beliefs 
about the genesis 
of their breast 
cancer 
Semi structured 
interviews 
 
 
59 consecutive 
admissions from 
an 
anthropological 
hospital with 59 
matched patients 
from a general 
hospital  
 
Sweden 
No Three themes emerged 
1) belief in a link to 
life lived 
2) Heredity as sole 
genesis 
3) Rejection of the 
question 
Bonadona et al 
(2002) 
To evaluate the 
consequences of 
disclosure of a 
positive genetic 
test result to 
people with 
cancer  
23 Structured 
interviews,  
 
Questionnaires,  
 
Psychological 
assessment scales
All clients with 
cancer who 
agreed to a 
retrospective 
interview 
following genetic 
testing between 
1994-1999 at one 
clinic 
 
France 
Yes 
But of Patients 
in remission 
Although patients did 
not regret testing a 
significant number 
were distressed by test 
result, found difficulty 
discussing this with 
relatives. Concerned 
about their own risk of 
developing future 
disease. 
 
Esplen et al 
(2007) 
Cohort study of 
colorectal cancer 
survivors with a 
319 colorectal 
cancer patients 
 
Recruitment from
a population 
based cancer 
No Concern for children’s 
future health was the 
most frequently given 
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family history of 
cancer who were 
undergoing 
genetic testing  
Validated 
questionnaires 
registry 
 
Canada 
reason for undergoing 
testing 
Forrest-Keenan 
et al (2005) 
To explore the 
barriers and 
facilitators in 
family 
communication 
about genetic risk 
56 Semi- 
structured 
interviews (29HD
& 27 HBOC) 
 
Grounded theory 
All clients 
recruited from 
one genetics 
clinic  
 
Scotland 
No: but death 
mentioned as 
affecting all 
three themes 
that emerged 
from the data 
Communication about 
genetic risk complex: 
dependant upon 
individual familial and 
cultural histories 
Foster et al 
(2004) 
To explore how 
families 
communicate 
about their 
potentially 
increased risk of 
disease 
Participants 
interviewed pre &
six months post 
predictive genetic
testing 
15 healthy 
women attending 
for predictive 
genetic testing for
cancer 
 
UK 
No: but death 
mentioned as 
affecting five of 
the seven 
themes that 
emerged from 
the data 
Women faced 
numerous dilemmas 
when deciding whether
or not to discuss 
testing with family  
Hallowell  
(1999) 
To understand 
how woman 
attending a 
genetics clinic 
perceived risk and
risk management 
options 
46 Semi-
structured 
interview 
 
Thematic analysis
All clients 
visiting a genetic 
clinic over a year
Excluded 
People with 
cancer & the 
recently bereaved
 
UK 
Yes Obligation to dead had
motivated some clients
to attend but 
motivation to living 
relatives more 
important 
Hallowell et al 
(2004) 
To explore the 
relationship 
between risk and 
uncertainty in 
people with 
cancer who 
underwent genetic
testing 
 
 
30 Semi-
structured 
interview 
 
Thematic analysis
All clients with 
cancer who 
agreed to a 
retrospective 
interview 
following genetic 
testing between 
1994-1995 at one 
clinic 
 
UK 
No 
But future 
concern 
Most participants had 
integrated the risk of 
cancer re-occurrence 
into their self identity 
and generally to 
comfort in being able 
to assist other family 
members evaluate their
health risk 
Kenen et al 
(2004)  
To explore how 
family 
communication 
patterns influence 
the dissemination 
of genetic 
information 
Semi – structured 
interviews 
 
Participant 
observation (in 
genetic clinic) 
21 healthy 
women who were
the first members 
of their family to 
be tested (or who 
were unaware of 
other family 
members who had
been tested) for 
breast cancer 
UK 
No: but noted 
that previous 
deaths within 
family affected 
family 
communication 
pattern in 
different ways 
Identified different 
communication 
patterns 
• Open 
• Blocked 
• Indirectly blocked
• Self-censored 
• Third party 
 
Walter et al 
(2004) 
Systematic review
& synthesis of the
qualitative 
literature about 
understanding of 
risk of familial 
disease 
Systematic 
Literature Review
11 original 
research based 
articles reviewed
 
UK 
No Sense of vulnerability 
informed by 
 a) Salience of family 
history 
 b) their personal 
model of disease 
causation and 
inheritance 
Wold et al 
(2005) 
To describe 
cancer survivors
beliefs about 
breast, 
colorectal and 
prostate cancer 
Survey of 670 
cancer survivors
Participants 
from a register 
of patients and 
relatives to 
support research
in cancer 
causation.  
USA 
No Cancer survivors 
beliefs about cancer 
causation are 
substantially 
different than those 
of experts 
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A Missing Discourse: ‘Outwith the Genetics Paradigm’ 
       This section considers the model of care identified in this study. It shows that 
consideration of the family history of cancer is presently ‘A Missing Discourse’ within 
palliative care. 
       The first key finding was that the patient-participants’ experiences had been 
significantly affected by the deaths of first degree blood relatives who died at a younger 
age than normal, as this had altered their family cohesion and communication 
structures. Several participants also noted the way that previous deaths of younger 
relatives (especially parental death in childhood), affected the social and emotional 
support that they were receiving from their families. The nurses also drew attention to 
the needs of families where an adult was dying at a younger age than normal. They 
described how caring could become more complex, as patients and families had to 
redefine their relationships and expectations of one another when a family member died 
at a younger age than anticipated. Despite the pattern of early deaths, none of the nurse-
participant and only one patient-participant (Diane) related the age at death, (or the age 
of first developing cancer), with the increased likelihood of an inherited genetic 
predisposition to cancer within families.  
       The second finding was that the family history of cancer could have a range of 
effects on patients’ emotional needs. This varied from patients who reported no impact 
on their present circumstances to overwhelming emotional distress associated with the 
deaths of previous family members. However the most commonly noted impact was an 
increased awareness of the dying process. This had the potential to affect quality of life 
for patients. It both equipped them with knowledge about the dying process and 
heightened the emotional significance of particular milestones in the cancer journey. 
The nurse-participants described the way they regularly spent time with patients, 
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listening and responding to concerns provoked by particular deaths within the family. 
They also described scenarios where they had liaised with the multidisciplinary team to 
support patients who were overwhelmed by emotional distress due to previous deaths 
within the family. However the focus of care was on providing emotional and social 
support for families and the assessment of family history of cancer was not considered. 
       Describing the family history of cancer as ‘a missing discourse’ is not meant to 
imply that individual needs and concerns that might be associated with their family 
history of cancer were not being met: rather that they were being attended to within 
different discourses. For instance, there is widespread awareness that dying at a 
younger age than anticipated can impact care needs (Willis et al 2001, Sheldon and 
Tribble 2004, MacPherson 2005, MacPherson and Emeleus 2007). 
       Care of the family is integral to the definition of palliative care (Twycross 2003). 
However the care of blood relatives appeared to be subsumed within the broader 
definition of ‘family’ that is widely used in the palliative care literature (as discussed 
p25). This includes caregivers and other people with strong societal, emotional and 
care-giving links to the patient (NICE 2004).  Hence concerns about family 
communication and cohesion appear to have been subsumed into concerns about 
whether patients were being physically, emotionally and socially supported through the 
dying process, without particular reference to whether family (as defined in this study) 
were aware of the family history of cancer and any potential risk of genetic 
predisposition. This model of care aims to ensure that the patient, (defined as person 
with cancer), and those people who had strong emotional and social links with the 
patient (NICE 2004) are supported in the presence of advancing incurable disease. 
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The Effect of Inherited Genetic Predisposition 
       An awareness of the potential for an inherited genetic predisposition was found in 
this study, however, and many participants were concerned that other family members 
might develop cancer in the future. The nurse-participants stated that patients who 
expressed concerns about the family history of cancer were referred to either their 
general practitioner (GP) or the regional specialist genetic service in accordance with 
the Department of Health guidelines (DH 2003). Hence these patients were receiving 
the same care as other patients, except that specific concerns about genetics were 
referred to an external expert.  
      Within the present model of care it is even questionable whether palliative care is 
an appropriate place to deal with these concerns. It has been stated that ‘In the field of 
palliative care, we believe that the doctor should either abstain from discussions or 
proceed with considerable caution’ (Mallet and Chekroud 2001: 149). This is because 
these conversations can promote anxiety and family discord during the dying process, 
which may outweigh the benefits to other family members (Mallet and Chekroud 
2001). The nurse-participants also felt that genetics was a separate speciality and that 
the imminence of death made discussion of genetic predisposition inappropriate in the 
circumstances. 
        This study adds to this debate. As discussed in Chapter Three it was designed to 
minimise the potential for emotional distress and the topic of genetic predisposition was 
not raised with patient-participants unless they themselves first introduced the topic. 
Despite this it uncovered significant and widespread concerns about familial disease. 
This suggests that it is possible to discuss these concerns using the appropriate 
communication skills. Buckman’s (1992) six step strategy for breaking bad news has 
been adapted for this task (Daly et al 2001). Merely signalling interest about previous 
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deaths from cancer within the family may draw out concerns from patients, enabling 
open discussion about specific fears and circumstances. This would allow reassurance 
to be given about inappropriate concern and/or discussion about appropriate actions 
(like documenting the family history of disease and referral to genetic services) to 
occur. This may be a sensitive topic for patients, but no more so than many other issues 
associated with death and dying. (For instance, helping patients prepare their children 
for parental death). 
        The research interviews highlighted several disadvantages to leaving discussions 
about familial disease until cancer was at an advanced stage. The fact that Grace was 
unable to continue the interview due to her high symptom load, despite a strong desire 
to share her experiences, showed how physical symptoms could inhibit/prevent 
discussion about this topic (p71). The interview with Iain showed not only that the topic 
could provoke distress but also that there could be insufficient time to appropriately 
follow through concerns about inherited disease prior to death (p161). The nurse-
participants universally felt that discussion of inherited disease should occur before 
cancer became incurable and concerns about imminent death and dying were of prime 
importance. 
       It is also noteworthy that the findings may suggest that the patient-participants did 
not view the participating hospice as the appropriate place to discuss these concerns. 
For instance, more participants had discussed their fears with other family members 
than with hospice staff. It is known that prior expectations of role can affect how 
patients communicate with healthcare professionals (Jarrett and Payne 1995, Jarrett et 
al 1999) and it may be that these participants did not view a hospice as the appropriate 
service to assist with this issue. This was perhaps realistic, as the nurse-participants 
clearly stated they felt cancer genetics was a separate speciality. They consistently said 
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that they did not have an adequate knowledge base to assess inherited risk, which is 
appropriate within this model of care where genetics and palliation are seen as separate 
specialities. 
       Hence the fact that this study showed that it was possible to discuss familial cancer 
within palliative care does not mean that conversations about inherited genetic 
predisposition should be left till a patient’s cancer is advanced and incurable. The 
inherent vulnerability of the dying (Dean & McClement 2002, Karim 2005), alongside 
the sensitivity of the topic of inherited disease (Hallowell et al 2003), suggests that 
leaving discussion about familial risk should ideally occur before people require 
palliative care and would be better seen as an integral part of supportive care. 
Supportive care helps patients cope with their condition throughout their cancer journey 
(NCPC 2007). The way that Diane was able to draw on earlier reassurance from genetic 
specialists shows that support earlier in the cancer journey can continue to reassure 
patients as their condition deteriorates (p159).  
      Nevertheless, even within this model of care, suggesting that discussions about 
genetic predisposition are more appropriately seen as a role for supportive care services 
does not negate the fact that it may still remain an important issue within palliative 
care. This is because the family history may not have been taken in full earlier in the 
cancer journey and/or the fact that patients may not have had an earlier opportunity to 
discuss these concerns (Kirk 2004a). This can prevent other family members learning 
about their own risk of disease (and accessing health promoting measures) till the next 
family member is diagnosed with cancer (Kirk 2004a).  
      It has been suggested that disease progression, especially being told cancer is 
incurable, can provoke new fears about genetic disease (Rees et al 2001, Kirk 2004a). 
This is important because, if this is a common occurrence, it increases the requirement 
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to respond to these new fears. The findings from this study indicate that concerns are 
present in the dying but does not demonstrate whether these concerns were evoked by 
the dying process as suggested by Kirk (2004a) and Rees et al (2001), or whether they 
were unmet needs that predated referral to palliative care. Although the research 
literature that considers the effect of knowledge of genetic predisposition on people 
with cancer is limited (Hallowell et al 2004), it does, on balance, suggest that for many 
people concerns are provoked by diagnosis rather than progression to terminal disease. 
       There is, nonetheless, one paper that shows that concerns about inherited disease 
can be provoked by impending death from cancer. Hallowell (1999) interviewed forty-
six women about their motivation for attending a genetic service for testing for genetic 
predisposition to breast cancer. All new clients who went to a regional clinical genetics 
service for an initial consultation over a year (1994-1995) were invited to participate 
(although women with a cancer diagnosis were excluded). She states that their 
attendance was strongly influenced by their sense of obligation to other family 
members. This included an obligation to the dead, and the study draws attention to nine 
participants who had been alerted to the possibility of genetic predisposition by a dying 
relative. These relatives had suggested that they seek advice about how to protect 
themselves. Hallowell (1999) shows that in some families the possibility of an inherited 
predisposition to cancer is discussed during the dying process and that these discussions 
have influenced the behaviour of surviving relatives.  It is, however, noteworthy that 
even within the article she goes on to say that more women described their risk 
management decisions as being influenced by their obligations to living relatives than 
to dead (Hallowell 1999: 110). Although Hallowell et al has since written widely about 
the experience of predictive genetic testing, she has never again discussed the concept 
of an obligation to the dead, or the role of dying or deceased family members, as a 
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major motivating force (Hallowell et al 2002, 2003, 2004, 2005a, 2005b, 2006); rather 
these papers emphasise the obligation to other living family members, especially 
children.  
        There is also evidence that many people are aware of the potential for heritable 
cancer earlier in their cancer journey. For instance, Espen et al (2007) report the 
baseline data from a cohort study of 314 Canadians with colorectal cancer and a family 
history of colorectal cancer, who were undergoing genetic testing for HNPCC. Only 
two percent had advanced (Stage 4) disease. Over eighty percent of participants stated 
that their motivation for testing included wanting to know if their children were at 
increased risk of developing cancer in the future: the most commonly given reason for 
undergoing testing. This shows that concerns are present in many people with cancer 
prior to the knowledge that their cancer is incurable.  
       Wold et al (2005) carried out a survey of people with cancer to look at their 
knowledge of cancer causation. Over seventy-five percent of respondents were aware 
that cancer could be genetic. This level of awareness was not affected by whether 
respondents had a family history of disease. The survey had a check box design that 
asked about nineteen possible causes of three different cancers. There was no option for 
multifactorial causation; hence the survey may have encouraged the idea of monocausal 
causation. The survey did not provide insight into how people evaluated their own risk 
of susceptibility or understood the term genetic, nor did it ascertain whether they had 
acted on any concerns about heritable disease. Nevertheless, like Espen et al 2007, it 
shows a general acceptance that genetics played an important role in cancer causation, 
albeit in people with cancer who live in North America (Wold et al 2005), suggesting 
that it may frequently be possible (and indeed preferable) to discuss the topic of 
inherited genetic predisposition to cancer before patients require palliative care.  
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       Hence ‘outwith the genetics paradigm’ it could be argued that it is acceptable for 
concerns about inherited genetic predisposition to primarily remain a missing discourse 
within palliative care. It could be suggested that the present model of care supports 
patients with the psychosocial outcomes of the disease within the family, albeit using 
different discourses to meet their individual needs. Specific concerns about inherited 
predisposition to cancer can be regarded as an ‘anomaly’ (Kuhn 1996), an aspect of 
care that in some way distorts the care needs of the dying, which would be better dealt 
with at an earlier stage in the dying process or referred to specialists in a different 
aspect of care.  
       It has, however, been argued by Lalloo et al (2000) and Kirk (2004a) that this 
response is inadequate. This study suggests it underestimates the challenge of caring for 
patients with a family history of cancer appropriately. For instance, it ignores the link 
between an inherited predisposition to disease and the likelihood of multiple 
bereavement, of developing cancer (and dying) at a younger age than normal, as well as 
the experience of multiple primary cancers and concurrent cancers in the family. It can 
also restrict the health promoting options available to other family members (Lalloo et 
al, Kirk 2004a). This study questions whether the present model of care ‘achieves the 
best quality of life for patients and their families’ (NICE 2004, NCPC 2007) in these 
circumstances?  It has been suggested that caring appropriately for patients with a 
family history of cancer demands a paradigmatic change in the theory and practice of 
nursing care (Anderson et al 2000). There has, however, been little discussion of what 
this means for palliative care patients. This is discussed below.  
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Within the Genetic Lens: A New Paradigm for Palliative Care? 
       This section uses the findings from the study in conjunction with the research 
literature to show how giving care through a genetic lens would affect the physical, 
social and emotional dimensions of palliative care. 
 
Physical  
       It is proposed that the core difference with familial cancers is that, like all inherited 
genetic diseases, they are, by definition, family diseases (Richards 1996). Hence it 
becomes inappropriate to consider a patient’s cancer in isolation from the family 
history of cancer: rather the patient’s experience needs to be seen as an integral part of 
a familial experience. Here the concept that ‘the patient is the family’ (Richards 1996) 
and that the family is the focus of care (Peterson 2005) has to be central to all aspects of 
care. Consequently, assessment of the patient and their family’s physical needs should 
be integrated and include a systematic assessment of the family history of cancer and, if 
appropriate, discussion of the health promoting measures that were available to 
relatives who were at increased risk of developing cancer in the future. This is fully in 
accordance with the World Health Organisation’s definition of palliative care, which 
states that palliative care works ‘through the prevention of suffering by means of early 
identification and treatment of…physical problems’ (WHO 2002). 
         This model of care would recognise that the death of a family member where the 
family history of cancer has not been taken into account may reduce the information 
and health promoting options available for other family members who are at risk of 
future disease. It would be recognised that leaving discussion about risk of an  inherited 
genetic susceptibility until after a death has significantly more implications for families 
than not having discussions about lifestyle factors (like smoking, diet and exercise), 
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where epidemiological and population data is used to inform any discussion of risk. 
Failure to highlight genetic disease would have ongoing and lasting consequences for 
all palliative services. For instance, it would be difficult to imagine offering 
bereavement support to relatives without having actively ensured that every measure 
had been taken to reduce their risk of developing the same or a related disease.  
       Within this model information about genetic predisposition would be available for 
all patients with concerns about familial disease, irrespective of whether these concerns 
had previously been raised earlier in the cancer journey. Care for patients and families 
who had already been told their disease was associated with a genetic predisposition 
(like Harry p159), would aim to support them deal with this sequellae of this 
knowledge during the dying process. This may help families cope after death as Rees et 
al (2001) argue (from theory) that the family experience around the time of death may 
have a significant impact on the way people live with their potential for future disease 
afterward. Patients and families (like Diane p160) who remain concerned about familial 
disease despite being told that their family history did not indicate a genetic 
predisposition would be offered ongoing reassurance and explanation about the 
reasoning behind the conclusion. Patients who had not been able to discuss their family 
history of cancer previously (like Iain p161) would be provided with a supportive 
environment where the topic could be raised and discussed. This would include the 
documentation of the family tree, as well as support for any psychosocial concerns that 
arose from previous experiences of cancer. If the family history of cancer met the 
guidelines for referral to a specialist, (see appendix one), a rapid referral process would 
be expedited.  
      Consequently, it will be important to be aware of the effect that knowing about an 
inherited predisposition has on people with cancer. There are two studies that consider 
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how the knowledge of a genetic predisposition (that has been confirmed through 
genetic testing) affects people with cancer. These both report complex interactions 
between the knowledge of heritable disease and concern about their own and other 
family members’ future.  
      Hallowell et al’s (2004) retrospective qualitative study considers the effect of 
genetic testing on thirty women with breast cancer. It concludes that for many 
participants genetic testing was one of the most positive things to emerge from the 
cancer experience, as it allowed them to act altruistically to enable other family 
members to make informed decisions about their future health (Hallowell et al 2004: 
263). They state that for the majority of women the risk of cancer recurrences had 
become an integral part of their self-identity prior to testing, and only a small group of 
women felt threatened by positive test results and the associated uncertainty about their 
future health (Hallowell et al 2004). 
       Bonadona et al (2002) interviewed twenty-three participants with cancer who had 
tested positive for a genetic predisposition to cancer. All eligible clients who had 
attended one French clinic were invited to participate. (Twenty-three percent of the 
potential participants had died before the study commenced). Bonadona et al document 
how participants had increased concerns about their own future deaths following testing 
and had an increased awareness of the risk of cancer reoccurrence. Quotes like ‘I’m not 
cured: that means relapse, death and horror (Bonadona et al 2002: 100) are used to 
emphasise the emotional impact of a positive test result. Despite these concerns, none 
of the participants regretted testing as it allowed them to plan for the future and enabled 
them and their children to access regular screening for (re)occurrence of the disease. 
Bonadona et al (2002) suggest that it was the knowledge of inherited disease (through 
testing) that strengthened the fears for self and relatives as opposed to the pre-existing 
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diagnosis of cancer. Nevertheless, both Bonadona et al (2002) and Hallowell (2004) 
found that participants had no overall regrets about testing because it had led to 
increased surveillance for them and their families. 
       These studies complement this study which looked at the people with advanced 
terminal disease, where fears about recurrence were redundant, but perhaps were 
replaced by an increased awareness of the dying process due to the family history of 
cancer. Unlike this study they describe the experience of people who were actively 
engaging with specialist genetic services. However, the fact that Bonadona et al (2002) 
and Hallowell et al (2004) found that even people who had been informed that there 
was an inherited predisposition within the family were helped by this knowledge 
(because it enabled relatives to make informed decisions about their future health), 
shows how open discussion of concern can be beneficial to patients and families.  
 
Social 
       The findings draw attention to the diverse ways that the family history of cancer 
could affect the social dimensions of care. They show how multiple deaths within the 
family, dying at a younger age than normal, and the experience of concurrent cancers 
all had the potential to affect the social needs at death. However, despite their different 
family circumstances the patient-participants consistently emphasised how this had 
affected their family cohesion and communication patterns. This suggests that the effect 
on family cohesion and communication of previous experiences of cancer within 
families will become increasingly important when caring for patients within the 
genetics lens. It emphasises the need to question whether poor family cohesion and 
communication patterns may be due to a genetic predisposition, and whether this may 
prevent relatives from accessing health promoting measures.  
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        Family communication about disease is an important issue for health services that 
support people with genetic predisposition to disease as it is the primary way that 
people learn about their own disease risk (Forrest et al 2003). Hence there are several 
studies that examine this issue. Although no study was found that directly focused on 
the effect of death on family communication, it is relevant to this study that several 
reported the way that certain deaths within participants’ families had affected family 
communication. For instance, Kenen et al (2004) identify five different family 
communication styles. They show that previous deaths in the family can block or 
partially block communication, saying that in some families ‘the script is to agree not to 
talk about the loss of a sibling or a mother’ (Kenen et al 2004: 340). Total blocking of 
communication meant that some relatives had totally refused to discuss particular 
familial deaths. Indirect blocking occurred when family members who did not want to 
discuss familial cancer made subtle signals about this rather than overtly cutting off 
conversations. Hiding past family illness also indirectly blocked family 
communication: one participant only had learnt that two aunts had died at a young age 
from breast cancer after she herself had developed the disease. In this study, the deaths 
of parents with dependant children appeared to be the  biggest block to knowledge 
about family disease, primarily because of the difficulties that the dying parents had 
discussing their illness with young children, but also because of the way family 
structures changed following the parent’s death. 
       Foster et al (2004) looked at some of the dilemmas women faced when talking 
about inherited breast disease within families. They show that women anticipated 
taking a key role in encouraging adult nieces and nephews to be tested following the 
death of a sibling, whilst trying to respect their in-laws’ ways of coping with familial 
cancer. Nonetheless, death had altered the family structure and thus the flow of 
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information between relatives. Foster et al (2004) also highlight that many participants 
felt isolated following disclosure of positive test results as the people they most needed 
to support them (mostly mothers but also sisters) had predeceased them. The study only 
included women who had attended a specialist genetics clinic for predictive genetic 
testing for BRCA 1/2; nevertheless their findings echo the findings of this study of men 
and woman receiving care from a hospice. The effect of previous deaths appeared to be 
more extreme in this study - with two participants (one male and one female) taking on 
a more overtly parental role through adoption/legal guardianship following a death, 
whilst others felt discouraged from maintaining contact with nieces and nephews 
because of difficulties in maintaining the relationship with in-laws. 
       Forrest-Keenan et al (2005) looked at the barriers and facilitators to family 
communication about genetic risk. Death is never explicitly highlighted as a barrier but 
is discussed in several of the themes that emerge. It is reported as influencing the 
decisions about whose responsibility it was, (or was not), to tell relatives about genetic 
predisposition to disease. Although they report general agreement that it was primarily 
a parental role (even with adult children), there was evidence of family discord about 
whose responsibility it was to inform the adult children of deceased siblings, especially 
if the surviving parent was reluctant to raise the issue.  
       Hence these studies acknowledge that death can affect the way families 
communicate about genetic disease; nevertheless death is not their main focus. Only 
Kenan et al (2004) discuss the nature of the deaths that had affected their participants’ 
ability to communicate. They state that communication and the family script ‘was 
traumatised by the death of a relatively young family member, particularly when 
children were left motherless’ (Kenan et al 2004: 343). The death of either parent was 
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shown to profoundly effect family communication and cohesion in this study, and this 
in turn continued to affect the dying process of patient-participants. 
       Hence, both the findings from this study and the literature suggest that within the 
genetics paradigm caring for patients with a family history of cancer would involve 
facilitating family cohesion to support family members who need to communicate 
about cancer, especially when death occurs at a young age. This accentuates the need to 
ensure that the family history is documented prior to death and discussed with all 
appropriate family members. It may also involve helping patients with young children 
consider who might be the appropriate person to discuss genetic predisposition to 
disease following parental death.  
       This also underlines the need for nurses to consider why family cohesion and 
communication may be poor. If this is due to a family history of cancer it becomes 
important to assess the risk of genetic predisposition and help ensure that all family 
members are informed of this if appropriate. Two participants within this study (Claire 
and Iain: see p153) were actively trying to restore links with first degree blood relatives 
in order to re-establish emotional and social bonds with them. However, within the 
genetic lens the need to re-establish links with other family members will also be driven 
by a concern to share information about the family history of cancer (Finkler 2000).  
 
Emotional 
      The fact that concerns about familial disease are likely to occur in scenarios that 
both patient and nurse-participants described as inherently stressful, (including the 
deaths of adults with dependant children, concurrent cancers within the family and the 
potential for overwhelming distress due to previous familial deaths), underlines that 
concerns about genetic predisposition will be present in scenarios where there are 
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already complex emotional needs. Although, (as discussed above p241), Bonadona et al 
(2002) and Hallowell et al (2004) show that knowledge of genetic predisposition need 
not be distressing for people with cancer, there is evidence that this knowledge can be 
associated with guilt, distress and isolation in relatives (Hallowell et al 2006, Keenan et 
al 2006, Van Oostrom 2007: discussed p35). Hence a wide range of emotional response 
should be anticipated in patients. This suggests that communication about familial 
disease has the potential to add complexity to scenarios that are already complex 
emotionally. However, many of the skills required to provide emotional support to 
terminally ill patients may be transferable to this new scenario. As noted above, the 
communication skills proposed for generic nurses discussing genetic issues are based 
on guidelines developed to help promote appropriate discussion about death and dying 
(Daly et al 2001). 
       It must also be noted that palliative care services regularly care for patients and 
families who have experienced the deaths of individuals who die at a younger age than 
normal, multiple bereavements, and concurrent cancers. Care within the genetic lens 
offers a new hope to families in these situations as tailored health promoting measures 
may prevent these scenarios from re-occurring in future generations. Conversely, care 
outwith the genetics lens denies this hope to patients and reduces families’ future 
options for health. Hence it is suggested that giving care within the genetics paradigm 
will alter the physical, social and emotional dimensions of care for patients with a 
family history of cancer.  
       On reflection, however, there is one significant limitation to this model of care. The 
focus on ‘the patient as the family’ (Richards 1996) could be interpreted as meaning 
that patients and family members have the same needs. This is patently not the case 
when one family member has advancing, incurable disease. The needs of the dying are 
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different to those who are at an earlier stage in their cancer journey, or relatives who are 
potentially anticipating future disease. Whether the genetics model suggested here, 
which is primarily based on  research with patients at an earlier stage in the cancer 
journey (Hallowell et al 2004, Bonadona et al 2002), or with concerned relatives 
(Kenan et al 2004, Foster et al 2004, Forrest-Keenan et al 2005) is appropriate for dying 
patients has yet to be explored. However, the widespread concerns about familial 
disease found in this study shows that a model of care that appropriately deals with 
patients’ and family’s concerns about future disease, which can be delivered as an 
integral part of the care of people with advancing terminal disease needs to be 
developed.   
 
 
Summary of Different Paradigms 
      Two different models of care for patients with a family history of cancer are 
presented above. The first model, ‘outwith the genetics paradigm’ reflects the care 
described by the participants in this study. Although care of the family is integral to 
care (Twycross 2003, NCPC 2007), only the physical needs of the person with 
advanced terminal disease are considered. As documented (p219) the patient-
participants consistently and spontaneously praised the care at the participating hospice. 
Nonetheless, findings from this study showed that the patient-participants had concerns 
about their family history, which were not being fully addressed within the present 
discourse. These concerns were considered from a particular interpretive stance, from 
‘within a genetic lens,’ and a new model of care proposed. The different assumptions 
that underpin the models of care are summarised in Table Nine (below).   
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Table 9: The difference between the two paradigms    
 Outwith the Genetic 
Paradigm 
Within the Genetic Paradigm 
Definition of Cancer Disease in which 
abnormal cells proliferate 
in an uncontrolled fashion
and spread throughout the
body 
A multifactorial disease of the 
human genome 
Definition of Family Carer: Strong emotional 
and societal bonds 
Blood-kin 
Focus of Nursing 
Care 
Patient and carers The Family is the Patient 
Significance of 
Aetiology 
Peripheral  Important: Other family 
members may be predisposed to 
cancer 
 
 
       Outwith the genetics paradigm care is focused on individuals with cancer 
(Saunders 2001). Cancer is culturally defined as a disease in which the abnormal cells 
proliferate in an uncontrolled fashion and spread throughout the body (Kleinsmith 
2006). As palliative care does not focus on cure the aetiology of cancer has little 
significance. It does not affect the assessment of patients’ physical care needs. The aim 
of social and emotional care is to support individual patients and people with strong 
emotional bonds to the patient. Little attention is paid to why certain families have 
particular social support structures or distribution of cancers within the family. The 
family history of cancer has a minimal impact on the care needs of patients.  The aim is 
to support patients so that they can cope with any emotional distress due to previous 
occurrences of cancer, rather than to evaluate the reasons for the previous deaths within 
the family and their implications for the future. 
        Within the genetics paradigm cancer would be defined as a multifactorial disease 
of the human genome. The aetiology of disease would be important because it can 
indicate that other family members are at risk of developing cancer in the future (Bell 
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2004). Hence the physical implications of disease for all family members would be 
integrated into care and an assessment of cancer within the family (not just the 
individual) would be integral to care. This is to expedite the early identification and 
treatment of other family members at risk of a genetic predisposition to cancer, as this 
associated with improved mortality and morbidity outcomes (Richards 1996). The 
emotional care of patients would encompass concerns about other family members 
developing cancer. Social dimensions of care would encompass an assessment of 
family communication and cohesion as this is essential to minimising the potential for 
future disease in other family members. The indications of an inherited genetic 
predisposition to cancer would be widely recognised (see Table Two p17), and 
particular attention given to supporting families to help them communicate about 
familial disease in these circumstances. As up to one in ten cancers are thought to be 
associated with an inherited predisposition to cancer (Claus et al 1991) expertise in 
familial cancers would be integrated into the multidisciplinary care team.  
       Which model of care will be perceived as appropriate in the future depends on 
many factors. However, it has frequently been noted that although the transition from 
genomic research to clinical genetics in multifactorial disease like cancer may take 
time, it appears to be inevitable (Bell 2004, Kirk 2004b). Since this study started there 
have been many diverse changes that may promote an increased awareness of the 
importance of genetics predisposition. This includes (but is not restricted to) the 
legalisation of embryo selection for a genetic predisposition to breast and bowel 
cancers (news.bbc.co.uk 08/05/2006), the identification of a new mechanism for 
transgenerational inheritance (Hitchens et al 2007), and the proposal that the protocols 
for cancer screening should not be based on age as a proxy for risk but offered to 
everyone with an increased risk whether this is due to age and/or a family history of 
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disease (Pharoah 2008). Findings from this study show that patients already have 
concerns about familial disease, hence it is suggested that the family history of cancer 
cannot long remain a missing discourse and that palliative services need to be equipped 
to give appropriate care to people with concerns about this issue.  
      However, although the findings from this study highlight the need for a change in 
the model of care for patients who have a family history of cancer, they also draw 
attention to two barriers that may hinder this change. These are described below.  
 
Barriers to Paradigm Change 
      Changing paradigm is difficult because the decision to accept a new worldview is 
always a decision to reject a previously held perspective. Kuhn (1996) states that it 
frequently takes a generation for a new worldview to become accepted because many 
individuals find it hard to reject their understanding of a phenomenon and to discard 
their old methods of working. Changing paradigm means that previously held 
assumptions, like how to provide optimum care to patients and families, must be 
questioned. It challenges people not only to review their traditional ways of responding 
to a phenomenon but also to learn new skills as they get to grips with the implications 
of the new information (Kuhn 1996). However, despite this, paradigm change occurs 
because it leads to solutions to problems that are insoluble using the old discourse 
(Kuhn 1996). 
        It is important to note that caring through a genetic lens should not ultimately 
increase workload as the traditional paradigm already integrates the care of the family. 
Rather it will alter the way that patients and families with a family history of cancer are 
cared for, ensuring that reassurance is given to people with unnecessary concerns and 
action is taken where there is the potential for an inherited genetic predisposition. 
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However, changing paradigm would have implications for both patient and nurse 
education. This is because findings suggest that there are two significant barriers to 
paradigm change which would best be overcome through education. These are a) the 
poor understanding of cancer as a multifactorial disease and b) the novice practice of 
nurses.  
 
a) The Poor Understanding of Cancer 
       The patient-participants had a limited understanding of the aetiology of cancer. 
This was juxtaposed with scepticism about the many given causes of cancer. As 
discussed in Chapter Nine, health behaviours are influenced by the understanding of 
disease (Ajken and Fishbein 2005).  Hence these factors may be a barrier that prevents 
patients from acting on concerns about familial disease. None of the participants had a 
concept of multifactorial cancer causation. This is significant because individuals need 
a clear coherent account of how risk factors are linked to disease to motivate 
behavioural change (Rees et al 2007). Hence the idea that cancer occurs due to a series 
of steps that are triggered by different causal factors (Nowell 1976, Kleinsmith 2006) 
might help reduce patient scepticism about the different risk factors for cancer and 
increase the understanding of the links between an inherited predisposition to disease 
and lifestyle and environmental factors.  
       The poor understanding of multifactorial disease was accompanied by a very basic 
knowledge of genetics and/or cancer. Several participants were unclear about the 
details of their own disease. Three were unclear about the nature of their own primary 
cancer and others appeared to believe that all cancer was the same. Similarly, half of 
the participants were unclear about the cause of death of (at least) one first-degree 
relative. 
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       Unfortunately this lack of knowledge about cancer, genetics and inherited 
susceptibility could be a barrier to patients acting on their concerns about familial 
disease.  Nevertheless there was some evidence to suggest that knowledge of genetic 
predisposition may cause people to re-evaluate their past experiences (p162). Hence 
people who view their illness through a genetic lens may come to evaluate the cancer 
within their family differently as different aspects of the phenomenon take on different 
meanings within the new paradigm. For instance, the significance of multiple primary 
cancers and the fact that individuals within a family develop cancer at a younger age 
than usual may become more pertinent for patients in the future.  
       The poor understanding of cancer found in this study is reflected in the research 
literature, suggesting that it be a significant barrier when discussing the implications of 
familial disease. Wold et al’s (2005) survey of the knowledge of cancer causation in 
people with cancer (discussed above), found that their beliefs differed substantially 
from those of experts. They overestimated the importance of stress and environmental 
causes and underestimated lifestyle causes (Wold et al 2005). 
        Much of the literature that looks at the understanding of an inherited 
predisposition to cancer within the United Kingdom has focused on the understanding 
of the aetiology of disease in first degree blood relatives of people with adult onset 
multifactorial disease, including cancer, heart disease and diabetes mellitus. Walter et al 
(2004) review and synthesis of this literature emphasises the commonalities between 
the different diseases. They discuss how a healthy relative’s assessment of risk is not 
primarily based on a systematic evaluation of their family history but on the salience 
that this history had for individuals, including the degree of emotional closeness to 
affected relatives. Individuals’ personal models of disease were often found to differ 
from the medical model. Walter et al (2004) highlight that different constructions of 
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disease can make communication between health care professionals and families 
difficult. This review of the literature suggests that the poor understanding of 
multifactorial disease found in this study is widespread within Britain.   
       However one study, undertaken in Sweden by Arman et al (2006), does report a 
good understanding of the multifactorial nature of breast cancer. This study used 
qualitative interviews to analyse the differences between breast cancer patients opting 
for treatment in an anthroposophical hospital compared to a general hospital. They 
found similar beliefs and perceptions about the aetiology of disease amidst the two 
groups. It was found that ‘the majority of participants felt that different factors in life 
had influenced the genesis and course of their cancer’ (Arman et al 2006: 144). 
Although patients mentioned external factors like diet, tobacco, alcohol, endocrine 
drugs, environmental triggers and stress, they were considered in combination with 
genetic factors, which were thought to combine to produce disease. They note that 
some participants who had a family history of breast cancer were convinced that their 
own cancer was purely hereditary, and that these participants therefore felt that their 
lifestyle choices had not influenced the development of their disease. Although Armand 
et al do highlight scepticism about the aetiology of cancer, they say it was only 
mentioned by a fifth of the participants whilst it was the overwhelmingly dominant 
theme in this study. The lack of scepticism reported, might be related to the more 
sophisticated understanding of the disease process or the fact that all the woman 
interviewed were still having active treatment for disease or in remission following 
treatment. As the participants lived in Sweden they will also have had access to 
different information about the aetiology of disease. Nevertheless Armand et al (2006) 
show it is possible for patients to be informed about multifactorial disease. 
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        In contrast, the research literature discussed above suggests that the limited 
understanding of the aetiology of cancer found in this study may be widespread within 
the United Kingdom. This could be a major barrier to the implementation of a model of 
care based on a genetic paradigm. It could even be argued that people who do not 
recognise a need do not have one! However, there are ethical and legal consequences 
for healthcare professionals who ignore a predisposition to cancer and its potential to 
affect other family members (Morgan 1996, Hope 2004). At the very least it could led 
to a breakdown in trust when the next member of the family develops cancer and learns 
that they had not been given information that would have facilitated access to 
appropriate health promoting services. In addition, nurses are expected to uphold the 
rights of all clients to informed decision making and voluntary action about the risk of 
familial disease (Kirk et al 2003, Haydon 2005). It is surely more appropriate to take 
the challenge of health education seriously and to research ways of promoting a better 
understanding of multifactorial disease, with the aim of breaking down the barrier that a 
poor understanding of the aetiology of cancer presents to the appropriate care of 
patients with a family history of cancer.  
 
b) Novice Practice 
     The second barrier to changing to a genetics paradigm for patients with a family 
history of cancer was that the nurse-participants were novice (Benner 1984: see p219) 
at providing care within the genetics lens. They clearly stated that they did not feel that 
they had the appropriate knowledge or clinical expertise to provide suitable care for 
patients with a family history of cancer. They described complex scenarios where they 
were aware of the potential for a genetic predisposition to cancer but highlighted the 
difficulty they had in prioritising and openly discussing these concerns. This occurred 
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despite the emphasis placed on caring for families within palliative care outwith the 
genetics paradigm. 
       There is some research that suggests that the nurse-participants were not atypical in 
their inexperience in this aspect of care. As discussed (p28), Clifford et al 2007 
surveyed hospice nurses to learn about capacity and training needs in supporting end of 
life patients with genetic conditions. This survey suggests that there is a widespread 
lack of confidence in caring for patients with a genetic predisposition to cancer. It 
found that seventy-six percent of adult nurses from forty adult hospices rated 
themselves as ‘not at all confident’ at integrating genetics into clinical practice 
(Clifford et al 2007). Respondents consistently rated themselves as having low 
confidence levels in the clinical, biological and psychosocial requirements of care, 
despite fifty percent of participants indicating that they felt it was an important issue for 
palliative care. Ninety percent of respondents had never referred a patient to genetic 
services although eighty percent indicated that they would be interested in receiving 
further training in this aspect of care. However, the survey, like this study, was 
restricted to qualified nurses and did not consider the role of other members of the 
multidisciplinary team in caring for families with a family history of cancer. The 
response rate was low (29%). It is not known why many nurses choose not to respond 
but it might be because they did not see the relevance of genetics (Clifford et al 2007). 
Nevertheless it is a large survey (N=328). It suggests that the views of the nurses in this 
study who felt that they had an inadequate knowledge base to appropriately support 
families who were concerned about genetic predisposition reflect concerns that are 
common to other palliative care nurses. 
       Nurses are expected to demonstrate a knowledge and understanding of the role of 
genetics and other factors in maintaining health, to underpin effective practice (Table 
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One p16, Kirk et al 2003). This highlights the need for more education about inherited 
susceptibility to disease for nurses working in palliative care. However, learning within 
a new paradigm does not only mean learning new skills but learning to see the world 
anew (Kuhn 1996). Hence more information about genetic predisposition to cancer may 
not be enough to change practice; rather role modelling from expert practitioners who 
can demonstrate expert care may be needed to show how care can be given within the 
genetic lens. It is important to develop these skills as novice practice has the potential 
to do harm both, through provoking unnecessary anxiety and ignoring patient fears. It 
may even allow patients to die without having had the opportunity to assist relatives 
through documenting the family history of cancer, undergoing genetic testing or 
banking blood to facilitate testing in the future. Competent practice (Benner 1984) will 
help ensure that families with an inherited genetic predisposition receive the optimum 
support available, promote understanding of the multifactorial nature of cancer and 
provide reassurance to patients with a family history of cancer that the cancer within 
their family is being appropriately managed. 
 
Implications for Practice 
       All healthcare professionals are expected to be confident and effective when 
dealing with multifactorial disease (DH 2003).  This study has explored the meaning of 
a family history of cancer for palliative care patients. As discussed above, a key 
implication for practice is to develop a model of care that provides ‘the best quality of 
life for patients and their families’ with a family history of cancer (NICE 2004, NCPC 
2007). Findings have described how the physical, social, emotional and cultural 
dimensions of care are subtly modified when viewed through the genetic lens. Table 
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Ten summarises the key differences between the two models of care presented in this 
study.  
 
Table 10: A Comparison of Care Needs between Paradigms 
Dimension of 
Care 
Outwith the Genetic Paradigm Within the Genetic Paradigm
Cultural Aetiology of cancer unimportant Aetiology of cancer is important 
as knowledge of an inherited 
genetic predisposition alongside 
tailored health promoting 
measures can reduce morbidity 
and mortality in relatives 
Physical Focus on the individual 
experience of cancer: 
e.g. symptom control 
Consideration of whether the 
distribution of cancer within the 
family indicates an inherited 
genetic predisposition 
 
Social Focus on supporting caregivers 
and people with strong emotional 
bonds to the patient 
Consideration of whether (and 
how) the family history of cancer 
has affected family cohesion and 
communication with particular 
regard to deaths from cancer that 
occurred at a younger age than 
normal 
 
Reflection on the way the family 
history affects the family’s ability 
to provide social support to the 
patient and consideration of how 
this affects the family’s ability to 
communicate about cancer 
 
Emotional Focus on care of patient (and 
family) as patient lives with the 
reality of advancing incurable 
disease and forthcoming death. 
 
This includes supporting patients 
who have a range of emotional 
needs due to the effect of previous
deaths in the family 
Supporting patients and families 
who know their family history is 
associated with an inherited 
predisposition and families who 
are concerned that this is a 
possible reason for the cancer in 
their family 
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       It is suggested that there are four priorities for service development to ensure that 
the care needs of patients with a family history are provided in an appropriate manner. 
A. The most urgent implication for practice is to ensure that all nurses have the 
ability to uphold the right of all patients to informed decision making and 
voluntary action. This is a core competency for all nurses (Table One p16). 
Even the suggestion that concerns might be more appropriately dealt with 
earlier in the disease trajectory does not negate the fact that palliative services 
will often be the last opportunity for patients to make an informed decision 
about whether to act on concerns about inherited genetic predisposition.  
        This means that nurses have to learn to listen to, and act on, the concerns 
of patients who are concerned about other family members developing cancer 
in the future. The widespread nature of the fears expressed by participants 
suggests that the care of patients with these concerns might best be designed 
with two separate objectives in mind. Firstly, it highlights a need to reassure 
people with a family history of cancer that did does not automatically indicate 
an inherited genetic predisposition. This would be aimed at preventing people 
from dying with unnecessary fears about their family’s future health. Secondly, 
it underlines the need for palliative services to develop appropriate strategies 
for patients whose concerns are appropriate. 
B. Nurses are expected to obtain and communicate credible, current information 
about genetics to patients (Table One p16, Skirton and Barnes 2005). However, 
the novice level of the nurses underlines the need to develop education and 
training programmes that allows them to develop their clinical expertise and 
knowledge base, and equips them to provide competent care that encompasses 
the core genetic competencies.  
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C. Nurses are also expected to appreciate the importance of sensitivity when 
communicating information about genetics and to provide this information in 
an appropriately tailored manner (Table One p16, Middleton et al 2005). This 
accentuates the need to develop the appropriate communication skills to 
facilitate discussions with patients who are concerned about their family history 
of disease. Discussing inherited genetic predisposition with patients who have 
advanced incurable disease may present complex challenges for palliative 
services as they attempt to convey complex ideas about disease aetiology and 
health promotion to concerned patients and families during an inherently 
stressful family time. 
D. Nurses are expected to recognise the limitations of their own genetic 
knowledge (See Table One p16, Benjamin and Gammet 2005). This 
emphasises the need to develop links with specialist genetics services to ensure 
that patients and their families, who have a family history of cancer that 
indicated the potential for an inherited genetic predisposition receive expert 
care, including advice about how to access appropriate cancer prevention 
measures. The appropriate expertise to support families with concerns about 
familial cancer also needs to be integrated into the multidisciplinary care team.  
 
 
Priorities for Further Research 
       As noted, there is a very limited research literature about the effect of knowledge 
of inherited genetic predisposition to cancer on people with cancer. Hence further 
research into almost any aspect of this study, especially if the research focused on 
people who have not attended specialist genetic services, would add to the knowledge 
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base. However, the priorities for research highlighted below indicate issues that might 
be especially pertinent in ensuring that the care needs of palliative care patients with a 
family history of cancer are appropriately met. 
1. No relatives were recruited into this study. Further research is needed to more 
fully understand how to support relatives who fear that they may go on to 
develop the same disease in the future. It is a priority to assess whether they too 
have concerns that are not presently being addressed by palliative services. 
More research that considers the needs of palliative care patients would also be useful 
to ensure that patients receive appropriate care. This would include:  
2. Case studies that demonstrate the provision of expert practice in the delivery of 
care to palliative patients with concerns about an inherited predisposition to 
cancer. This would help disseminate knowledge of good practice. 
3. A longitudinal study of cancer patients’ experience would help untangle 
whether the concerns about inherited genetic susceptibility were associated with 
advancing disease, or were frequently present earlier in the disease process. This 
would help ascertain whether it would be more appropriate to target resources 
into supportive or palliative care services.  
 
Further research into how to overcome the two major barriers that restrict the care of 
palliative care patients with a family history is also important. That is: 
4. Research into how best to provide appropriate education for palliative nurses 
that will help them develop into competent practitioners when caring for 
patients with a family history of cancer. 
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5. A study that considers how best to communicate the multifactorial nature of 
cancer to patients would be helpful in enabling nurses to develop this skill. 
 
Conclusion 
       This study is important because it identifies how the meaning of a family history of 
cancer is being altered by the knowledge that familial cancer can be associated with an 
inherited genetic predisposition. It proposes that the care needs of palliative care 
patients with a family history of cancer are changing in response to this. It suggests that 
the traditional paradigm, where the care needs of patients with a family history of 
cancer is a missing discourse, is no longer appropriate. The findings from this study are 
used in conjunction with the literature to propose a new model of care for patients with 
a family history of cancer. However prior to acting on research it is important to 
evaluate the research methods and methodology and their appropriateness to the 
research question (Greenhalgh 2006). This is the focus of the next chapter. 
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CHAPTER ELEVEN: STRENGTHS AND LIMITATIONS 
If we knew what we were doing it wouldn’t be called research, would it? 
(Albert Einstein 1879-1955) 
 
Introduction 
        This chapter presents the processes used during the research to ensure that the 
methods used were credible and trustworthy. The strengths and limitations inherent in 
the research methodology are discussed first, and then the strengths and limitations of 
the research methods are considered. Other minor limitations and strengths indubitably 
exist but it is hoped that enough methodological data has been included in Chapters 
Three and Four, which document the research process, to allow them to be evaluated in 
context.  
 
Methodology 
      The aim of phenomenology is to learn about a phenomenon not to prove a theory 
about it (Flyvberg 2006). The central strength of a phenomenological approach for this 
study was that it provides methodological and philosophical support in the attempt to 
capture and express the meaning of a significant human experience in a rigorous 
manner (Todres and Holloway 2006). Hence the research has strived to represent and 
conceptualise the experience of a family history of cancer.  
      Phenomenology does not give any indication of the distribution or frequency with 
which the phenomenon occurs. This is frequently referred to as a lack of 
generalizability and is sometimes described as a shortcoming of the chosen 
methodology (Mason 2002, Silverman 2005). However generalizability in qualitative 
study is obtained through the development of meaning (Morse 2007), and if the 
concepts are well described they should be recognisable and resonate in other places 
(Morse 2007). Consequently, if the given description accurately represents the features 
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of the phenomenon it will have resonance with others interacting with the phenomenon 
(Pyett 2003). This occurs when evidence is grounded in concrete, context-dependant, 
real-life experience (Flyvberg 2006). This resonance occurred during the research 
process (see real world validity below).  
       This study did not aim to measure or quantify the effect of a family history of 
cancer but to provide a deeper knowledge of the meaning and lived experience (Morse 
2007) of a family history for palliative care patients. It was undertaken because it was 
thought to be important to learn more about the phenomenon of a family history of 
cancer within palliative care, and because, as Flyvbjerg (2006) states, the power of an 
in-depth examination and intense observation is often underestimated in social research. 
      Qualitative research has been foundational to the social sciences disciplines (Morse 
2008) and the practice of palliative care. For instance, Glaser and Strauss (1965) 
Awareness of Dying helped promote the benefits of open communication about death to 
the benefit of palliative patients (Searle et al 1997). On Death and Dying (Kubler-Ross 
1969) had a profound impact on the way the dying process is considered. It helped 
prepared the ground for the growth of the hospice movement in North America 
(Saunders 2005). Like all research, the findings and methodologies of these seminal 
studies have been extensively questioned but they do demonstrate that palliative care is 
embedded in knowledge that is derived from qualitative research, despite the inherent 
methodological difficulties in generalising findings.   
      The fundamental strength of using the principles of a Heideggerian hermeneutical 
phenomenological methodology for this study was that it allowed an exploration of the 
sensitive topic of the family history of cancer with potentially vulnerable terminally ill 
patients. With this methodology researchers are expected to make their preconceptions 
explicit so that readers can evaluate the strengths and limitations of the interpretation 
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made (Todres and Holloway 2006). In this study the crucial explicit assumption made 
is that the understanding of the biological mechanisms that lead to an inherited 
susceptibility to cancer is an important and significant change that has the potential to 
affect health care needs. Hence the concept of ‘the genetics lens’ has been explicitly 
used as an interpretative framework (Todres and Holloway 2006) to draw attention to 
particular aspects of the participants’ experience of cancer.  
      This is clearly illustrated in the relational analysis, which is based on the 
participants’ account of how they had experienced previous occurrences of cancer 
within their family. Due to the active choice of the researcher these accounts were 
considered in a particular manner. This influenced the decision to focus the discussion 
around the effect on family communication and cohesion and how this affected the 
participants’ ability to know about their family history of disease. This choice reflects 
the importance of family communication when caring for people with inherited 
susceptibility to disease (Foster et al 2004, Forrest-Keenan et al 2005). Information 
about these subjects was abundant in the interview transcripts, however the same data 
considered through a feminist or psychological lens could have produced a different 
analysis.  
      This ability to see and express something from a new perspective is a crucial 
dimension of phenomenology’s discovery-orientated approach (Todres and Holloway 
2006) but is also one of the core concerns about the generalizability of the findings 
(Mason 2002). The need to be alert to the multiple ways of seeing things (Carter and 
Little 2007), however, has not detracted from the desire to demonstrate a truth, if not 
the truth (Frank 2004), about the evolving care needs of patients. Nevertheless, 
reflexive attention to the perspectives that informed the research methods, as well as 
attention to the inherent strengths and limitations of the research methods, is required 
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when evaluating the strengths and weaknesses of hermeneutic phenomenology (Frank 
2004, Cutcliffe 2003). 
       The use of Van Manen’s (1990) interpretative framework was pivotal to the 
construction of the phenomenological analysis. His concept of lifeworld existentials 
provided a systematic way of reflecting on the nature of the phenomenon of a family 
history of cancer for palliative care patients. It provided a systematic way of 
considering what constituted the essence of the lived-body, lived-space, lived-
relationship, lived-time and lived-knowledge for participants. It enabled systematic 
reflection about what data constituted part of the meaning of the family history of 
cancer for the participants. Nevertheless there are other ways of maintaining a strong 
and orientated approach to a phenomenon (for instance exegetically with other 
phenomenological descriptions), which would have given the analysis of the 
phenomenon a different orientation.  
       This research was undertaken with the awareness that the knowledge gained would 
be situated and contextual. This does not automatically nullify any relevance of the 
findings to other situations, rather that the findings have to be interpreted and translated 
with care due to the way that the findings arose both out of the context of the research 
process and the situated experience of the research participants. 
 
 
 
Methods 
The Interview Proforma 
       A phenomenological interview needs to be disciplined by the fundamental question 
that prompted the interview (Van Manen 1990). The interviews were guided by a semi-
structured proforma (See Appendix Four & Five). In retrospect, the proforma was 
focused on a very narrow and potentially biased concept of the nature of a family 
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history of cancer. It primarily focused on the effect of previous occurrences of cancer 
within the family and how this affected their dying process. In practice, the patient-
participants’ responses consistently focused on how they, and their experience of living, 
had been affected by different experiences of cancer. They consistently emphasised two 
aspects of inherited susceptibility to disease that the researcher was intellectually aware 
of but had not thought to call attention to during the interviews: the affects of young 
deaths on their family life and living with multiple primary cancers. The richness of the 
interview data was preserved by the strategy of using open questions based on 
predetermined themes (Robson 2002). The use of a semi-structured interview format 
minimised the shortcomings inherent in the preconceived concept of a family history 
within the interview proforma. 
       The proforma also focused on the nursing needs of patients. Reflexive attention to 
the data, (perhaps best seen in Chapter Six), suggests that the participants did not 
primarily see themselves as palliative care patients, but as people. Living with a 
terminal illness was only a part of their self-identity. Hence the findings contain a 
tension between the participants’ self-identity and the research focus on palliative care. 
        Biographical detail was not systematically collected about the research participants 
in this study. This was intended to make the interviews feel like a conversation with a 
purpose (Burgess 1984), and to encourage participants to speak freely about their 
experiences (Robson 2002). However as the analysis progressed age became an 
increasingly important factor and information about all the patient-participants ages 
would have enhanced the analysis. 
      Lastly, the interview proforma contained no prompts about the younger generation 
of the family. Questions about this topic were forbidden by LREC as they felt it 
increased the potential for the study to cause emotional distress to unacceptable levels. 
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It is a limitation of this study that it was not possible to probe about how participants 
communicated with their adult/children about inherited disease. The information about 
this is therefore much thinner than the information about how the participants’ own 
childhoods were affected by familial cancer. 
 
Interviews 
         Both participants in an interview are actively involved in constructing meaning 
during the interview process (Holstein and Gubrium 2004) and the researcher can be 
considered as the main instrument of data collection (Sorrell and Redmond 1995). 
Consequently, it is important to consider reflexively the effect that the interviewer had 
on the interview process (Nunkoosing 2005, Hewitt 2007). 
       I am an experienced palliative care nurse who has received professional training in 
communication skills. These were used to try to ensure that the participants felt 
attended to and heard. I used body language, eye contact and verbal responses to 
achieve this. I deliberately took an empathetic stance when participants told of their 
experiences 
Researcher (I1): No wonder you feel alone, I'm sorry, just listening to you, it's 
heavy  
 
Researcher (I6): No wonder you said it was frightening  
 
This sometimes meant attending to information that was not directly relevant to the 
research topic before returning to the research agenda. The extract below shows how 
one participant led the conversation into an area that he wanted to discuss. 
Participant (Iain): We haven’t spoke about how me missus feels have we? 
Researcher (I9): No, no yet but I’ll ask you. How does she feel? 
 
Although I made consistent efforts to be empathetic about the patient experience, this 
was balanced by a need to ensure that I did not ask leading questions or give leading 
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prompts about the nature of the lived-experience of a family history of cancer, as the 
whole purpose of the interviews was for the participants’ experience of the phenomena 
to emerge. For this reason I was constantly guided by the interview proforma which 
was always physically present and referred to during the interview. This may have 
increased the formality and stilted the flow of participant information during the 
interviews. 
Researcher (I1): I'm jumping quite a lot of questions here, but because you're 
talking about feeling alone, I just want to ask if you are able to discuss any of 
these things with your family? 
 
Researcher (I2): That leads on, quite clearly to my next question, which is...? 
 
      It is important to note, however, that the participants were just not passive providers 
of data (Nunkoosing 2005), but had their own motivation for participating in the 
research. Several participants spontaneously gave diverse reasons for participating; the 
most common reason was a desire to help other patients in their situation. This was 
commensurate with the stated aims of the research, which was explicitly mentioned in 
the participant information sheet (see Appendix Seven) 
It is hoped that information from this study will help hospices understand how 
best to support other patients and families in a similar situation to your own in 
the future (Patient Information Sheet) 
 
Other reasons given included a desire for memorialisation with one participant 
expressing interest in where the research would be published 
Will it be in the Lancet or the BMJ or somewhere like that, that it will be 
published? (Anne) 
 
Other participants clearly wanted to do anything they could to protect other family 
members in the future (see theme ‘No man is an island’), whilst some participants just 
seemed to want to be helpful. Lastly, one participant appeared to want to talk with me 
about my understanding of the aetiology of cancer. This was done, at length, at the end 
of the interview when the tape recorder had been switched off. The nurses most 
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commonly stated that it was an interesting research question and they wanted to support 
the research.  
 
Participant Characteristics 
     Commonly identified factors that can influence the outcome of interviews include 
age, gender, race, role, and locality (Manderson et al 2006, Hewitt 2007, Nunkoosing 
2005). The researcher was a white, female, palliative care nurse, characteristics shared 
by all the nurse-participants. However the patient-participants’ characteristics were 
more varied 
• The fundamental difference between interviewee and interviewer in this study 
was that the researcher was undertaking a PhD both to enhance the 
understanding of patient care needs and enhance her future prospects, whilst the 
participants were identified as having an advanced incurable cancer. This meant 
that the interviewees were ‘privileged’ knowers’ (Nunkoosing 2005) about the 
experience of terminal illness. Unfortunately this did partially inhibit some 
participants’ ability to fully contribute their experiences due to various physical 
symptoms that restricted speech and strength. More information might have 
been received if all the participants had been less unwell but one criticism of 
palliative care research is that it mostly focuses on the less symptomatic patient 
population (Jubb 2002), hence this may also be a strength of this study.   
• Age, Gender, Race: All the patients were older than the interviewer with an age 
gap of approximately five to thirty years (whereknown). Half the patients were 
male and half were female. Two participants were from the Caribbean. None of 
these factors appeared to have a discernable affect on the participants’ 
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responses. The diversity of the patients hopefully counterbalanced any 
individual affect due to these factors 
• Role: Not knowing is an important stance for the interviewer to take 
(Nunkoosing 2005). The patients were not aware of the researcher’s experience 
in palliative care but were aware that she was a nurse. This may have 
contributed to the high levels of praise given to the nursing staff as Richards and 
Emslie (2000) found that participants were more complimentary about medical 
care to a researcher who was also a doctor. However some of the younger, less 
experienced nurses stated that they felt nervous being interviewed by someone 
they knew was a more experienced palliative care nurse. This may have 
inhibited some responses, despite efforts to reassure them about the benefits of 
different perspectives.   
• Locality: One interview took place in a participant’s home. This had a notably 
different atmosphere to the interviews within the hospice. Photographs of family 
members were discussed and the participant’s spouse occasionally participated 
in the conversation. This emphasised the formality of the other interviews. 
Despite this, the data about the family history of disease did not appear to be 
significantly different in depth or content from the interviews that took place 
within the hospice.  
       Irrespective of where the interviews occurred, it is thought that that the high quality 
of care that the patients felt they had received from the participating hospice greatly 
contributed to the quality of the information received. It is thought that their openness 
about a complex and emotive phenomenon was based on the trust that they had in the 
participating institution. 
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Hawthorne affect  
        The Hawthorne affect was described by Franke and Kaul (1978). It refers to the 
effect that being observed and studied has on research participants. Although its effect 
is considered to be a confounding factor in quantitative research, in qualitative research 
it is good practice to consider reflexively how the research has affected the views and 
perceptions of participants (Tod 2006). An effect was apparent in this study, especially 
with nurse-participants who had seen presentations about the research when the study 
was introduced to the participating hospice, helped recruit patients and cared for them 
after interview.  This is illustrated by one extract which comes from one of the final 
interviews. 
Researcher (I21): Would you know where to go if you wanted further 
information for a family that was worried about a family history of cancer? 
Participant (NP9): You know, I don’t know that I would to be honest: I’d come 
to you. 
 
This awareness of the researcher’s interest suggests that the nurse-participants had had 
the opportunity to think about some of the issues raised by the research study prior to 
the interview. This may have enriched the data as they had time to reflect on particular 
issues at length, giving depth to the information upon which the concepts generated 
from this study have been built.  
 
Analysis 
         The decision to view the data from an epistemological stance; in this case 
‘through a genetic lens’, does not in and off itself give an interpretation validity nor 
does it make it invalid (Mason 2002). The rigour of the analysis comes from the power 
of inductive reasoning (Morton 2004), which ensures that the conclusions are 
connected to the evidence in a straight-forward way and that the conclusions do not go 
beyond the evidence given. This is a trustworthy method of reasoning (Morton 2004) 
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and it is hoped that the presentation of quotes, integrated into the text, provide adequate 
evidence for the analysis. For instance, it is reported in the theme ‘Shadows in the 
mind?’ that many of the patient-participants did not think that their family history of 
cancer had affected their care needs. Nevertheless, it is hoped that the other quotes from 
the same patients, other patients and nurse-participants lend weight to the analysis of 
the multiple, subtle and complex effects that previous occurrences of cancer within the 
family can have on patients: even without the complications inherent in the issue of 
inherited susceptibility to disease.  
        Other steps that were taken to enhance the rigour of the analysis included 
triangulation, using negative evidence and exceptional cases as well as considering 
counterintuitive or initially implausible evidence carefully.  
 
Triangulation 
       Triangulation is the use of two or more data sources, theoretical perspectives or 
methods in a research study to compare findings and hence achieve greater validity 
(Gerrish and Lacey 2006). It allows the researcher to explore the research question 
from different perspectives (Mason 2002). This study had intended to triangulate three 
sources of data by interviewing patients, relatives and nurses with the aim of forming a 
more complete picture of the effect on families. The lack of relative-participants is a 
major weakness in this study. Nevertheless, reflection on Farmer et al (2006) 
triangulation protocol helped ensure that the analysis was credible and dependable. 
They suggest testing the data from different sets for agreement, partial agreement, 
silence and dissonance.  
       Agreement occurs when the meaning and prominence of a theme is the same 
within each data set (Farmer et al 2006). This occurred in the study; one example where 
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it enhanced validity was the confirmation that the nurse-participants gave to the 
exceptional case of Anne, who described her whole dying process as being dominated 
by an overwhelming distress related to previous deaths within her family. Although 
qualitative research is not about making generalisable findings based on sample size, 
one remains a very small number (Pyett 2003). Hence the fact that nurse-participants 
spontaneously mentioned similar rare scenarios was reassuring and added strength to 
the analysis (Farmer et al 2006). 
        Partial agreement occurs when both data sets agree on either the meaning or 
prominence of a theme but not both (Farmer et al 2006). This was common in this 
study. For instance, neither patients nor nurses had a clear concept of the inherited 
susceptibility to cancer. However, as discussed, it had strong emotional overtones for 
patients who did not know why they had developed their disease and expressed 
scepticism about all the medico-scientific explanations. In contrast, it had few 
emotional overtones for the nurses. Nevertheless they could, and did, give examples of 
how it affected the care of particular patients. 
       Farmer et al (2006) use the term ‘silence’ to denote the situation when one data set 
highlights themes that do not emerge in the other (Farmer et al 2006). As the nurse-
participants were interviewed after much of the patients data had been coded it was 
possible to prompt them about some ‘silences’ in the data. For instance, prompts were 
added about the effect of multiple primaries and dying at a younger age than normal as 
no nurse-participant spontaneously mentioned these experiences. However, the full data 
analysis had not been completed. When this occurred it became evident that the patient 
data incorporated significant information about family coherence and communication 
that was missing from the nursing data set. More broadly, the nurse data was ‘silent’ 
about the role of the patient as an integrated member of their family whilst this was a 
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major theme for patients. These ‘silences’ have affected the structure of the analysis. 
This emphasised a benefit of accessing the patient’s perspective, they highlighted 
perspectives of their family history of cancer that were not apparent to nurse-
participants. 
      Dissonance occurs when the different data sets disagree about both the meaning and 
prominence of themes (Farmer et al 2006). Remarkably there was no theme where the 
patient-participant and nurse-participant differed in both meaning and prominence. 
However triangulation did have one strength for this study which is rarely mentioned in 
the literature. It was ethically acceptable to ask nurse-participants openly and directly 
about their views on caring for people with an inherited predisposition to cancer in a 
palliative care setting. This is reported in the spatial analysis. It added a whole 
dimension to the analysis that did not emerge from the patient data, who only praised 
the hospice staff, and which could not be obtained by direct questioning of patients 
because of the sensitivity of the topic of inherited genetic disease. 
 
Counterintuitive Evidence 
       Counter-intuitive and/or puzzling findings can be extra-ordinarily rich and 
stimulating to data analysis (Miles and Huberman 1994). A prime example was the 
understanding gained about why the family history of cancer was rarely a focus of care 
outwith the genetics lens. This had not been considered at the start of the study but 
several participants (especially nurse-participants) made strong and unexpected 
statements about how the effects of a family history of cancer could be beneficial. This 
led to a re-examination of the data, leading to the emergence of themes ‘Shadows in the 
Mind?’  Further reflection on this theme, the lack of literature, alongside the lack of 
research into the effect of inherited disease eventually led to the concept of the missing 
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discourse as an overarching theme for this study. This in turn influenced the structure of 
the analysis, as using the missing discourse as an overarching theme enabled the 
analysis to consider the effect of the family history of cancer phenomena from both 
within and outwith the genetics paradigm.  
 
Negative Evidence 
      Looking for negative evidence ensures that none of the data contradicts preliminary 
conclusions (Miles and Hubermans 1994). Absence of negative evidence does not 
prove a conclusion but the presence of negative evidence can negate a working 
conclusion (Morton 2004). One significant example occurs in theme ‘No man is an 
island’. It was clear from the data that most participants associated the prospect of 
inherited susceptibility to disease with concern for their children, and that these 
concerns were present even in participants who did not necessarily associate their own 
illness with inherited cancer. However, Harry was a ‘negative example’ in that he was 
the only participant who had been told by an oncologist that his illness had a genetic 
aetiology but he did not associate this with any future concerns. This was instructive to 
the analysis. The absence of concern about the future of his family appeared to be 
linked to two separate reasons: firstly that he had no children and all bar one of his 
siblings had predeceased him or were living with cancer, although Jenny who also had 
no children expressed real and potent concern for her nieces. Secondly, it appeared to 
be linked to his scepticism about the scientific orthodoxy of the genetic origins of 
disease. This did not negate the other participants’ experiences or the finding that 
participants were dying with unresolved concerns for the future, rather it bounded the 
claims made from this study. It stopped the analysis from making a perhaps facile 
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assumption that the knowledge of inherited cancer was always associated with concerns 
for the future.  
 
Real World Validity 
     Pyett (2003) discusses the concept of real world validation and suggests it is 
important to pay attention to the real world validation (or invalidation) of research. She 
discusses how serendipitous external validation increased her confidence in her 
conceptual analysis. This has occurred on several occasions throughout the research 
process. For instance, a poster about the emerging findings was submitted to a 
postgraduate student poster competition, where a judge commented on how it resonated 
with her own family’s experience. Similarly, a fellow student approached me after a 
presentation of my ongoing findings and offered to be a relative-participant. This was 
because the emerging findings resonated with their life experience and they wanted to 
support the study. Morse (2007) states that ‘if you have developed your concepts well, 
they should be recognisable in other places, in other groups and in other situations’ 
(Morse 2007: 148). This ongoing external validation of the study has been one of the 
most confirming aspects of the research process. 
 
Conclusion 
      Evidenced based care can be defined as the conscientious, explicit and judicious use 
of current best evidence in making decisions about the care of individual patients 
(Sackett et al 1996). The strengths and weaknesses of the research process have been 
discussed to facilitate the evaluation of the study’s usefulness with regard to the care of 
palliative care patients who have a family history of cancer. Health care professionals 
have a duty to provide the best possible care to patients at the end of their lives (Hanks 
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et al 2005). It is anticipated that this study will help inform the care of patients who are 
concerned about their family history of cancer at a time when the clinical significance 
of genetic research into inherited predisposition to cancer is becoming increasingly 
important.  
.
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POSTSCRIPT: REFLECTION ON THE PROCESS 
 ‘The horror of that moment’ the King went on, ‘I shall never, never forget’.  
‘You will though’ the Queen said, ‘if you don’t make a memorandum of it’  
(Lewis Carroll: Through the Looking Glass: And what Alice saw there) 
 
 
Through the Looking Glass 
       This research study had two main aims: the first frequently declared aim was to 
better understand how a family history of cancer affects the care needs of patients 
receiving palliative care. How well that aim has been achieved can be judged from the 
rest of the thesis. The second aim, which was implicit within the research process, was 
to develop my research skills. This has not always been the easiest of endeavours and at 
times I have felt like ‘Alice through the Looking Glass’ as I struggled to produce 
original and meaningful research. 
..... 
 ‘I don’t quite know yet’ said Alice very gently, ‘I should like to look all around me 
first, if I might’. ‘You may look in front of you, and on both sides if you like’ said the 
sheep ‘but you can’t look all around you – unless you have got eyes in the back of your 
head’ 
 
      One of the most important lessons learnt through this process has been the 
contingent nature of research findings (whether qualitative or quantitative) and the need 
to be aware of (and wary of) the way research has been conducted to properly evaluate 
results. Whatever else has (or has not) been gained from the research process, I have 
become a much more critical consumer of research findings. 
      The extent that the epistemology and ontology of the research methodology 
influenced the research process has surprised me more than how the research process 
was affected by the practical ‘real world’ constraints of time, finance, ethics and 
opportunity. Rather to my surprise I found the philosophical basis of the research a 
satisfying and meaningful part of the process, and have endeavoured to be consistent 
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throughout the study. One key challenge, that I think was appropriately overcome, was 
the challenge of using the principles of phenomenology in a study where it was 
ethically inappropriate to ask the participants directly about aspects of the phenomenon 
under investigation. 
      I have frequently asked myself whether it was sensible to use a phenomenological 
method to study a phenomenon ‘the family history of cancer’ in a study where it was 
deemed (by me and others) as ethically inappropriate to ask about the phenomenon 
directly. As the study progressed I became increasingly aware of a second 
complication: that the phenomenon of a family history was conceived of very 
differently in different paradigms, and that the whole phenomenon was in the middle of 
a paradigm change. Most research proceeds within one paradigm (Kuhn 1996), and this 
is true for all the other nursing phenomenological studies I have encountered. The need 
to understand that the meanings and significance of the family history of cancer 
differed between participants who understood the aetiology of their disease differently, 
and that most participants juxtaposed insights and meanings derived from admixing 
aspects of paradigms (for instance, concerns for children’s future health were all given 
in the context of genetics, whilst no participant drew attention to genetic disease when 
discussing the previous deaths of family members who had died at a young age) was a 
complicating factor in this study. 
      Was it sensible to choose phenomenology for this study? I can only paraphrase 
Churchill on democracy: ‘Phenomenology was the worst choice of research 
methodology, except for all the other methodologies that have been tried from time to 
time’. 
       Managing the ethical issues that arose throughout the research process has also 
been exacting and stimulating. The need/desire to minimise the risk to participants 
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directly limited the scope of the study: most directly in the way it affected the 
recruitment of relatives. At the time I thought this was a catastrophe, as encounters with 
distressed relatives was one of the major triggers for this study, nevertheless with time, 
I have come to see it as a strength. It forced the study to focus on an aspect of the 
psychosocial impact of inherited multifactorial disease that has been a much neglected 
area of study (Hallowell et al 2004): the effect on patients.  
….. 
 
‘You don’t know how to manage looking glass cakes’ the Unicorn remarked, ‘hand it 
round first and cut it up afterward’ 
 
       Kuhn’s (1996) book ‘The Structure of Scientific Revolutions’ had a significant 
influence on the way that I analyzed the data obtained from this study. The concept of 
paradigm gave me a logically coherent, conceptual device with which to consider the 
data from two different perspectives. Kuhn uses the concept of a gestalt switch to 
illustrate how this occurs. There is, for instance, a well known drawing that can either 
be seen as a black vase on a white background or as two white faces looking at one 
another on a black background, (although both perceptions derive from the same real 
lines on a piece of paper). Kuhn (1996) states that a similar change of perception of 
the real world objects that are known through our senses occurs with a paradigm shift. 
This is because the relationships between different objects are considered differently, 
linked within a new framework and seen within a different lens.  
       This allowed me to not only look at the data about the family history of cancer 
and consider whether the topic was discussed by the participants from ‘outwith’ or 
‘within’ a genetic lens, but also to take an interpretivist stance and consider the data 
that was given about the social and emotional consequences of a family history of 
cancer and link it together into a framework that was meaningful within the context of 
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an inherited genetic predisposition to cancer. Nevertheless I did feel like ‘Alice trying 
to manage looking glass cakes’ whilst doing this. It meant I had to pay close attention, 
not only to how the coded data related to interview data as a whole, but also to the 
lens through which I was coding the data. I have tried to ensure that this is sufficiently 
well signposted throughout the analysis for readers to be aware of the perspective 
taken. 
      I am, however, aware that this is a personal use of Kuhn’s concept of paradigm. 
Although the seminal nature of Kuhn’s work quickly led to it being a widely used 
concept especially in sociology (Bryant 1975), Kuhn primarily uses it with regard to 
the natural sciences. 
  
….. 
‘I am real’ said Alice, and began to cry. You won’t make yourself a bit realer by 
crying’ Tweedledum remarked, ‘There is nothing to cry about’  
 
      As discussed on p 42 I am a ‘realist’ in the sense that I believe that physical 
objects exist essentially independently from the mind of the perceiver. However, the 
epistemology that I adopted was social constructionism. This approach to knowledge 
is associated with ‘relativism’. Relativism asserts that in some sense what is true in 
one situation may not be true in another (Ruben 1991), and that truth is dependant on 
culture and experience (Ruben 1991). Hence it has been interesting to reflect on what 
is ‘real’ within this thesis and what is ‘relativist’.  
      What I understand to be ‘real’ is that real people, with real family histories of 
cancer, are dying with genuine concerns about whether their cancer might be due to 
an inherited genetic predisposition to disease. One concept that I have come to see as 
a relativist concept is the science of genetics. I now think of genetics (and the 
perception that cancer is a multifactorial disease), as a paradigm: a particular way of 
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understanding why some families have more cancer than others. The fact that I think 
that the genetics paradigm is useful (because of its potential to reduce the incidence of 
cancer in families with an inherited genetic predisposition, and because it allows 
individuals who are at increased risk of developing cancer to access health promoting 
measures) and a significantly better explanation of why some families have more 
cancer than other previous explanations does not mean that I think that it is the only 
way of conceiving of a family history of cancer. (For instance, I am very open to the 
potential for a new paradigm to emerge in the future that might explain the family 
history of cancer in a very different way). However the knowledge that my 
understanding that genetics is a relativist concept, because it is not independent of 
culture or experience does not prevent me from believing that it is having a real affect 
on people with cancer.   
       As I understand it, my ontological realism leaves me in an interesting position 
with regard to Heidegger. His seminal work, ‘Being and Time’ (1927) is concerned 
with the ontological questions of ‘being in the world’.  I have, however, used a 
methodology (and taken an epistemological stance) that is based on his work (Krell 
1991), without adopting his ontological stance. Perhaps surprisingly, this is not 
particularly unusual and is clearly discussed in the literature. Heideggerian 
phenomenology can be appropriately used as a methodology divorced from its 
philosophical roots (Farber 1991).  
..... 
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“I see nobody on the road” said Alice 
“I only wish I had such eyes” the king remarked in a fretful tone. “To be able to see 
nobody! And at such a distance too! Why it is as much as I can do to see real people by 
this light  
 
       This thesis is called ‘The Missing Discourse’. This title reflects my bafflement at 
the lack of discussion about the effect of familial cancers on patients and family at the 
time of death. I found no information about this when I first looked to inform my 
practice. My best hope for this study is that it will provoke others to consider the issue 
more deeply and from different perspectives. It is too important a topic to leave to 
novice researchers. Pragmatically the lack of previous research has been both a blessing 
and a curse. It means that the research is truly original and gave me great freedom to 
look at the data and build my own analysis of the meaning and lived experience from 
scratch. On the other hand I found this process incredibly difficult. 
      I have felt like both Alice and the King in the quote above: at times wondering 
whether the whole issue was a chimera. Nevertheless I cannot see how a movement that 
professes that the ’provision of psychological, social and spiritual support is 
paramount’ (NCPC 2007) can ignore it for much longer. The interblending of physical 
and social aspects of care is a novel challenge but, I think, one that needs to be taken 
seriously. 
     Nevertheless I found it incredibly difficult to delineate the subtle, complex processes 
described by the patients – who nearly all started by denying any discernable affect at 
all – before going on to tell their story. It was only through focused attention on the 
participant information that the insights into the phenomenon became apparent. I hope 
the analysis, which is as detailed as the word count allowed, persuades that this is a real 
phenomenon that will need to be taken increasingly seriously as the underlying 
mechanisms of inherited susceptibility to disease become better understood and more 
influential in treatment. I was, however, reassured by how much literature there was to 
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support the emergent themes and key findings. It was heartening to find that my 
findings juxtaposed nicely with other research that considered different but related 
discourses.  
 
..... 
‘When I use a word’ Humpty Dumpty said in a rather scornful tone, ‘it means just what 
I choose it to mean – neither more nor less’. ‘The question is’ said Alice ‘whether you 
can make words mean so many things’. ‘The question is’ said Humpty Dumpty ‘which 
is to be the master – that’s all’  
 
     The lack of prior research into the phenomenon has emphasised the need to be 
explicit about the fact that this is a hermeneutic interpretivist study. I undertook the 
research from a particular perspective, that I was nurse, interested in the nursing needs 
of patients. I have deliberately (and probably also sub-consciously) emphasised the 
aspects of the phenomenon that affect the nursing perspective. There is undoubtedly a 
powerful ability in taking a stance in research; nevertheless it does leave the research 
open to the potential for bias (Mason 2002). Chapter Eleven discusses the explicit steps 
that I took to minimise the bias and increase the trustworthiness of the investigation. 
      Although Humpty Dumpty’s words sound bleak, they in some ways echo Kuhn’s 
(1996) observation that science moves forward within a paradigm, and that how we 
perceive the world depends upon the paradigm in which we live. I think the paradigm 
of the multifactorial genetic/genomic aetiology of disease is an important paradigm and 
that palliative services will need, in time, to adapt to its consequences. 
 
 
 
….. 
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 ‘Now here you can see it takes all the running you can do to keep in the same place. If 
you want to get somewhere else you must run at least twice as fast as that’ 
 
      Everybody warned me that undertaking research at this level is hard work, and it 
has been. Nevertheless there have been good moments. I really ‘enjoyed’ the 
interviews. The truth of the old adage ‘Ask a different question and get a different 
answer’ was stunning. It made me question the narrowness of some of my previous 
care. Transcribing was also eye-opening and made me re-evaluate my communication 
skills. Analysis, as stated, was tough, whilst writing has been revealing as seeing ideas 
in black and white has challenged me to think critically and more deeply. Writing and 
rewriting the study into an acceptable format has been the true ‘horror’ in the process.   
      Completing a thesis is an individual endeavour but doing research is not. I want to 
end by again thanking all the participants who made this study possible. They did so 
primarily to help elucidate the meaning of a family history within palliative care: but in 
so doing they also helped me develop my research skills. This makes my debt to them 
personal as well as professional.  
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APPENDICES 
 
 
 
 
Appendix 1: The Amsterdam Criteria and the West Midland Family Cancer 
Service Guidelines (WMFCS) for referral  
 
 
 
The Amsterdam Criteria  
The following clinical criteria were established in 1991 to facilitate consistency in research. The criteria 
are now applied in diagnosing Hereditary Non-Polyposis Colorectal Cancer (HNPCC):  
• 3 or more cases of colorectal cancer  
• in a minimum of 2 generations  
• 1 affected individual should be first-degree to the other cases of 
colorectal cancer  
• 1 case of colorectal cancer should be diagnosed under age 50  
• A diagnosis of Familial Adenomatous Polyposis (FAP) should be 
excluded  
The criteria have since been modified - summary below:  
• 2 cases of colorectal cancer where families are small (one age under 55) 
• 2 cases of colorectal cancer and 1 case of endometrial cancer, or other 
early onset cancer  
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WMFACS cancer family history referral guidelines  
Many individuals have concerns about a family history of cancer. However, less than 
10% of all cancer is due to an inherited predisposition. Even in those rare families 
where this is the case, unaffected family members have a greater than 50% chance 
that they will not develop an inherited cancer. It is unlikely that familial cancer 
clusters are inherited if: 
• Different cancer sites are involved  
• The cancers occur later in life  
• The cancers have a strong environmental influence such as smoking or U.V. 
light 
Breast Cancer  
• 1 close relative, age under 40  
• 1 close relative with bilateral disease  
• 1 male relative, any age  
• 2 close relatives, age under 60  
• 3 close relatives, any age  
Ovarian Cancer  
• 2 close relatives with ovarian cancer, any age 
Breast AND Ovarian Cancer  
Minimum of 1 of each tumour; ovarian cancer any age, breast cancer age under 60   
Colorectal Cancer (or Colorectal Polyps)   
• 1 close relative age under 45  
• 2 close relatives, average age under 70 (includes both parents)  
• 3 or more close relatives, or with other gastrointestinal, renal, urinary tract, 
uterine or ovarian cancer at any age  
• Familial Adenomatous Polyposis (FAP)  
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Other cancers   
• Multiple primary cancers in one individual  
• 3 or more relatives with cancers at the same site  
• 3 or more relatives with any cancer at an earlier age than expected in the 
general population  
• 3 or more relatives with cancers of 
breast/ovary/prostate/pancreas/melanoma/thyroid, or other non-melanoma skin 
tumours or carcinoma  
The overall benefit of surveillance outside these guidelines has not been 
established 
Close relatives are:  
• mother/father  
• sister/brother  
• son/daughter  
• aunt/uncle  
• grandmother/grandfather 
Please make sure that you have considered recognised associated familial cancers 
when applying the guidelines.  
If uncertain, please refer for assessment. 
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Appendix 2: Eugenics and the 'New' Genetics 
 
     Although a discussion of eugenics, biological determinism and discrimination may 
not seem directly relevant to the context of this research, the study was carried out 
whilst the Human Fertilisation and Embryology Authority was discussing an 
application to screen embryos for a genetic predisposition to breast and bowel cancers 
(in families where it was thought that an affected embryo had an eighty per cent 
lifetime risk of developing cancer). This received widespread media coverage (for 
instance, timesonline.co.uk 01/11/2004, news.bbc.co.uk 08/05/2006), whilst the 
interviews were proceeding. Hence debate about whether society should allow 
individual families the choice of having a child without an inherited predisposition to 
cancer was a topical issue during the research process.  
       Concerns about selective reproduction are closely linked with the history of the 
eugenics movement. This culminated in the well-documented link between eugenics 
and the Nazi ideology with forced abortion, sterilisation and murder committed in the 
name of racial purity (Ridley 1999, Jones 2000). The roots of the concept of social 
discrimination based on biology can be traced to Hobbes (1588-1674). Hobbes 
considered that human behaviour was based in human biology. His understanding 
incorporated two philosophical components that are still important in current debates: 
reductionism and biological determinism (Pilnick 2002) 
        Reductionism is the attempt to explain the properties of complex systems and 
objects in terms of the basic units that make up the systems or objects (Pilnick 2002). 
Biological determinism can be viewed as a particular case of reductionism. It considers 
that human lives and actions are the consequences of the biological properties of the 
cells that make up an individual (Rose et al 1984). Hence a biological determinist 
would suggest that genes govern the properties of cells, which in turn govern the 
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characteristics of individuals, which then govern the characteristics of society (Pilnick 
2002). 
       Hence the eugenics movement did not see social inequalities arising due to cultural 
or social factors, rather as expressions of biological meritocracy (Pilnick 2002). 
Initially, eugenicists like Galton (1822-1911) focused on encouraging the interbreeding 
of the best human stock to improve the human race. However in many countries 
biology became enmeshed with nationalism. This produced a drive for evolutionary 
progress to be combined with economic progress (Ridley 1999). At the same time the 
focus of eugenics shifted to discouraging dysgenic breeding. This was endorsed by the 
legalised, state enforced sterilisation of people with learning difficulties and the 
mentally ill in many countries including the USA, Sweden, Canada, Norway and 
Germany (Ridley 1999). 
       There was a rise in the support for psychological and sociological explanation for 
human behaviour after the Second World War leading to enthusiasm for social and 
environmental schemes to improve the human condition (Cunningham-Burley & Kerr 
1999). There was also an increased awareness of the role of human agency in realising 
desired futures (Bandura 1997). However recent research into genetics and molecular 
biology has led to genetic determinism being in vogue once more (Cunningham-Burley 
& Kerr 1999). There have, however, been deliberate and specific strategies to limit the 
association of the ‘new genetics’ with historical eugenics movement (Cunningham-
Burley & Kerr 2002). This is achieved by focusing on the rights of individuals rather 
than the good of society, and by emphasising voluntary action rather than coercive 
practice. However, it can be argued that appeals to individual choice do not take serious 
account of the social context within which choices are made (Cunningham-Burley & 
Kerr 2002). For instance, the promotion of health as a right and value can be perceived 
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as constraining choice as choosing to have a child with a genetic predisposition to 
disease might be deemed irresponsible (Shakespeare 1999, Cunningham-Burley & Kerr 
2002). In other instances society has deliberately chosen to restrict choice: for instance, 
by refusing access to information about the sex of a child to prevent parents selecting 
the gender of their children (Pilnick 2002).  
         Pilnick (2002) suggests that the real conflict between biological determinism and 
human genetics is the concept of potentiality.  That is that molecular biology can only 
tell us about the genetic possibility for people to develop or acquire certain traits or 
diseases in certain contexts and environments and that, with rare exceptions, there is not 
a simple division between nature and nurture.  Consequently, except in certain genetic 
illnesses that have a high penetrance, it is now recognised that the social, physical, 
environment and lifestyles factors play a significant role in determining diseases 
(Petersen 2006) and that there is a huge complexity in the genotype-phenotype 
relationship (Cunningham-Burley & Kerr 2002). Consequently, reducing individuals to 
their genes does not allow them to be fully understood until we fully understand the 
interactions between genes and the environment as well as the interactions between 
individuals and society (Pilnick 2002).  
        There are many other concerns and discussions about the social consequences of 
the rapidly expanding understanding of human genetics (Cunningham-Burley & Kerr 
1999, Conrad & Gabe 1999, Cunningham-Burley & Kerr 2002, Bunyon & Peterson 
2005). Many of these focus on practical concerns about the use and misuse of genetic 
information. This is because genetic information contains both a unique identifier of 
every individual, as well as heritable information that has relevance to other family 
members (Feetham & Thomson 2006). Important concerns include issues of 
confidentiality, choice and discrimination. Sadly, society has a history of prejudice 
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about issues that are associated with genetic inheritance like race, colour, gender and 
disability.  Harris & Sulston (2004), therefore, suggest that a principle of genetic equity 
consistent with other human rights should be established. They state 
‘We propose the following principle of genetic equity: humans are born equal; 
they are entitled to freedom from discrimination and to equality of opportunity 
to flourish; genetic information may not be used to limit that equality.It follows 
that neither genetic constitution nor genetic information should be the basis of 
discrimination or stigmatisation of an individual, family or group. No 
individual’s genes, or genetic information about them, can or should detract 
from their equal standing and dignity in the community and their equal 
entitlement to the concern, respect and protection of others or of society’ (Harris 
& Sulston 2004: 798) 
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Appendix 3: Recruitment of Relatives 
      As stated, in the first iteration of this study it was intended that both patients and 
relatives (first degree blood kin) would be recruited into the study. Ethical approval for 
this was both sought and given. However, the local research ethics committee 
specifically stated that the patients’ consent was required prior to inviting their relatives 
to participate in the study (even if the patient to whom the relative was related was not 
themselves participating in the study). This led to a new exclusion criterion being added 
to the study protocol; that no relatives would be included as participants if the patient to 
whom they are related objects to their participation. This criterion had a significant 
effect on relative recruitment.  
       No relatives were recruited into the study. This was a major concern whilst data 
collection was being undertaken. Considerable thought was given to trying to 
understand why the researcher was able to recruit patients into the study but not 
relatives, with the aim of facilitating the recruitment of relatives.  
      One key factor appeared to be gatekeeping. This has been defined as ‘the process by 
which people’s capacity to be invited into a research project, or to make an informed 
decision regarding research participation, is inhibited by others’ (Hudson et al, 2005: 
165). This can occur at three levels: institutional, professional and family. The key 
factor preventing the recruitment of relatives in this study was the patients’ desire to 
protect their relatives. For instance, nine of the twelve patients were asked if their 
relatives could be approached to participate in the study. All refused. The most 
commonly given reason was that their illness was already greatly burdening their next 
of kin and they did not wish to add to this in any way. In some instances this sense of 
burden was expressed in terms of physical workload 
‘Since I’ve been given the one-way ticket upwards, all the pressure has gone on 
to her because she does all the forms and everything. She does all the cooking; 
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she does all the runs to the hospitals and everything. I know it is doing her head 
in … She won’t let me do nothing for her (Iain) 
 
Other patients were more conscious of the emotional burden that their illness was 
putting on their relatives 
My husband says that he doesn’t think he can live without me … that he can’t 
imagine not having me in his life (Grace) 
 
Other reasons included family discord and not wanting their relatives to talk about 
them. No patient-participant explicitly mentioned the sensitivity of the research topic or 
fears that the interview might make their relatives re-evaluate their family history of 
cancer; however it remains possible that this was an undisclosed cause for concern.  
Gatekeeping by patients is the most difficult type of gatekeeping to challenge within 
palliative care research and it is recommended that researchers who are denied access to 
family members respect this (Hudson et al 2005). 
      Attempts to recruit relatives who were not related to patient-participants continued 
for six months after the decision to stop recruiting patients was taken. This was 
unsuccessful. It has been suggested that using external clinical staff to recruit 
participants can lead to inappropriate or excessive gatekeeping (Hudson et al 2005). 
However Ross and Cornbleet (2003), who studied the attitudes of staff and patients to 
research studies in a hospice setting, found little evidence of this, saying that the culture 
of research has become more prominent in palliative care units (Ross and Cornbleet 
2003). Similarly, in this study the clinical staff did not appear to be unnecessarily 
gatekeeping participants (as demonstrated by the recruitment of patients into the study); 
rather the process of relative recruitment appeared to be too complex. Firstly the 
hospice link staff did not know always know the relatives as well as they knew the 
patients. For instance, one nurse stated 
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The whole relative thing is where I think I am getting a bit unstuck because I’m 
aware that we don’t always meet the relatives …We don’t get involved in the 
same way (Link Nurse) 
 
Secondly the relatives had to be approached in two stages. Initially the patient had to be 
informed of the study by the hospice link nurse to gain their permission to discuss the 
study with their relatives as stipulated by the ethics committee. Then the relative had to 
be approached and informed of the study separately. This meant that the link staff had 
to consider whether both the patient and their relatives were able to give informed 
consent to the study. Ross and Cornbleet (2003) found that around fifty percent of 
hospice in-patients were inappropriate for recruitment into any research study due to 
confusion, frailty and impending death. The researcher was aware that some relatives 
were not invited to participate because the link staff did not think that the patient to 
whom they were related were capable of consenting/or would consent to their relatives’ 
involvement. Similarly, it is known that a small number of relatives were approached to 
participate in this study with the patients’ permission but that they refused. 
      Ideas for simplifying the process of relative recruitment were considered. However 
as the requirement to obtain the patient’s permission to recruit relatives into the study 
had originated with the ethics committee it was not thought appropriate to challenge 
this. Other ways of increasing awareness of the study were discussed: for instance, the 
possibility of placing posters about the research in the visitors’ room. This might have 
increased awareness of the study amongst potential relatives and patients making it 
easier to initiate discussion about the research. However the participating hospice did 
not want display research posters in public areas so the idea was not taken back to the 
local research ethics committee. After ten months of trying to recruit relative-
participants it was decided to desist and to refocus the research study entirely on the 
patient experience as presented in the thesis. 
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Appendix 4: Interview Proforma for Patients 
 
This proforma indicates the anticipated structure of the interview with patients. 
 
A) Opening question 
 
  1. Can you tell me about yourself and your experience of cancer? 
      Probe 
 
B) Questions about the participants understanding of cancer? 
 
      -: understanding of their own cancer 
      -: causes of cancer 
      -: where have they learnt about cancer 
      -: do they discuss with other members of the family 
 
C) Questions about previous experiences of cancer within the family 
 
      -:  About family without cancer 
      -: About how this has affected their own experience of cancer 
 
D) Questions about Care Needs of Participant in the hospice 
 
      -: about how the previous experiences within the family have affected their 
                   care needs 
      -: about how their understanding of cancer has affected their care needs 
      -: about any specific incidences, people or actions that they feel have  
                   been particularly helpful to them in their care re above 
 
E) Questions about perceived family understanding and care needs 
 
      -: whether they are able to discuss their experience with family 
      -: whether they have discussed their understanding with the family 
      -: whether they think family would know where to go for information 
 
F) Final Questions 
 
1. Is there anything else about the way the previous experience of cancer in your family 
has affected your understanding; Is there anything which I have not mentioned, which 
you think is significant? 
 
2. Do you have any questions for me? 
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Appendix 5: Interview Proforma for Nurses 
This proforma indicates the anticipated structure of interviews with healthcare 
professionals 
 
A) Opening question 
 
1. Can you tell me about a memorable scenario (past or present), in which you 
were involved, where a previous experience of cancer had a significant affect on 
the care needs of a patient and their family  
       -: Why was it memorable?  What made it distinctive? 
      -: What did you learn from it? 
 
B) Questions about how information about family history obtained by participant.     
 
1. Do you routinely discuss a family history of cancer with patients and their 
family?    
      Probe:  When? Why? How? 
         
1b. (If answer to Q1 is no) When would you discuss previous experience of 
cancer with patients and their family?    
      Probe:  Why? 
 
2. How do you feel about discussing previous experiences of cancer within the 
family with patients and relatives? 
      Probe: What reasons? 
      Probe: Is it similar or different with relatives? 
 
C) Questions about understanding of cancer 
 
1. What do you think causes cancer? 
 
2. What do you think causes a family history of cancer? 
      Probe: Understanding of difference between inherited and familial cancer 
  
 
D) Questions about perception of care needs when there is a family history of cancer 
 
1. How do the think that the cause of cancer makes a difference to the care 
needs of patients and their families receiving palliative care?   
                     
                   Probe:  
 
2. How do you think a previous experience of cancer within a family usually 
influences the care needs of patients and their families receiving palliative care? 
 
      Probe: Affect on patient experience/ Staff experience 
      Probe: Positive and Negative affects of experience 
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3. Can you tell me about a time when you, or a patient, raised the topic of health 
promotion (eg smoking, diet, exercise) in a scenario where you, or the patient, 
felt shared risk factors might be a part of a family history of cancer 
      Probe: 
 
 
4. Can you tell me about a time when you, or a patient, raised the topic of 
genetic counselling when you, or the patient, thought genetic mutation might be 
part of a family history of cancer? 
      Probe 
      
  
5. Where would you go if you wanted further information or support for a 
family who was worried about a family history of cancer? 
      Probe 
 
E) Questions about the future of care of the family in palliative care 
 
1) How do you think that an increased awareness of the genetic linkage of some 
cancers will affect the care of the family in palliative care in future? 
      Probe about children/ grandchildren, same generation and older relatives? 
      Probe about patient care also? 
 
2) Have you ever cared for a family with a known genetic mutation for cancer? 
2b) If not, have you considered what you would do in it did occur and what do 
you think that the major issues will be? 
       Probe 
 
3) Do you think that a palliative care setting is the right place to consider the 
implications of a family history of cancer? 
      Probe: If no, where do they think is the appropriate place 
      Probe: if no, why not 
      Probe: if yes, what reasons,  
      Probe: if yes, transferable skills 
 
 
F) Any Questions 
 
1. Is there anything else about how a previous experience of cancer within a 
family affects the care needs of patients and their families within the hospice, 
which I have not asked yet, which you think would be relevant to this study? 
 
2. Do you have questions for me? 
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Appendix 6: Recruitment Flowchart 
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Appendix 7: Introductory Letter 
Hello  
 
     My name is Kate Lillie. My background is in nursing and I have an 
ongoing interest in hospice care. I am now working as a research and 
teaching assistant in the School of Health Sciences at the University of 
Birmingham. 
 
     In my work, as a researcher, I am looking at how the understanding of 
cancer, and previous experience of cancer within a family, affects care 
needs of patients and their relatives receiving hospice care. I am inviting 
patients, healthcare professionals and relatives of patients receiving care 
from the (Hospice Named) to be interviewed for this study. 
 
     Please read the information sheet, which is enclosed with this letter, to 
see what this involves. If you are interested in taking part, please inform 
(Named hospice link). I will arrange to visit you to answer any further 
questions that you have and see if you wish to take part in the study. 
 
Thank you for your consideration of this study 
 
Yours Faithfully 
 
330 
  
Appendix 8: Information Sheet 
An invitation to take part in an interview for a research study 
     You are being invited to participate in a research study. Before you decide whether 
or not you wish to take part in this study it is important that you understand why the 
research is being done and what is involved. Please read this information carefully and 
discuss it with friends, relatives and health care professionals if you wish. If there is 
anything that is not clear, or if you want more information about the study, please ask. I 
can be contacted using the details given at the top of the page. Please take time to 
decide whether or not you wish to take part. 
 
Full Name of Study: Family care and cancer in a hospice setting  
 
What is the purpose of this study? 
     There is at present very little information about how a previous experience of cancer 
within a family affects the care required by patients and their relatives in a hospice 
setting. In this study I will be talking to patients, relatives and health care professionals 
working at (Hospice Named), to find out their views on this subject.  
 
Why have I been invited to take part? 
     You have been invited to take part as you may have indicated to the hospice that 
another member of your family has had cancer in the past. I wish to interview up to 
twelve patients and twelve relatives of hospice patients to find out how they think their 
previous experiences of cancer affects the care needs of patients and their families 
receiving hospice care. You may take part in this study if you are a relative of a patient 
receiving care at (Hospice named) even if the patient to whom you are related does not 
wish to participate. 
     I will also be talking to doctors and nurses about this. 
 
Do I have to take part? 
     NO, it is up to you to decide. If you do decide to take part, you are still free to stop 
at anytime and you do not need to give a reason. It will not affect your usual care if you 
decide not to take part. 
 
What will happen if I take part? 
I will arrange to come and interview you. During the interview I will be asking 
questions about 
• Your own experience and understanding of cancer 
• How you feel that previous experience of cancer in your family has affected 
your own experience and understanding of cancer 
• How you think that this affects the care that you and your family need from the 
hospice now 
The interview is expected to take around one hour. With your permission the interview 
will be recorded. I will be the only person who will have access to the recording. The 
tape will be destroyed as soon as the interview is written up.  
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What are the possible risks of taking part? 
As health problems associated with cancer do cause distress there is a risk that you may 
become upset during the interview. You or the researcher may choose to stop if this 
occurs. 
 
What are the possible advantages of taking part? 
You may find it interesting to talk about your own experience and understanding of 
cancer and how you think it has been influenced by previous experiences in your 
family. However the researcher is not a counsellor and the interview may not be 
beneficial to you. It is hoped that information from this study will help hospices 
understand how best to support other patients and families in a similar situation to your 
own in the future.  
 
Will my part in this study be kept confidential? 
Yes, all the research information is strictly confidential. All names will be changed 
when the research is written up. Some hospice staff may know that you participated in 
the study but they will not know about what is said during the interview. The tape 
recording of your interview will be kept in a locked cupboard and then destroyed when 
the interview has been written up. The transcription will not have your name or address 
on it. I will use a study identification number. I do not have access to your hospice 
notes or any other confidential information held by the hospice about you. 
 
Who has reviewed this study? 
The South Birmingham local research ethics committee has reviewed this study. They 
aim to ensure that it is very unlikely that research will harm anybody. 
 
What will happen to the results of this study? 
It is intended to publish the results in a nursing or palliative care journal as well as 
presenting them to the hospice. The researcher also intends to write up the results in a 
format appropriate for the award of a PhD at the University of Birmingham.  
 
Who can I contact for further information? 
Please do not hesitate to contact me if you want further information about this study. 
My name is Kate Lillie and I am the researcher for this study. The contact details are at 
the top of the first page or you can ask the hospice nurse who gave you this information 
to contact me on your behalf. 
 
What if something goes wrong? 
This study is being sponsored and funded by the School of Health Sciences at the 
University of Birmingham. If you have any complaints about this research: how it is 
being conducted, or how you have been treated, you should contact the research 
administrator, [name, contact details] 
 
 
 
 
 
 
 
Thank you for reading this 
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Appendix 9: Reply Letter 
Research Title: Family care and cancer in a hospice setting 
 
Dear Kate Lillie 
                         I have read the participant information sheet about the 
study “Family care and cancer in a hospice setting”. I am interested in 
the study and am willing for you (Kate Lillie) to have my contact details as 
written below. I realize that this does not commit me to taking part in this 
study but will allow you (Kate Lillie) to contact me so that I can ask 
further questions prior to deciding whether I wish to be interviewed for this 
study.   
 
 
Name: ……………………………………………………..……. 
 
Address………………………………………………………….. 
………………………………………………………………...… 
………………………………………………………………...… 
………………………………………………………………...… 
…………………………………………………………………… 
 
Telephone……………………………………………………...… 
Email (if appropriate)………..………………………………………….. 
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Appendix 10: Letter to Hospice Link Staff 
Dear  ‘Hospice Link Nurse’ 
 
Thank you for agreeing to act as a link member of staff between the hospice and myself 
for the research study ‘Family care and cancer in a hospice setting’ 
 
As we discussed the main elements of this role is to help with the identification of 
appropriate patients and relatives who are physically, mentally and emotionally fit for 
interview and are able to give informed consent. It also involves giving potential 
participants the research information sheet and liaising with me about potential 
participants. 
 
As you know, there is the potential for concern about the ethics of combining the role 
of a health care professional with involvement in research. One reason is that patients 
can feel obliged to participate, either because they want to please the people who 
provide care for them, or as a way of saying ‘thank-you’ for the care they have 
received. This can be particularly true in a hospice environment where the social, 
emotional and spiritual aspects of cancer may have been addressed for the first time. 
Hence I an asking you to ensure that any potential participant you approach is aware 
that I am working for The University of Birmingham and am not part of the care team 
at the  hospice. It is very important that no patient is pressurized to participate in this 
study and that they know that their care will not be affected in anyway if they decide 
not to participate.   
 
Once again thank you for your willingness to act as a link person for this research 
project. Please do not hesitate to contact me at any time if you have any further 
questions about this or any other aspect of the study 
 
Yours sincerely 
  
 
Kate Lillie 
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Appendix 11: Consent Form 
Title of Study: Family care and cancer in a hospice setting  
Name of Researcher: Ms Kate Lillie 
 
Please tick the box 
 
1/ I have read and understood the participant information sheets 
and have had a chance to ask questions. 
 
 
2/ I understand that my participation is voluntary, and that I am 
free to withdraw at any time, and that this will not affect my 
medical or nursing care or my legal rights.  
 
 
3/I give permission for the researcher to inform (Hospice named) 
that I am taking part in this study 
 
 
4/ I understand that the interview will be taped and that the 
recording will be destroyed when the transcription is completed 
 
5/ I agree to take part in this study 
 
 
Yes       No   
 
 
 
Yes       No   
Yes       No   
 
 
 
Yes       No   
 
 
 
Yes       No   
 
 
 
Name of Participant……………………………………………………………………………………………………………………………. 
Signature……………………………………………………………………………………………………………………………………………………… 
Date……………………………………………………………………………………………………………………………………………………………….. 
 
Name of Researcher…………………………………………………………………………………………………………………………. 
Signature……………………………………………………………………………………………………………………………………………………… 
Date……………………………………………………………………………………………………………………………………………………………….. 
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Appendix 12: Matrix for Data Analysis  
(see over page) 
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Appendix 13: Family Trees 
Key For Family Trees
Participant
Female
Male
Sex Unknown
3 Multiple Individuals
Numbers Known
Multiple Individuals
Numbers Unknown
n
Deceased
Died from Cancer
Living with Cancer
Cancer discussed as possible 
Cause of death
Adopted/
Became legal guardian
No Children
Reason Unknown
Appendix 15
NB: For the reasons discussed on p 76 these family trees are incomplete and probably contain inaccuracies
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I 
II 
 III 
IV 
Anne’s Family Tree  
 
Brain Tumour 
30s (suicide) 
Brain 
Tumour 
(40s) 
Cancer Ca Lung  
30 s 
 
Ca Bowel 
Ca Breast 
(50s) 
 
 
Leukaemia 
(16) 
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340 
I 
 III 
 
Beth’s Family Tree  
II 
Not Cancer 
Ca Ovary 
Ca Bowel 
Ca Bowel 
 
 
 
 
 
  
I 
II 
 III 
IV 
Claire’s Family Tree  
?Cause 
?Ca (20s) 
RTA (41) Ca Breast  
(28) 
Accidental 
Death (20s) 
Ca Gullet 
(20s) 
2 
Ca Breast 
(50s) 
Ca Bowel 
(90s) 
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I 
II 
 III 
IV 
Diane’s Family Tree  
Ca Bowel 
(90s) 
Ca Rare Tumour (30s) 
Ca Breast (50s) 
Cancer 
(Not   Breast) 
(43) 
7 
Ca Breast 
(33) 
6 
Ca Breast 
(20s) 
3 2 
n 
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n 
n 
n 
May have been 
Cancer? 
May have been 
Cancer? 
Ca (50s) 
I 
II 
 III 
IV 
Ca (40s) Ca (40s) 
Ezra’s Family Tree  
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I 
 III 
 
Finlay’s Family Tree  
II 
IV 
Rare  
Ca (50s) 
Rare Abdominal 
Ca (50s) 
n 
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Cancer (40s) Cancer (40s) 
Cancer Cancer (50s) Cancer (70s) 
4 
I 
 
II 
III 
 
Grace’s Family Tree   
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II 
 III 
Harry’s Family Tree 
Ca Stomach  Rare Skin  
5 n 
Ca 
Bladder 
Ca Colon 
Ca Oesophagus 
Ca Bowel 
 
Ca  
Stomach  
Cancer  Ca  
Stomach  
Cancer 
I 
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Cancer  
Cancer Two primary 
cancers 
Cancer  Cancer Two primary 
cancers 
Cancer  Cancer  
 III 
I 
II 
Iain’s Family Tree  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
347 
  
I 
II 
 III 
IV 
Jenny’s Family Tree 
9 
Several cousins 
had developed  
cancer at a  
young age 
Ca breast Ca Ovary 
Ca bowel 
Ca breast 
3 3 
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II 
 III 
Cancer (30s)  
Not Ca 
 
Cancer 
(30s) 
5 
n 
Cancer Cancer  Cancer  
I 
Keith’s Family Tree  
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Ca Ovary 
(40s) 
Not cancer 
(40s) 
Prostate 
Cancer 
Prostate 
Cancer ?leukaemia?         (4) 
I 
II 
 III 
 
IV 
Leon’s Family Tree   
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Lillie, A.K. (2006) Exploring cancer genetics and care of the family: an evolving 
challenge for palliative care International Journal of Palliative Nursing 12(2): 70-74 
 
Conference Presentations and Posters 
Lillie, A.K. (2008) Dying with a family history of cancer: A phenomenological study 
European Meeting on Psychosocial Aspects of Genetics  Barcelona, Spain 31/5/08-
3/6/08 (European Journal of Human Genetics 16, Supplement 2: 462) 
 
Lillie, A.K. (2008) End-of-life care required by patients and families affected by an 
inherited genetic cancer: In Symposium 9: Building a programme of genetic research to 
inform practice: Metcalfe, A, Coad, J. Lillie, A.K. Royse, S. RCN International 
Nursing Research Conference Liverpool 8-11 April 2008: (RCN Events Book of 
Abstracts: 117) 
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Lillie, A.K. (2006) Genetics in palliative care: The challenge of designing a suitable 
research study  RCN International Nursing Research Conference 22-24 March 2006: 
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